
<link rel="stylesheet" href="https://api.manicmarket.com/static/annual-report/css/custom-bootstrap.css">
<link rel="stylesheet" href="https://api.manicmarket.com/static/annual-report/css/all.min.css">
<link rel="stylesheet" href="https://api.manicmarket.com/static/annual-report/css/app.css">
<script type="text/javascript" src="https://api.manicmarket.com/static/annual-report/js/jquery-3.3.1.slim.min.js"></script>
<script type="text/javascript" src="https://api.manicmarket.com/static/annual-report/js/popper.min.js"></script>
<script type="text/javascript" src="https://api.manicmarket.com/static/annual-report/js/bootstrap.min.js"></script>
<script type="text/javascript" src="https://api.manicmarket.com/static/annual-report/js/moment.js"></script>
<script type="text/javascript" src="https://api.manicmarket.com/static/annual-report/js/vanilla-picker.min.js"></script>
<style>.picker_wrapper.no_alpha .picker_alpha{display:none}.picker_wrapper.no_editor .picker_editor{position:absolute;z-index:-1;opacity:0}.picker_wrapper.no_cancel .picker_cancel{display:none}.layout_default.picker_wrapper{display:-webkit-box;display:flex;-webkit-box-orient:horizontal;-webkit-box-direction:normal;flex-flow:row wrap;-webkit-box-pack:justify;justify-content:space-between;-webkit-box-align:stretch;align-items:stretch;font-size:10px;width:25em;padding:.5em}.layout_default.picker_wrapper input,.layout_default.picker_wrapper button{font-size:1rem}.layout_default.picker_wrapper>*{margin:.5em}.layout_default.picker_wrapper::before{content:'';display:block;width:100%;height:0;-webkit-box-ordinal-group:2;order:1}.layout_default .picker_slider,.layout_default .picker_selector{padding:1em}.layout_default .picker_hue{width:100%}.layout_default .picker_sl{-webkit-box-flex:1;flex:1 1 auto}.layout_default .picker_sl::before{content:'';display:block;padding-bottom:100%}.layout_default .picker_editor{-webkit-box-ordinal-group:2;order:1;width:6.5rem}.layout_default .picker_editor input{width:100%;height:100%}.layout_default .picker_sample{-webkit-box-ordinal-group:2;order:1;-webkit-box-flex:1;flex:1 1 auto}.layout_default .picker_done,.layout_default .picker_cancel{-webkit-box-ordinal-group:2;order:1}.picker_wrapper{box-sizing:border-box;background:#f2f2f2;box-shadow:0 0 0 1px silver;cursor:default;font-family:sans-serif;color:#444;pointer-events:auto}.picker_wrapper:focus{outline:none}.picker_wrapper button,.picker_wrapper input{box-sizing:border-box;border:none;box-shadow:0 0 0 1px silver;outline:none}.picker_wrapper button:focus,.picker_wrapper button:active,.picker_wrapper input:focus,.picker_wrapper input:active{box-shadow:0 0 2px 1px dodgerblue}.picker_wrapper button{padding:.4em .6em;cursor:pointer;background-color:whitesmoke;background-image:-webkit-gradient(linear, left bottom, left top, from(gainsboro), to(transparent));background-image:-webkit-linear-gradient(bottom, gainsboro, transparent);background-image:linear-gradient(0deg, gainsboro, transparent)}.picker_wrapper button:active{background-image:-webkit-gradient(linear, left bottom, left top, from(transparent), to(gainsboro));background-image:-webkit-linear-gradient(bottom, transparent, gainsboro);background-image:linear-gradient(0deg, transparent, gainsboro)}.picker_wrapper button:hover{background-color:white}.picker_selector{position:absolute;z-index:1;display:block;-webkit-transform:translate(-50%, -50%);transform:translate(-50%, -50%);border:2px solid white;border-radius:100%;box-shadow:0 0 3px 1px #67b9ff;background:currentColor;cursor:pointer}.picker_slider .picker_selector{border-radius:2px}.picker_hue{position:relative;background-image:-webkit-gradient(linear, left top, right top, from(red), color-stop(yellow), color-stop(lime), color-stop(cyan), color-stop(blue), color-stop(magenta), to(red));background-image:-webkit-linear-gradient(left, red, yellow, lime, cyan, blue, magenta, red);background-image:linear-gradient(90deg, red, yellow, lime, cyan, blue, magenta, red);box-shadow:0 0 0 1px silver}.picker_sl{position:relative;box-shadow:0 0 0 1px silver;background-image:-webkit-gradient(linear, left top, left bottom, from(white), color-stop(50%, rgba(255,255,255,0))),-webkit-gradient(linear, left bottom, left top, from(black), color-stop(50%, rgba(0,0,0,0))),-webkit-gradient(linear, left top, right top, from(gray), to(rgba(128,128,128,0)));background-image:-webkit-linear-gradient(top, white, rgba(255,255,255,0) 50%),-webkit-linear-gradient(bottom, black, rgba(0,0,0,0) 50%),-webkit-linear-gradient(left, gray, rgba(128,128,128,0));background-image:linear-gradient(180deg, white, rgba(255,255,255,0) 50%),linear-gradient(0deg, black, rgba(0,0,0,0) 50%),linear-gradient(90deg, gray, rgba(128,128,128,0))}.picker_alpha,.picker_sample{position:relative;background:url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='2' height='2'%3E%3Cpath d='M1,0H0V1H2V2H1' fill='lightgrey'/%3E%3C/svg%3E") left top/contain white;box-shadow:0 0 0 1px silver}.picker_alpha .picker_selector,.picker_sample .picker_selector{background:none}.picker_editor input{font-family:monospace;padding:.2em .4em}.picker_sample::before{content:'';position:absolute;display:block;width:100%;height:100%;background:currentColor}.picker_arrow{position:absolute;z-index:-1}.picker_wrapper.popup{position:absolute;z-index:2;margin:1.5em}.picker_wrapper.popup,.picker_wrapper.popup .picker_arrow::before,.picker_wrapper.popup .picker_arrow::after{background:#f2f2f2;box-shadow:0 0 10px 1px rgba(0,0,0,0.4)}.picker_wrapper.popup .picker_arrow{width:3em;height:3em;margin:0}.picker_wrapper.popup .picker_arrow::before,.picker_wrapper.popup .picker_arrow::after{content:"";display:block;position:absolute;top:0;left:0;z-index:-99}.picker_wrapper.popup .picker_arrow::before{width:100%;height:100%;-webkit-transform:skew(45deg);transform:skew(45deg);-webkit-transform-origin:0 100%;transform-origin:0 100%}.picker_wrapper.popup .picker_arrow::after{width:150%;height:150%;box-shadow:none}.popup.popup_top{bottom:100%;left:0}.popup.popup_top .picker_arrow{bottom:0;left:0;-webkit-transform:rotate(-90deg);transform:rotate(-90deg)}.popup.popup_bottom{top:100%;left:0}.popup.popup_bottom .picker_arrow{top:0;left:0;-webkit-transform:rotate(90deg) scale(1, -1);transform:rotate(90deg) scale(1, -1)}.popup.popup_left{top:0;right:100%}.popup.popup_left .picker_arrow{top:0;right:0;-webkit-transform:scale(-1, 1);transform:scale(-1, 1)}.popup.popup_right{top:0;left:100%}.popup.popup_right .picker_arrow{top:0;left:0}</style>
<script type="text/javascript" src="https://api.manicmarket.com/static/annual-report/js/he.js"></script>
<script type="text/javascript" defer="true" src="https://api.manicmarket.com/static/annual-report/js/production.min.js?d=22-10-2021"></script>
<style type="text/css" id="customized-styles"> #dynamic-xbrl-form [enabled-taxonomy="true"][continued-taxonomy="false"]{border-top:2px solid #FF6600;border-bottom:2px solid #FF6600;display:inline;} #dynamic-xbrl-form [enabled-taxonomy="true"][continued-main-taxonomy="true"]{box-shadow:-2px 0px 0px 0px #FF6600, 2px 0px 0px 0px #FF6600;} #dynamic-xbrl-form [enabled-taxonomy="true"][text-block-taxonomy="true"]{box-shadow:-2px 0px 0px 0px #FF6600, 2px 0px 0px 0px #FF6600;border-top:none;border-bottom:none;} #dynamic-xbrl-form [highlight-taxonomy="true"]{background-color:#FFD700 !important;} #dynamic-xbrl-form [highlight-taxonomy="true"] > *{background-color:#FFD700 !important;} #dynamic-xbrl-form [selected-taxonomy="true"][continued-main-taxonomy="true"]{box-shadow:-2px 0px 0px 0px #003768, 2px 0px 0px 0px #003768;} #dynamic-xbrl-form [selected-taxonomy="true"][text-block-taxonomy="true"]{box-shadow:-2px 0px 0px 0px #003768, 2px 0px 0px 0px #003768;} #dynamic-xbrl-form [selected-taxonomy="true"][continued-taxonomy="false"]{border:3px solid #003768 !important;display:inline;} #dynamic-xbrl-form [hover-taxonomy="true"]{background-color:rgba(255,0,0,0.3);} .tagged-data-example-1{border-top:2px solid #FF6600;border-bottom:2px solid #FF6600;} .search-results-example-1{background-color:#FFD700;} .tag-shading-exmple-1:hover{background-color:rgba(255,0,0,0.3);} .selected-fact-example-1{border:3px solid #003768 !important;}</style>

 <div class="reboot main-container">
  <div class="reboot d-none" id="back-to-top">
  </div>
  <div class="position-relative" id="dynamic-xbrl-form">
   <!--?xml version="1.0" encoding="ASCII"?-->
   <!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
   <!-- Created: Mon Sep 13 19:26:44 UTC 2021 -->
   <title>
   </title>
   <meta content="text/html" http-equiv="Content-Type"/>
   <div style="font: 10pt Times New Roman, Times, Serif">
    <div>
    </div>
    <p style="text-align: center; margin-top: 0; margin-bottom: 0">
    </p>
    <div>
    </div>
    <!-- Field: Rule-Page -->
    <div style="margin-top: 0; margin-bottom: 0; width: 100%">
     <div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">
     </div>
    </div>
    <!-- Field: /Rule-Page -->
    <div>
    </div>
    <p style="font: 7pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
     <b>
      UNITED STATES
      <br/>
      SECURITIES AND EXCHANGE COMMISSION
      <br/>
      Washington, D.C. 20549
     </b>
    </p>
    <div>
    </div>
    <p style="font: 7pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
     <b>
      FORM
      <span>
       <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-0" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="dei:DocumentType" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        10-K
       </ix:nonnumeric>
      </span>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
     (Mark One)
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
     <span>
      <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" format="ixt:booleantrue" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-1" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="dei:DocumentAnnualReport" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
       ☒
      </ix:nonnumeric>
     </span>
     ANNUAL REPORT PURSUANT TO SECTION13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
    </p>
    <div>
    </div>
    <p style="font: 7pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
     For the fiscal year ended
     <b>
      <span style="text-decoration:underline">
       <span>
        <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" format="ixt:datemonthdayyearen" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-2" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="dei:DocumentPeriodEndDate" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
         June 30,
         <span>
          <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-3" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="dei:DocumentFiscalYearFocus" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
           2021
          </ix:nonnumeric>
         </span>
        </ix:nonnumeric>
       </span>
      </span>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 7pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
     <span>
      <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" format="ixt:booleanfalse" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-4" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="dei:DocumentTransitionReport" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
       ☐
      </ix:nonnumeric>
     </span>
     TRANSITION REPORT PURSUANT TO SECTION13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
    </p>
    <div>
    </div>
    <p style="font: 7pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
     For the transition period from [                    ] to [                   ]
    </p>
    <div>
    </div>
    <p style="font: 7pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
     Commission file number
     <span>
      <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-5" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="dei:EntityFileNumber" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
       <b>
        <span style="text-decoration:underline">
         001-31392
        </span>
       </b>
      </ix:nonnumeric>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 7pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
     <b>
     </b>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top; ">
       <td style="width: 100%; border-bottom: black 1.5pt solid; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center; font-size: 10pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <b>
          <span>
           <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-6" inside-table="true" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="dei:EntityRegistrantName" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
            PLURISTEM THERAPEUTICS INC
           </ix:nonnumeric>
          </span>
          .
         </b>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: center; font-size: 10pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (Exact name of registrant as specified in its charter)
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: bottom; ">
       <td style="width: 49%; border-bottom: black 1.5pt solid; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
        <span>
         <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" format="ixt-sec:stateprovnameen" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-7" inside-table="true" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="dei:EntityIncorporationStateCountryCode" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
          <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
           <b>
            Nevada
           </b>
          </span>
         </ix:nonnumeric>
        </span>
       </td>
       <td style="width: 2%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
       </td>
       <td style="width: 49%; border-bottom: black 1.5pt solid; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
        <span>
         <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-8" inside-table="true" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="dei:EntityTaxIdentificationNumber" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
          <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
           <b>
            98-0351734
           </b>
          </span>
         </ix:nonnumeric>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (State or other jurisdiction of
         <br/>
         incorporation or organization)
        </span>
       </td>
       <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
       </td>
       <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (I.R.S. Employer
         <br/>
         Identification No.)
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: bottom; ">
       <td style="width: 49%; border-bottom: black 1.5pt solid; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <b>
          <span>
           <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-9" inside-table="true" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="dei:EntityAddressAddressLine1" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
            MATAM Advanced Technology Park,
            <br/>
            Building No. 5
           </ix:nonnumeric>
          </span>
          ,
          <span>
           <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-10" inside-table="true" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="dei:EntityAddressCityOrTown" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
            Haifa
           </ix:nonnumeric>
          </span>
          ,
          <span>
           <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" format="ixt-sec:countrynameen" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-11" inside-table="true" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="dei:EntityAddressCountry" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
            Israel
           </ix:nonnumeric>
          </span>
         </b>
        </span>
       </td>
       <td style="width: 2%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
       </td>
       <td style="width: 49%; border-bottom: black 1.5pt solid; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
        <span>
         <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-12" inside-table="true" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="dei:EntityAddressPostalZipCode" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
          <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
           <b>
            3508409
           </b>
          </span>
         </ix:nonnumeric>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (Address of principal executive offices)
        </span>
       </td>
       <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
       </td>
       <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (Zip Code)
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 7pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
     Registrant’s telephone number
     <b>
      <span style="text-decoration:underline">
       011-972-74-7108600
      </span>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 7pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     Securities registered pursuant to Section 12(b) of the Act:
    </p>
    <div>
    </div>
    <p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: bottom; ">
       <td style="width: 34%; border-bottom: black 1.5pt solid; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Title of each class
        </span>
       </td>
       <td style="width: 1%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
       </td>
       <td style="width: 32%; border-bottom: black 1.5pt solid; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Trading Symbol
        </span>
       </td>
       <td style="width: 1%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
       </td>
       <td style="width: 32%; border-bottom: black 1.5pt solid; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Name of each exchange on which registered
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: #CCEEFF">
       <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
        <span>
         <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-13" inside-table="true" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="dei:Security12bTitle" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
          <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
           <b>
            Common Shares, par value $0.00001
           </b>
          </span>
         </ix:nonnumeric>
        </span>
       </td>
       <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
       </td>
       <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
        <span>
         <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-14" inside-table="true" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="dei:TradingSymbol" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
          <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
           <b>
            PSTI
           </b>
          </span>
         </ix:nonnumeric>
        </span>
       </td>
       <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
       </td>
       <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <b>
          The
          <span>
           <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" format="ixt-sec:exchnameen" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-15" inside-table="true" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="dei:SecurityExchangeName" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
            Nasdaq
           </ix:nonnumeric>
          </span>
          Global Market
         </b>
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     Securities registered pursuant to Section 12(g) of the Act:
    </p>
    <div>
    </div>
    <p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top; ">
       <td style="width: 100%; border-bottom: black 1.5pt solid; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <b>
          None.
         </b>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (Title of class)
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     Indicate by check mark if the registrant is awell-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Yes ☐
     <span>
      <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-16" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="dei:EntityWellKnownSeasonedIssuer" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
       No
      </ix:nonnumeric>
     </span>
     ☒
    </p>
    <div>
    </div>
    <p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     Indicate by check mark if the registrant is notrequired to file reports pursuant to Section 13 or Section 15(d) of the Act.  Yes ☐
     <span>
      <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-17" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="dei:EntityVoluntaryFilers" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
       No
      </ix:nonnumeric>
     </span>
     ☒
    </p>
    <div>
    </div>
    <p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     Indicate by check mark whether the registrant(1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to suchfiling requirements for the past 90 days.
     <span>
      <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-18" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="dei:EntityCurrentReportingStatus" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
       Yes
      </ix:nonnumeric>
     </span>
     ☒ No ☐
    </p>
    <div>
    </div>
    <p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     Indicate by check mark whether the registranthas submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒
     <span>
      <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-19" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="dei:EntityInteractiveDataCurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
       Yes
      </ix:nonnumeric>
     </span>
     ☐ No
    </p>
    <div>
    </div>
    <p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     Indicate by check mark whether the registrantis a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.See the definitions of “large accelerated filer”, “accelerated filer,” “smaller reporting company,”and “emerging growth company” in Rule 12b-2 of the Exchange Act.
    </p>
    <div>
    </div>
    <p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top; ">
       <td style="width: 23%">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Large accelerated filer
        </span>
       </td>
       <td style="width: 11%">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ☐
        </span>
       </td>
       <td style="width: 28%">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Accelerated filer
        </span>
       </td>
       <td style="width: 11%">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ☐
        </span>
       </td>
       <td style="width: 20%">
        <span>
         <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" format="ixt-sec:entityfilercategoryen" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-20" inside-table="true" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="dei:EntityFilerCategory" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
          <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
           Non-accelerated filer
          </span>
         </ix:nonnumeric>
        </span>
       </td>
       <td style="width: 7%">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ☒
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Smaller reporting company
        </span>
       </td>
       <td>
        <span>
         <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" format="ixt:booleantrue" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-21" inside-table="true" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="dei:EntitySmallBusiness" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
          <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
           ☒
          </span>
         </ix:nonnumeric>
        </span>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Emerging growth company
        </span>
       </td>
       <td>
        <span>
         <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" format="ixt:booleanfalse" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-22" inside-table="true" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="dei:EntityEmergingGrowthCompany" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
          <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
           ☐
          </span>
         </ix:nonnumeric>
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accountingstandards provided pursuant to Section 13(a) of the Exchange Act. ☐
    </p>
    <div>
    </div>
    <p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     Indicate by check mark whether the registrantis a shell company (as defined in Rule 12b-2 of the Act).   Yes ☐
     <span>
      <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" format="ixt:booleanfalse" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-23" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="dei:EntityShellCompany" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
       No
      </ix:nonnumeric>
     </span>
     ☒
    </p>
    <div>
    </div>
    <p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     State the aggregate market value of the votingand non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or theaverage bid and asked prices of such common equity, as of the last business day of the registrant’s most recently completed secondfiscal quarter.
    </p>
    <div>
    </div>
    <p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     $
     <span>
      <ix:nonfraction contextref="c2" continued-taxonomy="false" decimals="0" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-24" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="dei:EntityPublicFloat" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="usd">
       174,929,346
      </ix:nonfraction>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     Indicate the number of shares outstanding of eachof the registrant’s classes of common shares, as of the latest practicable date.
    </p>
    <div>
    </div>
    <p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span>
      <ix:nonfraction contextref="c1" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-25" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="dei:EntityCommonStockSharesOutstanding" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
       32,004,785
      </ix:nonfraction>
     </span>
     as of September 3, 2021
    </p>
    <div>
    </div>
    <p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     DOCUMENTS INCORPORATED BY REFERENCE
    </p>
    <div>
    </div>
    <p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     None.
    </p>
    <div>
    </div>
    <p style="font: 7pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <!-- Field: Rule-Page -->
    <div style="margin-top: 0; margin-bottom: 0; width: 100%">
     <div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">
     </div>
    </div>
    <!-- Field: /Rule-Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
     <b>
      TABLE OF CONTENTS
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: bottom">
       <td style="width: 10%">
       </td>
       <td style="width: 80%; text-align: center">
       </td>
       <td style="border-bottom: black 1.5pt solid; width: 10%; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <b>
          Page
         </b>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: bottom">
       <td>
       </td>
       <td style="text-align: center">
       </td>
       <td style="text-align: center">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td>
        <a href="#p_001" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          PART I
         </span>
        </a>
       </td>
       <td>
       </td>
       <td style="text-align: center">
        1
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: center">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td>
        <a href="#p_002" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Item 1.
         </span>
        </a>
       </td>
       <td>
        <a href="#p_002" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Business
         </span>
        </a>
       </td>
       <td style="text-align: center">
        1
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: center">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td>
        <a href="#p_003" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Item 1A.
         </span>
        </a>
       </td>
       <td>
        <a href="#p_003" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Risk Factors
         </span>
        </a>
       </td>
       <td style="text-align: center">
        14
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: center">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td>
        <a href="#p_004" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Item 1B.
         </span>
        </a>
       </td>
       <td>
        <a href="#p_004" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Unresolved Staff Comments
         </span>
        </a>
       </td>
       <td style="text-align: center">
        32
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: center">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td>
        <a href="#p_005" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Item 2.
         </span>
        </a>
       </td>
       <td>
        <a href="#p_005" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Properties
         </span>
        </a>
       </td>
       <td style="text-align: center">
        32
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: center">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td>
        <a href="#p_006" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Item 3.
         </span>
        </a>
       </td>
       <td>
        <a href="#p_006" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Legal Proceedings
         </span>
        </a>
       </td>
       <td style="text-align: center">
        32
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: center">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td>
        <a href="#p_007" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Item 4.
         </span>
        </a>
       </td>
       <td>
        <a href="#p_007" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Mine Safety Disclosures
         </span>
        </a>
       </td>
       <td style="text-align: center">
        32
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: center">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td>
        <a href="#p_008" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          PART II
         </span>
        </a>
       </td>
       <td>
       </td>
       <td style="text-align: center">
        33
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: center">
       </td>
      </tr>
      <tr style="background-color: rgb(204,238,255)">
       <td style="vertical-align: top">
        <a href="#p_009" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Item 5.
         </span>
        </a>
       </td>
       <td style="vertical-align: bottom; padding-left: 10pt; text-align: justify; text-indent: -10pt">
        <a href="#p_009" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
         </span>
        </a>
       </td>
       <td style="vertical-align: bottom; text-align: center">
        33
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: center">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td>
        <a href="#p_010" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Item 6.
         </span>
        </a>
       </td>
       <td>
        <a href="#p_010" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          [Reserved]
         </span>
        </a>
       </td>
       <td style="text-align: center">
        33
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: center">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td>
        <a href="#p_011" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Item 7.
         </span>
        </a>
       </td>
       <td>
        <a href="#p_011" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Management’s Discussion and Analysis of Financial Condition and Results of Operations
         </span>
        </a>
       </td>
       <td style="text-align: center">
        33
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: center">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td>
        <a href="#p_012" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Item 7A.
         </span>
        </a>
       </td>
       <td>
        <a href="#p_012" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Quantitative and Qualitative Disclosures About Market Risk
         </span>
        </a>
       </td>
       <td style="text-align: center">
        38
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: center">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td>
        <a href="#p_013" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Item 8.
         </span>
        </a>
       </td>
       <td>
        <a href="#p_013" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Financial Statements and Supplementary Data
         </span>
        </a>
       </td>
       <td style="text-align: center">
        40
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: center">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td>
        <a href="#p_014" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Item 9.
         </span>
        </a>
       </td>
       <td>
        <a href="#p_014" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Changes in and Disagreements With Accountants on Accounting and Financial Disclosure
         </span>
        </a>
       </td>
       <td style="text-align: center">
        41
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: center">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td>
        <a href="#p_015" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Item 9A.
         </span>
        </a>
       </td>
       <td>
        <a href="#p_015" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Controls and Procedures
         </span>
        </a>
       </td>
       <td style="text-align: center">
        41
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: center">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td>
        <a href="#p_016" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Item 9B.
         </span>
        </a>
       </td>
       <td>
        <a href="#p_016" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Other Information
         </span>
        </a>
       </td>
       <td style="text-align: center">
        41
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: center">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td>
        <a href="#p_017" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Item 9C.
         </span>
        </a>
       </td>
       <td>
        <a href="#p_023" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
         </span>
        </a>
       </td>
       <td style="text-align: center">
        41
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: center">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td>
        <a href="#p_017" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          PART III
         </span>
        </a>
       </td>
       <td>
       </td>
       <td style="text-align: center">
        42
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: center">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td>
        <a href="#p_018" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Item 10.
         </span>
        </a>
       </td>
       <td>
        <a href="#p_018" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Directors, Executive Officers and Corporate Governance
         </span>
        </a>
       </td>
       <td style="text-align: center">
        42
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: center">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td>
        <a href="#p_019" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Item 11.
         </span>
        </a>
       </td>
       <td>
        <a href="#p_019" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Executive Compensation
         </span>
        </a>
       </td>
       <td style="text-align: center">
        49
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: center">
       </td>
      </tr>
      <tr style="background-color: rgb(204,238,255)">
       <td style="vertical-align: top">
        <a href="#p_020" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Item 12.
         </span>
        </a>
       </td>
       <td style="vertical-align: bottom; padding-left: 10pt; text-align: justify; text-indent: -10pt">
        <a href="#p_020" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
         </span>
        </a>
       </td>
       <td style="vertical-align: bottom; text-align: center">
        58
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: center">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td>
        <a href="#p_021" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Item 13.
         </span>
        </a>
       </td>
       <td>
        <a href="#p_021" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Certain Relationships and Related Transactions and Director Independence
         </span>
        </a>
       </td>
       <td style="text-align: center">
        61
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: center">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td>
        <a href="#p_022" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Item 14.
         </span>
        </a>
       </td>
       <td>
        <a href="#p_022" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Principal Accounting Fees and Services
         </span>
        </a>
       </td>
       <td style="text-align: center">
        61
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: center">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td>
        <a href="#p_024" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          PART IV
         </span>
        </a>
       </td>
       <td>
       </td>
       <td style="text-align: center">
        63
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: center">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td>
        <a href="#p_025" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Item 15.
         </span>
        </a>
       </td>
       <td>
        <a href="#p_025" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Exhibits
         </span>
        </a>
       </td>
       <td style="text-align: center">
        63
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: center">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td>
        <a href="#p_026" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Item 16.
         </span>
        </a>
       </td>
       <td>
        <a href="#p_026" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Form 10-K Summary
         </span>
        </a>
       </td>
       <td style="text-align: center">
        65
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->
      i
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     Our financial statements are stated in thousandsUnited States Dollars and are prepared in accordance with United States Generally Accepted Accounting Principles, or U.S. GAAP.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     In this annual report, unless otherwise specified,all dollar, amounts are expressed in U.S. dollars.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     As used in this annual report, the terms “we”,“us”, “our”, the “Company”, and “Pluristem” mean Pluristem Therapeutics Inc., and ourwholly owned Israeli subsidiary and the wholly owned subsidiary of our Israeli subsidiary in Germany, unless otherwise indicated or requiredby the context.
    </p>
    <div>
    </div>
    <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
     <b>
      CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
     </b>
    </p>
    <div>
    </div>
    <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     The statements contained inthis Annual Report that are not historical facts are “forward-looking statements” within the meaning of the Private SecuritiesLitigation Reform Act of 1995 and other federal securities laws. Such forward-looking statements may be identified by, among other things,the use of forward-looking terminology such as “believes,” “intends,” “plans,” “expects,”“may,” “will,” “should,” or “anticipates” or the negative thereof or other variationsthereon or comparable terminology, and similar expressions are intended to identify forward-looking statements. We remind readers thatforward-looking statements are merely predictions and therefore inherently subject to uncertainties and other factors and involve knownand unknown risks that could cause the actual results, performance, levels of activity, or our achievements, or industry results, to bematerially different from any future results, performance, levels of activity, or our achievements, or industry results, expressed orimplied by such forward-looking statements. Such forward-looking statements appear in Item 1 – “Business” and Item 7– “Management’s discussion and Analysis of Financial Condition and Results of Operations,” (especially in thesection titled “Outlook”) as well as elsewhere in this Annual Report and include, among other statements, statements regardingthe following:
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         theexpected development and potential benefits from our products in treating various medical conditions;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ourplan to execute our strategy independently, using our own personnel, and through relationships with research and clinical institutionsor in collaboration with other companies;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ourentering into certain contracts with third parties;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         theprospects of entering into additional license agreements, or other forms of cooperation with other companies and medical institutions;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ourpre-clinical and clinical trials plans, including timing of initiation, enrollment and conclusion of trials;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         theexpected timing of the release of data from our various studies;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         achievingregulatory approvals, including under accelerated paths;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         receiptof future funding from the Israel Innovation Authority, or IIA, the European Union’s Horizon 2020 program, the Biomedical AdvancedResearch and Development Authority, as well as grants from other independent third parties;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 3; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->
      ii
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         thereceipt of funds pursuant to our agreement with the European Investment Bank, or the EIB Finance Agreement and EIB, respectively, andwhether we will achieve the milestones necessary to receive funds thereunder;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ourmarketing plans, including timing of marketing our product candidates, PLX-PAD and PLX-R18, and the filing of any requests for marketingauthorization;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         developingcapabilities for new clinical indications of placenta expanded (PLX) cells and new products;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ourplan for the initiation of a multinational regulated clinical trial program for the potential use of PLX cells in the treatment of patientssuffering from complications associated with the COVID-19 pandemic;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ourestimations regarding the size of the global market for our product candidates;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ourexpectations regarding our production capacity, including the use of our serum-free formulation;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ourexpectation to demonstrate a real-world impact and value from our pipeline, technology platform and commercial-scale manufacturing capacity;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ourexpectations regarding our short- and long-term capital requirements;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ouroutlook for the coming months and future periods, including but not limited to our expectations regarding future revenue and expenses;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         informationwith respect to any other plans and strategies for our business; and
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ourexpectations regarding the impact of the COVID-19 pandemic, including on our clinical trials and operations.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     The factors discussed herein,including those risks described in Item 1A. “Risk Factors”, and expressed from time to time in our filings with the Securitiesand Exchange Commission, or SEC, could cause actual results and developments to be materially different from those expressed in or impliedby such statements. In addition, historic results of scientific research, clinical and preclinical trials do not guarantee that the conclusionsof future research or trials would not suggest different conclusions. Also, historic results referred to in this Annual Report would beinterpreted differently in light of additional research, clinical and preclinical trials results. The forward-looking statements are madeonly as of the date of this filing, and except as required by law we undertake no obligation to publicly update such forward-looking statementsto reflect subsequent events or circumstances.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 4; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->
      iii
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
    </p>
    <div>
    </div>
    <div>
     <a id="p_001">
     </a>
    </div>
    <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
     <span style="text-transform: uppercase">
      <b>
       PART I
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
     <b>
     </b>
    </p>
    <div>
    </div>
    <div>
     <a id="p_002">
     </a>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="text-transform: uppercase">
      <b>
       Item 1.Business.
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      Our Current Business
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We are a biotechnology companyfocused in the field of regenerative medicine, and a leading developer of placenta-based cell therapy product candidates for the treatmentof multiple inflammatory, muscle injuries and hematologic conditions. Our operations are focused on the research, development, manufacturing,conducting clinical trials and business development of cell therapeutics and related technologies.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Placental expanded, or PLX,cells are derived from a class of placental cells that are harvested from donated placenta at the time of full term healthy delivery ofa baby. The cells are grown using our proprietary three-dimensional expansion technology and can be administered to patients off the-shelf,without blood or tissue matching prior to administration. PLX cells are believed to release a range of therapeutic proteins in responseto the patient’s condition, such as inflammation, muscle trauma, hematological disorders and radiation damage.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We are conducting severalmultinational clinical studies which consist of a Phase III clinical study in muscle recovery following surgery for hip fracture and twoPhase II clinical studies in Acute Respiratory Distress Syndrome, or ARDS, associated with COVID-19 in the United States, Europe and Israel.In addition, we are focusing on other clinical programs in the hematological field such as a Phase I clinical study for incomplete recoveryfollowing bone marrow transplantation in the United States and Israel, an investigator-led Phase I/II Chronic Graft versus Host Disease,or cGVHD, study in Israel, and Acute Radiation Syndrome, or ARS, under the U.S. Food and Drug Administration, or FDA, animal rule. Webelieve that each of these indications is a severe unmet medical need.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Our manufacturing facilitycomplies with the European, Japanese, Israeli, South Korean and the FDA’s current Good Manufacturing Practice, or cGMP, requirementsand has been inspected and approved by the European and Israeli regulators for production of PLX-PAD for late stage trials. We have alsobeen granted manufacturer/importer authorization and cGMP Certification by the Israeli Ministry of Health, or MOH. If we obtain FDA andother regulatory approvals to market PLX cells, we expect to have in-house production capacity to grow PLX cells in commercial quantities.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Our goal is to make significantprogress with our clinical pipeline and our clinical studies in order to ultimately bring innovative, potent therapies to patients whoneed new treatment options. We expect to demonstrate a real-world impact and value from our pipeline, technology platform and commercial-scalemanufacturing capacity. Our business model for commercialization and revenue generation includes, but is not limited to, licensing deals,joint ventures with pharmaceutical companies, direct sale of our products, and partnerships.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We were incorporated in Nevadain 2001, and we have a wholly owned subsidiary in Israel called Pluristem Ltd., or the Israeli Subsidiary, and a wholly owned subsidiaryin Germany called Pluristem GmbH.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      Scientific Background
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Cell therapy is an emergingfield within the regenerative medicine area. The characteristics and properties of cells vary as a function of tissue source and growthconditions. The human placenta from which our PLX cells are derived provides an uncontroversial source of non-embryonic, adult cells andrepresents an innovative approach in the cell therapy field. The different factors that PLX cells release suggest that the cells can beused therapeutically for a variety of ischemic, inflammatory, autoimmune and hematological deficiencies.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     PLX cells do not require tissue matchingprior to administration, which allows the development of ready-to-use / “off-the-shelf” allogeneic products.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      1
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      Our Technology
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We develop, and intend tocommercialize, cell therapy production technologies and products that are derived from the human placenta after a full-term delivery ofa healthy baby. Our PLX cells are adherent stromal cells that are expanded using a proprietary three-dimensional, or 3D, process. Thissystem utilizes a synthetic scaffold to create an artificial 3D environment where placental-derived stromal cells can grow. Our automatedproprietary 3D, cGMP approved, process enables the large-scale monitored and controlled production of reproducible, high quality cellproducts and can manufacture a large number of PLX doses. Additionally, our current manufacturing process, which has scaled up as comparedto previous years, has demonstrated batch-to-batch consistency, an important manufacturing challenge for biological products.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      Product Candidates
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Our primary objective is tobe the leading provider of allogeneic placenta-based cell therapy products that are true off-the-shelf products that do not require anymatching or additional manipulation prior to administration. From the physician’s and patient’s perspective, we believe thatour PLX products are comparable to any other product delivered in a vial. Currently, our PLX products are administered intramuscular,or IM, using a standard needle and syringe.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <b>
      <i>
       PLX-PAD
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Our first product candidate,PLX-PAD, is composed of maternal cells originating from the placenta. PLX-PAD is currently being used in a Phase III multinational clinicalstudy in recovery following surgery for hip fracture, and in two Phase II clinical studies in ARDS associated with COVID-19 in the UnitedStates, Europe and Israel.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We have also conducted a pivotalPhase III multinational clinical study in the use of PLX-PAD for the treatment of Critical Limb Ischemia, or CLI, which we terminatedin December 2020, and in a Phase II multinational clinical study in Intermittent Claudication, or IC.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     PLX-PAD is also under clinicaldevelopment in collaboration with Tel Aviv Sourasky Medical Center (Ichilov Hospital) through an investigator initiated study, and usedin a Phase I/II for the treatment of Steroid-Refractory cGVHD.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <b>
      <i>
       PLX-R18
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <b>
      <i>
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Our second product candidate,PLX-R18, is composed of fetal cells originated from the placenta.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     We have completed enrollment in our first in humanPhase I clinical study in incomplete hematopoietic recovery following hematopoietic cell transplantation, or HCT, in the United Statesand Israel.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Through our collaborationin the United States with the National Institutes of Health, or NIH, and the U.S. Department of Defense, or DoD, we are also developinga solution for ARS following or before exposure to massive radiation via the FDA Animal Rule regulatory pathway.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     <b>
      <i>
       Modified PLX cells
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In the last decade, we developedan allogeneic platform based on cells originated from the fetal and maternal cell from the placenta, and by using this platform we canproduce large quantities of high-quality cells in automated and robust manufacturing suitable for cGMP environment. As a platform technologycompany, we are currently developing additional product candidates, which are modified or induced PLX cells:
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     <b>
      <i>
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Induced PLX cells: we areusing cells from the placenta, induced with inflammatory cytokines, to transiently alter their secretion profile.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     <b>
      <i>
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Modified PLX cells using CRISPRtechnology: CRISPR is a unique technology that opens the door for precise gene editing of cells. Using such technology can initiate thenext evolution in cell therapy by allowing the reprograming of cells for specific needs. Our aim is to incorporate the genetic engineeringtechniques into our cell manufacturing platform in order to develop large scale allogenic engineered PLX products designed for specificindications.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We believe that using theplacenta as a unique cell source, combined with our innovative research, development and high-quality manufacturing capabilities, willbe the “engine” that drives this platform technology towards the successful development of additional PLX cell therapy productsand indications.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 6; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      2
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      Our Clinical Development Product Candidates
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <b>
      Orthopedic Indications
     </b>
     .Following FDA and European Medicine Agency, or EMA, clearance, a multinational Phase III study is currently being conducted in the UnitedStates, Europe and Israel. The primary endpoint of this study is the Short Physical Performance Battery (SPPB), a test for lower leg performanceand functional status. The study is planned to include 240 patients and will assess efficacy at six months and a year, as well as safetyfor up to two years. Currently, over 95% of the study patients have been enrolled in this study.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Our Phase III studyprotocol and design was based on our phase I/II, randomized, double-blind, placebo-controlled study (n=20) to assess the safety and efficacyof IM injections of allogeneic PLX-PAD cells for the regeneration of injured gluteal musculature after total hip replacement had beenconducted in Germany under the approval of PEI. In this study, PLX-PAD cells or placebo were administered into the traumatized glutealmuscle during total hip replacement surgery. The study results met its primary efficacy endpoint, change in maximal voluntary isometriccontraction force of the gluteal muscle at six months after total hip replacement. Patients treated with PLX-PAD had a significantly greaterimprovement of maximal voluntary muscle contraction force than the placebo group (p=0.0067). In addition, the study demonstrated thatPLX-PAD was safe and well tolerated by patients.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <b>
      COVID-19 Complicated byARDS
     </b>
     . In May 2020, the FDA cleared our Investigational New Drug Application, or IND, for a Phase II study of our PLX-PAD cells fortreatment of severe COVID-19 cases complicated by ARDS and we initiated the study in June 2020. The U.S. study is a randomized, double-blind,placebo-controlled, multicenter, parallel-group intended to evaluate the efficacy and safety of IM injections of PLX-PAD for the treatmentof severe COVID-19 cases complicated by ARDS. The primary endpoint is the number of ventilator free days during the 28-days followingdosing. Secondary efficacy endpoints include all-cause mortality, duration of mechanical ventilation, ICU free-days, and hospitalizationfree-days. Safety and survival follow-up will be conducted until week 52. In addition, the FDA has cleared our Expanded Access Program,or EAP, for the use of our PLX-PAD cells to treat ARDS caused by COVID-19 outside of the Phase II COVID-19 complicated by ARDS study inthe United States. The EAP approval was for up to 100 patients.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In August 2020, the PEI clearedour Phase II study in Germany titled, “A Randomized, Controlled, Multicenter, Parallel-Group Phase II Study to Evaluate the Efficacyand Safety of Intramuscular Injections of PLX PAD for the Treatment of severe COVID-19,” relating to the treatment of patients hospitalizedwith severe cases of COVID-19 complicated by ARDS. The primary efficacy endpoint of the study is the number of ventilator free days duringthe 28-days from day one through day 28 of the study. Secondary efficacy endpoints include all-cause mortality, duration of mechanicalventilation, ICU free-days, and hospitalization free-days. Safety and survival follow-up will be conducted until week 52. We enrolledpatients in Europe and Israel under this protocol.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif">
      OnJuly 8, 2021, we announced that we are bringing our COVID-19 complicated by ARDS Phase II studies in the United States, Europe and Israelto clinical readout. The analysis will be based on 89 patients enrolled. We expect to announce the topline results of the readout duringthe fourth quarter of 2021. We also announced that we will not pursue the previously announced plans in December 2020 to expand our COVID-19program in Mexico in collaboration with Innovare R&amp;D SA de CV.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span>
      <b>
       RecoveryFollowing HCT
      </b>
      . This Phase I study of PLX-R18 in HCT, has completed enrollment of 21 patients in the United States and Israel. Thestudy is designed to assess the safety of PLX-R18 by assessing adverse events, safety labs and vital signs in patients receiving differentdoses of PLX-R18. We expect to complete one year follow up for all patients in September 2021.
     </span>
     In April 2021, we announced toplineresults of this study. The 21 patients enrolled in the United States and Israel were at least three months after the HCT procedure (median:236 days) and had low blood counts in at least one blood cell lineage. They were assigned to one of three treatment arms: one millioncells/kg, two million cells/kg or four million cells/kg. Each patient received two treatments of the assigned dose.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Data from the six-month follow-upwere available for 14 of the 21 treated patients and demonstrated that (i) PLX-R18 was well-tolerated with a favorable safety profile;(ii) statistically significant improvement from baseline counts was observed in all cohorts for hemoglobin and platelet counts (p&lt;0.05)and the patients in the high dose arm (4 million cells/kg) exhibited statistically significant improvements in all three blood cell lineages(p&lt;0.01); (iii) approximately 60% of patients exhibited improvements in all three blood cell lineages: hemoglobin, neutrophil and plateletcounts that are above the initial criteria for inclusion in the study and (iv) 13 patients were transfusion dependent at baseline; sixof those became transfusion independent at 6 month follow-up and no patients who were transfusion independent at baseline became transfusiondependent.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <b>
      Peripheral and CardiovascularDiseases
     </b>
     . We investigated the use of PLX-PAD cells for the treatment of peripheral arterial disease, or PAD, including IC and CLI.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 7; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      3
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We completed two Phase I safety/dose-escalatingclinical studies for CLI, one in the United States and one in Germany. These CLI studies demonstrated that no blood type or human leukocyteantigen matching is required, and that the administration of PLX-PAD cells is safe, even if two doses are administered to a patient ontwo different occasions.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We conducted a pivotal PhaseIII study of PLX-PAD cells in the treatment of CLI for patients with minor tissue loss (Rutherford Category 5) who are unsuitable forrevascularization. This multinational Phase III study was conducted in the United States, Europe and Israel and enrolled 213 patientsin total.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     In December 2020, the independent Data MonitoringCommittee, or DMC, issued its recommendation letter following an interim analysis relating to the CLI Phase III study. A clinical datasetwas reviewed by the independent DMC for safety and analysis of the primary endpoint of amputation-free survival, defined as time to occurrenceof major amputation of the index leg or death. Based on the review, the DMC concluded that the CLI study was unlikely to meet the primaryendpoint by the time of the final analysis. Following the DMC’s recommendation, we decided to terminate the CLI study.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">
     <span>
      <b>
       ARS
      </b>
      .We have conducted several animal studies for the evaluation of PLX-R18 for the treatment of ARS, in collaboration with the National Instituteof Allergy and Infectious Diseases, or the NIAID. The NIH, funded and conducted a pilot study in non-human primates, or NHPs, to evaluatethe therapeutic effect of PLX-R18 on hematological aspects of ARS. In 2017, we announced results of the NHPs pilot study for PLX-R18 asa treatment for ARS. Although study size was not designed to show significance, results showed a trend toward improved survival of PLX-R18treated animals compared to control, placebo treated animals. The study, conducted and funded by the NIAID, was designed to assess thesafety and efficacy of PLX-R18 following IM injection into irradiated and non-irradiated NHPs. Efficacy measures included survival aswell as hematological parameters which are affected by exposure to high levels of radiation as may occur in a nuclear accident or attack.These data will help the design of a pivotal study to fulfill the requirements for a Biologics License Application, or BLA, submissionunder the FDA’s Animal Rule regulatory pathway.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We plan to continuethe discussions with the different government agencies with the goal of receiving their support for pivotal studies in NHPs as well asconducting the safety studies required in order to file BLA for this indication.
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In October 2017, we announcedthat the FDA granted us an orphan drug designation for our PLX-R18 cell therapy for the prevention and treatment of ARS.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In April 2018, we announcedthat the FDA approved our IND application for PLX-R18 cell therapy in the treatment of ARS. The IND allows us to treat victims who mayhave been acutely exposed to high dose radiation due to nuclear attack or accident.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In December 2015, wealso signed a memorandum of understanding, or MOU, for a collaboration with Fukushima Medical University, Fukushima Global Medical ScienceCenter. The purpose of the collaboration is to develop our PLX-R18 cells for the treatment of ARS, and for morbidities following radiotherapyin cancer patients. In June 2018, we reported positive animal data from studies conducted in collaboration with Fukushima Medical Universityevaluating PLX-R18 cells as a treatment for radiation damage to the gastrointestinal, or GI, tract and bone marrow. Data from these studiesshowed that PLX-R18 cells significantly increased survival rates, preserved GI stem cells activity that enhance the recovery of the GIsystem and prevented severe damage to the intestinal lining, suggesting PLX-R18 potential as a multi-organ therapy for ARS.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span>
      InJuly 2019, we presented positive results from a series of studies of our PLX-R18 cell therapy product conducted by the DoD, Armed ForcesRadiobiology Research Institute, part of the Uniformed Services University of Health Sciences. The studies were designed to evaluate PLX-R18as a potential prophylactic countermeasure against ARS administered prior to radiation exposure. These animal studies demonstrate thatPLX-R18, administered 24 hours before radiation exposure, and again 72 hours after exposure, resulted in a significant increase in survivalrates, from 4% survival rate in the placebo group to 74% in the treated group. In addition, the data shows an increase in recovery ofblood lineages and a favorable safety profile. Furthermore, histopathological analysis and hematopoietic progenitor clonogenic assay oftissues collected show a significant increase in bone marrow cell numbers and improved regenerative capability into all blood lineages.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <b>
      Steroid-Refractory cGVHD
     </b>
     .In September 2017, we signed an agreement with Tel Aviv Sourasky Medical Center (Ichilov Hospital) to conduct a Phase I/II clinical studyof PLX-PAD cell therapy for the treatment of Steroid-Refractory cGVHD. This study is an investigator-initiated study. As such, Tel AvivSourasky Medical Center supports the study and is responsible for its design and implementation.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 8; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      4
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      Regulatory and Clinical Affairs Strategy
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Our cell therapy developmentstrategy is to hold open and frequent discussions with regulators at all stages of development from preclinical studies to more advancedregulatory stages. We utilize this strategy in working with the FDA, the EMA, Germany’s PEI as well as other European national competentauthorities, the MOH, Japan’s Pharmaceuticals and Medical Devices Agency, or PMDA, and also the Ministry of Food and Drug Safety,or MFDS, of South Korea.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
       Intellectual Property
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <i>
     </i>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We understand that our successwill depend, in part, on maintaining our intellectual property, and therefore we are committed to protecting our technology and productcandidates with patents and other methods described below.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We are the sole owner of 133issued patents and approximately 70 pending patent applications in the United States, Europe, China, Japan and Israel, as well as in additionalcountries worldwide, including countries in the Far East and South America (in calculating the number of issued patents, each Europeanpatent validated in multiple jurisdictions was counted as a single patent).
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In April 2016, the Israelisubsidiary entered into a licensing agreement with TES Holdings Co., Ltd., a venture company derived from the University of Tokyo, toobtain a key patent in Japan to cover the treatment of ischemic diseases with placental cell therapy. This license is subject to futuresingle low-digit royalties from sales of our product for treatment in the field of ischemic diseases in Japan, until expiry of the patentin 2023. This license is in addition to the grant of 13 patents to us by the Japanese Patent Office, which address three dimensional methodsfor expanding placental and adipose cells, and specified cell therapies produced from placental tissue using these methods and bedsidethawing devices.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In February 2017, the IsraeliSubsidiary signed an agreement with founders of a certain patent for a five-year option to purchase a certain patent for an amount of€1 million. The agreement includes yearly payments of €75,000, €75,000 and €100,000 in February 2017, 2018 and 2019,respectively, which have been paid. We are entitled to terminate the agreement for convenience upon providing the founders 30 days priornotice.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In April 2019, we filed aU.S. provisional patent application titled “Methods and Compositions for Producing Cannabinoids,” which covers the use ofour state-of-the-art, proprietary 3D cell culturing technology for the potential manufacturing of cannabinoid-producing cells. In April2020, we filed a Patent Cooperation Treaty, or PCT, application with respect to the technology. In June 2021, national or regional phaseapplications of the PCT were filed in the United States, Europe, Japan, Canada, and Israel.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In March 2020, we filed aU.S. provisional patent application titled “Methods and Compositions for Treating Viral Infections and Sequelae Thereof,”which covers the use of placental adherent stromal cells for treating coronavirus infections and sequelae thereof. In May 2020, a relatedIsraeli patent application was filed, which was allowed in March 2021. In March 2021, a PCT application as well as national applicationswere filed in the United States and Israel. In June 2021, national or regional phase applications of the PCT were filed in Europe andMexico.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Based on the well-establishedunderstanding that the characteristics and therapeutic potential of a cell product are largely determined by the source of the cells andby the methods and conditions used during their culturing, our patent portfolio includes different types of claims that protect the variousunique aspects of our technology.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     Our multi-national portfolio of patent and patentapplications includes the following claims:
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ourproprietary expansion methods for 3D stromal cells;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         compositionof matter claims covering the cells;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         thetherapeutic use of PLX cells for the treatment of a variety of medical conditions; and
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         cell-culture,harvest, and thawing devices.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 9; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      5
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Through our experience withadherent stromal cell based product development, we have developed expertise and know-how in this field and have established proceduresfor manufacturing clinical-grade PLX cells in our facilities. Certain aspects of our manufacturing process are covered by patents andpatent applications. In addition, specific aspects of our technology are retained as know-how and trade secrets that are protected byour confidentiality agreements with our employees, consultants, contractors, manufacturers and advisors. These agreements generally providefor protection of confidential information, restrictions on the use of materials, and an obligation to assign to us inventions conceivedduring the course of performing services for us.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     The following table sets forthour key patents and patent applications and is not intended to represent an assessment of claims, limitations or scope. In some cases,a jurisdiction is listed as both pending and granted for a single patent family. This is due to pending continuation or divisional applicationsof the granted case.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     The expiration dates of thesepatents, based on filing dates, range from 2027 to 2041. Actual expiration dates will be determined according to extensions received basedon the Drug Price Competition and Patent Term Restoration Act of 1984 (P.L. 98-417), commonly known as the “Hatch-Waxman”Act, that permits extensions of pharmaceutical patents to reflect regulatory delays encountered in obtaining FDA market approval. TheHatch-Waxman Act is based on a U.S. federal law and therefore only relevant to U.S. patents.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     There is a risk that our patentswill be invalidated, and that our pending patent applications will not result in issued patents. We also cannot be certain that we willnot infringe on any patents that may be issued to others. See “Risk Factors - We must further protect and develop our technologyand products in order to become a profitable company.”
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      Our Patent Portfolio
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
      </i>
     </b>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: bottom; ">
       <td style="width: 41%; border-bottom: black 1.5pt solid">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <b>
          Patent Name/ Int. App. No.
         </b>
        </span>
       </td>
       <td style="width: 1%; text-align: center">
       </td>
       <td style="width: 16%; border-bottom: black 1.5pt solid; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <b>
          Pending Jurisdictions
         </b>
        </span>
       </td>
       <td style="width: 1%; text-align: center">
       </td>
       <td style="width: 20%; border-bottom: black 1.5pt solid; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <b>
          Granted Jurisdictions
         </b>
        </span>
       </td>
       <td style="width: 1%; text-align: center">
       </td>
       <td style="width: 20%; border-bottom: black 1.5pt solid; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <b>
          Expiry Date
         </b>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          METHODS FOR CELL EXPANSION AND USES OF CELLS AND CONDITIONED MEDIA    PRODUCED THEREBY FOR THERAPY
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          PCT/IL2007/000380
         </b>
        </p>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         China, Hong Kong
        </span>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Australia, Canada, China, Hong Kong, Europe, Israel, India, Japan, South Korea, Mexico, Russia, Singapore
        </span>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         March 23, 2027
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          ADHERENT CELLS FROM PLACENTA TISSUE AND USE THEREOF IN THERAPY
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          PCT/IL2008/001185
         </b>
        </p>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         United States, Israel
        </span>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Australia, Brazil, Canada, China, Europe, Hong Kong, Israel, India, Japan, Mexico, Russia, United States, South Korea
        </span>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         September 2, 2028
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          METHODS OF TREATING INFLAMMATORY COLON DISEASES
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          PCT/IL2009/000527
         </b>
        </p>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         United States, Israel, Russia
        </span>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         May 26, 2029
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          METHODS OF SELECTION OF CELLS FOR TRANSPLANTATION
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          PCT/IL2009/000844
         </b>
        </p>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Europe, Israel
        </span>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         September 1, 2029
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          ADHERENT CELLS FROM PLACENTA TISSUE AND USE THEREOF IN THERAPY
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          PCT/IL2009/000846
         </b>
        </p>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Australia, Canada, China, Europe, Hong Kong, Israel, India, Mexico, Russia, Singapore, United States
        </span>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         September 1, 2029
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          ADHERENT CELLS FROM PLACENTA TISSUE AND USE THEREOF IN THERAPY
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          PCT/IL2009/000845
         </b>
        </p>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         United States, Europe, Israel
        </span>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         September 1, 2029
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          ADHERENT STROMAL CELLS DERIVED FROM PLANCENTAS OF MULTIPLE DONORS    AND USES THEREOF
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          PCT/IB2011/001413
         </b>
        </p>
       </td>
       <td>
       </td>
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         United States
        </p>
       </td>
       <td>
       </td>
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         Israel
        </p>
       </td>
       <td>
       </td>
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         Israel: April 21, 2031
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         U.S: March 22, 2027
        </p>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          ADHERENT CELLS FROM PLACENTA AND USE OF SAME IN DISEASE TREATMENT
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          PCT/IB2010/003219
         </b>
        </p>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         United States, Israel
        </span>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Australia, Canada, China, Hong Kong, Europe, Israel, Mexico, New Zealand, United States
        </span>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         November 29, 2030
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="margin: 0">
    </p>
    <div>
    </div>
    <p style="margin: 0">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 10; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      6
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="margin: 0">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          METHODS AND SYSTEMS FOR HARVESTING ADHERENT STROMAL CELLS
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          PCT/IB2012/000933
         </b>
        </p>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         China, Israel
        </span>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Australia, Canada, Europe, Israel, India, South Korea, Mexico, Singapore, United States
        </span>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         April 15, 2032
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          METHODS FOR TREATING RADIATION OR CHEMICAL INJURY
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          PCT/IB2012/000664
         </b>
        </p>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         United States
        </span>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Europe, Hong Kong, Israel, Japan, South Korea, United States
        </span>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         March 22, 2032
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="width: 41%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          SKELETAL MUSCLE REGENERATION USING MESENCHYMAL STEM CELLS
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          PCT/EP2011/058730
         </b>
        </p>
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 16%">
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 20%">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         United States, Europe, Israel
        </span>
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 20%">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         May 27, 2031
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          GENE AND PROTEIN EXPRESSION PROPERTIES OF ADHERENT STROMAL CELLS    CULTURED IN 3D
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          PCT/IB2014/059114
         </b>
        </p>
       </td>
       <td>
       </td>
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
        </p>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Israel, United States
        </span>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         February 20, 2034
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          DEVICES AND METHODS FOR CULTURE OF CELLS
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          PCT/IB2013/058184
         </b>
        </p>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         United States, Israel
        </span>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         August 31, 2033
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          METHODS FOR PREVENTION AND TREATMENT OF PREECLAMPSIA
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          PCT/IB2013/058186
         </b>
        </p>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         China, Hong Kong, Europe, Israel, Japan, South Korea, United States
        </span>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         August 31, 2033
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          METHOD AND DEVICE FOR THAWING BIOLOGICAL MATERIAL
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          PCT/IB2013/059808
         </b>
        </p>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         China
        </span>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Australia, Europe, Hong Kong, Israel, India, Japan, South Korea, Russia, Singapore, United States
        </span>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         October 31, 2033
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td>
        <p style="margin-top: 0; margin-bottom: 0">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          <b>
           SYSTEMS AND METHODS FOR GROWING AND HARVESTING CELLS
          </b>
         </span>
        </p>
        <p style="margin-top: 0; margin-bottom: 0">
         <span style="font: 10pt Times New Roman, Times, Serif">
          <b>
           PCT/IB2015/051559
          </b>
         </span>
        </p>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Israel, United States
        </span>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         March 3, 2035
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING MUSCLE WASTING    DISORDERS
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          PCT/IB2015/059763
         </b>
        </p>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Israel, United States
        </span>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         December 18, 2035
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          USE OF ADHERENT STROMAL CELLS FOR ENHANCING HEMATOPOIESIS IN A SUBJECT    IN NEED THEREOF
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          PCT/IB2016/051585
         </b>
        </p>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         United States, China, Israel
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         March 21, 2036
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          ALTERED ADHERENT STROMAL CELLS AND METHODS OF PRODUCING AND USING    SAME
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          PCT/IB2016/053310
         </b>
        </p>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Europe, China, Israel
        </span>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         United States
        </span>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         June 6, 2036
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          METHODS AND COMPOSITIONS FOR TREATING CANCERS AND NEOPLASMS
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          PCT/IB2017/050868
         </b>
        </p>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         United States, Japan, Canada, Australia, Israel
        </span>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Europe
        </span>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         February 16, 2037
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td>
        <p style="margin-top: 0; margin-bottom: 0">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          <b>
           METHODS AND COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS
          </b>
         </span>
        </p>
        <p style="margin-top: 0; margin-bottom: 0">
         <span style="font: 10pt Times New Roman, Times, Serif">
          <b>
           PCT/IB2018/052806
          </b>
         </span>
        </p>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Israel, United States
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         April 23, 2038
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          METHODS AND COMPOSITIONS FOR TUMOR ASSESSMENT
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          PCT/IB2018/050984
         </b>
        </p>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         United States, Israel
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         February 18, 2038
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          METHODS AND COMPOSITIONS FOR TREATING ADDICTIONS
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          PCT/IB2018/055473
         </b>
        </p>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Israel, United States
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         July 23, 2038
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="margin: 0">
    </p>
    <div>
    </div>
    <p style="margin: 0">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 11; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      7
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="margin: 0">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="width: 41%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          METHODS AND COMPOSITIONS FOR DETACHING ADHERENT CELLS
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          Germany 10 2018 115 360.0
         </b>
        </p>
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 16%">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Germany
        </span>
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 20%">
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 20%">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         June 25-July 3, 2038
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <b>
          DRUG CONTAINING HUMAN PLACENTA-ORIGIN MESENCHYMAL CELLS AND PROCESS FOR PRODUCING VEGF USING THE CELLS JP20030579842
         </b>
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Japan
        </span>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         March 28, 2023
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <b>
          METHODS AND COMPOSITIONS FOR PRODUCING CANNABINOIDS
         </b>
        </span>
       </td>
       <td>
       </td>
       <td>
        PCT, Canada, Europe, Israel, Japan, United States
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         April 28, 2040
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          METHODS FOR EXPANDING ADHERENT STROMAL CELLS AND CELLS OBTAINED    THEREBY
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          PCT/IB2019/052569
         </b>
        </p>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Israel, Singapore, United States
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         March 28, 2039
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          METHODS AND COMPOSITIONS FOR TREATING SUBJECTS EXPOSED TO VESICANTS    AND OTHER CHEMICAL AGENTS
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          PCT/IB2019/055074
         </b>
        </p>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Israel, United States
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         June 18, 2039
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          METHODS AND COMPOSITIONS FOR FORMULATING AND DISPENSING PHARMACEUTICAL    FORMULATIONS
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          PCT/IB2019/053115
         </b>
        </p>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         United States
        </span>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Israel
        </span>
       </td>
       <td>
       </td>
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         United States: April 16, 2039
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         Israel: April 26, 2038
        </p>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          THERAPEUTIC DOSAGE REGIMENS COMPRISING ADHERENT STROMAL CELLS
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          PCT/IB2019/054828
         </b>
        </p>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Israel, United States
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         June 10, 2039
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          MODULAR BIOREACTOR
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          PCT/IB2019/058429
         </b>
        </p>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Europe, Israel, South Korea, Singapore, United States
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         October 3, 2039
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          THERAPEUTIC METHODS AND COMPOSITIONS
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          PCT/IB2019/059544
         </b>
        </p>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Israel, United States
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         November 6, 2039
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS AND SEQUELAE    THEREOF
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          PCT/IL2021/050268
         </b>
        </p>
       </td>
       <td>
       </td>
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         PCT, United States, Europe,
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         Israel, Mexico
        </p>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Israel
        </span>
       </td>
       <td>
       </td>
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         First Israeli application: May 14, 2040
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         Other applications: March 11, 2041
        </p>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          METHODS AND COMPOSITIONS FOR AESTHETIC AND COSMETIC TREATMENT AND    STIMULATING HAIR GROWTH
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          PCT/IL2020/050363
         </b>
        </p>
       </td>
       <td>
       </td>
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         PCT, United States, Europe,
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         Canada, China, Japan, Israel, Australia
        </p>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         March 26, 2040
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          METHODS FOR EXPANDING ADHERENT STROMAL CELLS AND CELLS OBTAINED    THEREBY
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          IL277560
         </b>
        </p>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Israel
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         September 23, 2040
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
     </b>
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 12; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      8
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
       Research and Development
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="text-decoration:underline">
      Foundational Research
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Our initial technology, the PluriX™ Bioreactor system, was inventedat the Technion – Israel Institute of Technology’s Rappaport Faculty of Medicine, in collaboration with researchers from theWeizmann Institute of Science. This technology was acquired by us and has been further significantly developed by our research and developmentteams over the ensuing years.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <span style="text-decoration:underline">
       Collaborations and Ongoing Research and Development Plans
      </span>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     <span style="text-decoration:underline">
      Charité Agreement
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In July 2007, we entered intoa five-year collaborative research agreement with the Berlin-Brandenburg Center for Regenerative Therapies at Charité – UniversityMedicine Berlin, or Charité, which was extended from time to time through June 2022. We and Charité are collaborating ona variety of indications utilizing PLX cells. According to the agreement, we will be the exclusive owner of the technology and any productsproduced as a result of the collaboration. Charité will receive between 1% to 2% royalties from net sales of new developments thathave been achieved during the joint development.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     <span style="text-decoration:underline">
      Fukushima Medical University
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We signed an MOU for a collaborationwith Fukushima Medical University, Fukushima Global Medical Science Center. The purpose of the collaboration is to develop Pluristem’sPLX-R18 cells for the treatment of ARS, and for morbidities following radiotherapy in cancer patients. The collaboration will proceedalongside research supported by the NIH, which is studying PLX-R18 as a potential treatment for the hematologic component of ARS. TheMOU for a collaboration with Fukushima will be renewed automatically on a yearly basis. Each party is entitled to terminate the agreementfor convenience upon providing the other party 30 days prior notice.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     <span style="text-decoration:underline">
      CHA Agreement
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span>
      OnJune 26, 2013, we entered into an exclusive out-licensing and commercialization agreement, or the CHA Agreement, with CHA for conductingclinical studies and commercialization of our PLX-PAD product candidate in South Korea in connection with two indications: the treatmentof CLI and IC.
     </span>
     We will continue to retain rights to our proprietary manufacturing technology and cell-related intellectual property.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span>
      Thefirst clinical study that was performed as part of the CHA Agreement was a Phase II study in IC. Upon the first regulatory approval fora PLX product in South Korea, if granted, for the specified indications, we and CHA will establish an equally owned joint venture withthe purpose of commercializing PLX cell products in South Korea. Additionally, we will be able to use the data generated by CHA to pursuethe development of PLX product candidates outside of South Korea.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     The term of the CHA Agreementextends from June 24, 2013 until the later of the expiration, lapse, cancellation, abandonment or invalidation of the last valid patentclaim covering the development of the product indications. The CHA Agreement contains customary termination provisions, including in theevent that the parties do not reach an agreement upon a development plan for conducting the clinical studies.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Upon termination of the CHAAgreement, the license granted thereunder will terminate, and all rights included therein will revert to us, whereupon we will be freeto enter into agreements with any other third parties for the granting of a license in or outside South Korea or to deal in any othermanner with such rights as it shall see fit in our sole discretion.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     <span style="text-decoration:underline">
      Horizon 2020
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     The Phase III study of PLX-PADin CLI was conducted as a collaborative project carried out by an international consortium led by the Berlin-Brandenburg Center for RegenerativeTherapies, together with the Company and with the participation of additional third parties.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Our Phase III study of PLX-PADcell therapy in the treatment of muscle recovery following surgery for hip fracture is a collaborative project carried out by an internationalconsortium led by Charité, together with us and with the participation of additional third parties.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In October 2017, we enteredinto a collaborative project, the nTRACK, carried out by an international consortium led by Leitat. The aim of this project is to examinegold nano particles labeling of stem cells to enable assessment of cells’ in vivo persistence and distribution in correlation tobiological efficacy. Under the project, PLX cells, labeled and non-labeled will be characterized and examined in animal models for muscleinjury.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 13; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      9
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     <span style="text-decoration:underline">
      Indiana University
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In April 2018, NIAID awardeda $2.5 million grant to Indiana University to conduct, together with us, studies of our PLX-R18 cell therapy in the treatment of ARS.The goal of this project is to extend the PLX-R18 ARS studies to include examination of survival in pediatric and geriatric populationsas well as the ability of PLX-R18 to alleviate delayed effects of radiation in survivors.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     <span style="text-decoration:underline">
      Thermo Fisher
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In July 2018, we entered intoa strategic collaboration agreement with Thermo Fisher Scientific Inc., or Thermo Fisher, with the aim of advancing the fundamental knowledgeof cell therapy industrialization and to improve quality control of the end-to-end supply chain. The collaboration enables us to combineThermo Fisher’s experience in cell therapy development and bioproduction scaleup with our expertise in cell therapy manufacturing,clinical development, and quality control.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     <span style="text-decoration:underline">
      Chart Industries
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In November 2018, we enteredinto a license agreement with a subsidiary of Chart Industries, Inc., or Chart, regarding our thawing device for cell-based therapies.Pursuant to the terms of the agreement, Chart obtained the exclusive rights to manufacture and market the thawing device in all territoriesworldwide, excluding Greater China, and we are to receive royalties from sales of the product and supply of an agreed upon number of thawingdevices. Royalties shall commence on the date of Chart’s first commercial sale of the thawing device.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     <span style="text-decoration:underline">
      NASA
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In February 2019, we entereda collaboration with NASA’s Ames Research Center to evaluate the potential of our PLX cell therapies in preventing and treatingmedical conditions caused during space missions.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     <span style="text-decoration:underline">
      U.S. Department of Defense
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span>
      In August 2017, we announcedthat a pilot study of our PLX-R18 cell therapy was initiated by the DoD. The study examined the effectiveness of PLX-R18 as a treatmentfor ARS prior to, and within the first 24 hours of exposure to radiation. In July 2019, we presented positive results from a series ofstudies of our PLX-R18 cell therapy product conducted by the DoD.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">
     <span style="text-decoration:underline">
      RESTORE
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We are members of a large-scaleresearch initiative, the RESTORE project which has received funding of €1,000,000 (approximately $1,100,000) from the European Union’sHorizon 2020 research and innovation program, to submit a full grant application for the development and advancement of transformativetherapeutics. Currently, due to COVID-19, there is no open call for full proposal. The members of the RESTORE project continue to collaboratein attempt to collectively submit the grant application once such call is available.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     <span style="text-decoration:underline">
      CRISPR-IL
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In June 2020, we announcedthat we were selected as a member of the CRISPR-IL consortium, a group funded by the IIA. CRISPR-IL brings together the leading expertsin life science and computer science from academia, medicine, and industry, to develop Artificial Intelligence, or AI, based end-to-endgenome-editing solutions. These next-generation, multi-species genome editing products for human, plant, and animal DNA, have applicationsin the pharma, agriculture, and aquaculture industries. CRISPR-IL is funded by the IIA with a total budget of approximately $10,000,000of which, an amount of approximately $480,000 is a direct grant allocated to us, for an initial period of 18 months, with a potentialfor extension of an additional 18 months, or the Second Period, with additional budget from the IIA.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In August 2021, we submittedan additional budget for the Second Period. The CRISPR-IL consortium program does not require us to pay royalties to the IIA.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 14; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      10
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     <span style="text-decoration:underline">
      United Arab Emirates-based Abu Dhabi Stem CellsCenter
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In August 2020, we signeda non-binding MOU with the United Arab Emirates-based Abu Dhabi Stem Cells Center, a specialist healthcare center focused on cell therapyand regenerative medicine. The aim of the collaboration is to capitalize on each party’s respective areas of expertise in cell therapies.The parties have agreed to exchange research results, share samples, join usage of equipment and testing, and other essential activitiesrelated to advancing the treatment and research of cell therapies for a broad range of medical conditions, including COVID-19.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We plan to continue to collaboratewith universities, academic institutions, and corporate partners worldwide to fully leverage our expertise and explore the use of ourcells in other indications.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
       In-House Clinical Manufacturing
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We have the in-house capabilityto perform clinical cell manufacturing. Our state-of-the-art Good Manufacturing Practice, or GMP, grade manufacturing facility in Haifahas been in use since February 2013 for the main purpose of clinical grade, large-scale manufacturing. The facility’s new automatedmanufacturing process and products were approved for production of PLX-PAD for clinical use by the FDA, EMA, MFDS, PMDA and the MOH. Oursecond product, PLX-R18, was cleared by the FDA and the MOH for clinical use. Furthermore, the site was inspected and approved by an EuropeanUnion qualified person (European accreditation body), approving that the site and production processes meet the current GMP for the purposeof manufacturing clinical grade products.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="text-align: justify; margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">
     The site was also inspected and approved by the MOH and we receiveda cGMP Certification and manufacturer-importer authorization.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We obtain the human placentasused for our research and manufacturing activities from various hospitals in Israel after receiving a written informed consent by themother and pathogen clearance. Any medical waste related to the use of placentas is treated in compliance with local environmental lawsand standards.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In June 2019, we announcedthat we developed a serum-free formulation to support the manufacturing of cell therapy products. This serum-free formulation was developedusing our deep understanding in cell therapy industrial scale production standards, and the quality methods designed to support implementationin Phase III development and marketing. Achieving this significant technological challenge is expected to provide us with large-scale,highly consistent production capacity with operational independency from third party suppliers for standard serum, an expensive and quantitylimited product. PLX-R18 is the first product candidate manufactured using the serum-free media.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      Government Regulation
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     The development, manufacturing,and future marketing of our cell therapy product candidates are subject to the laws and regulations of governmental authorities in theUnited States, Europe and Israel, as well as other countries in which our products may be marketed in the future like Japan, and SouthKorea. In addition, the manufacturing conditions are specifically inspected by the MOH.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     The FDA and the EMA must approveproducts prior to marketing. Furthermore, various governmental statutes and regulations also govern or influence testing, manufacturing,safety, labeling, storage and record keeping related to such products and their marketing. Governments in other countries have similarrequirements for testing and marketing.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     The process of obtaining theseapprovals and the subsequent compliance with appropriate statutes and regulations require the expenditure of substantial time, resourcesand money. There can be no assurance that our product candidates will ultimately receive marketing approval, or, if approved, will bereimbursed by public and private health insurance.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     There are several stages every drug undergoes duringits development process. Among these are:
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Performanceof nonclinical laboratory and animal studies to assess a drug’s biological activity and to identify potential safety concerns,and to characterize and document the product’s chemistry, manufacturing controls, formulation, and stability. In accordance withregulatory requirements, nonclinical safety and toxicity studies are conducted under Good Laboratory Practice, requirements toensure their quality and reliability;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Themanufacture of the product according to GMP regulations and standards;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Conductingadequate and well-controlled human clinical studies in compliance with Good Clinical Practice, or GCP, to establish the safety and efficacyof the product for its intended indication; and
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 15; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      11
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Potentialpost-marketing clinical testing and surveillance of the product after marketing approval, which can result in additional conditions onthe approvals or suspension of clinical use.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Approval of a drug for clinical
     <span>
      studies
     </span>
     in humans and approval of marketing are sovereign decisions of states, made by national,or, in case of the European Union, international regulatory competent authorities.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="text-decoration:underline">
      The Regulatory Process in the United States
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In the United States, ourproduct candidates are subject to regulation as a biological product under the Public Health Service Act and the Federal Food, Drug andCosmetic Act. The FDA, regulating the approval of clinical studies and marketing applications in the United States, generally requiresthe following steps prior to approving a new biological product for use either for clinical
     <span>
      studies
     </span>
     or for commercial sale:
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Submissionof an IND Application, which must become effective before clinical testing in humans can begin;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Obtainingapproval of Institutional Review Boards, or IRBs, of research institutions or other clinical sites to introduce the drug candidate intohumans in clinical studies;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         FDAmay grant approval for EAP prior to the completion of clinical
         <span>
          studies
         </span>
         , in order to allowaccess for the investigational drug, for patients that are excluded from the study;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         FDAmay grant priority review status to expedite the BLA review process. Obtaining a Fast Track designation allows access forthe request of priority review;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Submissionof a BLA for marketing authorization of the product, which must include adequate results of pre-clinical testing and clinical studies;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Submissionof BLA with a proof of efficacy that is based only on animal studies is feasible in instances where human efficacy studies cannot beconducted because the conduct of such studies is unethical and field studies after an accidental or deliberate exposure are not feasible;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         FDAreview of the BLA in order to determine, among other things, whether the product is safe and effective for its intended uses; and
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         FDAinspection and approval of the product manufacturing facility at which the product will be manufactured.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="text-decoration:underline">
      The Regulatory Process in Europe
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In the European Union, ourinvestigational cellular products are regulated under the Advanced Therapy Medicinal Product regulation, a regulation specific to celland tissue products. This European Union regulation requires:
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Filinga Clinical Trial Application for each European country involved in the clinical study. The application may be filed via a centralizedprocedure, which makes it possible to obtain a coordinated assessment of an application for a clinical study that is to take place inseveral European countries;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Obtainingapproval of affiliated ethics committees to test the investigational product into humans in clinical studies;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Adequateand well-controlled clinical studies to establish the safety and efficacy of the investigational product for its intended use; and
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; font-size: 10pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
         Since our investigational cellular products are regulated under theAdvanced Therapy Medicinal Product regulation, the application for marketing authorization to the EMA is mandatory within the 28 memberstates of the European Union. The EMA is expected to review and approve the MAA.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
        </p>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 14.15pt">
     In May 2015, we were selectedby the EMA for development of PLX-PAD cells via the EMA Adaptive Pathways Project.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 16; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      12
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="text-decoration:underline">
      Other Regulations
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In general, the approval procedurevaries among countries, and may involve additional preclinical testing and clinical studies. The requirements and time required may differfrom those required for FDA or EMA approval. Each country may impose certain procedures and requirements of its own. Most countries otherthan the United States, the European Union and Japan are willing to consider requests for marketing approval only after the product hadbeen approved for marketing by either the FDA, the EMA or the PMDA. The decision regarding marketing approval is made following the submissionof a dossier that is thoroughly assessed and critically addressed.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In Japan, we have completedthe required regulatory interactions with the PMDA, prior to the submission of clinical study notification, in the framework of the newregulations for regenerative therapy effective in November 2014, which promote expedited approval for regenerative therapies that arebeing developed for seriously debilitating/life-threatening indications.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="text-decoration:underline">
      Clinical Studies
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Typically, in the United States,as well as in the European Union, clinical development involves a three-phase process, although the phases may overlap. Phase I,clinical studies are conducted in a small number of healthy volunteers, or patients in cases of ethical issues with using healthy volunteersand are designed to provide information about product safety and to evaluate the pattern of drug distribution and metabolism within thebody.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Phase II clinical studiesare conducted with a homogenous group of patients afflicted with the specific target disease, to explore preliminary efficacy, optimaldosages and confirm the safety profile. In some cases, an initial study is conducted in patients to assess both preliminary efficacy andpreliminary safety and patterns of drug metabolism and distribution, in which case it is referred to as a Phase I/II study. Phase IIIclinical studies are generally large-scale, multi-center, controlled studies conducted with a heterogeneous group of patients afflictedwith the target disease, aiming to provide statistically significant support of efficacy, as well as safety and potency. The Phase IIIstudies are considered confirmatory for establishing the efficacy and safety profile of the drug and are critical for approval. In somecircumstances, a regulatory agency may require Phase IV, or post-marketing studies in case additional information needs to be collectedafter the drug is on the market.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     During all phases of clinicaldevelopment, regulatory agencies require extensive monitoring and auditing of all clinical activities, clinical data and clinical studysites investigators to minimize risks and ensure high quality and integrity of the collected data. The sponsor of a clinical study isrequired to submit an annual safety report to the relevant regulatory agencies, in which serious adverse events are reported, and alsoto submit in an expedited manner any individual serious adverse events that are suspected to be related to the tested drug and are unexpectedwith its use. An agency may, at its discretion, re-evaluate, alter, suspend, or terminate the clinical
     <span>
      study
     </span>
     based upon the data that have been accumulated to that point and its assessment of the risk/benefit ratio to the patient.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
       Employees
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     As of June 30, 2021, we employeda total of 153 full-time employees and nine part-time employees, of whom, 129 full-time employees and nine part-time employees are engagedin research and development, manufacturing and clinical development.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
       Competition
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     The regenerative medicinefield is characterized by intense competition, as global and local pharma players are becoming more engaged in the cell therapy fieldbased on the advancements made in clinical studies and due to the new favorable regenerative medicine legislation in certain regions.We face competition from both allogeneic and autologous cell therapy companies, academic, commercial and research institutions, pharmaceuticalcompanies, biopharmaceutical companies, and governmental agencies. Some of the clinical indications we currently have under developmentare also being investigated in preclinical and clinical programs by others.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     While there are hundreds ofcompanies in the regenerative medicine space globally, there are multiple participants in the cell therapy field based in the United States,Europe, Japan, Korea, and Australia such as Athersys Inc., Celularity Inc., Tigenix NV (acquired by Takeda), SanBio Inc. and MesoblastLtd. Among other things, we expect to compete based upon our intellectual property portfolio, our in-house manufacturing efficienciesand capabilities, and the efficacy of our products. Our ability to compete successfully will depend on our continued ability to attractand retain experienced and skilled executives, scientific and clinical development personnel, to identify and develop viable cellulartherapeutic candidates, and exploit these products commercially.
     <span>
      Given the magnitude of the potentialopportunity for cell therapy, we expect competition in this area to intensify.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
     </b>
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 17; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      13
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
       Impact of COVID-19
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In managing our ongoing global clinical studies, as well as our dailyoperations, in the ongoing COVID-19 global pandemic, we are taking all necessary precautions for the safety and well-being of patients,healthcare providers involved in our studies, and our employees. We are continuing our operational and manufacturing activities, subjectto the directives of the MOH, with a dedicated team on site at our facilities. In addition, the majority of our employees have been vaccinatedand we are using remote work technologies that enable the mitigation of office staff while allowing other activities to be conducted withoutthe need for a physical presence in our facilities. The COVID-19 global pandemic caused delays in enrollment of some of our clinical studies.Despite these impacts, we currently hold supplies of PLX cells in inventory in Israel, and in secure storage facilities in Europe andthe U.S. In addition, we are following the FDA and EMA guidelines regarding the management of clinical studies during COVID-19. However,the impact of the COVID-19 global pandemic is constantly evolving, and we may experience further impacts on our daily operations, includingthe need for employees to potentially self-isolate based on potential exposure to the virus, difficulties for our employees in travellingabroad, and delays in our clinical trials and our ongoing research work with various hospitals and academic institutions.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
       Available Information
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Additional information aboutus is contained on our Internet website at www.pluristem.com. Information on our website is not incorporated by reference into this report.Under the “SEC Filings” and “Financial Information” sections, under the “Investors&amp; Media” sectionof our website, we make available free of charge our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) of the Securities Exchange Act of 1934, as amended,or the Exchange Act, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. Ourreports filed with the SEC are also made available on the SEC’s website at www.sec.gov. The following Corporate Governance documentsare also posted on our website: Code of Business Conduct and Ethics, Trading Policy and the Charters for each of the Committees of ourBoard of Directors, or the Board.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <div>
     <a id="p_003">
     </a>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="text-transform: uppercase">
      <b>
       Item 1A. Risk Factors.
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     An investment in our securitiesinvolves a high degree of risk. You should consider carefully the following information about these risks, together with the other informationcontained in this Annual Report on Form 10-K before making an investment decision. Our business, prospects, financial condition and resultsof operations may be materially and adversely affected as a result of any of the following risks. The value of our securities could declineas a result of any of these risks. You could lose all or part of your investment in our securities. Some of the statements in “Item1A. Risk Factors” are forward-looking statements. The following risk factors are not the only risk factors facing our Company. Additionalrisks and uncertainties not presently known to us or that we currently deem immaterial may also affect our business, prospects, financialcondition and results of operations.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 0; text-align: center">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 0; text-align: center">
     <b>
      Summary of Risk Factors
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 0; text-align: justify">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Our business is subject to a number of risks,including risks that may adversely affect our business, financial condition and results of operations. These risks are discussed morefully below and include, but are not limited to, risks related to:
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        ●
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif">
         theCOVID-19 pandemic has caused interruptions and delays of our business plan and may have a significant adverse effect on our business;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        ●
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif">
         wehave a history of losses and have not generated significant revenues to date. We expect to experience future losses and do not foreseegenerating significant or steady revenues in the immediate future;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        ●
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif">
         wemay need to raise additional capital to meet our business requirements in the future, and such capital raising may be costly or difficultto obtain and could dilute our shareholders’ ownership interests, and such offers or availability for sale of a substantial numberof our common shares may cause the price of our publicly traded shares to decline;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        ●
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif">
         wemay become subject to claims by much larger and better funded competitors enforcing their intellectual property rights against us orseeking to invalidate our intellectual property or our rights thereto;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        ●
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif">
         clinicalstudies necessary to support the approval of our applications are often lengthy and expensive and require the enrollment of a large numberof patients. Suitable patients may be difficult to identify and enroll. Any delay or failure of clinical trials could delay us from commercializingour product candidates, which would materially and adversely affect our results of operations and the value of our business;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 18; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      14
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        ●
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif">
         wemay not be able to successfully license our product candidates;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        ●
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif">
         thereare inherent risks in the manufacturing of our product candidates, including meeting relevant high regulatory standards, the failureof which could materially and adversely affect our results of operations and the value of our business;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        ●
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif">
         wemay be subject, directly or indirectly, to applicable U.S. federal and state anti-kickback, false claims laws, healthcare and securitylaws and regulations, which could expose us to criminal sanctions civil penalties, contractual damages, reputational harm and diminishedprofits and future earnings;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        ●
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif">
         wemay be exposed to product liability and corporate claims and insurance may not be sufficient to cover these claims;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        ●
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif">
         inthe United States and Europe, our business could be significantly and adversely affected by healthcare reform initiatives and/or otherlegislation or judicial interpretations of existing or future healthcare laws and/or regulations;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        ●
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif">
         ifwe are unable to obtain and maintain intellectual property protection covering our products and technology, others may be able to utilizeour intellectual property, which would adversely affect our business;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        ●
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif">
         weare an international business, and we are exposed to various global and local risks that could have a material adverse effect on ourfinancial condition and results of operations;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        ●
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif">
         themarket prices of our common shares are subject to fluctuation and have been and may continue to be volatile, which could result in substantiallosses for investors;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        ●
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif">
         weanticipate being subject to fluctuations in currency exchange rates because a significant portion of our business is conducted outsidethe United States and we are exposed to currency exchange fluctuations in other currencies such as the New Israeli Shekel, or NIS, andthe Euro, because a significant portion of our expenses in Israel are paid in NIS, and we anticipate receipt of additional funds in Eurosfrom the EIB Finance Agreement;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        ●
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif">
         restrictionsand covenants contained in the EIB Finance Agreement may restrict our ability to conduct certain strategic initiatives;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 48px">
       </td>
       <td style="width: 24px; font-size: 10pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify; font-size: 10pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         limitations we may face relating to the grants we have received from the IIA may impact our plans and future decisions;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        ●
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif">
         ifthere are significant shifts in the political, economic and military conditions in Israel and its neighboring countries, it could havea material adverse effect on our business relationships and profitability; and
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        ●
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif">
         itmay be difficult for investors in the United States to enforce any judgments obtained against us or some of our directors or officers.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 19; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      15
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
     <b>
      Risk Related to Our Business
     </b>
    </p>
    <div>
    </div>
    <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
     <b>
      <i>
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
       We may need to raise additional financingto support the research, development and manufacturing of our cell therapy products in the future, but we cannot be sure we will be ableto obtain additional financing on terms favorable to us when needed. If we are unable to obtain additional financing to meet our needs,our operations may be adversely affected or terminated.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     It is highly likely that wewill need to raise significant additional capital in the future. Although we were successful in raising capital in the past, our currentfinancial resources are limited, and are dependent, to a certain extent, on our achieving certain milestones, and may not be sufficientto finance our operations until we become profitable, if that ever happens.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     It is likely that we willneed to raise additional funds in the future in order to satisfy our working capital and capital expenditure requirements. Therefore,we are dependent on our ability to sell our common shares for funds, receive grants, potentially receive milestone payments pursuant tothe EIB Finance Agreement, enter into collaborations and licensing deals or to otherwise raise capital. There can be no assurance thatwe will be able to obtain financing, including any funding under the EIB Finance Agreement. Any sale of our common shares in the futurewill result in dilution to existing shareholders and could adversely affect the market price of our common shares.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Also, we may not be able toborrow or raise additional capital in the future to meet our needs or to otherwise provide the capital necessary to conduct the developmentand commercialization of our potential cell therapy products, which could result in the loss of some or all of one’s investmentin our common shares.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
       Our likelihood of profitability dependson our ability to license and/or develop and commercialize our products based on our cell production technology, which is currently inthe development stage. If we are unable to complete the development and commercialization of our cell therapy products successfully, ourlikelihood of profitability will be limited severely
      </i>
      .
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We are engaged in the businessof developing cell therapy products. We have not realized a profit from our operations to date and there is little likelihood that wewill realize any profits in the short or medium term. Any profitability in the future from our business will be dependent upon successfulcommercialization of our potential cell therapy products and/or licensing of our products, which will require additional research anddevelopment.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
       The clinical manufacturing process for celltherapy products is complex and requires meeting high regulatory standards. Any delay or problem in the clinical manufacturing of PLXmay result in a material adverse effect on our business.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Our manufacturing process,controls, equipment and quality system for PLX-PAD have received approval from the FDA, EMA, Germany’s PEI, the MFDS and the PMDA.However, the clinical manufacturing process is complex, and we have no experience in manufacturing our product candidates at a commerciallevel.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     There can be no guaranteethat we will be able to successfully develop and manufacture our product candidates in a manner that is cost-effective or commerciallyviable, or that our development and manufacturing capabilities might not take much longer than currently anticipated to be ready for themarket. In addition, if we fail to maintain regulatory approvals for our manufacturing facilities, we may suffer delays in our abilityto manufacture our product candidates. This may result in a material adverse effect on our business.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
       If we are not able to successfully licenseand/or develop and commercialize our cell therapy product candidates and obtain the necessary regulatory approvals, we may not generatesufficient revenues to continue our business operations.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     So far, the product candidateswe are developing have completed one Phase I/II clinical trial of Gluteal Musculature rehabilitation after total hip arthroplasty (efficacy,ongoing for safety), two Phase I clinical trials for CLI, one Phase II clinical trial in IC and a multinational Phase III study in CLI.In addition, we currently have two ongoing Phase II FDA studies of PLX cells for the treatment of COVID-19 complicated by ARDS and onePhase III multinational clinical trial with our PLX-PAD product candidate in muscle recovery following surgery for hip fracture. In addition,our second product candidate, PLX-R18, is currently in a Phase I study for recovery following HCT. Our early stage cell therapy productcandidates may fail to perform as we expect. Moreover, even if our cell therapy product candidates successfully perform as expected, inlater stages of development they may fail to show the desired safety and efficacy traits despite having progressed successfully throughpre-clinical or initial clinical testing. We will need to devote significant additional research and development, financial resourcesand personnel to develop commercially viable products and obtain the necessary regulatory approvals.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 20; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      16
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     If our cell therapy productcandidates do not prove to be safe and effective in clinical trials, we will not obtain the required regulatory approvals. If we failto obtain such approvals, we may not generate sufficient revenues to continue our business operations.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Even if we obtain regulatoryapproval of a product, that approval may be subject to limitations on the indicated uses for which it may be marketed. Even after grantingregulatory approval, the FDA, the EMA, and regulatory agencies in other countries continue to regulate marketed products, manufacturersand manufacturing facilities, which may create additional regulatory barriers and burdens. Later discovery of previously unknown problemswith a product, manufacturer or facility, may result in restrictions on the product or manufacturer, including a withdrawal of the productfrom the market.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Further, regulatory agenciesmay establish additional regulations that could prevent or delay regulatory approval of our product candidates.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
       We have not generated significant or consistent revenues to date,which raises doubts with respect to our ability to generate revenues in the future.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We have a limited operatinghistory in our business of commercializing cell production technology. Until we entered into the prior license agreement with United TherapeuticsCorporation which was terminated in December 2015, we did not generate any material revenues and we have not generated any material revenuessince that date. It is not clear when we will generate revenues or whether we will experience further delays in recognizing revenues suchas if we experienced a clinical hold. Our primary source of funds has been the sale of our common shares, government grants and fundsdistributed pursuant to our EIB Finance Agreement. We cannot give assurances that we will be able to generate any significant revenuesor income in the future. There is no assurance that we will ever be profitable.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
       If we encounter problems or delays in theresearch and development of our potential cell therapy products, we may not be able to raise sufficient capital to finance our operationsduring the period required to resolve such problems or delays.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Our cell therapy productsare currently in the development stage and we anticipate that we will continue to incur substantial operating expenses and incur net lossesuntil we have successfully completed all necessary research and clinical trials. We, and any of our potential collaborators, may encounterproblems and delays relating to research and development, regulatory approval and intellectual property rights of our technology. Ourresearch and development programs may not be successful, and our cell culture technology may not facilitate the production of cells outsidethe human body with the expected result. Our cell therapy products may not prove to be safe and efficacious in clinical trials. If anyof these events occur, we may not have adequate resources to continue operations for the period required to resolve the issue delayingcommercialization and we may not be able to raise capital to finance our continued operation during the period required for resolutionof that issue. Accordingly, we may be forced to discontinue or suspend our operations.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
       Because most of our officers and directorsare located in non-U.S. jurisdictions, you may have no effective recourse against the management for misconduct and may not be able toenforce judgment and civil liabilities against our officers, directors, experts and agents.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Most of our directors andofficers are nationals and/or residents of countries other than the United States, and all or a substantial portion of their assets arelocated outside the United States.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     As a result, it may be difficultto enforce within the United States any judgments obtained against our officers or directors, including judgments predicated upon thecivil liability provisions of the securities laws of the United States or any U.S. state.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
     </b>
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 21; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      17
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
     <b>
      <i>
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; ">
     <b>
      Risks Related to Development,Clinical studies, and Regulatory Approval of Our Product Candidates
     </b>
    </p>
    <div>
    </div>
    <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
       We cannot market and sell our cell therapyproduct candidates in the United States, Europe, or in other countries if we fail to obtain the necessary regulatory approvals or licensure.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We cannot sell our cell therapyproduct candidates until regulatory agencies grant marketing approval, or licensure. The process of obtaining regulatory approval is lengthy,expensive and uncertain. It is likely to take at least several years to obtain the required regulatory approvals for our cell therapyproduct candidates, or we may never gain the necessary approvals.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Any difficulties that we encounterin obtaining regulatory approval may have a substantial adverse impact on our operations and cause our share price to decline significantly.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     To obtain marketing approvalsin the United States and Europe for cell therapy product candidates we must, among other requirements, complete carefully controlled andwell-designed clinical trials sufficient to demonstrate to the FDA, the EMA and the PMDA that the cell therapy product candidates is safeand effective for each disease for which we seek approval. So far, we have successfully conducted Phase I/II and Phase I clinical trialsfor our PLX-PAD product candidate. Several factors could prevent completion or cause significant delay of these trials, including an inabilityto enroll the required number of patients or failure to demonstrate adequately that cell therapy product candidates are safe and effectivefor use in humans. Negative or inconclusive results from or adverse medical events during a clinical trial could cause the clinical trialto be repeated or a program to be terminated, even if other studies or trials relating to the program are successful. The FDA or EMA (or,if we seek to conduct development efforts in Japan, the PMDA) can place a clinical trial on hold if, among other reasons, it finds thatpatients enrolled in the trial are or would be exposed to an unreasonable and significant risk of illness or injury. If safety concernsdevelop, we, the FDA, the EMA or other regulatory bodies could stop our trials before completion.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
       If we are not able to conduct our clinicaltrials properly and on schedule, marketing approval by FDA, EMA, MOH and other regulatory authorities may be delayed or denied.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     The completion of our clinicaltrials may be delayed or terminated for many reasons, such as:
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         TheFDA, the EMA or the MOH does not grant permission to proceed or places additional trials on clinical hold;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Subjectsdo not enroll in our trials at the rate we expect, including as a result of COVID-19 pandemic;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Governmentactions, such as those enacted during the ongoing COVID-19 pandemic, that limit the general populations movement;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Theregulators may ask to increase subject’s population in the clinical trials;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Subjectsexperience an unacceptable rate or severity of adverse side effects;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Third party clinical                                                                                                                                                                       investigators and other related vendors do not perform our clinical trials on our anticipated schedule or consistent with the                                                                                                                                                                       clinical trial protocol, GCP and regulatory requirements, or other third parties do not perform data collection and analysis in a                                                                                                                                                                       timely or accurate manner;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Third party clinical                                                                                                                                                                       investigators and other related vendors may declare bankruptcy or terminate their business unexpectedly, which most likely will                                                                                                                                                                       result in further delays in our clinical trials’ anticipated schedule and cause additional expenditures;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Inspectionsof clinical trial sites by the FDA, EMA, MOH and other regulatory authorities find regulatory violations that require us to undertakecorrective action, suspend or terminate one or more sites, or prohibit us from using some or all of the data in support of our marketingapplications; or
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Oneor more IRBs suspends or terminates the trial at an investigational site, precludes enrollment of additional subjects, or withdraws itsapproval of the trial.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Our development costs willincrease if we have material delays in our clinical trials, or if we are required to modify, suspend, terminate or repeat a clinical trial.If we are unable to conduct our clinical trials properly and on schedule, marketing approval may be delayed or denied by the FDA, EMA,MOH and other regulatory authorities.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
       The results of our clinical trials may notsupport our product candidates’ claims or any additional claims we may seek for our product candidates and our clinical trials mayresult in the discovery of adverse side effects.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Even if any clinical trialthat we need to undertake is completed as planned, or if interim results from existing clinical trials are released, we cannot be certainthat such results will support our product candidates claims or any new indications that we may seek for our products or that the FDAor foreign authorities will agree with our conclusions regarding the results of those trials. The clinical trial process may fail to demonstratethat our products or a product candidate is safe and effective for the proposed indicated use, which could cause us to stop seeking additionalclearances or approvals for our product candidates. Any delay or termination of our clinical trials will delay the filing of our regulatorysubmissions and, ultimately, our ability to commercialize a product candidate. It is also possible that patients enrolled in clinicaltrials will experience adverse side effects that are not currently part of the product candidate’s profile.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 22; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      18
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">
     <b>
      <i>
       If our processing and storage facilities or our clinicalmanufacturing facilities are damaged or destroyed, our business and prospects would be adversely affected.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     If our processing and storagefacilities, our clinical manufacturing facility or the equipment in such facilities were to be damaged or destroyed, the loss of someor all of the stored units of our cell therapy drug candidates would force us to delay or halt our clinical trial processes. Wehave one clinical manufacturing facility located in Haifa, Israel. If these facilities or the equipment in them are significantly damagedor destroyed, we may not be able to quickly or inexpensively replace our manufacturing capacity.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
       Favorable results from compassionate usetreatment or initial interim results from a clinical trial do not ensure that later clinical trials will be successful and success inearly stage clinical trials does not ensure success in later-stage clinical trials.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     PLX cells have been administeredas part of compassionate use treatments, which permit the administration of the PLX cells outside of clinical trials. No assurance canbe given that any positive results are attributable to the PLX cells, or that administration of PLX cells to other patients will havepositive results. Compassionate use is a term that is used to refer to the use of an investigational drug outside of a clinical trialto treat a patient with a serious or immediately life-threatening disease or condition who has no comparable or satisfactory alternativetreatment options. Regulators often allow compassionate use on a case-by-case basis for an individual patient or for defined groups ofpatients with similar treatment needs.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     There is no assurance thatwe will obtain regulatory approval for PLX cells. We will only obtain regulatory approval to commercialize a product candidate if we candemonstrate to the satisfaction of the FDA, the EMA or other applicable regulatory authorities, in well-designed and conducted clinicaltrials, that the product candidate is safe and effective and that the product candidate, including the cell production methodology, otherwisemeets the appropriate standards required for approval. Clinical trials can be lengthy, complex and extremely expensive processes withuncertain results. A failure of one or more clinical trials may occur at any stage of testing.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Success in early clinicaltrials does not ensure that later clinical trials will be successful, and initial results from a clinical trial do not necessarily predictfinal results. While results from treating patients through compassionate use have in certain cases been successful, we cannot be assuredthat further trials will ultimately be successful. Results of further clinical trials may be disappointing.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Even if early stage clinicaltrials are successful, we may need to conduct additional clinical trials for product candidates with patients receiving the drug for longerperiods before we are able to seek approvals to market and sell these product candidates from the FDA and regulatory authorities outsidethe United States. Even if we are able to obtain approval for our product candidates through an accelerated approval review program, wemay still be required to conduct clinical trials after such an approval. If we are not successful in commercializing any of our lead productcandidates, or are significantly delayed in doing so, our business will be materially harmed.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
       We may not be able to secure and maintain research institutionsto conduct our clinical trials.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We rely on research institutionsto conduct our clinical trials. Specifically, the limited number of centers experienced with cell therapy product candidates heightensour dependence on such research institutions. Our reliance upon research institutions, including hospitals and clinics, provides us withless control over the timing and cost of clinical trials and the ability to recruit subjects. If we are unable to reach agreements withsuitable research institutions on acceptable terms, or if any resulting agreement is terminated, we may be unable to quickly replace theresearch institution with another qualified institution on acceptable terms. We may not be able to secure and maintain suitable researchinstitutions to conduct our clinical trials.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 23; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      19
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
       Our product development programs are based on novel technologiesand are inherently risky.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We are subject to therisks of failure inherent in the development of products based on new technologies. The novel nature of our therapeutics createssignificant challenges in regard to product development and optimization, manufacturing, government regulation, third partyreimbursement and market acceptance. For example, the FDA, the EMA and other countries’ regulatory authorities have relativelylimited experience with cell therapies. Very few cell therapy products have been approved by regulatory authorities to date forcommercial sale, and the pathway to regulatory approval for our cell therapy product candidates may accordingly be more complex andlengthier. As a result, the development and commercialization pathway for our therapies may be subject to increased uncertainty, ascompared to the pathway for new conventional drugs.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
       There are very few drugs and limited therapiesthat the FDA or EMA and other regulatory authorities have approved as treatments for some of the disease indications we are pursuing.This could complicate and delay FDA, EMA or other countries’ regulatory authorities’ approval of our biologic drug candidates.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     There are very few drugs andlimited therapies currently approved for the treatment of COVID-19, IC, ARS, muscle recovery following surgery for hip fracture or HCT.As a result, the clinical efficacy endpoints, or the criteria to measure the intended results of treatment may be difficult to determine.Despite our eligibility for certain accelerated pathways, this could increase the difficulty of our obtaining FDA, EMA or other countries’regulatory authorities’ approval to market our products.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
       Our cell therapy drug candidates representnew classes of therapy that the marketplace may not understand or accept.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Even if we successfully developand obtain regulatory approval for our cell therapy candidates, the market may not understand or accept them. We are developing cell therapyproduct candidates that represent novel treatments and will compete with a number of more conventional products and therapies manufacturedand marketed by others, including major pharmaceutical companies. The degree of market acceptance of any of our developed and potentialproducts will depend on a number of factors, including:
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         theclinical safety and effectiveness of our cell therapy drug candidates and their perceived advantage over alternative treatment methods,if any;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         adverseevents involving our cell therapy product candidates or the products or product candidates of others that are cell-based; and
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         thecost of our products and the reimbursement policies of government and private third party payers.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     If the health care communitydoes not accept our potential products for any of the foregoing reasons, or for any other reason, it could affect our sales, having amaterial adverse effect on our business, financial condition and results of operations.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
       We have limited experience in conductingPhase III trials. If we fail in the conduct of such trials, our business will be materially harmed.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Even though we have conductedPhase I, Phase II and Phase III trials, and we are currently conducting one Phase III trial for our PLX-PAD product candidate, two PhaseII studies of PLX cells for the treatment of severe COVID-19 complicated by ARDS, and a Phase I study for our PLX-R18 product, and haverecruited employees who are experienced in managing and conducting clinical trials, we have limited experience in this area.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     We will need to expand our experience andrely on consultants in order to obtain regulatory approvals for our therapeutic product candidates. The failure to successfully conductclinical trials could materially harm our business.
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; ">
     <b>
      <i>
       Interim, “top-line,” andpreliminary data from our clinical trials that we announce or publish from time to time may change as more patient data become availableor as additional analyses are conducted, and as the data are subject to audit and verification procedures, that could result in materialchanges in the final data.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     From time to time, we may publish interim, “top-line,” orpreliminary data from our clinical studies. Interim data from clinical trials that we may complete are subject to the risk that one ormore of the clinical outcomes may materially change as patient enrollment continues and more patient data become available. Preliminaryor “top-line” data also remain subject to audit and verification procedures that may result in the final data beingmaterially different from the preliminary data we previously published. As a result, interim and preliminary data should be viewed withcaution until the final data are available. Material adverse changes between preliminary, “top-line,” or interimdata and final data could significantly harm our business prospects.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 24; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      20
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
     <b>
      Risk Related to Commercialization of Our ProductCandidates
     </b>
    </p>
    <div>
    </div>
    <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
       We may not successfully maintain our existingexclusive out-licensing agreement with CHA, or establish new collaborative and licensing arrangements, which could adversely affect ourability to develop and commercialize our product candidates.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     One of the elements of ourbusiness strategy is to license our technology to other companies. Our business strategy includes establishing collaborations and licensingagreements with one or more pharmaceutical or biotechnology companies. To date, we have a strategic partnership with CHA for both theIC and CLI indications in Korea. Notwithstanding, we may not be able to further establish or maintain such licensing and collaborationarrangements necessary to develop and commercialize our product candidates.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Even if we are able to maintainor establish licensing or collaboration arrangements, these arrangements may not be on favorable terms and may contain provisions thatwill restrict our ability to develop, test and market our product candidates. Any failure to maintain or establish licensing or collaborationarrangements on favorable terms could adversely affect our business prospects, financial condition or ability to develop and commercializeour product candidates.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Our agreements with our collaboratorsand licensees may have provisions that give rise to disputes regarding the rights and obligations of the parties. These and other possibledisagreements could lead to termination of the agreement or delays in collaborative research, development, supply, or commercializationof certain product candidates, or could require or result in litigation or arbitration. Moreover, disagreements could arise with our collaboratorsover rights to intellectual property or our rights to share in any of the future revenues of products developed by our collaborators.These kinds of disagreements could result in costly and time-consuming litigation. Any such conflicts with our collaborators could reduceour ability to obtain future collaboration agreements and could have a negative impact on our relationship with existing collaborators.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
       The market for our products will be heavily dependent on thirdparty reimbursement policies.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Our ability to successfullycommercialize our product candidates will depend on the extent to which government healthcare programs, as well as private health insurers,health maintenance organizations and other third party payers will pay for our products and related treatments.
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     Reimbursement by third party payers depends ona number of factors, including the payer’s determination that use of the product is safe and effective, not experimental or investigational,medically necessary, appropriate for the specific patient and cost-effective. Reimbursement in the United States or foreigncountries may not be available or maintained for any of our product candidates. If we do not obtain approvals for adequate thirdparty reimbursements, we may not be able to establish or maintain price levels sufficient to realize an appropriate return on our investmentin product development. Any limits on reimbursement from third party payers may reduce the demand for, or negatively affect theprice of, our products. The lack of reimbursement for these procedures by insurance payers has negatively affected the market forour products in this indication in the past.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Managing and reducing healthcare costs has been a general concern of federal and state governments in the United States and of foreign governments. In addition,third party payers are increasingly challenging the price and cost-effectiveness of medical products and services, and many limit reimbursementfor newly approved health care products. In particular, third party payers may limit the indications for which they will reimbursepatients who use any products that we may develop. Cost control initiatives could decrease the price for products that we may develop,which would result in lower product revenues to us.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 25; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      21
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
     <b>
      Risk Related to Intellectual Property
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
       Our success depends in large part on ourability to develop and protect our technology and our cell therapy products. If our patents and proprietary rights agreements do not providesufficient protection for our technology and our cell therapy products, our business and competitive position will suffer.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Our success will also dependin part on our ability to develop our technology and commercialize cell therapy products without infringing the proprietary rights ofothers. We have not conducted full freedom of use patent searches and no assurance can be given that patents do not exist or could notbe filed which would have an adverse effect on our ability to develop our technology or maintain our competitive position with respectto our potential cell therapy products. If our technology components, devices, designs, products, processes or other subject matter areclaimed under other existing United States or foreign patents or are otherwise protected by third party proprietary rights, we may besubject to infringement actions. In such event, we may challenge the validity of such patents or other proprietary rights or we may berequired to obtain licenses from such companies in order to develop, manufacture or market our technology or products. There can be noassurances that we would be able to obtain such licenses or that such licenses, if available, could be obtained on commercially reasonableterms. Furthermore, the failure to either develop a commercially viable alternative or obtain such licenses could result in delays inmarketing our proposed products or the inability to proceed with the development, manufacture or sale of products requiring such licenses,which could have a material adverse effect on our business, financial condition and results of operations. If we are required to defendourselves against charges of patent infringement or to protect our proprietary rights against third parties, substantial costs will beincurred regardless of whether we are successful. Such proceedings are typically protracted with no certainty of success. An adverse outcomecould subject us to significant liabilities to third parties and force us to curtail or cease our development of our technology and thecommercialization our potential cell therapy products.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We have built the abilityto manufacture clinical grade adherent stromal cells in-house. Through our experience with adherent stromal cell-based product development,we have developed expertise and know-how in this field. To protect these expertise and know-how, our policies require confidentialityagreements with our employees, consultants, contractors, manufacturers and advisors. These agreements generally provide for protectionof confidential information, restrictions on the use of materials and assignment of inventions conceived during the course of performancefor us. These agreements might not effectively prevent disclosure of our confidential information.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
       Third parties may initiate legal proceedingsalleging that we are infringing their intellectual property rights, the outcome of which would be uncertain and could have a materialadverse effect on our business.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Our commercial success dependsupon our ability and the ability of our collaborators to develop, manufacture, market and sell our product candidates and use our proprietarytechnologies without infringing the proprietary rights of third parties. We have yet to conduct comprehensive freedom-to-operate searchesto determine whether our proposed business activities or use of certain of the patent rights owned by us would infringe patents issuedto third parties. We may become party to, or threatened with, future adversarial proceedings or litigation regarding intellectual propertyrights with respect to our products and technology, including interference proceedings before the U.S. Patent and Trademark Office. Thirdparties may assert infringement claims against us based on existing patents or patents that may be granted in the future. If we are foundto infringe a third party’s intellectual property rights, we could be required to obtain a license from such third party to continuedeveloping and marketing our products and technology. However, we may not be able to obtain any required license on commercially reasonableterms or at all.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Even if we were able to obtaina license, it could be non-exclusive, thereby giving our competitors access to the same technologies licensed to us. We could be forced,including by court order, to cease commercializing the infringing technology or product. In addition, we could be found liable for monetarydamages. A finding of infringement could prevent us from commercializing our product candidates or force us to cease some of our businessoperations, which could materially harm our business. For example, we are aware of issued third party patents directed to placental stemcells and their use for therapy and in treating various diseases. We may need to seek a license for one or more of these patents. No assurancescan be given that such a license will be available on commercially reasonable terms, if at all. Claims that we have misappropriated theconfidential information or trade secrets of third parties could have a similar negative impact on our business.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Even if resolved in our favor,litigation or other legal proceedings relating to intellectual property claims may cause us to incur significant expenses and could distractour technical and management personnel from their normal responsibilities. In addition, there could be public announcements of the resultsof hearings, motions or other interim proceedings or developments and if securities analysts or investors perceive these results to benegative, it could have a substantial adverse effect on the price of our common shares. Such litigation or proceedings could substantiallyincrease our operating losses and reduce the resources available for development activities or any future sales, marketing or distributionactivities. We may not have sufficient financial or other resources to adequately conduct such litigation or proceedings. Some of ourcompetitors are able to sustain the costs of such litigation or proceedings more effectively than we can because of their greater financialresources. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could have a materialadverse effect on our ability to compete in the marketplace.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 26; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      22
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
       We must further protect and develop our technology and productsin order to become a profitable company.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     If we do not complete thedevelopment of our technology and products by the time our patents expire and create additional sufficient layers of patents or otherintellectual property rights, other companies may use the technology to develop competing products. If this happens, we may lose our competitiveposition and our business would likely suffer.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Furthermore, the scope ofour patents may not be sufficiently broad to offer meaningful protection. In addition, our patents could be successfully challenged, invalidatedor circumvented so that our patent rights would not create an effective competitive barrier. We also intend to seek patent protectionfor any of our potential cell therapy products once we have completed their development. We also rely on trade secrets and un-patentableknow-how that we seek to protect, in part, by confidentiality agreements with our employees, consultants, suppliers and licensees. Theseagreements may be breached, and we might not have adequate remedies for any breach. If this were to occur, our business and competitiveposition would likely suffer.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
       The patent approval process is complex,and we cannot be sure that our pending patent applications or future patent applications will be approved.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     The patent position of biotechnologyand pharmaceutical companies generally is highly uncertain, involves complex legal and factual questions and has in recent years beenthe subject of much litigation. As a result, the issuance, scope, validity, enforceability and commercial value of our and any futurelicensors’ patent rights are highly uncertain. Our pending and future patent applications may not result in patents being issuedwhich protect our technology or products or which effectively prevent others from commercializing competitive technologies and products.Changes in either the patent laws or interpretation of the patent laws in the United States and other countries may diminish the valueof our patents or narrow the scope of our patent protection. The laws of foreign countries may not protect our rights to the same extentas the laws of the United States and we may not be able to obtain meaningful patent protection for any of our commercial products eitherin or outside the United States.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     No assurance can be giventhat the scope of any patent protection granted will exclude competitors or provide us with competitive advantages, that any of the patentsthat have been or may be issued to us will be held valid if subsequently challenged, or that other parties will not claim rights to orownership of our patents or other proprietary rights that we hold. Furthermore, there can be no assurance that others have not developedor will not develop similar products, duplicate any of our technology or products or design around any patents that have been or may beissued to us or any future licensors. Since patent applications in the United States and in Europe are not publicly disclosed until patentsare issued, there can be no assurance that others did not first file applications for products covered by our pending patent applications,nor can we be certain that we will not infringe any patents that may be issued to others.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 27; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      23
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">
     <b>
      Risk Related to Our CommonShares
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
       The price of our common shares may fluctuate significantly.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     The market for our commonshares may fluctuate significantly. A number of events and factors may have an adverse impact on the market price of our common shares,such as:
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 0.5in">
       </td>
       <td style="width: 0.25in">
        <span style="font: 10pt Times New Roman, Times, Serif">
         ●
        </span>
       </td>
       <td>
        <span style="font: 10pt Times New Roman, Times, Serif">
         results of our clinical trials or adverse events associated with our products;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 48px">
       </td>
       <td style="width: 24px">
        <span style="font: 10pt Times New Roman, Times, Serif">
         ●
        </span>
       </td>
       <td>
        <span style="font: 10pt Times New Roman, Times, Serif">
         the amount of our cash resources and our ability to obtain additional funding;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 48px">
       </td>
       <td style="width: 24px">
        <span style="font: 10pt Times New Roman, Times, Serif">
         ●
        </span>
       </td>
       <td>
        <span style="font: 10pt Times New Roman, Times, Serif">
         changes in our revenues, expense levels or operating results;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 48px">
       </td>
       <td style="width: 24px">
        <span style="font: 10pt Times New Roman, Times, Serif">
         ●
        </span>
       </td>
       <td>
        <span style="font: 10pt Times New Roman, Times, Serif">
         entering into or terminating strategic relationships;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 48px">
       </td>
       <td style="width: 24px">
        <span style="font: 10pt Times New Roman, Times, Serif">
         ●
        </span>
       </td>
       <td>
        <span style="font: 10pt Times New Roman, Times, Serif">
         announcements of technical or product developments by us or our competitors;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 48px">
       </td>
       <td style="width: 24px">
        <span style="font: 10pt Times New Roman, Times, Serif">
         ●
        </span>
       </td>
       <td>
        <span style="font: 10pt Times New Roman, Times, Serif">
         market conditions for pharmaceutical and biotechnology shares in particular;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 48px">
       </td>
       <td style="width: 24px">
        <span style="font: 10pt Times New Roman, Times, Serif">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font: 10pt Times New Roman, Times, Serif">
         changes in laws and governmental regulations, including changes in tax, healthcare, competition and patent laws;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 48px">
       </td>
       <td style="width: 24px">
        <span style="font: 10pt Times New Roman, Times, Serif">
         ●
        </span>
       </td>
       <td>
        <span style="font: 10pt Times New Roman, Times, Serif">
         disputes concerning patents or proprietary rights;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 48px">
       </td>
       <td style="width: 24px">
        <span style="font: 10pt Times New Roman, Times, Serif">
         ●
        </span>
       </td>
       <td>
        <span style="font: 10pt Times New Roman, Times, Serif">
         new accounting pronouncements or regulatory rulings;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 48px">
       </td>
       <td style="width: 24px">
        <span style="font: 10pt Times New Roman, Times, Serif">
         ●
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font: 10pt Times New Roman, Times, Serif">
         public announcements regarding medical advances in the treatment of the disease states that we are targeting;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 48px">
       </td>
       <td style="width: 24px">
        <span style="font: 10pt Times New Roman, Times, Serif">
         ●
        </span>
       </td>
       <td>
        <span style="font: 10pt Times New Roman, Times, Serif">
         patent or proprietary rights developments;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 48px">
       </td>
       <td style="width: 24px">
        <span style="font: 10pt Times New Roman, Times, Serif">
         ●
        </span>
       </td>
       <td>
        <span style="font: 10pt Times New Roman, Times, Serif">
         regulatory actions that may impact our products;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 48px">
       </td>
       <td style="width: 24px">
        <span style="font: 10pt Times New Roman, Times, Serif">
         ●
        </span>
       </td>
       <td>
        <span style="font: 10pt Times New Roman, Times, Serif">
         future sales of our common shares, or the perception of such sales;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 48px">
       </td>
       <td style="width: 24px">
        <span style="font: 10pt Times New Roman, Times, Serif">
         ●
        </span>
       </td>
       <td>
        <span style="font: 10pt Times New Roman, Times, Serif">
         disruptions in our manufacturing processes; and
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 48px">
       </td>
       <td style="width: 24px">
        <span style="font: 10pt Times New Roman, Times, Serif">
         ●
        </span>
       </td>
       <td>
        <span style="font: 10pt Times New Roman, Times, Serif">
         competition.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In addition, a global pandemic,such as the COVID-19 pandemic and a market downturn in general and/or in the biopharmaceutical sector in particular, may adversely affectthe market price of our securities, which may not necessarily reflect the actual or perceived value of our Company.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
       Future sales of our common shares may cause dilution.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Future sales of our commonshares, or the perception that such sales may occur, could cause immediate dilution and adversely affect the market price of our commonshares. If we raise additional capital by issuing equity securities, the percentage ownership of our existing shareholders may be reduced,and accordingly these shareholders may experience substantial dilution. We may also issue equity securities that provide for rights, preferencesand privileges senior to those of our common shares. Given our need for cash and that equity raising is the most common type of fundraisingfor companies like ours, the risk of dilution is particularly significant for shareholders of our company.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 28; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      24
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
     <b>
      Risks Related to Foreign Exchange Rates
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
       We are exposed to fluctuations in currency exchange rates.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     A significant portion of ourbusiness is conducted outside the United States. Therefore, we are exposed to currency exchange fluctuations in other currencies suchas the NIS and the Euro, because a significant portion of our expenses in Israel are paid in NIS, and we have also received €20 millionpursuant to the EIB Finance Agreement, all of which subjects us to the risks of foreign currency fluctuations. Our primary expenses paidin NIS are employee salaries, and lease payments on our facilities. During the fiscal year ended June 30, 2021, or Fiscal Year 2021, weentered into options contracts to hedge against some of the risk of changes in future cash flows from payments of payroll and relatedexpenses and costs of operations denominated in NIS.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
       The dollar cost of our operations in Israelwill increase to the extent increases in the rate of inflation in Israel are not offset by a devaluation of the NIS in relation to thedollar, which would harm our results of operations.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Since a considerable portionof our expenses such as employees’ salaries are linked to an extent to the rate of inflation in Israel, the dollar cost of our operationsis influenced by the extent to which any increase in the rate of inflation in Israel is or is not offset by the devaluation of the NISin relation to the dollar. As a result, we are exposed to the risk that the NIS, after adjustment for inflation in Israel, will appreciatein relation to the dollar. In that event, the dollar cost of our operations in Israel will increase and our dollar-measured results ofoperations will be adversely affected. We cannot predict whether the NIS will appreciate against the dollar or vice versa in the future.Any increase in the rate of inflation in Israel, unless the increase is offset on a timely basis by a devaluation of the NIS in relationto the dollar, will increase labor and other costs, which will increase the dollar cost of our operations in Israel and harm our resultsof operations.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
       The dollar cost of our loan from the EIBwill be subject to currency valuations of the U.S. dollar and the Euro
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Following the receipt of thefirst tranche of the loan from the EIB, which was provided in Euros pursuant to the EIB Finance Agreement, we have established both acash asset and a liability in our financial statements. If the Euro increases in value in relation to the U.S. dollar, both the assetand the liability of our loan from the EIB will increase, and if the Euro decreases in relation to the U.S. dollar, both the asset andliability will conversely decrease.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Since the tranche of the loanreceived from the EIB and the accumulated interest are payable together in a single installment within five years from disbursement ofthe tranche, and we are likely to use the cash received from the EIB to finance our operations, as time progress the cost basis of theliability is expected to increase and the cash asset is expected to decrease.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Therefore, the effect of currencyfluctuations of the Euro in relation to the U.S. dollar on the liability resulting from the loan from the EIB is expected to be greaterthan the effect on the cash asset.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     As part of our hedging strategy,we may use currency transactions of options and forward contracts to minimize the risk of financial exposure from fluctuations in theexchange rate of the U.S. dollar against the Euro, but there are no guaranties that we will be able to offset some or all the losses ifthe Euro inclines in value in relation to the U.S. dollar.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
       Our cash may be subject to a risk of lossand we may be exposed to fluctuations in interest rates.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Our assets include a significant component of cash and cash equivalentsand bank deposits.  We adhere to an investment policy set by our investment committee which aims to preserve our financial assets,maintain adequate liquidity and maximize returns. We believe that our cash is held in institutions whose credit risk is minimal and thatthe value and liquidity of our deposits are accurately reflected in our consolidated financial statements as of June 30, 2021. Currently,we hold part of our cash assets in bank deposits. However, nearly all of our cash and bank deposits are not insured by the Federal DepositInsurance Corporation, or the FDIC, or similar governmental deposit insurance outside the United States. Therefore, ourcash and any bank deposits that we now hold or may acquire in the future may be subject to risks, including the risk of loss or of reducedvalue or liquidity, particularly in light of the increased volatility and worldwide pressures in the financial and banking sectors.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 29; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      25
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
     <b>
      Other Risks
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
       The COVID-19 pandemic, or any other pandemic,epidemic or outbreak of an infectious disease, may materially and adversely affect our business and operations.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <i>
     </i>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.15pt 0pt 0; text-align: justify; text-indent: 0.5in">
     While COVID-19is still spreading globally, and the final implications of the pandemic are difficult to estimate at this stage, it is clear that it hasaffected the lives of a large portion of the global population. At this time, the pandemic has caused states of emergency to be declaredin various countries, travel restrictions imposed globally, quarantines established in certain jurisdictions and various institutionsand companies being closed. We are actively monitoring any developments regarding the pandemic and we are taking any necessary measuresto respond to the situation in cooperation with the various stakeholders.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.15pt 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.15pt 0pt 0; text-align: justify; text-indent: 0.5in">
     COVID-19 infectionof our workforce could result in a temporary disruption in our business activities, including manufacturing and other functions. Basedon guidelines provided by the Israeli Government, we have increased as much as possible the capacity and arrangement for employees towork remotely, and although the vast majority of our employees have been vaccinated and we have adopted hybrid working models to minimizeexposure, we cannot guaranty that there will be no infection and spread of the virus among our employees and staff.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.15pt 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.15pt 0pt 0; text-align: justify; text-indent: 0.5in">
     The COVID-19 pandemicis also affecting the United States, Israel and global economies and has affected, and may continue to affect, the conduct of our clinicaltrials and may in the future affect our operations and those of third parties on which we rely, including by causing disruptions in ourraw material supply. In that regard, to date we have experienced delays in enrolling patients in our various studies due to the COVID-19pandemic.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.15pt 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.15pt 0pt 0; text-align: justify; text-indent: 0.5in">
     In addition, theCOVID-19 pandemic may affect the operations of the FDA and other health authorities, which could result in delays of reviews and approvals,including with respect to our Phase III clinical trial related to muscle recovery following surgery for hip fracture. The evolving COVID-19pandemic has already impacted, and may continue to, directly or indirectly impact the pace of enrollment in our clinical trials as patientsmay avoid or may not be able to travel to healthcare facilities and physicians’ offices unless due to a health emergency and clinicaltrial staff may not be able to physically arrive to the clinical sites. Additionally, such facilities and offices have been and may continueto be required to focus limited resources on non-clinical trial matters, including treatment of COVID-19 patients, thereby decreasingavailability, in whole or in part, for clinical trial services. Additionally, the stock market has been unusually volatile during theCOVID-19 outbreak and such volatility may continue. To date, during certain periods of the COVID-19 pandemic, our share price fluctuatedsignificantly, and such fluctuation may continue to occur.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.15pt 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.15pt 0pt 0; text-align: justify; text-indent: 0.5in">
     The ultimate impactof the COVID-19 pandemic is highly uncertain and subject to change. We do not yet know the full extent of potential delays or impactson our business, financing or clinical trial activities, or on healthcare systems or the global economy as a whole if the pandemic continuesfor an extended period of time or significantly worsens. However, these effects could have a material impact on our liquidity, capitalresources, operations and business and those of the third parties on which we rely.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 30; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      26
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
       Since we received grants from the IIA, we are subject to on-goingrestrictions.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We have received royalty-bearinggrants from the IIA, for research and development programs that meet specified criteria. The terms of the IIA’s grants limit ourability to transfer know-how developed under an approved research and development program outside of Israel, regardless of whether theroyalties are fully paid. Any non-Israeli citizen, resident or entity that, among other things, becomes a holder of 5% or more of ourshare capital or voting rights, is entitled to appoint one or more of our directors or our Chief Executive Officer, or CEO, serves asa director of our Company or as our CEO is generally required to notify the same to the IIA and to undertake to observe the law governingthe grant programs of the IIA, the principal restrictions of which are the transferability limits described above. For more information,see “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and CapitalResources.”
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
       Since we have signed the EIB Finance Agreement,we have agreed to guaranty the loan and have also agreed to other limitations that require us to notify the EIB, and in some cases obtaintheir approval, before we engage with other banks for additional sources of funding or with potential partners for certain strategic activities.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     The EIB Finance Agreementcontains certain limitations that we must adhere to such as the use of proceeds received from the EIB, the disposal of assets, substantivechanges in the nature of our business, our potential execution of mergers and acquisitions, changes in our holding structure, distributionsof future potential dividends and our engaging with other banks and financing entities for other loans.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
       Our principal research and development and manufacturing facilitiesare located in Israel and the unstable military and political conditions of Israel may cause interruption or suspension of our businessoperations without warning.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Our principal research anddevelopment and manufacturing facilities are located in Israel. As a result, we are directly influenced by the political, economic andmilitary conditions affecting Israel. Since the establishment of the State of Israel in 1948, a number of armed conflicts have taken placebetween Israel and its Arab neighbors. During June 2021, July and August 2014 and November 2012, Israel was engaged in an armed conflictwith a militia group and political party which controls the Gaza Strip, and during the summer of 2006, Israel was engaged in an armedconflict with Hezbollah, a Lebanese Islamist Shiite militia group and political party. These conflicts involved missile strikes againstcivilian targets in various parts of Israel, including areas in which our employees and some of our consultants are located, and negativelyaffected business conditions in Israel. We cannot predict if or when armed conflict will take place and the duration of each conflict.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Furthermore, certain of ouremployees may be obligated to perform annual reserve duty in the Israel Defense Forces and are subject to being called up for active militaryduty at any time. All Israeli male citizens who have served in the army are required to perform reserve duty until they are between 40and 49 years old, depending upon the nature of their military service.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In addition, Israeli-basedcompanies and companies doing business with Israel, have been the subject of an economic boycott by members of the Arab League and certainother predominantly Muslim countries since Israel’s establishment. Although Israel has entered into various agreements with certainArab countries and the Palestinian Authority, and various declarations have been signed in connection with efforts to resolve some ofthe economic and political problems in the Middle East, we cannot predict whether or in what manner these problems will be resolved. Warsand acts of terrorism have resulted in significant damage to the Israeli economy, including reducing the level of foreign and local investment.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 31; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      27
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
     <b>
      Risk Related to Our Industry
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
       The trend towards consolidation in the pharmaceutical and biotechnologyindustries may adversely affect us.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     There is a trend towards consolidationin the pharmaceutical and biotechnology industries. This consolidation trend may result in the remaining companies having greater financialresources and technical discovery capabilities, thus intensifying competition in these industries. This trend may also result in fewerpotential collaborators or licensees for our therapeutic product candidates. Also, if a consolidating company is already doing businesswith our competitors, we may lose existing licensees or collaborators as a result of such consolidation. This trend may adversely affectour ability to enter into license agreements or agreements for the development and commercialization of our product candidates, and asa result may materially harm our business.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
       If we do not keep pace with our competitorsand with technological and market changes, our technology and products may become obsolete and our business may suffer.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     The cellular therapeuticsindustry, of which we are a part, is very competitive and is subject to technological changes that can be rapid and intense. We have faced,and will continue to face, intense competition from biotechnology, pharmaceutical and biopharmaceutical companies, academic and researchinstitutions and governmental agencies engaged in cellular therapeutic and drug discovery activities or funding, both in the United Statesand internationally. Some of these competitors are pursuing the development of cellular therapeutics, drugs and other therapies that targetthe same diseases and conditions that we target in our clinical and pre-clinical programs.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Some of our competitors havegreater resources, more product candidates and have developed product candidates and processes that directly compete with our products.Our competitors may have developed, or could develop in the future, new products that compete with our products or even render our productsobsolete.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
       Potential product liability claims couldadversely affect our future earnings and financial condition.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We face an inherent businessrisk of exposure to product liability claims in the event that the use of our products results in adverse effects. We may not be ableto maintain adequate levels of insurance for these liabilities at reasonable cost and/or reasonable terms. Excessive insurance costs oruninsured claims would add to our future operating expenses and adversely affect our financial condition.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 32; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      28
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
     <b>
      Risk Related to Our Dependence on Third Parties
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
       We are dependent upon third party suppliersfor raw materials needed to manufacture PLX; if any of these third parties fails or is unable to perform in a timely manner, our abilityto manufacture and deliver will be compromised.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In addition to the placentaused in the clinical manufacturing process of PLX, we require certain raw materials. These items must be manufactured and supplied tous in sufficient quantities and in compliance with current GMP. To meet these requirements, we have entered into supply agreements withfirms that manufacture these raw materials to current GMP standards. Our requirements for these items are expected to increase if andwhen we transition to the manufacture of commercial quantities of our cell-based drug candidates.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In addition, as we proceedwith our clinical trial efforts, we must be able to continuously demonstrate to the FDA, EMA and other regulatory authorities that wecan manufacture our cell therapy product candidates with consistent characteristics. Accordingly, we are materially dependent on thesesuppliers for supply of current GMP-grade materials of consistent quality. Our ability to complete ongoing clinical trials may be negativelyaffected in the event that we are forced to seek and validate a replacement source for any of these critical materials.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We intend to decrease ourdependency in third party suppliers for raw materials. To that effect we have developed a serum-free formulation which is expected tosupport the manufacturing of cell therapy products. This serum-free formulation was developed using our deep understanding in cell therapyindustrial scale production standards, and the quality methods designed to support implementation in Phase III development and marketing.Achieving this significant technological challenge is expected to provide us with large-scale, highly consistent production with operationalindependency from third party suppliers for standard serum, an expensive and quantity limited product. There can be no guarantee thatwe will successfully implement the use of our serum-free formulation to support the manufacturing of cell therapy products or any otherfuture product candidates, if any, that we seek to produce using such formulation, or that such implementation of the serum-free formulationwill decrease our dependency on third party suppliers for raw materials.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
       We rely and will continue to rely on thirdparties to conduct our clinical trials. If these third parties do not successfully carry out their contractual duties or meet expecteddeadlines, we may not be able to obtain regulatory approval of or commercialize our product candidates.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We depend and will dependupon independent investigators and collaborators, such as universities, medical institutions, CROs, vendors and strategic partners toconduct our pre-clinical and clinical trials under agreements with us. We negotiate budgets and contracts with CROs, vendors and studysites which may result in delays to our development timelines and increased costs. We rely heavily on these third parties over the courseof our clinical trials, and we control only certain aspects of their activities. Nevertheless, we are responsible for ensuring that eachof our studies is conducted in accordance with applicable protocol, legal, regulatory and scientific standards, and our reliance on thirdparties does not relieve us of our regulatory responsibilities. We and these third parties are required to comply with current good clinicalpractices, or cGCPs, which are regulations and guidelines enforced by the FDA and comparable foreign regulatory authorities for productcandidates in clinical development.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Regulatory authorities enforcethese cGCPs through periodic inspections of trial sponsors, principal investigators and trial sites. If we or any of these third partiesfail to comply with applicable cGCP regulations, the clinical data generated in our clinical trials may be deemed unreliable and the FDAor comparable foreign regulatory authorities may require us to perform additional clinical trials before approving our marketing applications.We cannot assure that, upon inspection, such regulatory authorities will determine that any of our clinical trials comply with the cGCPregulations. In addition, any Phase III clinical trials which we may conduct must be conducted with biologic product produced under cGMPand may require a large number of test patients. Biologic products for commercial purposes must also be produced under cGMP. Our failureor any failure by these third parties to comply with these regulations or to recruit a sufficient number of patients may require us torepeat clinical trials, which would delay the regulatory approval process. Moreover, our business may be implicated if any of these thirdparties violates federal or state fraud and abuse or false claims laws and regulations or healthcare privacy and security laws and regulations.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 33; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      29
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Any third parties conductingour clinical trials are not and will not be our employees and, except for remedies available to us under our agreements with such thirdparties, which in some instances may be limited, we cannot control whether or not they devote sufficient time and resources to our ongoingpre-clinical, clinical and nonclinical programs. These third parties may also have relationships with other commercial entities, includingour competitors, for whom they may also be conducting clinical
     <span>
      trials
     </span>
     or otherdrug development activities, which could affect their performance on our behalf. If these third parties do not successfully carry outtheir contractual duties or obligations or meet expected deadlines, if they declare bankruptcy or if they need to be replaced for whateverreason or if the quality or accuracy of the clinical data they obtain is compromised due to the failure to adhere to our clinical protocolsor regulatory requirements or for other reasons, our clinical trials may be extended, delayed or terminated and we may not be able tocomplete development of, obtain regulatory approval of or successfully commercialize our product candidates. As a result, our financialresults and the commercial prospects for our product candidates would be harmed, our costs could increase and our ability to generaterevenue could be delayed. Switching or adding third parties to conduct our clinical trials involves substantial cost and requires extensivemanagement time and focus. In addition, there is a natural transition period when a new third party commences work. As a result, delaysoccur, which can materially impact our ability to meet our desired clinical development timelines.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
       Our internal computer systems, or thoseused by our CROs or other contractors or consultants, may fail or suffer security breaches.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We rely on and utilize servicesprovided by third parties in connection with our clinical trials, which services involve the collection, use, storage and analysis ofpersonal health information. While we receive assurances from these vendors that their services are compliant with the Health InsurancePortability and Accountability Act, or HIPAA, and other applicable privacy laws, there can be no assurance that such third parties willcomply with applicable laws or regulations. Non-compliance by such vendors may result in liability for us which would have a materialadverse effect on our business, financial conditions and results of operations.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Despite theimplementation of security measures, our internal computer systems and those of our current and future CROs and other contractorsand consultants are vulnerable to damage from computer viruses, cyber security incidents and unauthorized access. While, to ourknowledge, we have not experienced any such material system failure or security breach to date, if such an event were to occur andcause interruptions in our operations, it could result in a material disruption of our development programs and our businessoperations. For example, the loss of clinical trial data from completed or future clinical trials could result in delays in ourregulatory approval efforts and significantly increase our costs to recover or reproduce the data. To the extent that any disruptionor security breach were to result in a loss of, or damage to, our data or applications, or inappropriate disclosure of confidentialor proprietary information, we could incur liability and the further development and commercialization of our product candidatescould be delayed.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
       Unsuccessful compliance with certain Europeanprivacy regulations could have an adverse effect on our business and reputation.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">
     <span>
      Thecollection and use of personal health data in the European Union is governed by the provisions of the General Data Protection Regulation,or GDPR. This directive imposes several requirements relating to the consent of the individuals to whom the personal data relates, theinformation provided to the individuals, notification of data processing obligations to the competent national data protection authoritiesand the security and confidentiality of the personal data. The GPDR also extends the geographical scope of European Union data protectionlaw to non-European Union entities under certain conditions, tightens existing European Union data protection principles and creates newobligations for companies and new rights for individuals. Failure to comply with the requirements of the GDPR and the related nationaldata protection laws of the European Union Member States may result in fines and other administrative penalties. There may be circumstancesunder which a failure to comply with GDPR, or the exercise of individual rights under the GDPR, would limit our ability to utilize clinicaltrial data collected on certain subjects. The GDPR regulations impose additional responsibility and liability in relation to personaldata that we process and we intend to put in place additional mechanisms ensuring compliance with these and/or new data protection rules.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">
     <span>
      Changesto these European privacy regulations and unsuccessful compliance may be onerous and adversely affect our business, financial condition,prospects, results of operations and reputation.
     </span>
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 34; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      30
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      <i>
       Existing government programs and tax benefits may be terminated.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We have received certain Israeligovernment approvals under certain programs and may in the future utilize certain tax benefits in Israel by virtue of these programs.To remain eligible for such tax benefits, we must continue to meet certain conditions. If we fail to comply with these conditions in thefuture, the benefits we receive could be canceled and have to pay additional taxes. We cannot guarantee that these programs and tax benefitswill be continued in the future, at their current levels or at all. If these programs and tax benefits are ended, our business, financialcondition and results of operations could be materially adversely affected.
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
       If we fail to obtain or maintain orphandrug exclusivity for our products, our competitors may sell products to treat the same conditions and our potential future revenue willbe reduced.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Our business strategy focuseson the development of drugs that are eligible for FDA and European Union orphan drug designation. Under the Orphan Drug Act, the FDA maydesignate a product as an orphan drug if it is intended to treat a rare disease or condition, defined as a patient population of fewerthan 200,000 in the United States, or a patient population greater than 200,000 in the United States where there is no reasonable expectationthat the cost of developing the drug will be recovered from sales in the United States. In the European Union, the EMA’s Committeefor Orphan Medicinal Products, or COMP, grants orphan drug designation to promote the development of products that are intended for thediagnosis, prevention, or treatment of a life-threatening or chronically debilitating condition affecting not more than five in 10,000persons in the European Union Community. Additionally, designation is granted for products intended for the diagnosis, prevention, ortreatment of a life threatening, seriously debilitating or serious and chronic condition and when, without incentives, it is unlikelythat sales of the drug in the European Union would be sufficient to justify the necessary investment in developing the drug or biologicalproduct.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In the United States, orphandrug designation entitles a party to financial incentives such as opportunities for grant funding towards clinical trial costs, tax advantages,and user-fee waivers. In addition, if a product receives the first FDA approval for the indication for which it has orphan designation,the product is entitled to orphan drug exclusivity, which means the FDA may not approve any other application to market the same drugfor the same indication for a period of seven years, except in limited circumstances, such as a showing of clinical superiority over theproduct with orphan exclusivity or where the manufacturer is unable to assure sufficient product quantity. In the European Union, orphandrug designation also entitles a party to financial incentives such as reduction of fees or fee waivers and ten years of market exclusivityis granted following drug or biological product approval. This period may be reduced to six years if the orphan drug designation criteriaare no longer met, including where it is shown that the product is sufficiently profitable not to justify maintenance of market exclusivity.
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Even if we obtain orphan drugexclusivity for a product, that exclusivity may not effectively protect the product from competition because different drugs with differentactive moieties can be approved for the same condition.
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Even with orphan drug exclusivity,if a third party were to prepare or market a product which infringes upon our intellectual property, we may need to initiate litigation,which may be costly, to enforce our rights against such party. After an orphan drug is approved, the FDA can subsequently approve thesame drug with the same active moiety for the same condition if the FDA concludes that the later drug is safer, more effective, or makesa major contribution to patient care. Orphan drug designation on its own neither shortens the development time or regulatory review timefor a drug.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
       While orphan drug products are typicallysold at a high price relative to other medications, the market may not be receptive to high pricing of our products.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We develop our product candidatesto treat rare and ultra-rare diseases, a space where medications are usually sold at high prices compared with other medications.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Accordingly, even if regulatoryauthorities approve our product candidates, the market may not be receptive to, and it may be difficult for us to achieve, a per-patientper-year price high enough to allow us to realize a return on our investment.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 35; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      31
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <i>
       We may be exposed to liabilities under theForeign Corrupt Practices Act, and any determination that we violated the Foreign Corrupt Practices Act could have a material adverseeffect on our business.
      </i>
     </b>
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We are subject to the ForeignCorrupt Practice Act, or FCPA, and other laws that prohibit U.S. companies or their agents and employees from providing anything of valueto a foreign official or political party for the purposes of influencing any act or decision of these individuals in their official capacityto help obtain or retain business, direct business to any person or corporate entity or obtain any unfair advantage. We have operationsand agreements with third parties. Our international activities create the risk of unauthorized and illegal payments or offers of paymentsby our employees or consultants, even though they may not always be subject to our control. We discourage these practices by our employeesand consultants. However, our existing safeguards and any future improvements may prove to be less than effective, and our employees orconsultants, may engage in conduct for which we might be held responsible for Any failure by us to adopt appropriate compliance proceduresand ensure that our employees and consultants comply with the FCPA and applicable laws and regulations in foreign jurisdictions couldresult in substantial penalties or restrictions on our ability to conduct business in certain foreign jurisdictions.
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Violations of the FCPA mayresult in severe criminal or civil sanctions, and we may be subject to other liabilities, which could negatively affect our business,operating results and financial condition. In addition, the U.S. government may seek to hold our Company liable for successor liabilityFCPA violations committed by companies in which we invest or that we acquire.
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <div>
     <a id="p_004">
     </a>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="text-transform: uppercase">
      <b>
       Item 1B. Unresolved StaffComments.
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     <span style="text-transform: uppercase">
     </span>
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     Not Applicable.
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <div>
     <a id="p_005">
     </a>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="text-transform: uppercase">
      <b>
       Item 2.Properties.
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Our principal executive, manufacturingand research and development offices are located at MATAM Advanced Technology Park, Building No. 5, Haifa, Israel, where we occupy approximately4,389 square meters. Our gross monthly rent payment for these leased facilities as of July 2021 was 263,000 NIS (approximately $80,000).For Fiscal Year 2021, we recognized a net expense (rent expenses after deducting deferred participation payments from MATAM) in the amountof $702,000, according to the implementation of Accounting Standards Update No. 2016-02, “Leases.”
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We believe that the currentspace we have is adequate to meet our current and foreseeable future needs.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">
     <b>
     </b>
    </p>
    <div>
    </div>
    <div>
     <a id="p_006">
     </a>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="text-transform: uppercase">
      <b>
       Item 3. Legal Proceedings.
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     <span style="text-transform: uppercase">
     </span>
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     None.
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
     </b>
    </p>
    <div>
    </div>
    <div>
     <a id="p_007">
     </a>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="text-transform: uppercase">
      <b>
       Item 4. Mine Safety Disclosures.
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     Not applicable.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="text-transform: uppercase">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 36; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      32
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <div>
     <a id="p_008">
     </a>
    </div>
    <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">
      <b>
       PARTII
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <div>
     <a id="p_009">
     </a>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">
      <b>
       Item5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Ourcommon shares trade on the Nasdaq Global Market and the Tel Aviv Stock Exchange under the symbol PSTI.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     As of September 3, 2021, therewere 89 holders of record, and 32,004,785 of our common shares were issued and outstanding.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      AmericanStock Transfer and Trust Company, LLC is the registrar and transfer agent for our common shares. Their address is 6201 15th Avenue, 2ndFloor, Brooklyn, NY 11219, telephone: (718) 921-8300, (800) 937-5449.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <div>
     <a id="p_010">
     </a>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">
      <b>
       Item6. [Reserved]
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <div>
     <a id="p_011">
     </a>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">
      <b>
       Item7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Weare a biotechnology company focused in the field of regenerative medicine, and a leading developer of placenta-based cell therapy productcandidates for the treatment of multiple inflammatory, muscle injuries and hematologic conditions. Our operations are focused on theresearch, development, manufacturing, conducting clinical trials and business development of cell therapeutics and related technologies.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      PLXcells are derived from a class of placental cells that are harvested from donated placenta at the time of full term healthy deliveryof a baby. The cells are grown using our proprietary three-dimensional expansion technology and can be administered to patients off the-shelf,without blood or tissue matching prior to administration. PLX cells are believed to release a range of therapeutic proteins in responseto the patient’s condition, such as inflammation, muscle trauma, hematological disorders and radiation damage.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We are conducting severalmultinational clinical studies which consist of a Phase III clinical study in muscle recovery following surgery for hip fracture and twoPhase II clinical studies in ARDS associated with COVID-19 in the United States, Europe and Israel. In addition, we are focusing on otherclinical programs in the hematological field such as a Phase I clinical study for incomplete recovery following bone marrow transplantationin the United States and Israel, an investigator-led Phase I/II cGVHD study in Israel, and ARS under the FDA animal rule. We believe thateach of these indications is a severe unmet medical need.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Our manufacturing facilitycomplies with the European, Japanese, Israeli, South Korean and the FDA’s cGMP requirements and has been inspected and approvedby the European and Israeli regulators for production of PLX-PAD for late stage trials. We have also been granted manufacturer/importerauthorization and cGMP Certification by the MOH. If we obtain FDA and other regulatory approvals to market PLX cells, we expect to havein-house production capacity to grow PLX cells in commercial quantities.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Ourgoal is to make significant progress with our clinical pipeline and our clinical studies in order to ultimately bring innovative, potenttherapies to patients who need new treatment options. We expect to demonstrate a real-world impact and value from our pipeline, technologyplatform and commercial-scale manufacturing capacity. Our business model for commercialization and revenue generation includes, but isnot limited to, licensing deals, joint ventures with pharmaceutical companies, direct sale of our products, and partnerships.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 37; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      33
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <i>
       RESULTSOF OPERATIONS – YEAR ENDED JUNE 30, 2021 COMPARED TO YEAR ENDED JUNE 30, 2020.
      </i>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <i>
      </i>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       Revenues
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Revenuesfor the year ended June 30, 2020 were $23,000 compared to no revenues for the year ended June 30, 2021. The revenues in the year endedJune 30, 2020 were related to the sale of our PLX cells for research use.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       Researchand Development, Net
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Research and development net costs (costs less participation and grantsby the IIA, Horizon 2020 and other parties) increased by 39% from $21,577,000 for the year ended June 30, 2020 to $30,066,000 for theyear ended June 30, 2021. The increase is mainly attributed to (1) an increase in clinical study subcontractor expenses which mostly relatesto ARDS associated with COVID-19 Phase II clinical studies, (2) an increase in payroll expenses related to payroll adjustments and exchangerate adjustment that relates to the strength of the NIS against the U.S. dollar, (3) increased share-based compensation expenses due toincreased amount of restricted stock units, or RSUs, granted during the year ended June 30, 2021 compared to the amount of RSUs grantedduring the year ended June 30, 2020, and (4) a decrease in the participation of Horizon 2020 in our clinical programs. The increased researchand development net costs were partially offset by a decrease in travel abroad expenses due to the COVID–19 pandemic.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       Generaland Administrative
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     General and administrative expenses increased by 159% from $7,922,000for the year ended June 30, 2020 to $20,557,000 for the year ended June 30, 2021. The increase is mainly attributed to: (1) an increasein share-based compensation expenses related to the amount of RSUs granted, the fair value of such grants at the time of the grants andtheir expected vesting periods, including RSU awards to our CEO and Executive Chairman (see note 9(3) in our accompanying financial statements),(2) an increase in payroll expenses, mostly related to the entitlement of our Executive Chairman to certain adjustment fees pursuant tohis amended consulting agreement, payroll adjustments, accruals for target bonuses for our CEO and Chief Financial Officer, or CFO, accordingto their amended employment agreements during the year ended June 30, 2021, and an exchange rate adjustment that relates to the strengthof the NIS against the U.S. dollar, and (3) an increase in directors and officers insurance premium expense. The increase in general andadministrative expenses was partially offset by a decrease in RSU expenses relating to RSUs granted to consultants, lower travel abroadexpenses due to the COVID-19 pandemic and lower expenses related to the EIB Finance Agreement.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       FinancialIncome, Net
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Financial income increasedfrom $324,000 for the year ended June 30, 2020 to $758,000 for the year ended June 30, 2021. This increase is mainly attributable to (1)increased income from exchange rate differences related to the strength of the NIS against the U.S. dollar on deposits linked to NIS,and (2) increased interest income from bank deposits due to an increase in our deposits. The increase in financial income was partiallyoffset by an increase in interest expenses relating to the EIB loan.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       LossFor The Year
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Loss for the year ended June 30, 2021 amounted to $49,865,000 as comparedto a loss of $29,152,000 for the year ended June 30, 2020. The changes were mainly due to increases in general and administrative expensesand research and development expenses, net, for the reasons mentioned above. Loss per share for the year ended June 30, 2021 was $1.77,as compared to $1.60 loss per share for the year ended June 30, 2020. The loss per share for the year increased mainly as a result ofan increase in the loss for the year, offset by an increase in our weighted average number of shares due to the issuance of additionalshares during Fiscal Year 2021.
    </p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Theincrease in weighted average common shares outstanding reflects the issuances of shares pursuant to a securities purchase agreement withcertain institutional investors in February 2021, issuances of shares pursuant to our Open Market Sale Agreement
      <sup>
       SM
      </sup>
      , or theATM Agreement, that we entered into with Jefferies LLC, or Jefferies, on July 16, 2020, and issuances of additional shares upon settlementof RSUs issued to directors, employees and consultants, and shares issued as a result of the exercise of outstanding warrants and options.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 38; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      34
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       Liquidityand Capital Resources
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Asof June 30, 2021, our total current assets were $67,371,000 and our total current liabilities were $11,517,000. On June 30, 2021, wehad a working capital surplus of $55,854,000 and an accumulated deficit of $330,021,000.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Asof June 30, 2020, our total current assets were $48,461,000 and our total current liabilities were $7,987,000. On June 30, 2020, we hada working capital surplus of $40,474,000 and an accumulated deficit of $280,156,000.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Ourcash and cash equivalents and restricted cash as of June 30, 2021 amounted to $31,838,000 which reflects an increase of $22,609,000 fromthe $9,229,000 reported as of June 30, 2020. Cash balances increased in the year ended June 30, 2021 for the reasons presented below.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Our cash used by operating activities was $30,910,000 during the yearended June 30, 2021 and $26,369,000 during the year ended June 30, 2020. Cash used by operating activities in the year ended June 30,2021 primarily consisted of payments to subcontractors, suppliers, and professional services providers related to our ongoing clinicalstudies and payments of salaries to our employees, offset by participation of the IIA, Horizon 2020 and other grants. Cash used by operatingactivities in the year ended June 30, 2020 primarily consisted of payments to subcontractors, suppliers, and professional services providersprimarily related to our ongoing clinical trials and payments of salaries to our employees, offset by participation of the IIA, Horizon2020 and other grants.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Cash used for investing activitieswas $7,265,000 during the year ended June 30, 2021 and $30,458,000 during the year ended June 30, 2020. The investing activities in theyear ended June 30, 2021 consisted primarily of cash used for investment in long-term deposits of $10,953,000 and payments of $373,000related to investments in property and equipment, partially offset by the withdrawal of $4,061,000 of short-term deposits. The investingactivities in the year ended June 30, 2020 consisted primarily of cash used for investment in short-term deposits of $17,949,000, investmentin long-term deposits of $12,239,000 and payments of $270,000 related to investments in property and equipment.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Financing activitiesgenerated cash in the amount of $61,402,000 during the year ended June 30, 2021 and $60,870,000 during the year ended June 30, 2020.The cash generated in the year ended June 30, 2021 from financing activities is related to: (1) net proceeds of $36,589,000comprised of funds received from our registered direct offering which closed in February 2021 and common shares issuances made underthe ATM Agreement, (2) proceeds of $24,449,000 received from the EIB pursuant to the EIB Finance Agreement, and (3) net proceeds of$364,000 from the exercise of outstanding warrants. The cash generated in the year ended June 30, 2020 from financing activities isrelated to net proceeds of $43,262,000 from issuing our common shares under our prior Open Market Sales Agreement
     <sup>
      SM
     </sup>
     weexecuted with Jefferies LLC on February 6, 2019, net proceeds of $14,901,000 from issuing our common shares in a registered directoffering in May 2020 and net proceeds of $2,707,000 from issuing our common shares from the exercise of warrants.
    </p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      OnJuly 16, 2020, we entered into the ATM Agreement with Jefferies, pursuant to which we may issue and sell shares of our common shareshaving an aggregate offering price of up to $75,000,000 from time to time through Jefferies. Upon entering into the ATM Agreement, wefiled a new shelf registration statement on Form S-3, which was declared effective by the SEC on July 23, 2020. During the year endedJune 30, 2021, we sold 1,045,097 of our common shares under the ATM Agreement at an average price of $8.50 per share for aggregate netproceeds of approximately $8,506,000.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Inthe year ended June 30, 2021, warrants to purchase up to 51,999 shares from our April 2019 firm commitment public offering were exercisedby investors at an exercise price of $7.00 per share, resulting in the issuance of 51,999 common shares for net proceeds of approximately$364,000.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      OnFebruary 2, 2021, we entered into a securities purchase agreement with several institutional investors, or the Investors, pursuant towhich we sold, in a registered direct offering, directly to the Investors, 4,761,905 common shares, for gross proceeds of $30,000,000.The aggregate net proceeds were approximately $28,077,000, net of issuance expenses of approximately $1,923,000.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In April 2020, we and oursubsidiaries, Pluristem Ltd. and Pluristem GmbH, executed the EIB Finance Agreement for funding of up to €50 million in the aggregate,payable in three tranches. The proceeds from the EIB Finance Agreement are intended to support our research and development in the EuropeanUnion to further advance our regenerative cell therapy platform, and to bring the products in our pipeline to market. The proceeds fromthe EIB Finance Agreement are expected to be deployed in three tranches, subject to the achievement of certain clinical, regulatory andscaling up milestones.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      DuringJune 2021, we received the first tranche in the amount of $24,449,000 (€20 million) pursuant to the EIB Finance Agreement. The amountreceived is due to be repaid on June 1, 2026 and bears annual interest of 4% to be paid together with the principal of the loan. As ofJune 30, 2021, the interest accrued was in the amount of $78,000 (€65,000).
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 39; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      35
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <i>
       Non-dilutivegrants
      </i>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Duringthe years ended June 30, 2021 and 2020, we received total cash grants of approximately $239,000 and $1,227,000, respectively, from theEuropean Union research and development consortiums relating to the Horizon 2020 program.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <i>
      </i>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      TheIIA has supported our research activity. Our last program was approved by the IIA in 2019 and relates to a grant of approximately $500,000.The grant was used to cover research and development expenses for the period January 1, 2019 to December 31, 2019.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Accordingto the IIA grant terms, we are required to pay royalties at a rate of 3% on sales of products and services derived from technology developedusing this and other IIA grants until 100% of the dollar-linked grants amount plus interest are repaid. In the absence of such sales,no payment is required. During the year ended June 30, 2021, no royalties were paid to the IIA. The IIA may impose certain conditionson any arrangement under which the IIA permits the Company to transfer technology or development out of Israel or outsource manufacturingout of Israel. While the grant is given to the Company over a certain period of time (usually a year), the requirements and restrictionsunder the Israeli Law for the Encouragement of Industrial Research and Development, 1984 continue and do not have a set expiration period,except for the royalties, which requirement to pay them expires after payment in full.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      InMay 2020, we were selected as a member of the CRISPR-IL consortium, a group funded by the IIA. CRISPR-IL brings together the leadingexperts in life science and computer science from academia, medicine, and industry, to develop AI based end-to-end genome-editing solutions.CRISPR-IL is funded by the IIA with a total budget of approximately $10,000,000 of which, an amount of approximately $480,000 is a directgrant allocated to us, for a period of 18 months, with a potential for extension of an additional 18 months and additional budget fromthe IIA. CRISPR-IL participants include leading companies, and medical and academic institutions. As of June 30, 2021, we received totalgrants of approximately $401,000 in cash from the IIA pursuant to the CRISPR-IL consortium program. The CRISPR-IL consortium programdoes not require any obligation to pay royalties
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      InJuly 2018, we were awarded a marketing grant of approximately $52,000 under the “Shalav” program of the Israeli Ministryof Economy and Industry. The grant is intended to facilitate certain marketing and business development activities with respect to ouradvanced cell therapy products in the U.S. market.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      InJuly 2017, we were awarded an additional Smart Money grant of approximately $229,000 from Israel’s Ministry of Economy. The Israeligovernment granted us budget resources that we intend to use to advance our product candidate towards marketing in China-Hong Kong markets.We will also receive close support from Israel’s trade representatives stationed in China, including Hong Kong, along with expertsappointed by the Smart Money program.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      InAugust 2016, our CLI program in the European Union was awarded a €7,600,000 (approximately $8,500,000) non-royalty bearing grant.The grant is part of the European Union’s Horizon 2020 program. The Phase III study of PLX-PAD in CLI will be a collaborative projectcarried out by an international consortium led by the Berlin-Brandenburg Center for Regenerative Therapies together with the Companyand with participation of additional third parties. The grant covered a significant portion of the CLI program costs. An amount of €1,900,000(approximately $2,100,000) is a direct grant allocated to us, and the Company also had cost savings resulting from grant amounts allocatedto the other consortium members. In July 2017, the consortium amended the consortium agreement, pursuant to which the original grantallocation was amended such that we will receive an additional direct grant of €1,177,000 (approximately $1,295,000). The additionaldirect grant was allocated to us from the total amount of the original grant. As of June 30, 2021, we received €2,615,000 (approximately$2,946,000) and we expect to receive an additional €461,000 (approximately $548,000).
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      InSeptember 2017, our Phase III study of PLX-PAD cell therapy in the treatment of muscle injury following surgery for hip fracture wasawarded a €7,400,000 (approximately $8,300,000) grant, as part of the European Union’s Horizon 2020 program. This Phase IIIstudy will be a collaborative project carried out by an international consortium led by Charité, together with us, and with participationof additional third parties. The grant will cover a significant portion of the project costs. An amount of € 2,550,000 (approximately$2,900,000) is a direct grant allocated to us for manufacturing and other costs, and we also expect to have a direct benefit from costsavings resulting from grant amounts allocated to the other consortium members. As of June 30, 2021, we received €2,166,000 (approximately$2,540,000) and we expect to receive an additional €382,000 (approximately $454,000).
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      InOctober 2017, the nTRACK, a collaborative project carried out by an international consortium led by Leitat was awarded a €6,800,000(approximately $7,600,000) non-royalty bearing grant. An amount of €500,000 (approximately $560,000) is a direct grant allocatedto us. We also expect to benefit from cost savings resulting from grant amounts allocated to the other consortium members. As of June30, 2021, we received €414,000 (approximately $473,000) and we expect to receive an additional €73,000 (approximately $87,000).
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 40; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      36
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       Outlook
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Wehave accumulated a deficit of $330,021,000 since our inception in May 2001. We do not expect to generate any significant revenues fromsales of products in the next twelve months. Our cash needs may increase in the foreseeable future. We expect to generate revenues, fromthe sale of licenses to use our technology or products, but in the short and medium terms will unlikely exceed our costs of operations.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Wemay be required to obtain additional liquidity resources in order to support the commercialization of our products and maintain our researchand development and clinical trials activities.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Weare continually looking for sources of funding, including non-diluting sources such as collaboration with other companies via licensingagreements, the EIB Finance Agreement, the IIA grants, the European Union grant and other research grants, and sales of our common shares.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Webelieve that we have sufficient cash to fund our operations for at least the next 12 months.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       Applicationof Critical Accounting Policies and Estimates
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Oursignificant accounting policies are more fully described in Note 2 to our consolidated financial statements appearing in this AnnualReport. We believe that the accounting policies below are critical for one to fully understand and evaluate our financial condition andresults of operations.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     The discussion and analysisof our financial condition and results of operations is based on our financial statements, which we prepared in accordance with U.S. GAAP.The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assetsand liabilities, as well as the reported revenues and expenses during the reporting periods. On an ongoing basis, we evaluate such estimatesand judgments, including those described in greater detail below. We base our estimates on historical experience and on various otherfactors that we believe are reasonable under the circumstances. Actual results may differ from these estimates under different assumptionsor conditions.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       Share-BasedCompensation
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Share-basedcompensation is considered a critical accounting policy due to the significant expenses of RSUs which were granted to our employees,directors and consultants. In Fiscal Year 2021, we recorded share-based compensation expenses related to options, restricted shares andRSUs in the amount of $13,968,000.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In accordance with ASC 718, “Compensation-Stock Compensation”,or ASC 718, RSUs granted to employees and directors are measured at their fair value on the grant date. All RSUs granted in fiscal years2021 and 2020 were granted for no consideration; therefore their fair value was equal to the share price at the date of grant unless theRSUs include a market-based condition in which case the fair value RSUs at the date of grant was calculated using the Monte Carlo model.The RSUs granted in Fiscal Year 2021 to non-employee consultants were measured at their fair value on the grant date in accordance withASU No. 2018-07 - “Compensation—Share Compensation”.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Thevalue of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periodsin our consolidated statements of operations. We have graded vesting based on the accelerated method over the requisite service periodof each of the awards. The expected pre-vesting forfeiture rate affects the number of the shares. Based on our historical experience,the pre-vesting forfeiture rate per grant is 13% for the shares granted to employees and 0% for the shares granted to our directors andofficers and non-employee consultants.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       Researchand Development Expenses, Net
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Weexpect our research and development expenses to remain our primary expense in the near future as we continue to develop our product candidates.Our research and development expenses consist primarily of clinical trials expenses, consultant and subcontractor expenses, payroll andrelated expenses, lab material expenses, share-based compensation expenses, rent and maintenance expenses. The followingtable provides a breakdown of the related costs for fiscal years 2020 and 2021 (in thousands of dollars):
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
     <tbody>
      <tr style="vertical-align: bottom">
       <td>
       </td>
       <td style="font-weight: bold; padding-bottom: 1.5pt">
       </td>
       <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
        Year ended June 30,
       </td>
       <td style="padding-bottom: 1.5pt; font-weight: bold">
       </td>
      </tr>
      <tr style="vertical-align: bottom">
       <td style="text-align: justify">
       </td>
       <td style="font-weight: bold; padding-bottom: 1.5pt">
       </td>
       <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
        2021
       </td>
       <td style="padding-bottom: 1.5pt; font-weight: bold">
       </td>
       <td style="font-weight: bold; padding-bottom: 1.5pt">
       </td>
       <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
        2020
       </td>
       <td style="padding-bottom: 1.5pt; font-weight: bold">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="width: 76%; text-align: left">
        Payroll and related expenses
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 1%; text-align: left">
        $
       </td>
       <td style="width: 9%; text-align: right">
        10,563
       </td>
       <td style="width: 1%; text-align: left">
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 1%; text-align: left">
        $
       </td>
       <td style="width: 9%; text-align: right">
        8,478
       </td>
       <td style="width: 1%; text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td style="text-align: left">
        Materials expenses
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        2,843
       </td>
       <td style="text-align: left">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        2,821
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-align: left">
        Clinical trials expenses
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        10,024
       </td>
       <td style="text-align: left">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        6,021
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td style="text-align: left">
        Depreciation expenses
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        1,252
       </td>
       <td style="text-align: left">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        1,453
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-align: left">
        Consultants and subcontractor expenses
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        2,411
       </td>
       <td style="text-align: left">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        1,351
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td style="text-align: left">
        Rent and maintenance expenses
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        1,369
       </td>
       <td style="text-align: left">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        1,227
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-align: left">
        Share-based compensation expenses
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        1,538
       </td>
       <td style="text-align: left">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        556
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td style="text-align: left; padding-bottom: 1.5pt">
        Other Research and development expenses
       </td>
       <td style="padding-bottom: 1.5pt">
       </td>
       <td style="border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="border-bottom: Black 1.5pt solid; text-align: right">
        533
       </td>
       <td style="padding-bottom: 1.5pt; text-align: left">
       </td>
       <td style="padding-bottom: 1.5pt">
       </td>
       <td style="border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="border-bottom: Black 1.5pt solid; text-align: right">
        1,189
       </td>
       <td style="padding-bottom: 1.5pt; text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-align: left">
        Total expenses
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        30,533
       </td>
       <td style="text-align: left">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        23,096
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td style="text-align: left; padding-bottom: 1.5pt">
        Less: Research and development participation grants
       </td>
       <td style="padding-bottom: 1.5pt">
       </td>
       <td style="border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="border-bottom: Black 1.5pt solid; text-align: right">
        (467
       </td>
       <td style="padding-bottom: 1.5pt; text-align: left">
        )
       </td>
       <td style="padding-bottom: 1.5pt">
       </td>
       <td style="border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="border-bottom: Black 1.5pt solid; text-align: right">
        (1,519
       </td>
       <td style="padding-bottom: 1.5pt; text-align: left">
        )
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-align: left; padding-bottom: 4pt">
        Research and development expenses, net
       </td>
       <td style="padding-bottom: 4pt">
       </td>
       <td style="border-bottom: Black 4pt double; text-align: left">
        $
       </td>
       <td style="border-bottom: Black 4pt double; text-align: right">
        30,066
       </td>
       <td style="padding-bottom: 4pt; text-align: left">
       </td>
       <td style="padding-bottom: 4pt">
       </td>
       <td style="border-bottom: Black 4pt double; text-align: left">
        $
       </td>
       <td style="border-bottom: Black 4pt double; text-align: right">
        21,577
       </td>
       <td style="padding-bottom: 4pt; text-align: left">
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 41; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      37
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      We invest heavily in research and development. Research and developmentexpenses, net, were our major operating expenses, representing 59% and 73% of the total operating expenses for each of our fiscal years2021 and 2020, respectively. We expect that in the upcoming years our research and development expenses, net, will continue to be ourmajor operating expense.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <div>
     <a id="p_012">
     </a>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">
      <b>
       Item7A. Quantitative and Qualitative Disclosures about Market Risk.
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Weare exposed to a variety of risks, including changes in interest rates, foreign currency exchange rates and inflation.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Asof June 30, 2021, we had $31.25 million in cash and cash equivalents, $34.31 million in short-term bank deposits and restricted depositsand $23.27 million in long-term bank deposits and restricted deposits.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Weadhere to an investment policy set by our investment committee, which aims to preserve our financial assets, maintain adequate liquidityand maximize return while minimizing exposure to the NIS and Euro. As of June 30, 2021, the currency of our financial portfolio is mainlyin U.S. dollars and we use options contracts in order to hedge our exposures to currencies other than the U.S. dollar.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       InterestRate Risk
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Weinvest a major portion of our cash surplus in bank deposits in banks in Israel. Since the bank deposits typically carry fixed interestrates, financial income over the holding period is not sensitive to changes in interest rates. However, our interest gains from futuredeposits may decline in the future as a result of changes in the financial markets. In any event, given the historic low levels of theinterest rate, we estimate that a further decline in the interest rate we are receiving will not result in a material adverse effectto our business.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 42; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      38
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       ForeignCurrency Exchange Risk and Inflation
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       ForeignCurrency Exchange Risk -
       <i>
        NIS
       </i>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Asignificant portion of our expenditures, including salaries, materials, consultants’ fees and facility expenses relate to our operationsin Israel. The cost of those Israeli operations, as expressed in U.S. dollars, is influenced by the extent to which any increase in therate of inflation in Israel is not offset (or is offset on a lagging basis) by a devaluation of the NIS in relation to the U.S. dollar.If the U.S. dollar declines in value in relation to the NIS, it will become more expensive for us to fund our operations in Israel. Inaddition, as of June 30, 2021, we own net financial balances in NIS of approximately ($1,614,000).
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Assuminga 10% appreciation of the NIS against the U.S. dollar, we would experience exchange rate loss of approximately $179,000, while assuminga 10% devaluation of the NIS against the U.S. dollars, we would experience an exchange rate gain of approximately $147,000, in both casesexcluding the effect of our hedging transactions (as described below).
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Theexchange rate of the U.S. dollar to the NIS, based on exchange rates published by the Bank of Israel, was as follows:
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
     <tbody>
      <tr style="vertical-align: bottom">
       <td>
       </td>
       <td style="padding-bottom: 1.5pt">
       </td>
       <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          <b>
           Year Ended June 30,
          </b>
         </span>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         </span>
        </p>
       </td>
       <td style="padding-bottom: 1.5pt">
       </td>
      </tr>
      <tr style="vertical-align: bottom">
       <td>
       </td>
       <td style="font-weight: bold; padding-bottom: 1.5pt">
       </td>
       <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
        2020
       </td>
       <td style="padding-bottom: 1.5pt; font-weight: bold">
       </td>
       <td style="font-weight: bold; padding-bottom: 1.5pt">
       </td>
       <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
        2021
       </td>
       <td style="padding-bottom: 1.5pt; font-weight: bold">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="width: 76%">
        Average rate for period
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 1%; text-align: left">
       </td>
       <td style="width: 9%; text-align: right">
        3.507
       </td>
       <td style="width: 1%; text-align: left">
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 1%; text-align: left">
       </td>
       <td style="width: 9%; text-align: right">
        3.322
       </td>
       <td style="width: 1%; text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td style="text-align: left">
        Rate at period-end
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        3.466
       </td>
       <td style="text-align: left">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        3.260
       </td>
       <td style="text-align: left">
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Weuse currency transactions of options and forward contracts to decrease the risk of financial exposure from fluctuations in the exchangerate of the U.S. dollar against the NIS.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       ForeignCurrency Exchange Risk -
       <i>
        Euro (
       </i>
      </b>
      €)
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Followingthe receipt of the first tranche in amount of €20 million (approximately $24 million) of the loan from the EIB pursuant to the EIBFinance Agreement, we have established both a cash asset and a liability in our financial statements. If the Euro increases in valuein relation to the U.S. dollar, both the asset and liability of our loan from the EIB will increase, and if the Euro decreases in relationto the U.S. dollar, both the asset and liability will conversely decrease.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Sincethe tranche and the accumulated interest are payable together in a single installment within five years from disbursement of the tranche,and we are likely to use the cash received to finance our operations, as time progress the cost basis of the liability of our loan isexpected to increase and the cash asset is expected to decrease.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Aspart of our hedging strategy, we may use currency transactions of options and forward contracts to minimize the risk of financial exposurefrom fluctuations in the exchange rate of the U.S. dollar against the Euro
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 43; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      39
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <div>
     <a id="p_013">
     </a>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">
      <b>
       Item8. Financial Statements and Supplementary Data.
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Our financial statements are stated in thousands United States dollarsand are prepared in accordance with U.S. GAAP.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Thefollowing audited consolidated financial statements are filed as part of this Annual Report:
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 90%; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="#a_001" tabindex="18">
          Reports of Independent Registered Public Accounting Firm, dated September 13, 2021
         </a>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 10%; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         F-2    - F-3
        </span>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; ">
       <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="#a_002" tabindex="18">
          Consolidated Balance Sheets
         </a>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         F-4    - F-5
        </span>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; ">
       <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="#a_003" tabindex="18">
          Consolidated Statements of Operations
         </a>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         F-6
        </span>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; ">
       <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Consolidated    Statements of Comprehensive Loss
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; ">
       <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="#a_004" tabindex="18">
          Statements of Changes in Equity
         </a>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         F-7    - F-8
        </span>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; ">
       <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="#a_005" tabindex="18">
          Consolidated Statements of Cash Flows
         </a>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         F-9
        </span>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; ">
       <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="#a_006" tabindex="18">
          Notes to the Consolidated Financial Statements
         </a>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         F-10    - F-31
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 44; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      40
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
    </p>
    <div>
    </div>
    <p style="text-align: center; margin-top: 0; margin-bottom: 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
     <b>
      PLURISTEM THERAPEUTICSINC. AND ITS SUBSIDIARIES
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
     <b>
      CONSOLIDATED FINANCIALSTATEMENTS
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
     <span style="font-size: 10pt">
      <b>
       Asof June 30, 2021
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 45 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
     <b>
      PLURISTEM THERAPEUTICSINC. AND ITS SUBSIDIARIES
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
     <b>
      CONSOLIDATED FINANCIAL STATEMENTS
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.15pt; text-align: center">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
     <b>
      As of June 30, 2021
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
     <b>
      U.S. DOLLARS IN THOUSANDS
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
     <b>
      <span style="text-decoration:underline">
       INDEX
      </span>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
     <b>
     </b>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: center">
        <span style="font-size: 10pt">
         <b>
         </b>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center; width: 10%">
        <span style="font-size: 10pt">
         <b>
          Page
         </b>
        </span>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-size: 10pt">
         <a href="#a_001" tabindex="18">
          Reports of Independent Registered Public Accounting Firm
         </a>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
        F-2
        <span style="font-size: 10pt">
         - F-3
        </span>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-size: 10pt">
         <a href="#a_002" tabindex="18">
          Consolidated Balance Sheets
         </a>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
        F-4
        <span style="font-size: 10pt">
         - F-5
        </span>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-size: 10pt">
         <a href="#a_003" tabindex="18">
          Consolidated Statements of Operations
         </a>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
        F-6
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-size: 10pt">
         <a href="#a_004" tabindex="18">
          Statements of Changes in Shareholders’ Equity
         </a>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
        <span style="font-size: 10pt">
         F-7 - F-8
        </span>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-size: 10pt">
         <a href="#a_005" tabindex="18">
          Consolidated Statements of Cash Flows
         </a>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
        <span style="font-size: 10pt">
         F-9
        </span>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-size: 10pt">
         <a href="#a_006" tabindex="18">
          Notes to Consolidated Financial Statements
         </a>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
        <span style="font-size: 10pt">
         F-10 - F-31
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15in">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 46; Options: NewSection; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      F-
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      1
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.15in">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">
     <img alt="" data-src="https://www.sec.gov/Archives/edgar/data/1158780/000121390021047664/image_001.jpg" src="https://www.sec.gov/Archives/edgar/data/1158780/000121390021047664/image_001.jpg"/>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <div>
     <a id="a_001">
     </a>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center">
     <b>
      Report of Independent RegisteredPublic Accounting Firm
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     To the board of directors and shareholders of Pluristem TherapeuticsInc.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      Opinion on the Financial Statements
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     We have audited the accompanying consolidatedbalance sheet of Pluristem Therapeutics Inc. and its subsidiaries (the “Company”) as of June 30, 2021, and the related consolidatedstatements of operations, of changes in shareholders’ equity and of cash flows for the year then ended, including the related notes (collectivelyreferred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly,in all material respects, the financial position of the Company at June 30, 2021, and the results of its operations and its cash flowsfor the year then ended, in conformity with accounting principles generally accepted in the United States of America.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      Basis for Opinion
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     These consolidated financial statements are the responsibility ofthe Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements basedon our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) andare required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rulesand regulations of the Securities and Exchange Commission and the PCAOB.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 28.35pt">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">
     We conducted our audit of these consolidated financial statementsin accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assuranceabout whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company isnot required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our auditwe are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinionon the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 28.35pt">
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-size: 10pt">
      Our audit included performing proceduresto assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performingprocedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosuresin the consolidated financial statements. Our audit also included evaluating the accounting principles used and significant estimatesmade by management, as well as evaluating the overall presentation of the
     </span>
     <span style="font-family: Times New Roman, Times, Serif">
      consolidated
     </span>
     <span style="font-size: 10pt">
      financial statements. We believe that our audit provides a reasonable basis for our opinion.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      Critical Audit Matters
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     Critical audit matters are matters arising from the current periodaudit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that(i) relate to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging,subjective, or complex judgments. We determined there are no critical audit matters.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     /s/ Kesselman &amp; Kesselman
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     Certified Public Accountants (lsr.)
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     A member firm of PricewaterhouseCoopers InternationalLimited
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">
     Haifa, Israel
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">
     September 13, 2021
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">
     We have served as the Company’sauditor since 2021.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
     <img alt="" data-src="https://www.sec.gov/Archives/edgar/data/1158780/000121390021047664/image_002.jpg" src="https://www.sec.gov/Archives/edgar/data/1158780/000121390021047664/image_002.jpg"/>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 47; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      F-
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      2
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.15pt; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 48%">
        <img alt="" data-src="https://www.sec.gov/Archives/edgar/data/1158780/000121390021047664/image_003.jpg" src="https://www.sec.gov/Archives/edgar/data/1158780/000121390021047664/image_003.jpg"/>
       </td>
       <td style="text-align: left; width: 31%; vertical-align: bottom">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          Kost Forer Gabbay &amp; Kasierer
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         144 Menachem Begin Road, Building A,
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         Tel-Aviv 6492102, Israel
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
        </p>
       </td>
       <td style="width: 2%; font-size: 10pt; text-align: left">
       </td>
       <td style="text-align: left; width: 19%; vertical-align: bottom">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         Tel: +972-3-6232525
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         Fax: +972-3-5622555
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         ey.com
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
        </p>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.15pt; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
     <b>
      REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTINGFIRM
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
     <b>
      To the Stockholders
      <span style="font-size: 10pt">
       andBoard of Directors
      </span>
      Of
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
     <b>
      PLURISTEM THERAPEUTICS INC.
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      Opinion on the Financial Statements
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">
     <span style="font-size: 10pt">
      Wehave audited the accompanying consolidated balance sheets of Pluristem Therapeutics Inc. and its
     </span>
     subsidiaries
     <span style="font-size: 10pt">
      (the“Company”) as of June 30, 2020, the related consolidated statements of operations, comprehensive loss, changes in stockholders’equity and cash flows for the year ended June 30, 2020 and the related notes (collectively referred to as the “consolidated financialstatements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial positionof the Company at June 30, 2020, and the results of its operations and its cash flows for the year ended June 30, 2020, in conformitywith U.S. generally accepted accounting principles.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">
    </p>
    <div>
    </div>
    <p style="text-indent: 0; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      Basis for Opinion
     </b>
    </p>
    <div>
    </div>
    <p style="text-indent: 0; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0">
     These financial statements are the responsibilityof the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits.We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are requiredto be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulationsof the Securities and Exchange Commission and the PCAOB.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0">
     We conducted our audits in accordance with thestandards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financialstatements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engagedto perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understandingof internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internalcontrol over financial reporting. Accordingly, we express no such opinion.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0">
     Our audits included performing procedures toassess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respondto those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluatingthe overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">
     /s/ KOST FORER GABBAY &amp;KASIERER
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">
     A Member of Ernst &amp; YoungGlobal
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">
     We have served as the Company’sauditor from 2003 to 2020.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">
     Tel Aviv, Israel
    </p>
    <div>
    </div>
    <p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">
     September 10, 2020
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.15pt; text-align: center">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.15pt; text-align: center">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 48; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      F-
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      3
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.15pt; text-align: center">
     <b>
     </b>
    </p>
    <div>
    </div>
    <div>
     <a id="a_002">
     </a>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: right">
     <b>
      PLURISTEM THERAPEUTICS INC. AND ITSSUBSIDIARIES
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 33.3pt 0pt 11.15pt; text-align: right">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 100%">
        <p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          CONSOLIDATED BALANCE SHEETS
         </b>
        </p>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-size: 10pt">
         <b>
          U.S. Dollars in thousands (except share and    per share data)
         </b>
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.15pt; text-align: center">
     <b>
     </b>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center">
        June    30,
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center">
        Note
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center">
        2021
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center">
        2020
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
       <td style="font: bold 10pt Times New Roman, Times, Serif">
        ASSETS
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
       <td style="font: 10pt Times New Roman, Times, Serif">
        CURRENT ASSETS:
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left">
        Cash and cash equivalents
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">
        <span>
         <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-26" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          31,241
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">
        <span>
         <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-27" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          8,270
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        Short-term bank deposits
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
        2f
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-28" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShortTermInvestments" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          33,709
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-29" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShortTermInvestments" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          37,514
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        Restricted cash
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
        2f
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-30" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          597
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-31" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          555
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        Prepaid expenses and other current assets
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
        3
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        <span>
         <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-32" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:OtherAssetsCurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          1,824
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        <span>
         <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-33" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:OtherAssetsCurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          2,122
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-decoration: none; text-align: left">
        <span style="text-decoration:underline">
         Total
        </span>
        <span style="text-decoration: none">
         current    assets
        </span>
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-34" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AssetsCurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          67,371
         </ix:nonfraction>
        </span>
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-35" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AssetsCurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          48,461
         </ix:nonfraction>
        </span>
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        LONG-TERM ASSETS:
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        Long-term deposits
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-36" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:LongTermInvestments" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          23,269
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-37" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:LongTermInvestments" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          12,249
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        Restricted bank deposits
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
        2g
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-0">
         <span>
          <ix:nonfraction contextref="c3" continued-taxonomy="false" data-original-id="hidden-fact-0" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-38" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="true" iscustomonly="true" ishiddenelement="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:RestrictedBankDepositsNoncurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           -
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-39" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:RestrictedBankDepositsNoncurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          404
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif">
        Severance pay fund
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-40" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          664
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-41" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          631
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        Property and equipment, net
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
        4
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-42" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:PropertyPlantAndEquipmentNet" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          1,499
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-43" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:PropertyPlantAndEquipmentNet" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          2,516
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        Operating lease right-of-use asset
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
        6
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-44" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:OperatingLeaseRightOfUseAsset" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          728
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-45" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:OperatingLeaseRightOfUseAsset" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          1,259
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        Other long-term assets
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        <span>
         <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-46" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:OtherAssetsNoncurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          7
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        <span>
         <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-47" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:OtherAssetsNoncurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          12
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-decoration: none; text-align: left">
        <span style="text-decoration:underline">
         Total
        </span>
        long-term assets
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-48" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AssetsNoncurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          26,167
         </ix:nonfraction>
        </span>
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-49" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AssetsNoncurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          17,071
         </ix:nonfraction>
        </span>
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; text-decoration: none; text-align: left">
        <span style="text-decoration:underline">
         Total
        </span>
        assets
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">
        <span>
         <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-50" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:Assets" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          93,538
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">
        <span>
         <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-51" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:Assets" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          65,532
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
     The accompanying notes arean integral part of the consolidated financial statements.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
     </b>
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 49; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      F-
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      4
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.15pt; text-align: center">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
     <b>
      PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARIES
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
     <b>
     </b>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 100%">
        <p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          CONSOLIDATED BALANCE SHEETS
         </b>
        </p>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td style="font-size: 10pt">
        <span style="font-size: 10pt">
         <b>
          U.S. Dollars in thousands (except share and per share data)
         </b>
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.15pt; text-align: center">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center">
        June    30,
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in">
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center">
        Note
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center">
        2021
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center">
        2020
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in">
        LIABILITIES AND SHAREHOLDERS’    EQUITY
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in">
        CURRENT LIABILITIES
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; width: 64%; text-align: left">
        Trade    payables
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">
        <span>
         <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-52" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AccountsPayableTradeCurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          2,526
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">
        <span>
         <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-53" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AccountsPayableTradeCurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          1,968
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Accrued expenses
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-54" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AccruedLiabilitiesCurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          5,941
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-55" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AccruedLiabilitiesCurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          3,018
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Operating lease    liability
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
        6
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-56" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:OperatingLeaseLiabilityCurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          634
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-57" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:OperatingLeaseLiabilityCurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          1,020
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">
        Other    accounts payable
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">
        5
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        <span>
         <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-58" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          2,416
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        <span>
         <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-59" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          1,981
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-decoration: none; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        <span style="text-decoration:underline">
         Total
        </span>
        current liabilities
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-60" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:LiabilitiesCurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          11,517
         </ix:nonfraction>
        </span>
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-61" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:LiabilitiesCurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          7,987
         </ix:nonfraction>
        </span>
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        LONG-TERM LIABILITIES
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Accrued severance    pay
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-62" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:PostemploymentBenefitsLiabilityNoncurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          920
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-63" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:PostemploymentBenefitsLiabilityNoncurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          879
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Operating lease    liability
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
        6
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-64" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:OperatingLeaseLiabilityNoncurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          100
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-65" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:OperatingLeaseLiabilityNoncurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          565
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">
        Loan from the European Investment Bank (EIB)
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">
        7
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        <span>
         <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-66" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:OtherLongTermDebtNoncurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          23,850
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-1">
         <span>
          <ix:nonfraction contextref="c4" continued-taxonomy="false" data-original-id="hidden-fact-1" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-67" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:OtherLongTermDebtNoncurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           -
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-decoration: none; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        <span style="text-decoration:underline;text-decoration: none">
         Total
        </span>
        long-term liabilities
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-68" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:LiabilitiesNoncurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          24,870
         </ix:nonfraction>
        </span>
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-69" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:LiabilitiesNoncurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          1,444
         </ix:nonfraction>
        </span>
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        COMMITMENTS    AND CONTINGENCIES
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
        8
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-2">
         <span>
          <ix:nonfraction contextref="c3" continued-taxonomy="false" data-original-id="hidden-fact-2" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-70" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:CommitmentsAndContingencies" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-3">
         <span>
          <ix:nonfraction contextref="c4" continued-taxonomy="false" data-original-id="hidden-fact-3" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-71" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:CommitmentsAndContingencies" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        SHAREHOLDERS’    EQUITY
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in">
        Share capital:
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
        9
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in">
        Common shares, $
        <span>
         <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="5" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-72" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:CommonStockParOrStatedValuePerShare" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="usdPershares">
          <span>
           <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="5" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-73" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:CommonStockParOrStatedValuePerShare" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="usdPershares">
            0.00001
           </ix:nonfraction>
          </span>
         </ix:nonfraction>
        </span>
        par value per share: Authorized:
        <span>
         <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-74" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:CommonStockSharesAuthorized" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
          <span>
           <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-75" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:CommonStockSharesAuthorized" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
            60,000,000
           </ix:nonfraction>
          </span>
         </ix:nonfraction>
        </span>
        shares Issued and outstanding:
        <span>
         <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-76" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:CommonStockSharesIssued" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
          <span>
           <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-77" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:CommonStockSharesOutstanding" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
            31,957,782
           </ix:nonfraction>
          </span>
         </ix:nonfraction>
        </span>
        shares as of June 30, 2021;
        <span>
         <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-78" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:CommonStockSharesIssued" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
          <span>
           <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-79" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:CommonStockSharesOutstanding" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
            25,492,713
           </ix:nonfraction>
          </span>
         </ix:nonfraction>
        </span>
        shares as of June 30, 2020
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span style="font-size: 10pt">
         *
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-4">
         <span>
          <ix:nonfraction contextref="c4" continued-taxonomy="false" data-original-id="hidden-fact-4" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-80" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:CommonStockValue" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           <span style="font-size: 10pt">
            *
           </span>
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Additional paid-in    capital
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-81" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AdditionalPaidInCapital" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          387,172
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-82" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AdditionalPaidInCapital" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          336,257
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">
        Accumulated    deficit
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-83" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="true" isstandardonly="true" istextonly="false" name="us-gaap:RetainedEarningsAccumulatedDeficit" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
          330,021
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-84" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="true" isstandardonly="true" istextonly="false" name="us-gaap:RetainedEarningsAccumulatedDeficit" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
          280,156
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
        )
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-decoration: none; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        <span style="text-decoration:underline;text-decoration: none">
         Total
        </span>
        shareholders’ equity
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-85" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockholdersEquity" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          57,151
         </ix:nonfraction>
        </span>
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-86" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockholdersEquity" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          56,101
         </ix:nonfraction>
        </span>
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; text-decoration: none; padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt">
        <span style="text-decoration:underline">
         Total
        </span>
        liabilities    and shareholders’ equity
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">
        <span>
         <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-87" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:LiabilitiesAndStockholdersEquity" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          93,538
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">
        <span>
         <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-88" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:LiabilitiesAndStockholdersEquity" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          65,532
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.15pt; text-align: center">
     <b>
     </b>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left">
        (*)
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <ix:footnote id="ix_0_footnote" xml:lang="en-US">
         Less than $1
        </ix:footnote>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.15pt">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
     The accompanying notes arean integral part of the consolidated financial statements.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.15pt">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.15pt">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 50; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      F-
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      5
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.15pt">
    </p>
    <div>
    </div>
    <div>
     <a id="a_003">
     </a>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: right">
     <b>
      PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARIES
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 33.3pt 0pt 11.15pt; text-align: right">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 100%">
        <p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          CONSOLIDATED STATEMENTS OF OPERATIONS
         </b>
        </p>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td style="font-size: 10pt">
        <span style="font-size: 10pt">
         <b>
          U.S. Dollars in thousands (except share and per share data)
         </b>
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.15pt">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center">
        Year    ended June 30,
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: center">
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center">
        Note
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center">
        2021
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center">
        2020
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; width: 64%; text-align: left">
        Revenues
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: center">
        2h
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-5">
         <span>
          <ix:nonfraction contextref="c0" continued-taxonomy="false" data-original-id="hidden-fact-5" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-89" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:Revenues" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           -
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-90" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:Revenues" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          23
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">
        Cost    of revenues
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-6">
         <span>
          <ix:nonfraction contextref="c0" continued-taxonomy="false" data-original-id="hidden-fact-6" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-91" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:CostOfRevenue" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           -
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-7">
         <span>
          <ix:nonfraction contextref="c5" continued-taxonomy="false" data-original-id="hidden-fact-7" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-92" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:CostOfRevenue" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           -
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">
        Gross    profit
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-8">
         <span>
          <ix:nonfraction contextref="c0" continued-taxonomy="false" data-original-id="hidden-fact-8" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-93" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:GrossProfit" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           -
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-94" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:GrossProfit" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          23
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Operating Expenses:
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Research and    development expenses
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-95" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ResearchAndDevelopmentExpense" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          30,533
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-96" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ResearchAndDevelopmentExpense" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          23,096
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">
        Less:    participation grants by the Israel Innovation Authority, Horizon 2020 and other parties
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-97" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:GovernmentAndThirdPartyGrantsReceived" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          467
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-98" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:GovernmentAndThirdPartyGrantsReceived" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          1,519
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Research and    development expenses, net
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
        2l
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-99" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:ResearchAndDevelopmentExpensesNet" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          30,066
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-100" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:ResearchAndDevelopmentExpensesNet" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          21,577
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">
        General    and administrative expenses
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-101" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:GeneralAndAdministrativeExpense" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          20,557
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-102" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:GeneralAndAdministrativeExpense" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          7,922
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
        )
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Total operating    loss
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-103" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="true" isstandardonly="true" istextonly="false" name="us-gaap:OperatingIncomeLoss" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
          50,623
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-104" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="true" isstandardonly="true" istextonly="false" name="us-gaap:OperatingIncomeLoss" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
          29,476
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">
        Financial    income, net
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">
        10
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-105" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:FinancialIncomeNet" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          758
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-106" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:FinancialIncomeNet" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          324
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt">
        Loss    for the year
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-107" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="true" isstandardonly="true" istextonly="false" name="us-gaap:NetIncomeLoss" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
          49,865
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-108" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="true" isstandardonly="true" istextonly="false" name="us-gaap:NetIncomeLoss" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
          29,152
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">
        )
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Loss per share:
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt">
        Basic    and diluted loss per share
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-109" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="true" isstandardonly="true" istextonly="false" name="us-gaap:EarningsPerShareBasicAndDiluted" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" sign="-" tabindex="18" unitref="usdPershares">
          1.77
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-110" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="true" isstandardonly="true" istextonly="false" name="us-gaap:EarningsPerShareBasicAndDiluted" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" sign="-" tabindex="18" unitref="usdPershares">
          1.60
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">
        )
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt">
        Weighted    average number of shares used in computing basic and diluted loss per share
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: center">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-111" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
          28,113,636
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-112" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
          18,197,303
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
     The accompanying notes arean integral part of the consolidated financial statements.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 78.45pt">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 51; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      F-
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      6
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <div>
     <a id="a_004">
     </a>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right">
     <b>
      PLURISTEM THERAPEUTICS INC.AND ITS SUBSIDIARIES
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 100%">
        <p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          STATEMENTS OF CHANGES IN SHAREHOLDERS’    EQUITY
         </b>
        </p>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td style="font-size: 10pt">
        <span style="font-size: 10pt">
         <b>
          U.S. Dollars in thousands (except share and per share data)
         </b>
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
       <td style="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in; font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">
        Common Share
       </td>
       <td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">
       </td>
       <td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: center">
        Additional Paid-in
       </td>
       <td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">
       </td>
       <td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: center">
        Accumulated
       </td>
       <td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">
       </td>
       <td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: center">
        Total Shareholders’
       </td>
       <td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
       <td style="padding-left: 0.125in; text-indent: -0.125in; font: 10pt Times New Roman, Times, Serif; text-align: center">
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center">
        Shares
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center">
        Amount
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center">
        Capital
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center">
        Deficit
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center">
        Equity
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="padding-left: 0.125in; text-indent: -0.125in; font: bold 10pt Times New Roman, Times, Serif; width: 40%">
        Balance as of July 1, 2019
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">
        <span>
         <ix:nonfraction contextref="c6" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-113" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:SharesOutstanding" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
          15,082,852
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-9">
         <span>
          <ix:nonfraction contextref="c6" continued-taxonomy="false" data-original-id="hidden-fact-9" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-114" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockholdersEquity" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           (*
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">
        <span>
         <ix:nonfraction contextref="c7" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-115" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockholdersEquity" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          272,825
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c8" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-116" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="true" isstandardonly="true" istextonly="false" name="us-gaap:StockholdersEquity" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
          251,004
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">
        <span>
         <ix:nonfraction contextref="c9" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-117" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockholdersEquity" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          21,821
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="padding-left: 0.125in; text-indent: -0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">
        Share-based compensation to employees, directors and non-employee    consultants
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c10" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-118" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
          357,755
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-10">
         <span>
          <ix:nonfraction contextref="c10" continued-taxonomy="false" data-original-id="hidden-fact-10" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-119" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           (*
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c11" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-120" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          2,562
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-11">
         <span>
          <ix:nonfraction contextref="c12" continued-taxonomy="false" data-original-id="hidden-fact-11" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-121" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           -
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-122" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          2,562
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="padding-left: 0.125in; text-indent: -0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">
        Issuance of common shares under Open Market Sales Agreement, net of aggregate issuance costs of $
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-123" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:AggregateNetOfIssuanceCosts" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          3,573
         </ix:nonfraction>
        </span>
        (Note 9b)
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c10" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-124" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:IssuanceOfCommonShareUnderOpenMarketSalesAgreementNetOfAggregateIssuanceCostsShares" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
          8,060,950
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-12">
         <span>
          <ix:nonfraction contextref="c10" continued-taxonomy="false" data-original-id="hidden-fact-12" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-125" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" ishiddenelement="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:IssuanceOfCommonStockUnderOpenMarketSalesAgreementNetOfAggregateIssuanceCosts" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           (*
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c11" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-126" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:IssuanceOfCommonStockUnderOpenMarketSalesAgreementNetOfAggregateIssuanceCosts" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          43,262
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-13">
         <span>
          <ix:nonfraction contextref="c12" continued-taxonomy="false" data-original-id="hidden-fact-13" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-127" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" ishiddenelement="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:IssuanceOfCommonStockUnderOpenMarketSalesAgreementNetOfAggregateIssuanceCosts" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           -
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-128" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:IssuanceOfCommonStockUnderOpenMarketSalesAgreementNetOfAggregateIssuanceCosts" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          43,262
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="padding-left: 0.125in; text-indent: -0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">
        Issuance of common shares related to May 2020 registered direct offering, net of issuance costs of $
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-129" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          99
         </ix:nonfraction>
        </span>
        (Note 9d)
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c10" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-130" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:IssuanceOfCommonShareRelatedRegisteredDirectOfferingNetOfIssuance" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
          1,587,302
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-14">
         <span>
          <ix:nonfraction contextref="c10" continued-taxonomy="false" data-original-id="hidden-fact-14" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-131" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" ishiddenelement="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:IssuanceOfCommonStockRelatedToMayTwentyTwentyRegisteredDirectOfferingNetOfIssuanceCostsValue" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           (*
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c11" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-132" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:IssuanceOfCommonStockRelatedToMayTwentyTwentyRegisteredDirectOfferingNetOfIssuanceCostsValue" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          14,901
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-15">
         <span>
          <ix:nonfraction contextref="c12" continued-taxonomy="false" data-original-id="hidden-fact-15" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-133" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" ishiddenelement="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:IssuanceOfCommonStockRelatedToMayTwentyTwentyRegisteredDirectOfferingNetOfIssuanceCostsValue" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           -
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-134" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:IssuanceOfCommonStockRelatedToMayTwentyTwentyRegisteredDirectOfferingNetOfIssuanceCostsValue" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          14,901
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="padding-left: 0.125in; text-indent: -0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">
        Exercise of options by employees and non-employee consultants
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c10" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-135" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
          15,884
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-16">
         <span>
          <ix:nonfraction contextref="c10" continued-taxonomy="false" data-original-id="hidden-fact-16" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-136" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           (*
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-17">
         <span>
          <ix:nonfraction contextref="c11" continued-taxonomy="false" data-original-id="hidden-fact-17" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-137" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           -
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-18">
         <span>
          <ix:nonfraction contextref="c12" continued-taxonomy="false" data-original-id="hidden-fact-18" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-138" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           -
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-19">
         <span>
          <ix:nonfraction contextref="c5" continued-taxonomy="false" data-original-id="hidden-fact-19" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-139" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           -
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="padding-left: 0.125in; text-indent: -0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">
        Exercise of warrants by investors (Note 9c)
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c10" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-140" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:ExerciseOfWarrantsByInvestors" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
          386,678
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-20">
         <span>
          <ix:nonfraction contextref="c10" continued-taxonomy="false" data-original-id="hidden-fact-20" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-141" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" ishiddenelement="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:StockIssuedDuringPeriodExerciseOfWarrantsByInvestors" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           (*
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c11" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-142" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:StockIssuedDuringPeriodExerciseOfWarrantsByInvestors" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          2,707
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-21">
         <span>
          <ix:nonfraction contextref="c12" continued-taxonomy="false" data-original-id="hidden-fact-21" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-143" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" ishiddenelement="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:StockIssuedDuringPeriodExerciseOfWarrantsByInvestors" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           -
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-144" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:StockIssuedDuringPeriodExerciseOfWarrantsByInvestors" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          2,707
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="padding-left: 0.125in; text-indent: -0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">
        Round up of shares due to reverse share split effectuated    on July 25, 2019 (Note 9a)
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c10" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-145" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:RoundUpOfSharesDueToReverseShareSplitEffectuatedShares" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
          1,292
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-22">
         <span>
          <ix:nonfraction contextref="c10" continued-taxonomy="false" data-original-id="hidden-fact-22" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-146" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" ishiddenelement="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:RoundUpOfSharesDueToReverseShareSplitEffectuated" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           (*
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-23">
         <span>
          <ix:nonfraction contextref="c11" continued-taxonomy="false" data-original-id="hidden-fact-23" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-147" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" ishiddenelement="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:RoundUpOfSharesDueToReverseShareSplitEffectuated" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           -
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-24">
         <span>
          <ix:nonfraction contextref="c12" continued-taxonomy="false" data-original-id="hidden-fact-24" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-148" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" ishiddenelement="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:RoundUpOfSharesDueToReverseShareSplitEffectuated" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           -
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-25">
         <span>
          <ix:nonfraction contextref="c5" continued-taxonomy="false" data-original-id="hidden-fact-25" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-149" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" ishiddenelement="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:RoundUpOfSharesDueToReverseShareSplitEffectuated" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           -
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="padding-left: 0.125in; text-indent: -0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">
        Loss for the year
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        -
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-26">
         <span>
          <ix:nonfraction contextref="c10" continued-taxonomy="false" data-original-id="hidden-fact-26" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-150" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:NetIncomeLoss" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           -
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-27">
         <span>
          <ix:nonfraction contextref="c11" continued-taxonomy="false" data-original-id="hidden-fact-27" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-151" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:NetIncomeLoss" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           -
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c12" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-152" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="true" isstandardonly="true" istextonly="false" name="us-gaap:NetIncomeLoss" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
          29,152
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-153" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="true" isstandardonly="true" istextonly="false" name="us-gaap:NetIncomeLoss" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
          29,152
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
        )
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="padding-left: 0.125in; text-indent: -0.125in; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">
        Balance as of June 30, 2020
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">
        <span>
         <ix:nonfraction contextref="c13" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-154" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:SharesOutstanding" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
          25,492,713
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-28">
         <span>
          <ix:nonfraction contextref="c13" continued-taxonomy="false" data-original-id="hidden-fact-28" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-155" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockholdersEquity" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           (*
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">
        <span>
         <ix:nonfraction contextref="c14" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-156" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockholdersEquity" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          336,257
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c15" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-157" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="true" isstandardonly="true" istextonly="false" name="us-gaap:StockholdersEquity" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
          280,156
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">
        <span>
         <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-158" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockholdersEquity" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          56,101
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left">
        (*)
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        Less                                            than $1
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
     The accompanying notes arean integral part of the consolidated financial statements.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 52; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      F-
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      7
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
     <b>
      PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARIES
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
     <b>
     </b>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 100%">
        <p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          STATEMENTS OF CHANGES IN SHAREHOLDERS’    EQUITY
         </b>
        </p>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td style="font-size: 10pt">
        <span style="font-size: 10pt">
         <b>
          U.S. Dollars in thousands (except share and per share data)
         </b>
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: center">
       </td>
       <td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">
        Common Share
       </td>
       <td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">
       </td>
       <td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: center">
        Additional Paid-in
       </td>
       <td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">
       </td>
       <td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: center">
        Accumulated
       </td>
       <td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">
       </td>
       <td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif; text-align: center">
        Total Shareholders’
       </td>
       <td style="padding-bottom: 1.5pt; font: bold 10pt Times New Roman, Times, Serif">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: center">
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center">
        Shares
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center">
        Amount
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center">
        Capital
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center">
        Deficit
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center">
        Equity
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; width: 40%">
        Balance as of    July 1, 2020
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">
        <span>
         <ix:nonfraction contextref="c13" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-159" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:SharesOutstanding" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
          25,492,713
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-29">
         <span>
          <ix:nonfraction contextref="c13" continued-taxonomy="false" data-original-id="hidden-fact-29" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-160" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockholdersEquity" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           (*
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">
        <span>
         <ix:nonfraction contextref="c14" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-161" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockholdersEquity" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          336,257
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c15" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-162" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="true" isstandardonly="true" istextonly="false" name="us-gaap:StockholdersEquity" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
          280,156
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">
        <span>
         <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-163" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockholdersEquity" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          56,101
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Share-based    compensation to employees, directors and non-employee consultants
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c16" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-164" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
          591,033
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-30">
         <span>
          <ix:nonfraction contextref="c16" continued-taxonomy="false" data-original-id="hidden-fact-30" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-165" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           (*
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c17" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-166" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          13,968
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-31">
         <span>
          <ix:nonfraction contextref="c18" continued-taxonomy="false" data-original-id="hidden-fact-31" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-167" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           -
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-168" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          13,968
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Issuance of common shares under ATM Agreement, net of issuance costsof $
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-169" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:IssuanceOfCommonSharesUnderAgreement" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          380
         </ix:nonfraction>
        </span>
        (Note 9e)
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c16" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-170" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:IssuanceOfCommonSharesUnderAgreementNetOfIssuance" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
          1,045,097
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-32">
         <span>
          <ix:nonfraction contextref="c16" continued-taxonomy="false" data-original-id="hidden-fact-32" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-171" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" ishiddenelement="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:IssuanceOfCommonSharesAgreementNetOfIssuanceCosts" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           (*
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c17" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-172" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:IssuanceOfCommonSharesAgreementNetOfIssuanceCosts" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          8,506
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-33">
         <span>
          <ix:nonfraction contextref="c18" continued-taxonomy="false" data-original-id="hidden-fact-33" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-173" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" ishiddenelement="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:IssuanceOfCommonSharesAgreementNetOfIssuanceCosts" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           -
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-174" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:IssuanceOfCommonSharesAgreementNetOfIssuanceCosts" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          8,506
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Issuance of common shares related to February 2021 registered direct offering net of issuance costs of $
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-175" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          1,923
         </ix:nonfraction>
        </span>
        (Note 9g)
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c16" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-176" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:IssuanceOfCommonSharesOfferingNetOfIssuance" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
          4,761,905
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-34">
         <span>
          <ix:nonfraction contextref="c16" continued-taxonomy="false" data-original-id="hidden-fact-34" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-177" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" ishiddenelement="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:IssuanceOfCommonSharesRegisteredDirectOfferingNetOfIssuance" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           (*
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c17" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-178" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:IssuanceOfCommonSharesRegisteredDirectOfferingNetOfIssuance" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          28,077
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-35">
         <span>
          <ix:nonfraction contextref="c18" continued-taxonomy="false" data-original-id="hidden-fact-35" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-179" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" ishiddenelement="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:IssuanceOfCommonSharesRegisteredDirectOfferingNetOfIssuance" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           -
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-180" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:IssuanceOfCommonSharesRegisteredDirectOfferingNetOfIssuance" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          28,077
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Exercise of    options by employees and non-employee consultants
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c16" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-181" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
          15,035
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-36">
         <span>
          <ix:nonfraction contextref="c16" continued-taxonomy="false" data-original-id="hidden-fact-36" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-182" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           (*
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-37">
         <span>
          <ix:nonfraction contextref="c17" continued-taxonomy="false" data-original-id="hidden-fact-37" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-183" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           -
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-38">
         <span>
          <ix:nonfraction contextref="c18" continued-taxonomy="false" data-original-id="hidden-fact-38" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-184" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           -
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-39">
         <span>
          <ix:nonfraction contextref="c0" continued-taxonomy="false" data-original-id="hidden-fact-39" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-185" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           -
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Exercise of    warrants by investors (Note 9f)
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c16" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-186" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:ExerciseOfWarrantsByInvestors" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
          51,999
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-40">
         <span>
          <ix:nonfraction contextref="c16" continued-taxonomy="false" data-original-id="hidden-fact-40" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-187" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" ishiddenelement="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:StockIssuedDuringPeriodExerciseOfWarrantsByInvestors" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           (*
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c17" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-188" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:StockIssuedDuringPeriodExerciseOfWarrantsByInvestors" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          364
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-41">
         <span>
          <ix:nonfraction contextref="c18" continued-taxonomy="false" data-original-id="hidden-fact-41" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-189" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" ishiddenelement="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:StockIssuedDuringPeriodExerciseOfWarrantsByInvestors" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           -
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-190" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:StockIssuedDuringPeriodExerciseOfWarrantsByInvestors" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          364
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">
        Loss    for the year
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        -
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-42">
         <span>
          <ix:nonfraction contextref="c16" continued-taxonomy="false" data-original-id="hidden-fact-42" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-191" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:NetIncomeLoss" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           -
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-43">
         <span>
          <ix:nonfraction contextref="c17" continued-taxonomy="false" data-original-id="hidden-fact-43" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-192" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:NetIncomeLoss" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           -
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c18" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-193" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="true" isstandardonly="true" istextonly="false" name="us-gaap:NetIncomeLoss" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
          49,865
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-194" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="true" isstandardonly="true" istextonly="false" name="us-gaap:NetIncomeLoss" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
          49,865
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
        )
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 4pt">
        Balance    as of June 30, 2021
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">
        <span>
         <ix:nonfraction contextref="c19" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-195" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:SharesOutstanding" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
          31,957,782
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-44">
         <span>
          <ix:nonfraction contextref="c19" continued-taxonomy="false" data-original-id="hidden-fact-44" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-196" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockholdersEquity" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           (*
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">
        <span>
         <ix:nonfraction contextref="c20" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-197" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockholdersEquity" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          387,172
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c21" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-198" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="true" isstandardonly="true" istextonly="false" name="us-gaap:StockholdersEquity" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
          330,021
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 4pt double; text-align: right">
        <span>
         <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-199" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockholdersEquity" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          57,151
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left">
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left">
        (*)
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <ix:footnote id="ix_1_footnote" xml:lang="en-US">
         Less than $1
        </ix:footnote>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">
     The accompanying notes are anintegral part of the consolidated financial statements.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 53; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      F-
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      8
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify">
    </p>
    <div>
    </div>
    <div>
     <a id="a_005">
     </a>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
     <b>
      PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARIES
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 11.15pt; text-align: right">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 100%">
        <p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          CONSOLIDATED STATEMENTS OF CASH FLOWS
         </b>
        </p>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td style="font-size: 10pt">
        <span style="font-size: 10pt">
         <b>
          U.S. Dollars in thousands
         </b>
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in">
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center">
        Year    ended June 30,
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: center">
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt">
       </td>
       <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center">
        2021
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt">
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt">
       </td>
       <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: center">
        2020
       </td>
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in">
        CASH FLOWS FROM OPERATING    ACTIVITIES:
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; width: 76%; text-align: left">
        Loss    for the year
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-200" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="true" isstandardonly="true" istextonly="false" name="us-gaap:NetIncomeLoss" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
          49,865
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-201" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="true" isstandardonly="true" istextonly="false" name="us-gaap:NetIncomeLoss" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
          29,152
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">
        )
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Adjustments    to reconcile loss to net cash used in operating activities:
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in">
        Depreciation
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-202" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:Depreciation" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          1,370
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-203" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:Depreciation" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          1,570
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Share-based    compensation to employees, directors and non-employee consultants
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-204" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensation" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          13,968
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-205" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensation" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          2,562
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Decrease (increase)    in prepaid expenses and other current assets and other long-term assets
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-206" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="true" isstandardonly="true" istextonly="false" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
          303
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-207" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          150
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Increase (decrease)    in trade payables
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-208" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:IncreaseDecreaseInAccountsPayable" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          578
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-209" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="true" isstandardonly="true" istextonly="false" name="us-gaap:IncreaseDecreaseInAccountsPayable" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
          291
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Decrease in    operating lease right-of-use asset and liability, net
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-210" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:DecreaseInOperatingLeaseRight-Of-UseAssetAndLiability" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          321
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-211" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:DecreaseInOperatingLeaseRight-Of-UseAssetAndLiability" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          295
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Increase (decrease)    in other accounts payable, accrued expenses, other long-term liabilities and other current liabilities
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-212" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          3,353
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-213" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="true" isstandardonly="true" istextonly="false" name="us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
          638
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Decrease (increase)    in interest receivable on short-term deposits
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-214" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          256
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-215" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="true" isstandardonly="true" istextonly="false" name="us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
          45
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Long term interest    payable pursuant to EIB loan
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-216" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:IncreaseDecreaseInInterestPayableNet" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          78
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-45">
         <span>
          <ix:nonfraction contextref="c5" continued-taxonomy="false" data-original-id="hidden-fact-45" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-217" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:IncreaseDecreaseInInterestPayableNet" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           -
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Linkage differences    and interest on long-term deposits and restricted bank deposits
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-218" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="true" isnegativesonly="true" isstandardonly="false" istextonly="false" name="psti:LinkageDifferencesAndInterestOnShortAndLongtermDepositsAndRestrictedBankDeposits" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
          126
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-219" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="true" isnegativesonly="true" isstandardonly="false" istextonly="false" name="psti:LinkageDifferencesAndInterestOnShortAndLongtermDepositsAndRestrictedBankDeposits" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
          11
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">
        Accrued    severance pay, net
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-220" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          8
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-221" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="true" isstandardonly="true" istextonly="false" name="us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
          9
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
        )
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Net cash used    for operating activities
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">
        $
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-222" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="true" isstandardonly="true" istextonly="false" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
          30,910
         </ix:nonfraction>
        </span>
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">
        $
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-223" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="true" isstandardonly="true" istextonly="false" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
          26,369
         </ix:nonfraction>
        </span>
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        CASH FLOWS    FROM INVESTING ACTIVITIES:
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Purchase of    property and equipment
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-224" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          373
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-225" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          270
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Proceeds from    withdrawal of (investment in) short-term deposits
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-226" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:ProceedsFromWithdrawalOfShorttermDeposits" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          4,061
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-227" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="true" isnegativesonly="true" isstandardonly="false" istextonly="false" name="psti:ProceedsFromWithdrawalOfShorttermDeposits" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
          17,949
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">
        Investment    in long-term deposits and restricted bank deposits
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-228" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:RepaymentOfinvestmentInLongtermDepositsAndRestrictedBankDeposits" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          10,953
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-229" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:RepaymentOfinvestmentInLongtermDepositsAndRestrictedBankDeposits" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          12,239
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
        )
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Net cash used    for investing activities
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">
        $
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-230" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="true" isstandardonly="true" istextonly="false" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
          7,265
         </ix:nonfraction>
        </span>
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">
        $
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-231" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="true" isstandardonly="true" istextonly="false" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
          30,458
         </ix:nonfraction>
        </span>
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        CASH    FLOWS FROM FINANCING ACTIVITIES:
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Proceeds related    to issuance of common shares, net of issuance costs
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-232" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ProceedsFromIssuanceOfCommonStock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          36,589
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        $
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-233" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ProceedsFromIssuanceOfCommonStock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          58,163
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Proceeds related    to exercise of warrants
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-234" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ProceedsFromWarrantExercises" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          364
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-235" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ProceedsFromWarrantExercises" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          2,707
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">
        Proceeds    from EIB loan
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-236" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ProceedsFromBankDebt" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          24,449
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-46">
         <span>
          <ix:nonfraction contextref="c5" continued-taxonomy="false" data-original-id="hidden-fact-46" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-237" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ProceedsFromBankDebt" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           -
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Net cash provided    by financing activities
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">
        $
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-238" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          61,402
         </ix:nonfraction>
        </span>
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">
        $
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-239" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          60,870
         </ix:nonfraction>
        </span>
       </td>
       <td style="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        EFFECT    OF EXCHANGE RATE ON CASH AND CASH EQUIVALENTS
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        (
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-240" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="true" isstandardonly="true" istextonly="false" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
          618
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
        )
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <div style="-sec-ix-hidden: hidden-fact-47">
         <span>
          <ix:nonfraction contextref="c5" continued-taxonomy="false" data-original-id="hidden-fact-47" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-241" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
           -
          </ix:nonfraction>
         </span>
        </div>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Increase in    cash, cash equivalents and restricted cash
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-242" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          22,609
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-243" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          4,043
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">
        Cash,    cash equivalents and restricted cash at the beginning of the period
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-244" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          9,229
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c9" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-245" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          5,186
         </ix:nonfraction>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in; text-indent: -0.125in; text-align: left">
        Cash,    cash equivalents and restricted cash at the end of the period
       </td>
       <td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">
        $
       </td>
       <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-246" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          31,838
         </ix:nonfraction>
        </span>
       </td>
       <td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
       <td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">
        $
       </td>
       <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">
        <span>
         <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-247" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          9,229
         </ix:nonfraction>
        </span>
       </td>
       <td style="padding-bottom: 4pt; font: 10pt Times New Roman, Times, Serif; text-align: left">
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">
     The accompanying notes are anintegral part of the consolidated financial statements.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0in; text-align: justify">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 54; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      F-
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      9
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
     <b>
     </b>
    </p>
    <div>
    </div>
    <div>
     <a id="a_006">
     </a>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
     <b>
      PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARIES
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top">
       <td style="border-bottom: Black 1.5pt solid; width: 100%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          NOTES TO CONSOLIDATED FINANCIAL    STATEMENTS
         </b>
        </p>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td style="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">
        <span style="font-size: 10pt">
         <b>
          U.S. Dollars in thousands (except share and per share amounts)
         </b>
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
    </span>
    <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
    </span>
    <span>
     <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_GeneralTextBlock-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-248" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="true" name="psti:GeneralTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">
       <b>
        NOTE 1: - GENERAL
       </b>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">
       <b>
       </b>
      </p>
     </ix:nonnumeric>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_GeneralTextBlock-c0_cont_2" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_GeneralTextBlock-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">
       <tbody>
        <tr style="vertical-align: top">
         <td style="width: 0">
         </td>
         <td style="width: 0.25in">
          <span style="font-size: 10pt">
           a.
          </span>
         </td>
         <td style="text-align: justify">
          <span style="font-size: 10pt">
           Pluristem Therapeutics Inc., a Nevada corporation (“Pluristem Therapeutics”),was incorporated on May 11, 2001. Pluristem Therapeutics has a wholly owned subsidiary, Pluristem Ltd. (the “Subsidiary”),which is incorporated under the laws of the State of Israel. In January 2020, the Subsidiary established a wholly owned subsidiary, PluristemGmbH (the “German Subsidiary”
          </span>
          )
          <span style="font-size: 10pt">
           which is incorporated under the laws of Germany. PluristemTherapeutics, the Subsidiary and the German Subsidiary are referred to as the “Company” or “Pluristem”. The Subsidiaryand the German Subsidiary are referred to as the “Subsidiaries”.
          </span>
         </td>
        </tr>
       </tbody>
      </table>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_GeneralTextBlock-c0_cont_3" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_GeneralTextBlock-c0_cont_2" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
       The Company’scommon shares are traded on the Nasdaq Global Market and on the Tel-Aviv Stock Exchange under the symbol “PSTI”.
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_GeneralTextBlock-c0_cont_4" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_GeneralTextBlock-c0_cont_3" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">
       <tbody>
        <tr style="vertical-align: top">
         <td style="width: 0">
         </td>
         <td style="width: 0.25in">
          b.
         </td>
         <td style="text-align: justify">
          The Company is a bio-technology company focused in the field of regenerative medicine and operates in onebusiness segment. The Company is developing placenta-based cell therapy product candidates for the treatment of muscle trauma, hematologicaldisorders, radiation damage and inflammation.
         </td>
        </tr>
       </tbody>
      </table>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_GeneralTextBlock-c0_cont_5" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_GeneralTextBlock-c0_cont_4" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
       The Company has incurredan accumulated deficit of approximately $
       <span>
        <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-253" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="true" isstandardonly="true" istextonly="false" name="us-gaap:RetainedEarningsAccumulatedDeficit" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
         330,021
        </ix:nonfraction>
       </span>
       and incurred recurring operating losses and negative cash flows from operating activitiessince inception. As of June 30, 2021, the Company’s total shareholders’ equity amounted to $
       <span>
        <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-254" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockholdersEquityNoteSubscriptionsReceivable" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
         57,151
        </ix:nonfraction>
       </span>
       . During the year ended June 30,2021, the Company incurred losses of $
       <span>
        <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-255" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ProfitLoss" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
         49,865
        </ix:nonfraction>
       </span>
       and its negative cash flow from operating activities was $
       <span>
        <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-256" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:IncurredOperatingLoss" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
         30,910
        </ix:nonfraction>
       </span>
       .
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_GeneralTextBlock-c0_cont_5" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
       <span style="font-size: 10pt">
        Asof June 30, 2021, the Company’s cash position (cash and cash equivalents, short-term bank deposits and long-term bankdeposits) totaled approximately $
        <span>
         <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-258" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          88,219
         </ix:nonfraction>
        </span>
        . The Company plans to continue to finance its operations from its current resources
       </span>
       ,
       <span style="font-size: 10pt">
        byentering into licensing or other commercial agreements, from grants to support its research and development activities from sales ofits equity securities and from the proceeds from the loan previously provided by the European Investment Bank (the“EIB”, see also note 7), as well as the potential additional draw down of funds from the Finance Contract (as definedherein) executed with the EIB, assuming applicable milestones will be achieved. Management believes that its current resources,together with its existing operating plan, are sufficient for the Company to meet its obligations as they come due at least for aperiod of twelve months from the date of the issuance of these consolidated financial statements. There are no assurances, however,that the Company will be able to obtain an adequate level of financial resources that are required for the long-term development andcommercialization of its products.
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">
     <b>
     </b>
    </p>
    <div>
    </div>
    <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
    </span>
    <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
    </span>
    <span>
     <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-259" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:SignificantAccountingPoliciesTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">
       <b>
        NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES
       </b>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.2pt; text-align: justify">
      </p>
     </ix:nonnumeric>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_2" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
       The consolidated financial statementshave been prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”) applied on consistentbasis.
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_3" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_2" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_UseOfEstimates-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-262" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:UseOfEstimates" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
         <tbody>
          <tr style="vertical-align: top">
           <td style="width: 0%">
           </td>
           <td style="width: 0.25in">
            <b>
             a.
            </b>
           </td>
           <td style="text-align: justify">
            <b>
             Use of estimates
            </b>
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: 0pt">
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_4" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_3" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_UseOfEstimates-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         The preparation offinancial statements in conformity with generally accepted accounting principles requires management to make estimates, judgments, andassumptions that are reasonable based upon information available at the time they are made. These estimates, judgments and assumptionscan affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: -27pt">
         <b>
         </b>
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_5" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_4" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-266" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
         <tbody>
          <tr style="vertical-align: top">
           <td style="width: 0%">
           </td>
           <td style="width: 0.25in">
            <b>
             b.
            </b>
           </td>
           <td style="text-align: justify">
            <b>
             Functional currency
            </b>
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: -27pt">
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_6" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_5" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         TheCompany’s management believes that the dollar is the primary currency of the economic environment in which the Company and theSubsidiaries operate. Thus, the dollar is the Company’s functional and reporting currency. Accordingly, non-dollardenominated transactions and balances have been re-measured into the functional currency in accordance with Accounting StandardsCodification (“ASC”) 830, “Foreign Currency Matters”. All transaction gains and losses from the re-measuredmonetary balance sheet items are reflected in the statements of income as financial income or expenses, as appropriate.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 55; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      F-
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      10
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
     <b>
      PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARIES
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top">
       <td style="border-bottom: Black 1.5pt solid; width: 100%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          NOTES TO CONSOLIDATED FINANCIAL    STATEMENTS
         </b>
        </p>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td style="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">
        <span style="font-size: 10pt">
         <b>
          U.S. Dollars in thousands (except share and per share amounts)
         </b>
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      NOTE 2: - SIGNIFICANT ACCOUNTING POLICIES (CONT.)
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: -27pt">
     <b>
     </b>
    </p>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_7" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_6" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_ConsolidationPolicyTextBlock-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-270" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:ConsolidationPolicyTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
         <tbody>
          <tr style="vertical-align: top">
           <td style="width: 0%">
           </td>
           <td style="width: 0.25in">
            <b>
             c.
            </b>
           </td>
           <td style="text-align: justify">
            <b>
             Principles of consolidation
            </b>
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: 0pt">
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_8" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_7" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_ConsolidationPolicyTextBlock-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         The consolidated financialstatements include the accounts of Pluristem Therapeutics and the Subsidiaries. Intercompany transactions and balances have been eliminatedupon consolidation.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: -27pt">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_9" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_8" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_CashAndCashEquivalentsPolicyTextBlock-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-274" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">
         <tbody>
          <tr style="vertical-align: top">
           <td style="width: 0">
           </td>
           <td style="width: 0.25in">
            <b>
             d.
            </b>
           </td>
           <td style="text-align: justify">
            <b>
             Cash and cash equivalents
            </b>
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_10" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_9" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_CashAndCashEquivalentsPolicyTextBlock-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         Cash equivalentsare short-term highly liquid investments that are readily convertible to cash with maturities of three months or less at the date acquired.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">
         <b>
         </b>
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_11" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_10" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_ShortTermBankDepositPolicyTextBlock-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-278" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="true" name="psti:ShortTermBankDepositPolicyTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">
         <tbody>
          <tr style="vertical-align: top">
           <td style="width: 0">
           </td>
           <td style="width: 0.25in">
            <b>
             e.
            </b>
           </td>
           <td style="text-align: justify">
            <b>
             Short-term bank deposit
            </b>
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in">
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_12" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_11" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_ShortTermBankDepositPolicyTextBlock-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         Bank deposits withoriginal maturities of more than three months but less than one year are presented as part of short-term investments. Deposits are presentedat their cost which approximates market values including accrued interest. Interest on deposits is recorded as financial income.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_13" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_12" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-282" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
         <tbody>
          <tr style="vertical-align: top">
           <td style="width: 0%">
           </td>
           <td style="width: 0.25in">
            <b>
             f.
            </b>
           </td>
           <td style="text-align: justify">
            <b>
             Restricted cash and short-term bank deposits
            </b>
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_14" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_13" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         Short-term restricted bank depositsand restricted cash used to secure derivative and hedging transactions and the Company’s credit line. The restricted cash and short-termbank deposits are presented at cost which approximates market values including accrued interest.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_15" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_14" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_LongTermRestrictedBankDepositsPolicyTextBlock-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-286" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="true" name="psti:LongTermRestrictedBankDepositsPolicyTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
         <tbody>
          <tr style="vertical-align: top">
           <td style="width: 0%">
           </td>
           <td style="width: 0.25in">
            <b>
             g.
            </b>
           </td>
           <td style="text-align: justify">
            <b>
             Long-term restricted bank deposits
            </b>
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_16" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_15" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_LongTermRestrictedBankDepositsPolicyTextBlock-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         Long-term restricted bank depositswith maturities of more than one year used to secure operating lease agreement are presented at cost which approximates market valuesincluding accrued interest.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_17" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_16" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-290" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
         <tbody>
          <tr style="vertical-align: top">
           <td style="width: 0%">
           </td>
           <td style="width: 0.25in">
            <b>
             h.
            </b>
           </td>
           <td style="text-align: justify">
            <span style="font-size: 10pt">
             <b>
              Revenue Recognition
             </b>
            </span>
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_18" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_17" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure-c0_cont_2" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         Revenues are recognized when control of the promised goodsis transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for thosegoods.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_19" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_18" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure-c0_cont_3" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure-c0_cont_2" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         The Company determines revenue recognition through thefollowing steps:
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_20" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_19" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure-c0_cont_4" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure-c0_cont_3" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif">
         <tbody>
          <tr>
           <td style="width: 0.25in; font-size: 10pt">
           </td>
           <td style="vertical-align: top; width: 0.25in; font-size: 10pt">
            <span style="font-size: 10pt">
             ●
            </span>
           </td>
           <td style="vertical-align: top; font-size: 10pt">
            <span style="font-size: 10pt">
             identification of the contract with a customer;
            </span>
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_21" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_20" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure-c0_cont_5" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure-c0_cont_4" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif">
         <tbody>
          <tr>
           <td style="width: 0.25in; font-size: 10pt">
           </td>
           <td style="vertical-align: top; width: 0.25in; font-size: 10pt">
            <span style="font-size: 10pt">
             ●
            </span>
           </td>
           <td style="vertical-align: top; font-size: 10pt">
            <span style="font-size: 10pt">
             identification of the performance obligations in the contract;
            </span>
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_22" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_21" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure-c0_cont_6" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure-c0_cont_5" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif">
         <tbody>
          <tr>
           <td style="width: 0.25in; font-size: 10pt">
           </td>
           <td style="vertical-align: top; width: 0.25in; font-size: 10pt">
            <span style="font-size: 10pt">
             ●
            </span>
           </td>
           <td style="vertical-align: top; font-size: 10pt">
            <span style="font-size: 10pt">
             determination of the transaction price;
            </span>
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_23" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_22" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure-c0_cont_7" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure-c0_cont_6" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif">
         <tbody>
          <tr>
           <td style="width: 0.25in; font-size: 10pt">
           </td>
           <td style="vertical-align: top; width: 0.25in; font-size: 10pt">
            <span style="font-size: 10pt">
             ●
            </span>
           </td>
           <td style="vertical-align: top; font-size: 10pt">
            <span style="font-size: 10pt">
             allocation of the transaction price to the performance obligations in the contract; and
            </span>
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_24" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_23" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure-c0_cont_7" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif">
         <tbody>
          <tr>
           <td style="width: 0.25in; font-size: 10pt">
           </td>
           <td style="vertical-align: top; width: 0.25in; font-size: 10pt">
            <span style="font-size: 10pt">
             ●
            </span>
           </td>
           <td style="vertical-align: top; font-size: 10pt">
            <span style="font-size: 10pt">
             recognition of revenue when, or as, the Company satisfies a performance obligation.
            </span>
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
         </b>
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 56; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      F-
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      11
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
     <b>
      PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARIES
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 100%">
        <p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          NOTES TO CONSOLIDATED FINANCIAL    STATEMENTS
         </b>
        </p>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td style="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">
        <span style="font-size: 10pt">
         <b>
          U.S. Dollars in thousands (except share and per share amounts)
         </b>
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      NOTE 2: - SIGNIFICANT ACCOUNTING POLICIES (CONT.)
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">
    </p>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_25" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_24" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-306" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
         <tbody>
          <tr style="vertical-align: top">
           <td style="width: 0%">
           </td>
           <td style="width: 0.25in">
            <b>
             i.
            </b>
           </td>
           <td style="text-align: justify">
            <b>
             Property and equipment
            </b>
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: 0pt">
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_26" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_25" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_2" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         Property and equipmentare stated at cost, net of accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated usefullives of the assets, at the following annual rates:
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: -27pt">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_27" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_26" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-310" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="true" name="psti:PropertyPlantAndEquipmentEstimatedUsefulLivesRateTableTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" text-block-taxonomy="true">
        <span>
         <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_PropertyPlantAndEquipmentPolicyTextBlock-c0_cont_2" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
          <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
           <tbody>
            <tr style="vertical-align: top">
             <td style="width: 50%; text-align: justify; font-size: 10pt">
             </td>
             <td style="border-bottom: Black 1.5pt solid; width: 50%">
              <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
               %
              </p>
             </td>
            </tr>
            <tr style="vertical-align: top; background-color: rgb(204,238,255)">
             <td style="font-size: 10pt">
              <span style="font-size: 10pt">
               Laboratory equipment
              </span>
             </td>
             <td style="font-size: 10pt">
              <span style="font-size: 10pt">
               <span>
                <ix:nonfraction contextref="c22" continued-taxonomy="false" decimals="0" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-312" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:PropertyPlantAndEquipmentOther" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="usd">
                 10
                </ix:nonfraction>
               </span>
               -
               <span>
                <ix:nonfraction contextref="c23" continued-taxonomy="false" decimals="0" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-313" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:PropertyPlantAndEquipmentOther" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="usd">
                 40
                </ix:nonfraction>
               </span>
              </span>
             </td>
            </tr>
            <tr style="vertical-align: top; ">
             <td style="font-size: 10pt">
              <span style="font-size: 10pt">
               Computers and peripheral equipment
              </span>
             </td>
             <td style="font-size: 10pt">
              <span style="font-size: 10pt">
               <span>
                <ix:nonfraction contextref="c24" continued-taxonomy="false" decimals="0" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-314" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:PropertyPlantAndEquipmentOther" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="usd">
                 33
                </ix:nonfraction>
               </span>
              </span>
             </td>
            </tr>
            <tr style="vertical-align: top; background-color: rgb(204,238,255)">
             <td style="font-size: 10pt">
              <span style="font-size: 10pt">
               Office furniture and equipment
              </span>
             </td>
             <td style="font-size: 10pt">
              <span style="font-size: 10pt">
               <span>
                <ix:nonfraction contextref="c25" continued-taxonomy="false" decimals="0" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-315" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:PropertyPlantAndEquipmentOther" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="usd">
                 15
                </ix:nonfraction>
               </span>
              </span>
             </td>
            </tr>
            <tr style="vertical-align: top; ">
             <td style="font-size: 10pt">
              <span style="font-size: 10pt">
               Leasehold improvements
              </span>
             </td>
             <td style="font-size: 10pt">
              <span style="font-size: 10pt">
               <span>
                <ix:nonnumeric contextref="c26" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-316" inside-table="true" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="true" name="psti:EstimatedUsefulLifePercentageDescription" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
                 The shorter of the expected useful life or the term of the lease.
                </ix:nonnumeric>
               </span>
              </span>
             </td>
            </tr>
           </tbody>
          </table>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
           <b>
           </b>
          </p>
         </ix:continuation>
        </span>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_28" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_27" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-318" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
         <tbody>
          <tr style="vertical-align: top">
           <td style="width: 0%">
           </td>
           <td style="width: 0.25in">
            <b>
             j.
            </b>
           </td>
           <td style="text-align: justify">
            <b>
             Impairment of long-lived assets
            </b>
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_29" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_28" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         TheCompany’s long-lived assets are reviewed for impairment in accordance with ASC 360, “Property, Plant andEquipment”, whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to the futureundiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to berecognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During fiscalyears 2021 and 2020, no triggering events were identified, and no impairment losses were recorded.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: -27pt">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_30" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_29" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_CompensationRelatedCostsPolicyTextBlock-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-322" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
         <tbody>
          <tr style="vertical-align: top">
           <td style="width: 0%">
           </td>
           <td style="width: 0.25in">
            <b>
             k.
            </b>
           </td>
           <td style="text-align: justify">
            <b>
             Accounting for share-based compensation
            </b>
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_31" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_30" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_CompensationRelatedCostsPolicyTextBlock-c0_cont_2" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_CompensationRelatedCostsPolicyTextBlock-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         The Company accountsfor share-based compensation in accordance with ASC 718, “Compensation-Share Compensation” (“ASC 718”). ASC 718requires companies to estimate the fair value of equity-based payment awards on the date of grant using an option-pricing model. The Companyestimates the fair value of share options granted using the Black-Scholes option-pricing model. The Company accounts for employees’ share-basedpayment awards classified as equity awards (restricted shares (“RS”) or restricted share units (“RSUs”)) usingthe grant-date fair value method. The fair value of share-based payment transactions is recognized as an expense over the requisite serviceperiod, net of estimated forfeitures. The Company estimates forfeitures based on historical experience and anticipated future conditions.The Company recognized compensation cost for an award with service conditions that has a graded vesting schedule using the acceleratedmethod based on the multiple-option award approach.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_32" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_31" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_CompensationRelatedCostsPolicyTextBlock-c0_cont_3" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_CompensationRelatedCostsPolicyTextBlock-c0_cont_2" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         The Company measuresthe cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: 0.05pt">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_33" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_32" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_CompensationRelatedCostsPolicyTextBlock-c0_cont_4" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_CompensationRelatedCostsPolicyTextBlock-c0_cont_3" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         The fair valueof service-based share option grants is estimated on the grant date using a Black-Scholes option-pricing model and compensationexpense related to share option grants is recognized on a graded vesting schedule over the vesting period. For share optionscontaining a market condition, the market conditions are required to be considered when calculating the grant date fair value. ASC718 requires selection of a valuation technique that best fits the circumstances of an award. In order to reflect the substantivecharacteristics of the market condition option award, a Monte Carlo simulation valuation model was used to calculate the grant datefair value of such share options. Expense for the market condition share options is recognized over the derived service period asdetermined through the Monte Carlo simulation model.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 57; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      F-
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      12
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
     <b>
      PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARIES
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 100%">
        <p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          NOTES TO CONSOLIDATED FINANCIAL    STATEMENTS
         </b>
        </p>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td style="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">
        <span style="font-size: 10pt">
         <b>
          U.S. Dollars in thousands (except share and per share amounts)
         </b>
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      NOTE 2: - SIGNIFICANT ACCOUNTING POLICIES (CONT.)
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
     </b>
    </p>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_34" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_33" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_CompensationRelatedCostsPolicyTextBlock-c0_cont_5" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_CompensationRelatedCostsPolicyTextBlock-c0_cont_4" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         In accordance with ASC 718, RS andRSUs are measured at their fair value. All RS and RSUs to employees and directors granted during fiscal 2021 and 2020, were granted forno consideration. Therefore, their fair value was equal to the share price at the date of grant, unless the RSUs include a market-basedcondition in which case the fair value RSUs at the date of grant was calculated using the Monte Carlo model.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_35" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_34" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_CompensationRelatedCostsPolicyTextBlock-c0_cont_6" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_CompensationRelatedCostsPolicyTextBlock-c0_cont_5" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         The fair value ofall RS and RSUs was determined based on the close trading price of the Company’s shares known at the grant date. The weighted averagegrant date fair value of shares granted during fiscal 2021 and 2020, was $
         <span>
          <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-333" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="usdPershares">
           9.76
          </ix:nonfraction>
         </span>
         and $
         <span>
          <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-334" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="usdPershares">
           3.65
          </ix:nonfraction>
         </span>
         per share, respectively.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_36" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_35" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_CompensationRelatedCostsPolicyTextBlock-c0_cont_6" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         During fiscal years2021 and 2020, there were no options granted to employees or directors.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.05pt; text-align: justify; text-indent: -28.35pt">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_37" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_36" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_ResearchAndDevelopmentExpensePolicy-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-338" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:ResearchAndDevelopmentExpensePolicy" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
         <tbody>
          <tr style="vertical-align: top">
           <td style="width: 0%">
           </td>
           <td style="width: 0.25in">
            <b>
             l.
            </b>
           </td>
           <td style="text-align: justify">
            <b>
             Research and Development expenses, royalty bearing grants and non-royalty bearing grants
            </b>
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify">
         <b>
         </b>
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_38" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_37" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_ResearchAndDevelopmentExpensePolicy-c0_cont_2" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_ResearchAndDevelopmentExpensePolicy-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         Research and developmentexpenses include costs directly attributable to the conduct of research and development programs, including the cost of salaries, share-basedcompensation expenses, payroll taxes and other employee benefits, subcontractors and materials used for research and development activities,including clinical trials, manufacturing costs and professional services. All costs associated with research and developments are expensedas incurred.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -1.35pt">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_39" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_38" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_ResearchAndDevelopmentExpensePolicy-c0_cont_3" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_ResearchAndDevelopmentExpensePolicy-c0_cont_2" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         Grantsreceived from the Israel Innovation Authority (the “IIA”) were recognized when the grant becomes receivable, provided therewas reasonable assurance that the Company will comply with the conditions attached to the grant and there was reasonable assurance thegrant will be received. The grant is deducted from the research and development expenses as the applicable costs are incurred.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -1.35pt">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_40" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_39" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_ResearchAndDevelopmentExpensePolicy-c0_cont_4" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_ResearchAndDevelopmentExpensePolicy-c0_cont_3" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         Research anddevelopment expenses, net for the year ended June 30, 2021 and 2020 include participation in research and development expenses in theamount of approximately $
         <span>
          <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-345" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ResearchAndDevelopmentInProcess" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
           467
          </ix:nonfraction>
         </span>
         and $
         <span>
          <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-346" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ResearchAndDevelopmentInProcess" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
           1,519
          </ix:nonfraction>
         </span>
         , respectively.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -1.35pt">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_41" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_40" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_ResearchAndDevelopmentExpensePolicy-c0_cont_5" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_ResearchAndDevelopmentExpensePolicy-c0_cont_4" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         <span style="font-size: 10pt">
          Clinicaltrial expenses are charged to research and development expense as incurred. The Company accrues for expenses resulting from obligationsunder contracts with clinical research organizations (
         </span>
         “
         <span style="font-size: 10pt">
          CROs
         </span>
         ”
         <span style="font-size: 10pt">
          ).The financial terms of these contracts are subject to negotiations, which vary from contract to contract and may result in payment flowsthat do not match the periods over which materials or services are provided. The Company’s objective is to reflect the appropriatetrial expense in the consolidated financial statements by matching the appropriate expenses with the period in which services and effortsare expended. In the event advance payments are made to a CRO, the payments are recorded as other assets, which will be recognized asexpenses as services are rendered.
         </span>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -1.35pt">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_42" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_41" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_ResearchAndDevelopmentExpensePolicy-c0_cont_5" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         During fiscalyears 2021 and 2020, the Company also received non-royalty bearing grants from the European Union research and developmentconsortiums, under Horizon 2020, and from the IIA, under the CRISPR-IL consortium, in the amount of approximately $
         <span>
          <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-351" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:GrantsReceivable" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
           566
          </ix:nonfraction>
         </span>
         and $
         <span>
          <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-352" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:GrantsReceivable" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
           1,227
          </ix:nonfraction>
         </span>
         , forthe year ended June 30, 2021 and 2020, respectively. The non-royalty bearing grants for funding the projects are recognized at thetime the Company is entitled to each such grant on the basis of the related costs incurred and recorded as a deduction from researchand development expenses.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">
         <b>
         </b>
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_43" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_42" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_EarningsPerSharePolicyTextBlock-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-354" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:EarningsPerSharePolicyTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
         <tbody>
          <tr style="vertical-align: top">
           <td style="width: 0pt">
           </td>
           <td style="width: 0.25in">
            <b>
             m.
            </b>
           </td>
           <td style="text-align: justify">
            <b>
             Loss per share
            </b>
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_44" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_43" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_EarningsPerSharePolicyTextBlock-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         Basic and dilutedloss per share is computed based on the weighted average number of common shares outstanding during each year. All outstanding share optionsand unvested RSUs have been excluded from the calculation of the diluted loss per common share because all such securities are anti-dilutivefor each of the periods presented. The total weighted average number of shares related to the outstanding options, warrants and RSU’sexcluded from the calculations of diluted net earnings per share due to their anti-dilutive effect was
         <span>
          <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-357" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:DilutedNetEarningsPerShareDueToAntidilutiveShare" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
           5,700,994
          </ix:nonfraction>
         </span>
         and
         <span>
          <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-358" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:DilutedNetEarningsPerShareDueToAntidilutiveShare" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
           3,708,807
          </ix:nonfraction>
         </span>
         for theyears ended June 30, 2021 and 2020, respectively.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <!-- Field: Page; Sequence: 58; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      F-
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      13
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27.35pt; text-align: justify; text-indent: -27pt">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
     <b>
      PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARIES
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 100%">
        <p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          NOTES TO CONSOLIDATED FINANCIAL    STATEMENTS
         </b>
        </p>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td style="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">
        <span style="font-size: 10pt">
         <b>
          U.S. Dollars in thousands (except share and per share amounts)
         </b>
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27.35pt; text-align: justify; text-indent: -27pt">
     <b>
      NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (CONT.)
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_45" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_44" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_IncomeTaxPolicyTextBlock-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-360" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:IncomeTaxPolicyTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
         <tbody>
          <tr style="vertical-align: top">
           <td style="width: 0pt">
           </td>
           <td style="width: 0.25in">
            <b>
             n.
            </b>
           </td>
           <td style="text-align: justify">
            <b>
             Income taxes
            </b>
           </td>
          </tr>
         </tbody>
        </table>
        <p style="margin-top: 0; margin-bottom: 0">
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_46" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_45" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxPolicyTextBlock-c0_cont_2" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxPolicyTextBlock-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
         <tbody>
          <tr style="vertical-align: top">
           <td style="width: 0.25in">
           </td>
           <td style="width: 0.25in">
            1.
           </td>
           <td>
            Deferred taxes
           </td>
          </tr>
         </tbody>
        </table>
        <p style="margin-top: 0; margin-bottom: 0">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_47" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_46" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxPolicyTextBlock-c0_cont_3" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxPolicyTextBlock-c0_cont_2" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">
         Income taxesare computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities aredetermined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using thecurrently enacted tax rates and laws. A valuation allowance is recognized to the extent that it is more likely than not that the deferredtaxes will not be realized in the foreseeable future.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; ">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_48" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_47" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxPolicyTextBlock-c0_cont_4" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxPolicyTextBlock-c0_cont_3" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
         <tbody>
          <tr style="vertical-align: top">
           <td style="width: 0.25in">
           </td>
           <td style="width: 0.25in">
            2.
           </td>
           <td>
            Uncertainty in income taxes
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_49" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_48" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxPolicyTextBlock-c0_cont_4" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">
         The Companyfollows a two-step approach in recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognitionby determining if the available evidence indicates that it is more likely than not that the position will be sustained based on technicalmerits. If this threshold is met, the second step is to measure the tax position as the largest amount that has more than a
         <span>
          <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-369" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlements" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
           50
          </ix:nonfraction>
         </span>
         % likelihoodof being realized upon ultimate settlement.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_50" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_49" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_ConcentrationRiskCreditRisk-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-371" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:ConcentrationRiskCreditRisk" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
         <tbody>
          <tr style="vertical-align: top">
           <td style="width: 0pt">
           </td>
           <td style="width: 0.25in">
            <b>
             o.
            </b>
           </td>
           <td style="text-align: justify">
            <b>
             Concentration of credit risk
            </b>
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0pt">
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_51" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_50" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_ConcentrationRiskCreditRisk-c0_cont_2" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_ConcentrationRiskCreditRisk-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         Financial instrumentsthat potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, restricted cash,short-term deposits, long-term deposits and restricted deposits.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0pt">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_52" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_51" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_ConcentrationRiskCreditRisk-c0_cont_2" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         The majorityof the Company’s cash and cash equivalents, restricted cash and short-term and long-term deposits are mainly invested in dollarinstruments of major banks in Israel and in the United States. Deposits in the United States may be in excess of insured limits and arenot insured in other jurisdictions. Generally, these deposits may be redeemed upon demand and therefore bear minimal risk. The Companyinvests its surplus cash in cash deposits in financial institutions and has established guidelines, approved by the Company’s InvestmentCommittee, relating to diversification and maturities to maintain safety and liquidity of the investments. The Company utilizes optionsand forward contracts to protect against the risk of overall changes in exchange rates. The derivative instruments hedge a portion ofthe Company’s non-dollar currency exposure. Counterparties to the Company’s derivative instruments are all major financialinstitutions.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -1.35pt">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_53" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_52" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_SeverancePayPolicyTextBlock-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-377" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="true" name="psti:SeverancePayPolicyTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
         <tbody>
          <tr style="vertical-align: top">
           <td style="width: 0pt">
           </td>
           <td style="width: 0.25in">
            <b>
             p.
            </b>
           </td>
           <td style="text-align: justify">
            <b>
             Severance pay
            </b>
           </td>
          </tr>
         </tbody>
        </table>
        <p style="margin-top: 0; margin-bottom: 0">
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_54" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_53" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_SeverancePayPolicyTextBlock-c0_cont_2" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SeverancePayPolicyTextBlock-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         The majorityof the Company’s agreements with employees in Israel are subject to Section 14 of the Israeli Severance Pay Law, 1963 (“SeverancePay Law”). The Company’s contributions for severance pay have replaced its severance obligation. Upon contribution of thefull amount of the employee’s monthly salary for each year of employment, no additional calculations are conducted between the partiesregarding the matter of severance pay and no additional payments are made by the Company to the employee. Further, the related obligationand amounts deposited on behalf of the employee for such obligation are not stated on the balance sheet, as the Company is legally releasedfrom the obligation to employees once the deposit amounts have been paid.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_55" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_54" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_SeverancePayPolicyTextBlock-c0_cont_3" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SeverancePayPolicyTextBlock-c0_cont_2" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         For some employees,which their agreement is not subject to Section 14 of the Severance Pay Law, the Subsidiary’s liability for severance pay is calculatedpursuant to Israeli Severance Pay Law, based on the most recent salary of the employees multiplied by the number of years of employment,as of the balance sheet date. Employees are entitled to one month’s salary for each year of employment or a portion thereof. The Company’sliability for all of its employees is fully provided by monthly deposits with insurance policies and by an accrual. The value of thesepolicies is recorded as an asset in the Company’s balance sheet.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <!-- Field: Page; Sequence: 59; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      F-
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      14
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
     <b>
      PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARIES
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 100%">
        <p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          NOTES TO CONSOLIDATED FINANCIAL    STATEMENTS
         </b>
        </p>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td style="font-size: 10pt">
        <span style="font-size: 10pt">
         <b>
          U.S. Dollars in thousands (except share and per share amounts)
         </b>
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27.35pt; text-align: justify; text-indent: -27pt">
     <b>
      NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (CONT.)
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -1.35pt">
    </p>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_56" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_55" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SeverancePayPolicyTextBlock-c0_cont_3" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         <span style="font-size: 10pt">
          Thedeposited funds include profits or losses accumulated up to the balance sheet date. The deposited funds may be withdrawn only upon thefulfillment of the obligation pursuant to the Severance Pay Law or labor agreements. The value of the deposited funds is based on thecash surrendered value of these policies, and includes immaterial profits or losses. Severance expenses for the years ended June 30, 2021and 2020 were $
         </span>
         <span>
          <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-384" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:SeveranceCosts1" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
           748
          </ix:nonfraction>
         </span>
         <span style="font-size: 10pt">
          and $
         </span>
         <span>
          <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-385" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:SeveranceCosts1" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
           604
          </ix:nonfraction>
         </span>
         <span style="font-size: 10pt">
          , respectively.
         </span>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -1.35pt">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_57" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_56" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_FairValueOfFinancialInstrumentsPolicy-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-387" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
         <tbody>
          <tr style="vertical-align: top">
           <td style="width: 0pt">
           </td>
           <td style="width: 0.25in">
            <b>
             q.
            </b>
           </td>
           <td style="text-align: justify">
            <b>
             Fair value of financial instruments
            </b>
           </td>
          </tr>
         </tbody>
        </table>
        <p style="margin-top: 0; margin-bottom: 0">
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_58" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_57" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_FairValueOfFinancialInstrumentsPolicy-c0_cont_2" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         The carryingamounts of the Company’s financial instruments, including cash and cash equivalents, restricted cash, short-term and restricted bank deposits,accounts receivable and other current assets, trade payable and other accounts payable and accrued liabilities, approximate fair valuebecause of their generally short term maturities.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_59" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_58" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_FairValueOfFinancialInstrumentsPolicy-c0_cont_3" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_2" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         The Companymeasures its derivative instruments at fair value under ASC 820, “Fair Value Measurement” (“ASC 820”). Fair valueis an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transactionbetween market participants.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_60" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_59" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_FairValueOfFinancialInstrumentsPolicy-c0_cont_4" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_3" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         As such, fairvalue is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an assetor a liability. As a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputsused in the valuation methodologies in measuring fair value:
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -1.35pt">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -1.35pt">
    </p>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_61" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_60" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_FairValueOfFinancialInstrumentsPolicy-c0_cont_5" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_4" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
         <tbody>
          <tr style="vertical-align: top; text-align: justify">
           <td style="width: 0.25in">
           </td>
           <td style="white-space: nowrap; width: 0.65in; text-align: left">
            <b>
             Level 1
            </b>
            -
           </td>
           <td style="text-align: justify">
            Quoted                                            prices (unadjusted) in active markets for identical assets or liabilities;
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -1.35pt">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_62" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_61" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_FairValueOfFinancialInstrumentsPolicy-c0_cont_6" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_5" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
         <tbody>
          <tr style="vertical-align: top; text-align: justify">
           <td style="width: 0.25in">
           </td>
           <td style="white-space: nowrap; width: 0.65in; text-align: left">
            <b>
             Level 2
            </b>
            -
           </td>
           <td style="text-align: justify">
            Inputs                                            other than Level 1 that are observable for the asset or liability, either directly or indirectly;                                            and
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -1.35pt">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_63" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_62" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_FairValueOfFinancialInstrumentsPolicy-c0_cont_7" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_6" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
         <tbody>
          <tr style="vertical-align: top; text-align: justify">
           <td style="width: 0.25in">
           </td>
           <td style="white-space: nowrap; width: 0.65in; text-align: left">
            <b>
             Level 3
            </b>
            -
           </td>
           <td style="text-align: justify">
            Unobservable                                            inputs for the asset or liability.
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -1.35pt">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_64" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_63" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_FairValueOfFinancialInstrumentsPolicy-c0_cont_8" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_7" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         The fair valuehierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuringfair value. The Company categorized each of its fair value measurements in one of these three levels of hierarchy.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -1.35pt">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_65" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_64" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_FairValueOfFinancialInstrumentsPolicy-c0_cont_8" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         The Companymeasures its liability pursuant to the Finance Contract with the EIB based on the aggregate outstanding amount of the combined principaland accrued interest. The Company does not reflect its liability for future royalty payments pursuant to the Finance Contract with theEIB since the royalty payments are to be paid as a percentage of the Company’s future consolidated revenues, pro-rated to the amountdisbursed, beginning in the fiscal year 2024 and continuing up to and including its fiscal year 2030, which cannot be measured at thistime.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -1.35pt">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_66" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_65" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_DerivativesPolicyTextBlock-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-405" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:DerivativesPolicyTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
         <tbody>
          <tr style="vertical-align: top">
           <td style="width: 0pt">
           </td>
           <td style="width: 0.25in">
            <b>
             r.
            </b>
           </td>
           <td style="text-align: justify">
            <b>
             Derivative financial instruments
            </b>
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in">
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_67" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_66" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_DerivativesPolicyTextBlock-c0_cont_2" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_DerivativesPolicyTextBlock-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         The Company accountsfor derivatives and hedging based on ASC 815, “Derivatives and hedging”, as amended and related interpretations (“ASC815”). ASC 815 requires the Company to recognize all derivatives on the balance sheet at fair value. If a derivative meets the definitionof a hedge and is so designated, depending on the nature of the hedge, changes in the fair value of the derivative will either be offsetagainst the change in fair value of the hedged assets, liabilities, or firm commitments through earnings (for fair value hedge transactions)or recognized in other comprehensive income (loss) until the hedged item is recognized in earnings (for cash flow hedge transactions).
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_68" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_67" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_DerivativesPolicyTextBlock-c0_cont_3" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_DerivativesPolicyTextBlock-c0_cont_2" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         If a derivativedoes not meet the definition of a hedge, the changes in the fair value are included in earnings. Cash flows related to Company’s currenthedging are classified as operating activities. The Company enters into option contracts in order to limit the exposure to exchange ratefluctuation associated with expenses mainly incurred in New Israeli Shekels (“NIS”). Since the derivative instruments thatthe Company holds do not meet the definition of hedging instrumentsunder ASC 815, any gain or loss derived from such instruments is recognized immediately as “financial income, net”.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 60; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      F-
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      15
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
     <b>
      PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARIES
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top">
       <td style="border-bottom: Black 1.5pt solid; width: 100%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          NOTES TO CONSOLIDATED FINANCIAL    STATEMENTS
         </b>
        </p>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td style="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">
        <span style="font-size: 10pt">
         <b>
          U.S. Dollars in thousands (except share and per share amounts)
         </b>
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27.35pt; text-align: justify; text-indent: -27pt">
     <b>
      NOTE 2:- SIGNIFICANT ACCOUNTING POLICIES (CONT.)
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in">
    </p>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_69" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_68" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_DerivativesPolicyTextBlock-c0_cont_3" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         The Company measuredthe fair value of the contracts in accordance with ASC 820. Foreign currency derivative contracts are classified within Level 2 as thevaluation inputs are based on quoted prices and market observable data of similar instruments. As of June 30, 2021 and 2020, the fairvalue of the options contracts was immaterial and is presented in “other current assets” (see Note 3). The net gains (losses)recognized in “Financial income, net” during the years ended June 30, 2021 and 2020, were $
         <span>
          <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-412" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:InterestIncomeOnDeposits" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
           35
          </ix:nonfraction>
         </span>
         and $
         <span>
          <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-413" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:InterestIncomeOnDeposits" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
           13
          </ix:nonfraction>
         </span>
         , respectively.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: 0in">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_70" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_69" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_LesseeLeasesPolicyTextBlock-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-415" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:LesseeLeasesPolicyTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
         <tbody>
          <tr style="vertical-align: top">
           <td style="width: 0pt">
           </td>
           <td style="width: 0.25in">
            <b>
             s.
            </b>
           </td>
           <td style="text-align: justify">
            <b>
             Leases
            </b>
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_71" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_70" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_LesseeLeasesPolicyTextBlock-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         Operating leasesare included in operating lease right-of-use (“ROU”) asset, accrued expenses, and operating lease liability. ROU assets representCompany’s right to use an underlying asset for the lease term and lease liabilities represent obligation to make lease payments arisingfrom the lease. Operating lease ROU assets and liabilities are recognized at the lease commencement date based on the present value oflease payments over the lease term. In determining the present value of lease payments, the Company uses the incremental borrowing ratebased on the information available at the lease commencement date as the rate implicit in the lease is not readily determinable. The determinationof the incremental borrowing rate requires management judgment based on information available at lease commencement. The operating leaseROU assets also include adjustments for prepayments, accrued lease payments and exclude lease incentives. Lease terms may include optionsto terminate the lease when it is reasonably certain that such options will be exercise. Operating lease cost is recognized on a straight-linebasis over the expected lease term. Lease agreements entered into after the adoption of ASC 842, “Leases” that include leaseand non-lease components are accounted for as a single lease component. Lease agreements with a noncancelable term of less than 12 monthsare not recorded on the balance sheets.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
         <b>
         </b>
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_72" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_71" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_CommitmentsAndContingenciesPolicyTextBlock-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-419" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
         <tbody>
          <tr style="vertical-align: top">
           <td style="width: 0pt">
           </td>
           <td style="width: 0.25in">
            <b>
             t.
            </b>
           </td>
           <td style="text-align: justify">
            <b>
             Loss contingencies
            </b>
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_73" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_72" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_CommitmentsAndContingenciesPolicyTextBlock-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         The Company may become involved, fromtime to time, in various lawsuits and legal proceedings which arise in the ordinary course of business. The Company records accruals forloss contingencies to the extent that it concludes their occurrence is probable and that the related liabilities are estimable.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_74" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_73" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-423" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
         <tbody>
          <tr style="vertical-align: top">
           <td style="width: 0pt">
           </td>
           <td style="width: 0.25in">
            <b>
             u.
            </b>
           </td>
           <td style="text-align: justify">
            <b>
             Recently Issued Accounting Pronouncements
            </b>
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_75" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_74" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_2" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         <span style="text-decoration:underline">
          ASU No. 2016-13 - “FinancialInstruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”):
         </span>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_76" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_75" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_NewAccountingPronouncementsPolicyPolicyTextBlock-c0_cont_2" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         InJune 2016, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2016-13, “Financial Instruments - CreditLosses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). ASU 2016-13 changesthe impairment model for most financial assets and certain other instruments. For trade and other receivables, held-to-maturity debtsecurities, loans, and other instruments, entities will be required to use a new forward-looking “expected loss” modelthat generally will result in the earlier recognition of allowances for losses. The guidance also requires increased disclosures.The amendments contained in ASU 2016-13 were originally effective for fiscal years beginning after December 15, 2019, includinginterim periods within those fiscal years for the Company. In November 2019, the FASB issued ASU No. 2019-10, whichdelayed the effective date of ASU 2016-13 for smaller reporting companies (as defined by the U.S. Securities and ExchangeCommission, “SRC”) to fiscal years beginning after December 15, 2022, including interim periods. Early adoption ispermitted.  The Company meets the definition of an SRC and is adopting the deferral period for ASU 2016-13. The guidancerequires a modified retrospective transition approach through a cumulative-effect adjustment to retained earnings as of thebeginning of the period of adoption. The Company is currently evaluating the impact of the adoption of ASU 2016-13 on itsconsolidated financial statements but does not expect that the adoption of this standard will have a material impact on itsconsolidated financial statements.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_SignificantAccountingPoliciesTextBlock-c0_cont_77" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_76" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_ComprehensiveIncomePolicyPolicyTextBlock-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-429" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
         <tbody>
          <tr style="vertical-align: top">
           <td style="width: 0pt">
           </td>
           <td style="width: 0.25in">
            <b>
             v.
            </b>
           </td>
           <td style="text-align: justify">
            <b>
             Comprehensive loss
            </b>
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">
         <b>
         </b>
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_SignificantAccountingPoliciesTextBlock-c0_cont_77" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_ComprehensiveIncomePolicyPolicyTextBlock-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
         For all periods presented, loss isthe same as comprehensive loss as there are no comprehensive income items.
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 61; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      F-
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      16
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27.35pt; text-align: justify; text-indent: -27pt">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
     <b>
      PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARIES
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 100%">
        <p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          NOTES TO CONSOLIDATED FINANCIAL    STATEMENTS
         </b>
        </p>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td style="padding-right: 0pt; padding-left: 0pt; font-size: 10pt">
        <span style="font-size: 10pt">
         <b>
          U.S. Dollars in thousands (except share and per share amounts)
         </b>
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
    </span>
    <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
    </span>
    <span>
     <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_PrepaidExpensesAndOtherCurrentAssetsTextBlock-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-432" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="true" name="psti:PrepaidExpensesAndOtherCurrentAssetsTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
       <b>
        NOTE 3: - PREPAID EXPENSES AND OTHER CURRENT ASSETS
       </b>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
       <b>
       </b>
      </p>
     </ix:nonnumeric>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_PrepaidExpensesAndOtherCurrentAssetsTextBlock-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-434" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="true" name="psti:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" text-block-taxonomy="true">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
         <tbody>
          <tr style="vertical-align: bottom">
           <td style="text-align: center">
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
            June 30,
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom">
           <td style="text-align: center">
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
            2021
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
            2020
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="width: 76%; text-align: left">
            Accounts receivable from the Horizon 2020 grants
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
            $
           </td>
           <td style="width: 9%; text-align: right">
            <span>
             <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-435" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AccountsReceivableGross" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              1,089
             </ix:nonfraction>
            </span>
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
            $
           </td>
           <td style="width: 9%; text-align: right">
            <span>
             <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-436" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AccountsReceivableGross" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              1,071
             </ix:nonfraction>
            </span>
           </td>
           <td style="width: 1%; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="text-align: left">
            Prepaid expenses
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-437" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:PrepaidExpenseCurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              333
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-438" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:PrepaidExpenseCurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              445
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="text-align: left">
            Accounts receivable from the IIA
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <div style="-sec-ix-hidden: hidden-fact-48">
             <span>
              <ix:nonfraction contextref="c0" continued-taxonomy="false" data-original-id="hidden-fact-48" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-439" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:InterestAndDividendIncomeSecuritiesOther" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
               -
              </ix:nonfraction>
             </span>
            </div>
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-440" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:InterestAndDividendIncomeSecuritiesOther" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              142
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="text-align: left">
            Value Added Tax (VAT) receivables
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-441" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ValueAddedTaxReceivable" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              382
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-442" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ValueAddedTaxReceivable" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              336
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="text-align: left">
            Accounts receivable from the Ministry of Economy and Industry
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-443" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              19
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-444" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              35
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="text-align: left">
            Derivatives not designated as hedge instruments
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-445" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:DerivativeLiabilityNotionalAmount" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              1
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-446" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:DerivativeLiabilityNotionalAmount" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              67
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="text-align: left; padding-bottom: 1.5pt">
            Other receivables
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <div style="-sec-ix-hidden: hidden-fact-49">
             <span>
              <ix:nonfraction contextref="c3" continued-taxonomy="false" data-original-id="hidden-fact-49" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-447" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:OtherReceivables" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
               -
              </ix:nonfraction>
             </span>
            </div>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-448" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:OtherReceivables" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              26
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="padding-bottom: 4pt">
            Total
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-449" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:PrepaidExpenseAndOtherAssets" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              1,824
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-450" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:PrepaidExpenseAndOtherAssets" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              2,122
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
          </tr>
         </tbody>
        </table>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
    </span>
    <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
    </span>
    <span>
     <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_PropertyPlantAndEquipmentDisclosureTextBlock-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-451" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
       <b>
        NOTE 4: - PROPERTY AND EQUIPMENT, NET
       </b>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
       <b>
       </b>
      </p>
     </ix:nonnumeric>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_PropertyPlantAndEquipmentDisclosureTextBlock-c0_cont_2" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_PropertyPlantAndEquipmentDisclosureTextBlock-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-453" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:PropertyPlantAndEquipmentTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" text-block-taxonomy="true">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
         <tbody>
          <tr style="vertical-align: bottom">
           <td>
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
            June 30,
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom">
           <td>
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
            2021
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
            2020
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom">
           <td style="font-weight: bold">
            Cost:
           </td>
           <td>
           </td>
           <td colspan="2" style="text-align: center">
           </td>
           <td>
           </td>
           <td>
           </td>
           <td colspan="2" style="text-align: center">
           </td>
           <td>
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="width: 76%; text-align: left; padding-left: 0.75pt">
            Laboratory equipment
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
            $
           </td>
           <td style="width: 9%; text-align: right">
            <span>
             <ix:nonfraction contextref="c27" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-454" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:PropertyPlantAndEquipmentGross" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              6,715
             </ix:nonfraction>
            </span>
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
            $
           </td>
           <td style="width: 9%; text-align: right">
            <span>
             <ix:nonfraction contextref="c28" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-455" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:PropertyPlantAndEquipmentGross" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              6,514
             </ix:nonfraction>
            </span>
           </td>
           <td style="width: 1%; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="text-align: left; padding-left: 0.75pt">
            Computers and peripheral equipment
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c29" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-456" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:PropertyPlantAndEquipmentGross" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              1,473
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c30" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-457" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:PropertyPlantAndEquipmentGross" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              1,322
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="text-align: left; padding-left: 0.75pt">
            Office furniture and equipment
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c31" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-458" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:PropertyPlantAndEquipmentGross" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              681
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c32" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-459" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:PropertyPlantAndEquipmentGross" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              681
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.75pt">
            Leasehold improvements
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c33" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-460" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:PropertyPlantAndEquipmentGross" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              8,662
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c34" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-461" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:PropertyPlantAndEquipmentGross" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              8,661
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">
            Total Cost
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-462" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:PropertyPlantAndEquipmentGross" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              17,531
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-463" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:PropertyPlantAndEquipmentGross" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              17,178
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="font-weight: bold; text-align: left; padding-left: 0in">
            Accumulated depreciation:
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="text-align: left; padding-left: 0.75pt">
            Laboratory equipment
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c27" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-464" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              6,152
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c28" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-465" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              5,955
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="text-align: left; padding-left: 0.75pt">
            Computers and peripheral equipment
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c29" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-466" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              1,310
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c30" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-467" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              1,221
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="text-align: left; padding-left: 0.75pt">
            Office furniture and equipment
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c31" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-468" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              663
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c32" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-469" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              646
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.75pt">
            Leasehold improvements
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c33" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-470" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              7,907
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c34" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-471" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              6,840
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">
            Total accumulated depreciation
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-472" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              16,032
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-473" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              14,662
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="font-weight: bold; text-align: left; padding-bottom: 4pt; padding-left: 0.75pt">
            Property and equipment, net
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-474" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:PropertyPlantAndEquipmentNet" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              1,499
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-475" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:PropertyPlantAndEquipmentNet" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              2,516
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_PropertyPlantAndEquipmentDisclosureTextBlock-c0_cont_3" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_PropertyPlantAndEquipmentDisclosureTextBlock-c0_cont_2" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
       Depreciation expenses amounted to $
       <span>
        <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-477" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:Depreciation" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
         1,370
        </ix:nonfraction>
       </span>
       and $
       <span>
        <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-478" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:Depreciation" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
         1,570
        </ix:nonfraction>
       </span>
       for the years ended June 30, 2021 and 2020, respectively.
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_PropertyPlantAndEquipmentDisclosureTextBlock-c0_cont_3" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
       During the fiscal years ended June 30,2021 and 2020, the Company recorded a reduction of $
       <span>
        <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-480" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:PropertyAndEquipmentReductionAmount" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
         0
        </ix:nonfraction>
       </span>
       and $
       <span>
        <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-481" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:PropertyAndEquipmentReductionAmount" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
         74
        </ix:nonfraction>
       </span>
       , respectively, to the cost accumulated depreciation of fully depreciatedequipment no longer in use.
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 62; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      F-
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      17
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
     <b>
      PLURISTEM THERAPEUTICS INC. AND ITS SUBSIDIARIES
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 100%">
        <p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          NOTES TO CONSOLIDATED FINANCIAL    STATEMENTS
         </b>
        </p>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td style="padding-right: 0pt; padding-left: 0pt">
        <span style="font-size: 10pt">
         <b>
          U.S. Dollars in thousands (except share and per share amounts)
         </b>
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
    </span>
    <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
    </span>
    <span>
     <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-482" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">
       <b>
        NOTE 5: - OTHER ACCOUNTSPAYABLE
       </b>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">
       <b>
       </b>
      </p>
     </ix:nonnumeric>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-484" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" text-block-taxonomy="true">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
         <tbody>
          <tr style="vertical-align: bottom">
           <td style="text-align: center">
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
            June 30,
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom">
           <td style="text-align: center">
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
            2021
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
            2020
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="width: 76%; text-align: left">
            Accrued vacation and recuperation
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
            $
           </td>
           <td style="width: 9%; text-align: right">
            <span>
             <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-485" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AccruedVacationCurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              1,203
             </ix:nonfraction>
            </span>
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
            $
           </td>
           <td style="width: 9%; text-align: right">
            <span>
             <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-486" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AccruedVacationCurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              928
             </ix:nonfraction>
            </span>
           </td>
           <td style="width: 1%; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="text-align: left">
            Deferred income from the Horizon 2020 grant and CRISPR-IL
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-487" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:DeferredRevenueCurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              40
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-488" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:DeferredRevenueCurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              126
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="text-align: left">
            Accrued payroll
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-489" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              612
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-490" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              489
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="padding-bottom: 1.5pt; text-align: left">
            Payroll institutions
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-491" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:OtherAccountsPayablePayrollInstitutions" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              561
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-492" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:OtherAccountsPayablePayrollInstitutions" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              438
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td>
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="padding-bottom: 4pt">
            Total
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-493" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AccountsPayableOtherCurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              2,416
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-494" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AccountsPayableOtherCurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              1,981
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
          </tr>
         </tbody>
        </table>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
     </b>
    </p>
    <div>
    </div>
    <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
    </span>
    <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
    </span>
    <span>
     <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_LesseeOperatingLeasesTextBlock-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-495" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:LesseeOperatingLeasesTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
       <b>
        NOTE 6: - LEASES
       </b>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
       <b>
       </b>
      </p>
     </ix:nonnumeric>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_LesseeOperatingLeasesTextBlock-c0_cont_2" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_LesseeOperatingLeasesTextBlock-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
       The Company hasvarious operating leases for office space that expire through fiscal 2022 and vehicles that expire through fiscal 2025. Below is a summaryof the Company’s operating right-of-use assets and operating lease liabilities as of June 30, 2021:
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
       <b>
       </b>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_LesseeOperatingLeasesTextBlock-c0_cont_3" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_LesseeOperatingLeasesTextBlock-c0_cont_2" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-498" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="true" name="psti:ScheduleOfOperatingRightOfUseAssetsAndOperatingLeaseLiabilitiesTableTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" text-block-taxonomy="true">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
         <tbody>
          <tr style="vertical-align: bottom">
           <td>
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
            June 30,
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom">
           <td>
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
            2021
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
            2020
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="width: 76%; text-align: left; padding-bottom: 1.5pt">
            Operating right-of-use assets
           </td>
           <td style="width: 1%; padding-bottom: 1.5pt">
           </td>
           <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">
            $
           </td>
           <td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-499" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:OperatingLeaseRightOfUseAsset" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              728
             </ix:nonfraction>
            </span>
           </td>
           <td style="width: 1%; padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="width: 1%; padding-bottom: 1.5pt">
           </td>
           <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">
            $
           </td>
           <td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-500" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:OperatingLeaseRightOfUseAsset" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              1,259
             </ix:nonfraction>
            </span>
           </td>
           <td style="width: 1%; padding-bottom: 1.5pt; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td>
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="text-align: left">
            Operating lease liabilities, current
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-501" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:OperatingLeaseLiabilityCurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              634
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-502" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:OperatingLeaseLiabilityCurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              1,020
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="text-align: left; padding-bottom: 1.5pt">
            Operating lease liabilities long-term
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-503" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:OperatingLeaseLiabilityNoncurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              100
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-504" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:OperatingLeaseLiabilityNoncurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              565
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="text-align: left; padding-bottom: 4pt">
            Total operating lease liabilities
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-505" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:OperatingLeaseLiability" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              734
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-506" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:OperatingLeaseLiability" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              1,585
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_LesseeOperatingLeasesTextBlock-c0_cont_4" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_LesseeOperatingLeasesTextBlock-c0_cont_3" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
       Minimum lease payments for the Company’s ROU assetsover the remaining lease periods as of June 30, 2021 are as follows:
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_LesseeOperatingLeasesTextBlock-c0_cont_5" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_LesseeOperatingLeasesTextBlock-c0_cont_4" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-509" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="true" name="psti:ScheduleOfFutureMinimumRentalPaymentForOperatingLeasesTableTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" text-block-taxonomy="true">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
         <tbody>
          <tr style="vertical-align: bottom">
           <td>
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">
            June 30,
            <br/>
            2021
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="width: 88%; text-align: left">
            2022
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 9%; text-align: right">
            <span>
             <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-510" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:OperatingLeaseFutureMinimumPaymentsDueInTwoYears" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              664
             </ix:nonfraction>
            </span>
           </td>
           <td style="width: 1%; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="text-align: left">
            2023
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-511" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:OperatingLeaseFutureMinimumPaymentsDueInThreeYears" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              99
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="text-align: left; padding-bottom: 1.5pt">
            2024
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-512" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:OperatingLeaseFutureMinimumPaymentsDueInFourYears" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              5
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="text-align: left; padding-bottom: 4pt">
            Total undiscounted lease payments
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-513" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:OperatingLeaseFutureMinimumPaymentsDue" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              768
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="text-align: left; padding-bottom: 4pt">
            Less: Interest
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-514" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:OperatingLeasesFutureMinimumPaymentsDueLessInterest" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              34
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="padding-bottom: 4pt">
            Present value of lease liabilities
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-515" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:PresentValueOfLeaseLiabilities" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              734
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <!-- Field: Page; Sequence: 63; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      F-
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      18
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15pt 0pt 0; text-align: right">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15pt 0pt 0; text-align: right">
     <b>
      PLURISTEM THERAPEUTICS INC. AND ITSSUBSIDIARIES
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15pt 0pt 0; text-align: right">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top">
       <td style="border-bottom: Black 1.5pt solid; width: 100%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          NOTES TO CONSOLIDATED FINANCIAL    STATEMENTS
         </b>
        </p>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td style="font-size: 10pt">
        <span style="font-size: 10pt">
         <b>
          U.S. Dollars in thousands (except share and per share amounts)
         </b>
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      NOTE 6: - LEASES (CONT.)
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
    </p>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_LesseeOperatingLeasesTextBlock-c0_cont_6" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_LesseeOperatingLeasesTextBlock-c0_cont_5" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">
       The components of lease expense and supplemental cash flowinformation related to leases for the year ended June 30, 2021 were as follows:
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_LesseeOperatingLeasesTextBlock-c0_cont_7" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_LesseeOperatingLeasesTextBlock-c0_cont_6" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-518" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" text-block-taxonomy="true">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
         <tbody>
          <tr style="vertical-align: bottom">
           <td style="text-align: justify">
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">
            Year ended June 30,
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom">
           <td style="text-align: justify">
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">
            2021
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">
            2020
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="font-weight: bold; text-align: left">
            Components of lease expense
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="width: 76%; text-align: left">
            Operating lease cost, net *
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
            $
           </td>
           <td style="width: 9%; text-align: right">
            <span>
             <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-519" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:OperatingLeaseCost" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              984
             </ix:nonfraction>
            </span>
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
            $
           </td>
           <td style="width: 9%; text-align: right">
            <span>
             <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-520" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:OperatingLeaseCost" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              919
             </ix:nonfraction>
            </span>
           </td>
           <td style="width: 1%; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="text-align: left">
            Sublease income
           </td>
           <td>
           </td>
           <td style="text-align: left">
            $
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-521" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:SubleaseIncome" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              55
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
            $
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-522" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:SubleaseIncome" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              51
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="font-weight: bold; text-align: left">
            Supplemental cash flow information
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="text-align: left">
            Cash paid for amounts included in the measurement of lease liabilities
           </td>
           <td>
           </td>
           <td style="text-align: left">
            $
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-523" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              1,214
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
            $
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-524" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              1,152
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="text-align: left">
            Supplemental non-cash information related to lease liabilities arising from obtaining ROU assets
           </td>
           <td>
           </td>
           <td style="text-align: left">
            $
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-525" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:OperatingLeasePayments" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              154
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
            $
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-526" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:OperatingLeasePayments" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              83
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
         <b>
         </b>
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_LesseeOperatingLeasesTextBlock-c0_cont_8" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_LesseeOperatingLeasesTextBlock-c0_cont_7" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
       <tbody>
        <tr style="vertical-align: top; text-align: justify">
         <td style="width: 0in">
         </td>
         <td style="width: 0.25in; text-align: left">
          <b>
           *
          </b>
         </td>
         <td style="text-align: justify">
          The operating lease costs are presented net after eliminationof deferred participation payments in amount of $
          <span>
           <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-528" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:DeferredParticipationPayment" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
            248
           </ix:nonfraction>
          </span>
          .
         </td>
        </tr>
       </tbody>
      </table>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
       <b>
       </b>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_LesseeOperatingLeasesTextBlock-c0_cont_8" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
       As of June 30, 2021,the weighted average remaining lease term is
       <span>
        <ix:nonnumeric contextref="c3" continued-taxonomy="false" enabled-taxonomy="true" format="ixt-sec:duryear" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-530" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
         1.2
        </ix:nonnumeric>
       </span>
       years, and the weighted average discount rate is
       <span>
        <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-531" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
         10
        </ix:nonfraction>
       </span>
       percent. The discount rate was determinedbased on the estimated collateralized borrowing rate of the Company, adjusted to the specific lease term and location of each lease.
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">
     <b>
     </b>
    </p>
    <div>
    </div>
    <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
    </span>
    <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
    </span>
    <span>
     <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_LoanFromTheEIBTextBlock-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-532" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="true" name="psti:LoanFromTheEIBTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">
       <b>
        NOTE 7: - LOAN FROM THE EIB
       </b>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
      </p>
     </ix:nonnumeric>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_LoanFromTheEIBTextBlock-c0_cont_2" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_LoanFromTheEIBTextBlock-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
       <span style="font-size: 10pt">
        On April30, 2020, Pluristem entered into a finance contract
       </span>
       (the “Finance Contract”)
       <span style="font-size: 10pt">
        with theEIB, pursuant to which Pluristem, through the German Subsidiary can obtain a loan in the amount of up to €
        <span>
         <ix:nonfraction contextref="c35" continued-taxonomy="false" decimals="-6" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-534" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:SubsidiaryLoan" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="6" selected-taxonomy="false" tabindex="18" unitref="eur">
          50
         </ix:nonfraction>
        </span>
        million, subject tocertain milestones being reached (the “Loan”), payable in three tranches, with the first tranche consisting of €
        <span>
         <ix:nonfraction contextref="c36" continued-taxonomy="false" decimals="-6" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-535" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:LoansPayable" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="6" selected-taxonomy="false" tabindex="18" unitref="eur">
          20
         </ix:nonfraction>
        </span>
        million,second of €
        <span>
         <ix:nonfraction contextref="c37" continued-taxonomy="false" decimals="-6" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-536" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:LoansPayable" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="6" selected-taxonomy="false" tabindex="18" unitref="eur">
          18
         </ix:nonfraction>
        </span>
        million and third of €
        <span>
         <ix:nonfraction contextref="c38" continued-taxonomy="false" decimals="-6" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-537" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:LoansPayable" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="6" selected-taxonomy="false" tabindex="18" unitref="eur">
          12
         </ix:nonfraction>
        </span>
        million for a period of
        <span>
         <ix:nonnumeric contextref="c35" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-538" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="true" name="psti:ContractPeriod" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
          36 months
         </ix:nonnumeric>
        </span>
        from the signing of the Finance Contract.
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_LoanFromTheEIBTextBlock-c0_cont_3" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_LoanFromTheEIBTextBlock-c0_cont_2" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
       The tranches will be treated independently,each with its own interest rate and maturity period. The interest rate is
       <span>
        <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-540" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
         4
        </ix:nonfraction>
       </span>
       % in the aggregate (consisting of a
       <span>
        <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-541" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:FixedInterestRate" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
         0
        </ix:nonfraction>
       </span>
       % fixed interest rateand a
       <span>
        <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-542" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:DeferredInterestRatePercentage" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
         4
        </ix:nonfraction>
       </span>
       % deferred interest rate payable upon maturity, respectively) per year for the first tranche,
       <span>
        <ix:nonfraction contextref="c39" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-543" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
         4
        </ix:nonfraction>
       </span>
       % in the aggregate (consisting ofa
       <span>
        <ix:nonfraction contextref="c40" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-544" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:FixedInterestRate" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
         1
        </ix:nonfraction>
       </span>
       % fixed interest rate and a
       <span>
        <ix:nonfraction contextref="c40" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-545" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:DeferredInterestRatePercentage" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
         3
        </ix:nonfraction>
       </span>
       % deferred interest rate payable upon maturity, respectively) per year for the second tranche and
       <span>
        <ix:nonfraction contextref="c41" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-546" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
         3
        </ix:nonfraction>
       </span>
       % (consistingof a
       <span>
        <ix:nonfraction contextref="c42" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-547" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:FixedInterestRate" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
         1
        </ix:nonfraction>
       </span>
       % fixed interest rate and a
       <span>
        <ix:nonfraction contextref="c42" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-548" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:DeferredInterestRatePercentage" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
         2
        </ix:nonfraction>
       </span>
       % deferred interest rate payable upon maturity, respectively) per year for the third tranche.
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_LoanFromTheEIBTextBlock-c0_cont_4" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_LoanFromTheEIBTextBlock-c0_cont_3" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
       In addition to any interestpayable on the Loan, the EIB is entitled to receive royalties from future revenues, if any, of Pluristem for a period of seven yearsstarting in 2024, in an amount equal to between
       <span>
        <ix:nonfraction contextref="c43" continued-taxonomy="false" decimals="3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-550" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:CompanysConsolidatedRevenuesPercentage" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
         0.2
        </ix:nonfraction>
       </span>
       % to
       <span>
        <ix:nonfraction contextref="c44" continued-taxonomy="false" decimals="3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-551" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:CompanysConsolidatedRevenuesPercentage" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
         2.3
        </ix:nonfraction>
       </span>
       % of the Company’s consolidated revenues, pro-rated to the amountdisbursed from the Loan to Pluristem beginning in the fiscal year 2024 and continuing up to and including its fiscal year 2030.
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_LoanFromTheEIBTextBlock-c0_cont_4" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
       During June 2021, Pluristem receivedthe first tranche in an amount of $
       <span>
        <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="0" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-553" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:FirstTranchePrice" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="usd">
         24,449
        </ix:nonfraction>
       </span>
       (€
       <span>
        <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-6" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-554" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:FirstTranchePrice" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="6" selected-taxonomy="false" tabindex="18" unitref="eur">
         20
        </ix:nonfraction>
       </span>
       million) of the Finance Contract. The amount received is due on June 1, 2026 and bearsannual interest of
       <span>
        <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-555" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:AnnualInterestPercentage" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
         4
        </ix:nonfraction>
       </span>
       % to be paid with the principal of the Loan. As of June 30, 2021, the linked principal balance in the amount of $
       <span>
        <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="0" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-556" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:InvestmentOwnedBalancePrincipalAmount" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="usd">
         23,772
        </ix:nonfraction>
       </span>
       and the interest accrued in the amount of $
       <span>
        <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="0" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-557" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:AccruedInterest" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="usd">
         78
        </ix:nonfraction>
       </span>
       are presented as part of the Loan at long term liabilities (See also note 8h).
       <span style="clear: both">
        <br/>
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 64; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      F-
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      19
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15pt 0pt 0; text-align: right">
     <b>
      PLURISTEM THERAPEUTICS INC. AND ITSSUBSIDIARIES
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15pt 0pt 0; text-align: right">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top">
       <td style="border-bottom: Black 1.5pt solid; width: 100%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          NOTES TO CONSOLIDATED FINANCIAL    STATEMENTS
         </b>
        </p>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td style="font-size: 10pt">
        <span style="font-size: 10pt">
         <b>
          U.S. Dollars in thousands (except share and per share amounts)
         </b>
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
    </span>
    <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
    </span>
    <span>
     <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-558" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">
       <b>
        NOTE 8: - COMMITMENTS AND CONTINGENCIES
       </b>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">
       <b>
       </b>
      </p>
     </ix:nonnumeric>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_2" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
       <tbody>
        <tr style="vertical-align: top; text-align: justify">
         <td style="width: 0">
         </td>
         <td style="width: 0.25in; text-align: left">
          <b>
           a.
          </b>
         </td>
         <td style="text-align: justify">
          As of June 30, 2021, an amount of $
          <span>
           <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-560" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:CashAndDeposits" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
            597
           </ix:nonfraction>
          </span>
          of cash and deposits waspledged by the Subsidiary to secure its credit line and bank guarantees.
         </td>
        </tr>
       </tbody>
      </table>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_3" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_2" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
       <tbody>
        <tr style="vertical-align: top; text-align: justify">
         <td style="width: 0">
         </td>
         <td style="width: 0.25in; text-align: left">
          <b>
           b.
          </b>
         </td>
         <td style="text-align: justify">
          Under the Law for the Encouragement of Industrial Research andDevelopment, 1984, (the “Research Law”), research and development programs that meet specified criteria and are approvedby the IIA are eligible for grants of up to
          <span>
           <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-562" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:PercentageOfQualifiedExpenditures" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
            50
           </ix:nonfraction>
          </span>
          % of the project’s expenditures, as determined by the research committee, in exchangefor the payment of royalties from the sale of products developed under the program. Regulations under the Research Law generally providefor the payment of royalties to the IIA of
          <span>
           <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-563" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:RoyaltyRateSales" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
            3
           </ix:nonfraction>
          </span>
          % on sales of products and services derived from a technology developed using these grantsuntil
          <span>
           <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-564" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:RoyaltyRatePayableOnGrantsReceived" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
            100
           </ix:nonfraction>
          </span>
          % of the dollar-linked grant is repaid. The Company’s obligation to pay these royalties is contingent on its actual saleof such products and services. In the absence of such sales, no payment is required. Outstanding balance of the grants will be subjectto interest at a rate equal to the 12 month LIBOR applicable to dollar deposits that is published on the first business day of each calendaryear. Following the full repayment of the grant, there is no further liability for royalties.
         </td>
        </tr>
       </tbody>
      </table>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_4" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_3" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
       Through June 30, 2021, total grantsobtained aggregated to approximately $
       <span>
        <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-566" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:AggregateGrantsReceiveds" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
         27,743
        </ix:nonfraction>
       </span>
       and total royalties paid and accrued amounted to $
       <span>
        <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-567" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:RoyaltiesAmountPaidAndAccrued" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
         169
        </ix:nonfraction>
       </span>
       . As of June 30, 2021, the Company’scontingent liability in respect to royalties to the IIA amounted to $
       <span>
        <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-568" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:RoyaltyGuaranteesCommitmentsAmount" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
         27,574
        </ix:nonfraction>
       </span>
       , not including LIBOR interest as described above.
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_5" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_4" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
       <tbody>
        <tr style="vertical-align: top; text-align: justify">
         <td style="width: 0">
         </td>
         <td style="width: 0.25in; text-align: left">
          <span style="font-size: 10pt">
           <b>
            c.
           </b>
          </span>
         </td>
         <td style="text-align: justify">
          <span style="font-size: 10pt">
           The Company has been awarded a marketinggrant under the “Smart Money” program of the Israeli Ministry of Economy and Industry. The program’s aim is to assistcompanies to extend their activities in international markets. The goal market that was chosen was Japan. The Israeli government grantedthe Company budget resources that are intended to be used to advance the Company’s product candidate towards marketing in Japanand for regulatory activities there. As part of the program, the Company will repay royalties of
           <span>
            <ix:nonfraction contextref="c45" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-570" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:RoyaltyRateSales" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
             5
            </ix:nonfraction>
           </span>
           % from the Company’s income inJapan during five years, starting the year in which the Company will not be entitled to reimbursement of expenses under the program andwill be spread for a period of up to
           <span>
            <ix:nonnumeric contextref="c45" continued-taxonomy="false" enabled-taxonomy="true" format="ixt-sec:duryear" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-571" inside-table="true" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="true" name="psti:TermOfRoyaltyGrantReceived" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
             5
            </ix:nonnumeric>
           </span>
           years or until the amount of the grant is fully paid
          </span>
          .
         </td>
        </tr>
       </tbody>
      </table>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_6" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_5" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
       As of June 30, 2021, total grantsobtained under this Smart Money program amounted to approximately $
       <span>
        <ix:nonfraction contextref="c46" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-573" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:AggregateGrantsReceived" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
         112
        </ix:nonfraction>
       </span>
       . As of June 30, 2021, the Company’s contingent liability with respectto royalties for this “Smart Money” program was $
       <span>
        <ix:nonfraction contextref="c46" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-574" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:RoyaltyGuaranteesCommitmentsAmount" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
         112
        </ix:nonfraction>
       </span>
       and no royalties were paid or accrued.
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_7" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_6" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
       <tbody>
        <tr style="vertical-align: top; text-align: justify">
         <td style="width: 0">
         </td>
         <td style="width: 0.25in; text-align: left">
          <span style="font-size: 10pt">
           <b>
            d.
           </b>
          </span>
         </td>
         <td style="text-align: justify">
          <span style="font-size: 10pt">
           The Company was awarded an additionalSmart Money grant of approximately $
           <span>
            <ix:nonfraction contextref="c47" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-576" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:AmountOfGrantsReceivedConditionalAward" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
             229
            </ix:nonfraction>
           </span>
           from Israel’s Ministry of Economy and Industry to facilitate certain marketing and businessdevelopment activities with respect to its advanced cell therapy products in the Chinese market, including Hong Kong. The Israeli governmentgranted the Company budget resources that are intended to be used to advance the Company’s product candidate towards marketingin the China-Hong Kong markets. The Company will also receive close support from Israel’s trade representatives stationed in China,including Hong Kong, along with experts appointed by the Smart Money program. As part of the program, the Company will repay royaltiesof
           <span>
            <ix:nonfraction contextref="c47" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-577" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:RoyaltyRateSales" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
             5
            </ix:nonfraction>
           </span>
           % from the Company’s revenues in the region for a five year period, beginning the year in which the Company will not be entitledto reimbursement of expenses under the program and will be spread for a period of up to
           <span>
            <ix:nonnumeric contextref="c47" continued-taxonomy="false" enabled-taxonomy="true" format="ixt-sec:duryear" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-578" inside-table="true" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="true" name="psti:TermOfRoyaltyGrantReceived" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
             5
            </ix:nonnumeric>
           </span>
           years or until the amount of the grant is fullypaid
          </span>
          .
         </td>
        </tr>
       </tbody>
      </table>
      <p style="margin-top: 0; margin-bottom: 0">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_8" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_7" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
       <tbody>
        <tr style="vertical-align: top; text-align: justify">
         <td style="width: 0">
         </td>
         <td style="width: 0.25in; text-align: left">
          <b>
           e.
          </b>
         </td>
         <td style="text-align: justify">
          As of June 30, 2021, the aggregate amount of grant obtained fromthis Smart Money program was approximately $
          <span>
           <ix:nonfraction contextref="c47" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-580" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:AggregateGrantsReceiveds" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
            160
           </ix:nonfraction>
          </span>
          . As of June 30, 2021, the Company’s contingent liability with respect to royalties forthis “Smart Money” program is $
          <span>
           <ix:nonfraction contextref="c48" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-581" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:RoyaltyGuaranteesCommitmentsAmount" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
            160
           </ix:nonfraction>
          </span>
          and no royalties were paid or accrued.
         </td>
        </tr>
       </tbody>
      </table>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 65; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      F-
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      20
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15pt 0pt 0; text-align: right">
     <b>
      PLURISTEM THERAPEUTICS INC. AND ITSSUBSIDIARIES
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15pt 0pt 0; text-align: right">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top">
       <td style="border-bottom: Black 1.5pt solid; width: 100%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          NOTES TO CONSOLIDATED FINANCIAL    STATEMENTS
         </b>
        </p>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td style="font-size: 10pt">
        <span style="font-size: 10pt">
         <b>
          U.S. Dollars in thousands (except share and per share amounts)
         </b>
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">
     <span style="font-size: 10pt">
      <b>
       NOTE8: - COMMITMENTS AND CONTINGENCIES
      </b>
     </span>
     <b>
      (CONT.)
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">
     <b>
     </b>
    </p>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_9" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_8" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
       <tbody>
        <tr style="vertical-align: top; text-align: justify">
         <td style="width: 0">
         </td>
         <td style="width: 0.25in; text-align: left">
          <span style="font-size: 10pt">
           <b>
            f.
           </b>
          </span>
         </td>
         <td style="text-align: justify">
          <span style="font-size: 10pt">
           In September 2017, the Company signedan agreement with the Tel-Aviv Sourasky Medical Center (Ichilov Hospital) to conduct a Phase I/II trial of PLX-PAD cell therapy for thetreatment of Steroid-Refractory Chronic Graft-Versus-Host-Disease (“
          </span>
          cGVHD
          <span style="font-size: 10pt">
           ”).
          </span>
         </td>
        </tr>
       </tbody>
      </table>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_10" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_9" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
       <span style="font-size: 10pt">
        As partof the agreement with the Tel-Aviv Sourasky Medical Center (Ichilov Hospital), the Company will pay royalties of
        <span>
         <ix:nonfraction contextref="c49" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-584" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:RoyaltyRatePayableOnGrantsReceived" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
          1
         </ix:nonfraction>
        </span>
        % from its net salesof the PLX-PAD product relating to
       </span>
       cGVHD
       <span style="font-size: 10pt">
        , with a maximum aggregate royalty amount of approximately$
        <span>
         <ix:nonfraction contextref="c50" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-585" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:RoyaltyGuaranteesCommitmentsAmount" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
          250
         </ix:nonfraction>
        </span>
        .
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_11" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_10" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
       <tbody>
        <tr style="vertical-align: top; text-align: justify">
         <td style="width: 0">
         </td>
         <td style="width: 0.25in; text-align: left">
          <b>
           g.
          </b>
         </td>
         <td style="text-align: justify">
          The Company was awarded a marketing grant of approximately $
          <span>
           <ix:nonfraction contextref="c51" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-587" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:GrantsReceivableCurrent" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
            52
           </ix:nonfraction>
          </span>
          under the “Shalav” program of the Israeli Ministry of Economy and Industry. The grant is intended to facilitate certain marketingand business development activities with respect to the Company’s advanced cell therapy products in the U.S. market. As part ofthe program, the Company will repay royalties of
          <span>
           <ix:nonfraction contextref="c52" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-588" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:RoyaltyRateSales" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
            3
           </ix:nonfraction>
          </span>
          %, but only with respect to the Company’s revenues in the U.S. market in excess of $
          <span>
           <ix:nonfraction contextref="c52" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-589" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:MarketDataRevenue" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
            250
           </ix:nonfraction>
          </span>
          of its revenues in fiscal year 2018, upon the earlier of the five year period beginning the year in which the Company will not be entitledto reimbursement of expenses under the program and/or until the amount of the grant, which is linked to the Consumer Price Index, is fullypaid.
         </td>
        </tr>
       </tbody>
      </table>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_12" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_11" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
       As of June 30, 2021, total grants obtainedunder the “Shalav” program amounted to approximately $
       <span>
        <ix:nonfraction contextref="c52" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-591" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:AggregateGrantsReceiveds" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
         52
        </ix:nonfraction>
       </span>
       . As of June 30, 2021, the Company’s contingent liability with respectto royalties for the “Shalav” program was $
       <span>
        <ix:nonfraction contextref="c51" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-592" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:RoyaltyGuaranteesCommitmentsAmount" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
         52
        </ix:nonfraction>
       </span>
       and no royalties were paid or accrued.
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_13" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_12" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
       <tbody>
        <tr style="vertical-align: top; text-align: justify">
         <td style="width: 0">
         </td>
         <td style="width: 0.25in; text-align: left">
          <b>
           h.
          </b>
         </td>
         <td style="text-align: justify">
          On April 30, 2020, Pluristem entered into the Finance Contractwith the EIB, pursuant to which the German Subsidiary can obtain the Loan in the amount of up to €
          <span>
           <ix:nonfraction contextref="c35" continued-taxonomy="false" decimals="-6" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-594" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:RevenueRecognitionMilestoneMethodRevenueRecognized" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="6" selected-taxonomy="false" tabindex="18" unitref="eur">
            50
           </ix:nonfraction>
          </span>
          million, subject to certainmilestones being reached, payable in three tranches. The first tranche in amount of $
          <span>
           <ix:nonfraction contextref="c53" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-595" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:FirstTrancheAmountReceived" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
            23,772
           </ix:nonfraction>
          </span>
          (€
          <span>
           <ix:nonfraction contextref="c35" continued-taxonomy="false" decimals="-6" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-596" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:FirstTrancheAmountReceived" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="6" selected-taxonomy="false" tabindex="18" unitref="eur">
            20
           </ix:nonfraction>
          </span>
          million) was received during June2021.
         </td>
        </tr>
       </tbody>
      </table>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_CommitmentsAndContingenciesDisclosureTextBlock-c0_cont_13" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
       The EIB is entitled to receive royaltiesfrom future revenues, if any, of Pluristem for a period of
       <span>
        <ix:nonnumeric contextref="c35" continued-taxonomy="false" enabled-taxonomy="true" format="ixt-sec:durwordsen" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-598" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="true" name="psti:TermOfRoyaltyGrantReceived" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
         seven years
        </ix:nonnumeric>
       </span>
       starting in 2024, in an amount equal to between
       <span>
        <ix:nonfraction contextref="c54" continued-taxonomy="false" decimals="3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-599" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
         0.2
        </ix:nonfraction>
       </span>
       % to
       <span>
        <ix:nonfraction contextref="c55" continued-taxonomy="false" decimals="3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-600" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
         2.3
        </ix:nonfraction>
       </span>
       % ofthe Company’s consolidated revenues, pro-rated to the amount disbursed from the Loan to Pluristem beginning in the fiscal year 2024and continuing up to and including its fiscal year 2030.
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
    </p>
    <div>
    </div>
    <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
    </span>
    <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
    </span>
    <span>
     <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-601" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">
       <b>
        NOTE 9: - SHAREHOLDERS’ EQUITY
       </b>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">
       <b>
       </b>
      </p>
     </ix:nonnumeric>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_2" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
       <tbody>
        <tr style="vertical-align: top; text-align: justify">
         <td style="width: 0">
         </td>
         <td style="width: 0.25in; text-align: left">
          <b>
           (1)
          </b>
         </td>
         <td style="text-align: justify">
          The Company’s authorized common shares consist of
          <span>
           <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-603" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:CommonStockSharesAuthorized" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
            60,000,000
           </ix:nonfraction>
          </span>
          shareswith a par value of $
          <span>
           <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="5" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-604" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:CommonStockParOrStatedValuePerShare" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="usdPershares">
            0.00001
           </ix:nonfraction>
          </span>
          per share. All shares have equal voting rights and are entitled to one vote per share in all matters tobe voted upon by shareholders. The shares have no pre-emptive, subscription, conversion or redemption rights and may be issued only asfully paid and non-assessable shares. Holders of the common shares are entitled to equal ratable rights to dividends and distributionswith respect to the common share, as may be declared by the Board of Directors out of funds legally available. The Company’s authorizedpreferred shares consist of
          <span>
           <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-605" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:PreferredStockSharesAuthorized" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
            1,000,000
           </ix:nonfraction>
          </span>
          shares of preferred share, par value $
          <span>
           <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="5" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-606" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:PreferredStockParOrStatedValuePerShare" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="usdPershares">
            0.00001
           </ix:nonfraction>
          </span>
          per share, with series, rights, preferences, privilegesand restrictions as may be designated from time to time by the Company’s Board of Directors. No preferred shares havebeen issued.
         </td>
        </tr>
       </tbody>
      </table>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <!-- Field: Page; Sequence: 66; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      F-
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      21
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15pt 0pt 0; text-align: right">
     <b>
      PLURISTEM THERAPEUTICS INC. AND ITSSUBSIDIARIES
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15pt 0pt 0; text-align: right">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top">
       <td style="border-bottom: Black 1.5pt solid; width: 100%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          NOTES TO CONSOLIDATED FINANCIAL    STATEMENTS
         </b>
        </p>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td style="font-size: 10pt">
        <span style="font-size: 10pt">
         <b>
          U.S. Dollars in thousands (except share and per share amounts)
         </b>
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-size: 10pt">
      <b>
       NOTE 9: - SHAREHOLDERS’ EQUITY
      </b>
     </span>
     <b>
      (CONT.)
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_3" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_2" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
       <tbody>
        <tr style="vertical-align: top; text-align: justify">
         <td style="width: 0">
         </td>
         <td style="width: 0.25in; text-align: left">
          <b>
           a.
          </b>
         </td>
         <td style="text-align: justify">
          <b>
           Reverse share split:
          </b>
         </td>
        </tr>
       </tbody>
      </table>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
       <b>
       </b>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_4" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_3" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
       In July 2019,
       <span>
        <ix:nonnumeric contextref="c56" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-609" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:StockholdersEquityReverseStockSplit" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
         the Board of Directorsapproved a 1-for-10 reverse share split of the Company’s (a) authorized common shares; (b) issued and outstanding common shares and (c)authorized preferred shares. The reverse split became effective on July 25, 2019. The reverse share split did not have any effect on thestated par value of the common shares. All common shares, options, warrants and securities convertible or exercisable into common shares,as well as loss per share, were adjusted to give retroactive effect to this reverse share split for all periods presented.
        </ix:nonnumeric>
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_5" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_4" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
       <tbody>
        <tr style="vertical-align: top; text-align: justify">
         <td style="width: 0">
         </td>
         <td style="width: 0.25in; text-align: left">
          <b>
           b.
          </b>
         </td>
         <td style="text-align: justify">
          Pursuant to a shelf registration on Form S-3 declared effective by the Securities and Exchange Commission on June 23, 2017, on February 6, 2019, the Company entered into the Open Market Sale Agreement
          <sup>
           SM
          </sup>
          (the “Sales Agreement”) with Jefferies LLC (“Jefferies”) which provides that, upon the terms and subject to the conditions and limitations in the sales agreement, the Company may elect, from time to time, to offer and sell common shares having an aggregate offering price of up to $
          <span>
           <ix:nonfraction contextref="c57" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-611" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:ValueOfCommonStockCompanyCanPeriodicallyIssueThroughAgentsPerTermsOfAtmAgreement" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
            50,000
           </ix:nonfraction>
          </span>
          through Jefferies acting as sales agent. During the year ended June 30, 2019, the Company sold
          <span>
           <ix:nonfraction contextref="c58" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-612" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:SharesIssued" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
            236,800
           </ix:nonfraction>
          </span>
          common shares under the Sales Agreement at an average price of $
          <span>
           <ix:nonfraction contextref="c58" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-613" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:AveragePricePerShare" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="usdPershares">
            9.70
           </ix:nonfraction>
          </span>
          per share for aggregate net proceeds of approximately $
          <span>
           <ix:nonfraction contextref="c59" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-614" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
            2,051
           </ix:nonfraction>
          </span>
          , net of issuance expenses of $
          <span>
           <ix:nonfraction contextref="c59" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-615" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
            255
           </ix:nonfraction>
          </span>
          .
         </td>
        </tr>
       </tbody>
      </table>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_6" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_5" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
       During the year ended June 30, 2020,the Company sold
       <span>
        <ix:nonfraction contextref="c60" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-617" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:SharesIssued" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
         8,060,950
        </ix:nonfraction>
       </span>
       common shares under the Sales Agreement at an average price of $
       <span>
        <ix:nonfraction contextref="c60" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-618" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:AveragePricePerShare" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="usdPershares">
         5.81
        </ix:nonfraction>
       </span>
       per share for aggregate net proceeds ofapproximately $
       <span>
        <ix:nonfraction contextref="c61" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-619" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
         43,262
        </ix:nonfraction>
       </span>
       , net of issuance expenses of $
       <span>
        <ix:nonfraction contextref="c61" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-620" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
         3,573
        </ix:nonfraction>
       </span>
       .
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_7" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_6" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
       On June 30, 2020, this shelf registrationstatement on Form S-3 expired, and as a result thereof, the Sales Agreement was terminated.
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_8" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_7" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
       <tbody>
        <tr style="vertical-align: top; text-align: justify">
         <td style="width: 0">
         </td>
         <td style="width: 0.25in; text-align: left">
          <b>
           c.
          </b>
         </td>
         <td style="text-align: justify">
          During the year ended June 30, 2020, a total of
          <span>
           <ix:nonfraction contextref="c62" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-623" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:WarrantsToPurchaseOfCommonStock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
            386,678
           </ix:nonfraction>
          </span>
          warrantsto purchase shares from the April 2019 offering were exercised by investors at an exercise price of $
          <span>
           <ix:nonfraction contextref="c63" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-624" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="usdPershares">
            7.00
           </ix:nonfraction>
          </span>
          per share, resulting in theissuance of
          <span>
           <ix:nonfraction contextref="c62" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-625" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:IssuanceOfSharesOfCommonStock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
            386,678
           </ix:nonfraction>
          </span>
          common shares for net proceeds of approximately $
          <span>
           <ix:nonfraction contextref="c62" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-626" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
            2,707
           </ix:nonfraction>
          </span>
          .
         </td>
        </tr>
       </tbody>
      </table>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_9" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_8" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
       <tbody>
        <tr style="vertical-align: top; text-align: justify">
         <td style="width: 0">
         </td>
         <td style="width: 0.25in; text-align: left">
          <b>
           d.
          </b>
         </td>
         <td style="text-align: justify">
          On May 5, 2020, the Company entered into a securities purchaseagreement with two institutional investors (the “Investors”) pursuant to which the Company sold, in a registered public offeringdirectly to the Investors,
          <span>
           <ix:nonfraction contextref="c64" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-628" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:SharesIssued" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
            1,587,302
           </ix:nonfraction>
          </span>
          common shares for net proceeds of approximately $
          <span>
           <ix:nonfraction contextref="c65" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-629" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
            14,901
           </ix:nonfraction>
          </span>
          .
         </td>
        </tr>
       </tbody>
      </table>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_10" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_9" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
       <tbody>
        <tr style="vertical-align: top; text-align: justify">
         <td style="width: 0">
         </td>
         <td style="width: 0.25in; text-align: left">
          <b>
           e.
          </b>
         </td>
         <td style="text-align: justify">
          Pursuant to a shelf registration on Form S-3 declared effectiveby the SEC on July 23, 2020, in July 2020 the Company entered into a new Open Market Sale Agreement (“ATM Agreement”) withJefferies, which provides that, upon the terms and subject to the conditions and limitations in the ATM Agreement, the Company may elect,from time to time, to offer and sell common shares having an aggregate offering price of up to $
          <span>
           <ix:nonfraction contextref="c66" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-631" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:ValueOfCommonStockCompanyCanPeriodicallyIssueThroughAgentsPerTermsOfATMAgreement" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
            75,000
           </ix:nonfraction>
          </span>
          through Jefferies acting as salesagent. During the year ended June 30, 2021, the Company sold
          <span>
           <ix:nonfraction contextref="c67" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-632" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:SharesIssued" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
            1,045,097
           </ix:nonfraction>
          </span>
          common shares under the ATM Agreement at an average price of $
          <span>
           <ix:nonfraction contextref="c67" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-633" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:AveragePricePerShare" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="usdPershares">
            8.50
           </ix:nonfraction>
          </span>
          per share for aggregate net proceeds of approximately $
          <span>
           <ix:nonfraction contextref="c68" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-634" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
            8,506
           </ix:nonfraction>
          </span>
          , net of issuance expenses of $
          <span>
           <ix:nonfraction contextref="c68" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-635" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
            380
           </ix:nonfraction>
          </span>
          .
         </td>
        </tr>
       </tbody>
      </table>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_11" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_10" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
       <tbody>
        <tr style="vertical-align: top; text-align: justify">
         <td style="width: 0">
         </td>
         <td style="width: 0.25in; text-align: left">
          <span style="font-size: 10pt">
           <b>
            f.
           </b>
          </span>
         </td>
         <td style="text-align: justify">
          <span style="font-size: 10pt">
           During the year ended June 30, 2021,a total of
           <span>
            <ix:nonfraction contextref="c69" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-637" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:WarrantsToPurchaseOfCommonStock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
             519,990
            </ix:nonfraction>
           </span>
           warrants to purchase
          </span>
          common
          <span style="font-size: 10pt">
           shares from the April 2019 offering were exercisedby investors at an exercise price of $
           <span>
            <ix:nonfraction contextref="c70" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-638" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="usdPershares">
             7.00
            </ix:nonfraction>
           </span>
           per share, resulting in the issuance of
           <span>
            <ix:nonfraction contextref="c69" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-639" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:IssuanceOfSharesOfCommonStock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
             51,999
            </ix:nonfraction>
           </span>
           common shares for net proceeds of approximately$
           <span>
            <ix:nonfraction contextref="c69" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-640" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
             364
            </ix:nonfraction>
           </span>
           .
          </span>
         </td>
        </tr>
       </tbody>
      </table>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_12" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_11" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
       <tbody>
        <tr style="vertical-align: top; text-align: justify">
         <td style="width: 0">
         </td>
         <td style="width: 0.25in; text-align: left">
          <b>
           g.
          </b>
         </td>
         <td style="text-align: justify">
          On February 2, 2021, the Company, entered into a securities purchaseagreement, with certain institutional investors, pursuant to which the Company agreed to issue and sell, in a registered direct offering,by the Company directly to the investors,
          <span>
           <ix:nonfraction contextref="c71" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-642" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
            4,761,905
           </ix:nonfraction>
          </span>
          common shares for gross proceeds of $
          <span>
           <ix:nonfraction contextref="c71" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-643" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
            30,000
           </ix:nonfraction>
          </span>
          . The aggregate net proceeds were approximately$
          <span>
           <ix:nonfraction contextref="c72" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-644" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
            28,077
           </ix:nonfraction>
          </span>
          , net of issuance expenses of $
          <span>
           <ix:nonfraction contextref="c72" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-645" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:AdjustmentsToAdditionalPaidInCapitalStocksIssuedIssuanceCosts" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
            1,923
           </ix:nonfraction>
          </span>
          .
         </td>
        </tr>
       </tbody>
      </table>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 67; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      F-
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      22
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15pt 0pt 0; text-align: right">
     <b>
      PLURISTEM THERAPEUTICS INC. AND ITSSUBSIDIARIES
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15pt 0pt 0; text-align: right">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top">
       <td style="border-bottom: Black 1.5pt solid; width: 100%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          NOTES TO CONSOLIDATED FINANCIAL    STATEMENTS
         </b>
        </p>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td style="font-size: 10pt">
        <span style="font-size: 10pt">
         <b>
          U.S. Dollars in thousands (except share and per share amounts)
         </b>
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-size: 10pt">
      <b>
       NOTE 9: - SHAREHOLDERS’EQUITY
      </b>
     </span>
     <b>
      (CONT.)
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">
    </p>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_13" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_12" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
       <tbody>
        <tr style="vertical-align: top; text-align: justify">
         <td style="width: 0">
         </td>
         <td style="width: 0.25in; text-align: left">
          <b>
           h.
          </b>
         </td>
         <td style="text-align: justify">
          <b>
           Share options, RS and RSUs to employees, directors and consultants:
          </b>
         </td>
        </tr>
       </tbody>
      </table>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
       <b>
       </b>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_14" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_13" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
       The Company adopted, afterreceiving shareholder approval, the 2005 Share Option Plan in 2005 (the “2005 Plan”). Under the 2005 Plan, shareoptions, RS and RSUs were granted to the Company’s officers, directors, employees and consultants. The 2005 Plan expired onDecember 31, 2018. The Company adopted, after receiving shareholder approval, the 2016 Equity Incentive Plan in 2016 (the“2016 Plan”). Under the 2016 Plan, share options, RS and RSUs may be granted to the Company’s officers, directors,employees and consultants or the officers, directors, employees and consultants of the  Subsidiaries. In addition, atthe Company’s annual meeting of its shareholders, held on June 13, 2019, the Company’s shareholders approved the 2019Equity Compensation Plan (the “2019 Plan”).
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_15" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_14" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
       Under the 2019 Plan, share options,RS and RSUs may be granted to the Company’s officers, directors, employees and consultants or the officers, directors, employeesand consultants of the Subsidiary.
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_16" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_15" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
       As of June 30, 2021,
       <span>
        <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-650" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="true" name="psti:CommonStockSharesFutureIssuancePlanDescription" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
         the number of commonshares authorized for issuance under the 2016 Plan amounted to 879,945 for calendar year 2021, of which 859,945 are available for futuregrant during calendar year 2021 under the 2016 Plan. As of June 30, 2021, the number of common shares authorized for issuance under the2019 Plan amounted to 3,783,807, all of which are available for future grant under the 2019 Plan.
        </ix:nonnumeric>
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_17" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_16" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.5in">
       <b>
        <span style="text-decoration:underline">
         (2) Optionsto consultants:
        </span>
       </b>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.5in">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_18" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_17" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">
       A summary of the share options to non-employeeconsultants under the 2005 Plan and 2016 Plan is as follows:
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.5in">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_19" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_18" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c75" continued-main-taxonomy="true" continuedat="_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock-c75_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-654" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
         <tbody>
          <tr style="vertical-align: bottom">
           <td>
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">
            Year ended June 30, 2020
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom">
           <td style="white-space: nowrap">
           </td>
           <td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">
            Number
           </td>
           <td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">
           </td>
           <td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">
            Weighted
            <br/>
            Average
            <br/>
            Exercise
            <br/>
            Price
           </td>
           <td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">
           </td>
           <td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">
            Weighted
            <br/>
            Average
            <br/>
            Remaining
            <br/>
            Contractual
            <br/>
            Terms
            <br/>
            (in years)
           </td>
           <td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">
           </td>
           <td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">
            Aggregate
            <br/>
            Intrinsic
            <br/>
            Value
            <br/>
            Price
           </td>
           <td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="width: 52%">
            Share options outstanding at beginning of period
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 9%; text-align: right">
            <span>
             <ix:nonfraction contextref="c76" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-655" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              89,580
             </ix:nonfraction>
            </span>
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
            $
           </td>
           <td style="width: 9%; text-align: right">
            -
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 9%; text-align: right">
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 9%; text-align: right">
           </td>
           <td style="width: 1%; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td>
            Share options granted
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c77" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-656" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              1,050
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
            $
           </td>
           <td style="text-align: right">
            -
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td>
            Share options exercised
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            (
            <span>
             <ix:nonfraction contextref="c77" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-657" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              15,884
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
            )
           </td>
           <td>
           </td>
           <td style="text-align: left">
            $
           </td>
           <td style="text-align: right">
            -
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="padding-bottom: 1.5pt">
            Share options forfeited
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            (
            <span>
             <ix:nonfraction contextref="c77" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-658" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              19,875
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
            )
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            -
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt; text-align: right">
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt; text-align: right">
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="text-align: left; padding-bottom: 4pt">
            Share options outstanding at end of the period
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c78" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-659" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              54,871
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            -
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonnumeric contextref="c77" continued-taxonomy="false" enabled-taxonomy="true" format="ixt-sec:duryear" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-660" inside-table="true" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
              7.89
             </ix:nonnumeric>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c78" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-661" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              485
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="text-align: left; padding-bottom: 4pt">
            Share options exercisable at the end of the period
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c78" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-662" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              48,621
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            -
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonnumeric contextref="c77" continued-taxonomy="false" enabled-taxonomy="true" format="ixt-sec:duryear" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-663" inside-table="true" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
              7.81
             </ix:nonnumeric>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c78" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-664" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              430
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="text-align: left; padding-bottom: 4pt">
            Share options vested and expected to vest at the end of the period
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c78" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-665" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              54,871
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            -
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonnumeric contextref="c77" continued-taxonomy="false" enabled-taxonomy="true" format="ixt-sec:duryear" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-666" inside-table="true" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
              7.89
             </ix:nonnumeric>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c78" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-667" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              485
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 68; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      F-
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      23
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15pt 0pt 0; text-align: right">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15pt 0pt 0; text-align: right">
     <b>
      PLURISTEM THERAPEUTICS INC. AND ITSSUBSIDIARIES
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15pt 0pt 0; text-align: right">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top">
       <td style="border-bottom: Black 1.5pt solid; width: 100%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          NOTES TO CONSOLIDATED FINANCIAL    STATEMENTS
         </b>
        </p>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td style="font-size: 10pt">
        <span style="font-size: 10pt">
         <b>
          U.S. Dollars in thousands (except share and per share amounts)
         </b>
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-size: 10pt">
      <b>
       NOTE 9: - SHAREHOLDERS’ EQUITY
      </b>
     </span>
     <b>
      (CONT.)
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.5in">
    </p>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_20" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_19" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock-c75_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
         <tbody>
          <tr style="vertical-align: bottom">
           <td>
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">
            Year ended June 30, 2021
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom">
           <td style="white-space: nowrap">
           </td>
           <td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">
            Number
           </td>
           <td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">
           </td>
           <td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">
            Weighted
            <br/>
            Average
            <br/>
            Exercise
            <br/>
            Price
           </td>
           <td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">
           </td>
           <td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">
            Weighted
            <br/>
            Average
            <br/>
            Remaining
            <br/>
            Contractual
            <br/>
            Terms
            <br/>
            (in years)
           </td>
           <td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">
           </td>
           <td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">
            Aggregate
            <br/>
            Intrinsic
            <br/>
            Value
            <br/>
            Price
           </td>
           <td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="width: 52%">
            Share options outstanding at beginning of period
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 9%; text-align: right">
            <span>
             <ix:nonfraction contextref="c79" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-670" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              54,871
             </ix:nonfraction>
            </span>
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
            $
           </td>
           <td style="width: 9%; text-align: right">
            -
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 9%; text-align: right">
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 9%; text-align: right">
           </td>
           <td style="width: 1%; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td>
            Share options granted
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <div style="-sec-ix-hidden: hidden-fact-50">
             <span>
              <ix:nonfraction contextref="c75" continued-taxonomy="false" data-original-id="hidden-fact-50" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-671" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="shares" xsi:nil="true">
               -
              </ix:nonfraction>
             </span>
            </div>
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
            $
           </td>
           <td style="text-align: right">
            <div style="-sec-ix-hidden: hidden-fact-51">
             <span>
              <ix:nonfraction contextref="c75" continued-taxonomy="false" data-original-id="hidden-fact-51" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-672" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usdPershares" xsi:nil="true">
               -
              </ix:nonfraction>
             </span>
            </div>
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td>
            Share options exercised
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            (
            <span>
             <ix:nonfraction contextref="c75" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-673" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              15,035
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
            )
           </td>
           <td>
           </td>
           <td style="text-align: left">
            $
           </td>
           <td style="text-align: right">
            <div style="-sec-ix-hidden: hidden-fact-52">
             <span>
              <ix:nonfraction contextref="c75" continued-taxonomy="false" data-original-id="hidden-fact-52" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-674" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usdPershares" xsi:nil="true">
               -
              </ix:nonfraction>
             </span>
            </div>
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="padding-bottom: 1.5pt">
            Share options forfeited
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <div style="-sec-ix-hidden: hidden-fact-53">
             <span>
              <ix:nonfraction contextref="c75" continued-taxonomy="false" data-original-id="hidden-fact-53" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-675" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="shares" xsi:nil="true">
               -
              </ix:nonfraction>
             </span>
            </div>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <div style="-sec-ix-hidden: hidden-fact-54">
             <span>
              <ix:nonfraction contextref="c75" continued-taxonomy="false" data-original-id="hidden-fact-54" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-676" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usdPershares" xsi:nil="true">
               -
              </ix:nonfraction>
             </span>
            </div>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt; text-align: right">
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt; text-align: right">
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="text-align: left; padding-bottom: 4pt">
            Share options outstanding at end of the period
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c80" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-677" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              39,836
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            -
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonnumeric contextref="c75" continued-taxonomy="false" enabled-taxonomy="true" format="ixt-sec:duryear" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-678" inside-table="true" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
              6.99
             </ix:nonnumeric>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c80" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-679" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              158
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="text-align: left; padding-bottom: 4pt">
            Share options exercisable at the end of the period
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c80" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-680" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              36,086
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            -
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonnumeric contextref="c75" continued-taxonomy="false" enabled-taxonomy="true" format="ixt-sec:duryear" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-681" inside-table="true" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
              6.94
             </ix:nonnumeric>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c80" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-682" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              143
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="padding-bottom: 4pt">
            Share options unvested
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c75" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-683" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedShares" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              3,750
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
           <td style="font-size: 0.75pt; padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; font-size: 0.75pt; text-align: left">
           </td>
           <td style="border-bottom: Black 4pt double; font-size: 0.75pt; text-align: right">
           </td>
           <td style="padding-bottom: 4pt; font-size: 0.75pt; text-align: left">
           </td>
           <td style="font-size: 0.75pt; padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; font-size: 0.75pt; text-align: left">
           </td>
           <td style="border-bottom: Black 4pt double; font-size: 0.75pt; text-align: right">
           </td>
           <td style="padding-bottom: 4pt; font-size: 0.75pt; text-align: left">
           </td>
           <td style="font-size: 0.75pt; padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; font-size: 0.75pt; text-align: left">
           </td>
           <td style="border-bottom: Black 4pt double; font-size: 0.75pt; text-align: right">
           </td>
           <td style="padding-bottom: 4pt; font-size: 0.75pt; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="text-align: left; padding-bottom: 4pt">
            Share options vested and expected to vest at the end of the period
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c80" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-684" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              39,836
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            -
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonnumeric contextref="c75" continued-taxonomy="false" enabled-taxonomy="true" format="ixt-sec:duryear" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-685" inside-table="true" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
              6.99
             </ix:nonnumeric>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c80" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-686" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              158
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
        </p>
       </ix:continuation>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_21" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_20" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
       Compensation expensesrelated to share options granted to consultants were recorded as follows:
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_22" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_21" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c75" continued-taxonomy="false" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-689" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" text-block-taxonomy="true">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
         <tbody>
          <tr style="vertical-align: bottom">
           <td style="text-align: justify">
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">
            Year ended June 30,
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom">
           <td style="text-align: justify">
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">
            2021
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">
            2020
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="width: 76%; text-align: left">
            Research and development expenses
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
            $
           </td>
           <td style="width: 9%; text-align: right">
            <div style="-sec-ix-hidden: hidden-fact-55">
             <span>
              <ix:nonfraction contextref="c81" continued-taxonomy="false" data-original-id="hidden-fact-55" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-690" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AllocatedShareBasedCompensationExpense" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
               -
              </ix:nonfraction>
             </span>
            </div>
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
            $
           </td>
           <td style="width: 9%; text-align: right">
            (
            <span>
             <ix:nonfraction contextref="c82" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-691" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="true" isstandardonly="true" istextonly="false" name="us-gaap:AllocatedShareBasedCompensationExpense" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
              35
             </ix:nonfraction>
            </span>
           </td>
           <td style="width: 1%; text-align: left">
            )
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="text-align: left; padding-bottom: 1.5pt">
            General and administrative expenses
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c83" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-692" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AllocatedShareBasedCompensationExpense" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              11
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c84" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-693" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AllocatedShareBasedCompensationExpense" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              64
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="text-align: justify; padding-bottom: 4pt">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c75" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-694" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AllocatedShareBasedCompensationExpense" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              11
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c85" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-695" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AllocatedShareBasedCompensationExpense" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              29
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_23" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_22" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.5in">
       <b>
        <span style="text-decoration:underline">
         (3) RSand RSUs to employees and directors:
        </span>
       </b>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_24" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_23" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
       The following tablesummarizes the activity related to unvested RS and RSUs granted to employees and directors under the 2005 Plan, 2016 Plan and 2019 Planfor the years ended June 30, 2021 and 2020:
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_25" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_24" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c86" continued-taxonomy="false" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-699" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" text-block-taxonomy="true">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
         <tbody>
          <tr style="vertical-align: bottom">
           <td>
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
            Year ended June 30,
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom">
           <td style="text-align: center">
           </td>
           <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">
            2021
           </td>
           <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">
           </td>
           <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">
            2020
           </td>
           <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom">
           <td>
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
            Number
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="width: 76%; text-align: left">
            Unvested at the beginning of period
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 9%; text-align: right">
            <span>
             <ix:nonfraction contextref="c87" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-700" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="shares">
              415,194
             </ix:nonfraction>
            </span>
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 9%; text-align: right">
            <span>
             <ix:nonfraction contextref="c88" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-701" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="shares">
              795,633
             </ix:nonfraction>
            </span>
           </td>
           <td style="width: 1%; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td>
            Granted
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c86" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-702" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="shares">
              2,646,120
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c89" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-703" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="shares">
              19,500
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td>
            Forfeited
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            (
            <span>
             <ix:nonfraction contextref="c86" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-704" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="shares">
              76,804
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
            )
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            (
            <span>
             <ix:nonfraction contextref="c89" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-705" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="shares">
              101,256
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
            )
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="padding-bottom: 1.5pt">
            Vested
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            (
            <span>
             <ix:nonfraction contextref="c86" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-706" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="shares">
              580,095
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
            )
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            (
            <span>
             <ix:nonfraction contextref="c89" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-707" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="shares">
              298,683
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
            )
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="text-align: left; padding-bottom: 4pt">
            Unvested at the end of the period
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c90" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-708" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="shares">
              2,404,415
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c87" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-709" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="shares">
              415,194
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="text-align: left; padding-bottom: 4pt">
            Expected to vest after the end of period
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c90" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-710" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="shares">
              2,404,415
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c87" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-711" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="shares">
              402,491
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 69; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      F-
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      24
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15pt 0pt 0; text-align: right">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15pt 0pt 0; text-align: right">
     <b>
      PLURISTEM THERAPEUTICS INC. AND ITSSUBSIDIARIES
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15pt 0pt 0; text-align: right">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top">
       <td style="border-bottom: Black 1.5pt solid; width: 100%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          NOTES TO CONSOLIDATED FINANCIAL    STATEMENTS
         </b>
        </p>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td style="font-size: 10pt">
        <span style="font-size: 10pt">
         <b>
          U.S. Dollars in thousands (except share and per share amounts)
         </b>
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-size: 10pt">
      <b>
       NOTE 9: - SHAREHOLDERS’EQUITY
      </b>
     </span>
     <b>
      (CONT.)
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
    </p>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_26" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_25" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
       Compensation expensesrelated to RS and RSUs granted to employees and directors were recorded as follows:
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_27" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_26" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c86" continued-taxonomy="false" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-714" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" text-block-taxonomy="true">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
         <tbody>
          <tr style="vertical-align: bottom">
           <td style="text-align: justify">
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">
            Year ended June 30,
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom">
           <td style="text-align: justify">
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">
            2021
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">
            2020
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="width: 76%; text-align: left">
            Research and development expenses
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
            $
           </td>
           <td style="width: 9%; text-align: right">
            <span>
             <ix:nonfraction contextref="c91" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-715" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensation" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              1,363
             </ix:nonfraction>
            </span>
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
            $
           </td>
           <td style="width: 9%; text-align: right">
            <span>
             <ix:nonfraction contextref="c92" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-716" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensation" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              578
             </ix:nonfraction>
            </span>
           </td>
           <td style="width: 1%; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="text-align: left; padding-bottom: 1.5pt">
            General and administrative expenses
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c93" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-717" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensation" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              12,253
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c94" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-718" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensation" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              1,786
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="text-align: justify; padding-bottom: 4pt">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c86" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-719" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensation" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              13,616
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c89" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-720" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensation" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              2,364
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_28" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_27" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
       Unamortized compensation expensesrelated to RSUs granted to employees and directors is approximately $
       <span>
        <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-722" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
         10,174
        </ix:nonfraction>
       </span>
       to be recognized by the end of March 2025.
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_29" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_28" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.25in; text-indent: 35.45pt">
       <b>
        Market-based awards
       </b>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">
       <b>
       </b>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_30" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_29" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
       <span>
        <ix:nonnumeric contextref="c73" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-725" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="true" name="psti:DescriptionExecutiveOfficers" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
         In September 2020, the Company granted
         <span>
          <ix:nonfraction contextref="c74" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt-sec:numwordsen" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-726" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:NumberOfExecutiveOfficers" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="pure">
           two
          </ix:nonfraction>
         </span>
         of its executive officers an aggregate of 1,000,0000 RSUs (500,000 each) under the 2019 Plan.
        </ix:nonnumeric>
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_31" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_30" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
       The RSUs will vest in full uponthe achievement of a milestone of the Company increasing the market capitalization of its common shares on the NasdaqGlobal Market to $
       <span>
        <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-728" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:MilestoneAchievementValue" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
         550,000
        </ix:nonfraction>
       </span>
       within no more than three years from the date of grant.
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_32" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_31" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
       For market-based awards, the Companydetermines the grant-date fair value utilizing a Monte Carlo simulation model, which incorporates various assumptions including expectedshare price volatility, risk-free interest rates, and the expected date of a qualifying event. The Company estimates the volatility ofthe common shares based on its historical share price volatility for a period of
       <span>
        <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" format="ixt-sec:duryear" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-730" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
         4
        </ix:nonnumeric>
       </span>
       years from the grant date based on the daily changesin the share price. The risk-free interest rate is based on the zero-coupon yield of U.S. Treasury bonds for the expiration date of theRSUs.
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_33" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_32" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0">
       The fair valueof the market-based award uses the assumptions noted in the following table:
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_34" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_33" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-733" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" text-block-taxonomy="true">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
         <tbody>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="width: 88%; text-align: left">
            Risk-free interest rates
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 9%; text-align: right">
            <span>
             <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="4" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-734" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
              0.16
             </ix:nonfraction>
            </span>
           </td>
           <td style="width: 1%; text-align: left">
            %
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="text-align: left">
            Dividend yield
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-735" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
              0
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
            %
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="text-decoration: underline; text-align: left">
            Expected volatility
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="4" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-736" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateVestedinShares" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
              69.44
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
            %
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_35" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_34" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
       The Company recognizescompensation expenses for the value of its market-based awards based on the results of the Monte Carlo valuation model. The fairvalue of the market-based awards granted on the grant date was $
       <span>
        <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-738" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="usdPershares">
         7.28
        </ix:nonfraction>
       </span>
       per share and the expected time for the market condition toachieve, based on the Monte Carlo valuation model, is thirteen and a half months from the date of the grant. As of June 30, 2021,the Company recognized $
       <span>
        <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-739" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:OtherGeneralAndAdministrativeExpense" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
         5,156
        </ix:nonfraction>
       </span>
       of expenses included in general and administrative expenses.
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 70; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      F-
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      25
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15pt 0pt 0; text-align: right">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15pt 0pt 0; text-align: right">
     <b>
      PLURISTEM THERAPEUTICS INC. AND ITSSUBSIDIARIES
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15pt 0pt 0; text-align: right">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top">
       <td style="border-bottom: Black 1.5pt solid; width: 100%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          NOTES TO CONSOLIDATED FINANCIAL    STATEMENTS
         </b>
        </p>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td style="font-size: 10pt">
        <span style="font-size: 10pt">
         <b>
          U.S. Dollars in thousands (except share and per share amounts)
         </b>
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-size: 10pt">
      <b>
       NOTE 9: - SHAREHOLDERS’EQUITY
      </b>
     </span>
     <b>
      (CONT.)
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
    </p>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_36" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_35" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.5in">
       <b>
        <span style="text-decoration:underline">
         (4) RSUsto consultants:
        </span>
       </b>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_37" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_36" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
       The following tablesummarizes the activity related to unvested RS and RSUs granted to consultants for the years ended June 30, 2021 and 2020:
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_38" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_37" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c95" continued-taxonomy="false" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-743" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" text-block-taxonomy="true">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
         <tbody>
          <tr style="vertical-align: bottom">
           <td>
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">
            Year ended June 30,
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom">
           <td>
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">
            2021
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">
            2020
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom">
           <td>
           </td>
           <td style="font-weight: bold">
           </td>
           <td colspan="6" style="font-weight: bold; text-align: center">
            Number
           </td>
           <td style="font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="width: 76%; text-align: left">
            Unvested at the beginning of period
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 9%; text-align: right">
            <span>
             <ix:nonfraction contextref="c96" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-744" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              6,250
             </ix:nonfraction>
            </span>
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 9%; text-align: right">
            <span>
             <ix:nonfraction contextref="c97" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-745" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              30,107
             </ix:nonfraction>
            </span>
           </td>
           <td style="width: 1%; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td>
            Granted
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c98" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-746" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              110,000
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c99" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-747" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              42,000
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td>
            Forfeited
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            (
            <span>
             <ix:nonfraction contextref="c98" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-748" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              29,063
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
            )
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            (
            <span>
             <ix:nonfraction contextref="c99" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-749" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              6,785
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
            )
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="padding-bottom: 1.5pt">
            Vested
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            (
            <span>
             <ix:nonfraction contextref="c98" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-750" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              10,938
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
            )
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            (
            <span>
             <ix:nonfraction contextref="c99" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-751" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              59,072
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
            )
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="text-align: left; padding-bottom: 4pt">
            Unvested at the end of the period
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c100" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-752" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              76,249
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c96" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-753" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              6,250
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">
         <b>
         </b>
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_39" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_38" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
       Compensation expensesrelated to RSUs granted to consultants were recorded as follows:
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_40" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_39" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c95" continued-taxonomy="false" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-756" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" text-block-taxonomy="true">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
         <tbody>
          <tr style="vertical-align: bottom">
           <td style="font-weight: bold; text-align: justify">
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
            Year ended June 30,
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom">
           <td style="text-align: justify">
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
            2021
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
            2020
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="width: 76%; text-align: left">
            Research and development expenses
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
            $
           </td>
           <td style="width: 9%; text-align: right">
            <span>
             <ix:nonfraction contextref="c101" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-757" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AllocatedShareBasedCompensationExpense" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              176
             </ix:nonfraction>
            </span>
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
            $
           </td>
           <td style="width: 9%; text-align: right">
            <span>
             <ix:nonfraction contextref="c102" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-758" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AllocatedShareBasedCompensationExpense" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              14
             </ix:nonfraction>
            </span>
           </td>
           <td style="width: 1%; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="text-align: left; padding-bottom: 1.5pt">
            General and administrative expenses
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c103" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-759" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AllocatedShareBasedCompensationExpense" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              165
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c104" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-760" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AllocatedShareBasedCompensationExpense" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              155
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="text-align: justify; padding-bottom: 4pt">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c98" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-761" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AllocatedShareBasedCompensationExpense" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              341
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c99" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-762" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:AllocatedShareBasedCompensationExpense" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              169
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_41" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_40" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
       <tbody>
        <tr style="vertical-align: top; text-align: justify">
         <td style="width: 0in">
         </td>
         <td style="width: 0.25in; text-align: left">
          <b>
           i.
          </b>
         </td>
         <td style="text-align: justify">
          <b>
           Summary of warrants and options:
          </b>
         </td>
        </tr>
       </tbody>
      </table>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_42" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_41" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-765" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" text-block-taxonomy="true">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
         <tbody>
          <tr style="vertical-align: bottom">
           <td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">
            Warrants / Options
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
            Exercise
            <br/>
            Price per
            <br/>
            Share
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
            Options and
            <br/>
            Warrants
            <br/>
            for Common
            <br/>
            Share
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
            Options and
            <br/>
            Warrants
            <br/>
            Exercisable
            <br/>
            for Common
            <br/>
            Share
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
            Weighted
            <br/>
            Average
            <br/>
            Remaining
            <br/>
            Contractual
            <br/>
            Terms
            <br/>
            (in years)
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="width: 52%; font-weight: bold">
            Warrants:
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
            $
           </td>
           <td style="width: 9%; text-align: right">
            <span>
             <ix:nonfraction contextref="c105" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-766" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="usdPershares">
              7.00
             </ix:nonfraction>
            </span>
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 9%; text-align: right">
            <span>
             <ix:nonfraction contextref="c105" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-767" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              2,418,466
             </ix:nonfraction>
            </span>
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 9%; text-align: right">
            <span>
             <ix:nonfraction contextref="c105" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-768" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              2,418,466
             </ix:nonfraction>
            </span>
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 9%; text-align: right">
            <span>
             <ix:nonnumeric contextref="c106" continued-taxonomy="false" enabled-taxonomy="true" format="ixt-sec:duryear" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-769" inside-table="true" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
              2.77
             </ix:nonnumeric>
            </span>
           </td>
           <td style="width: 1%; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c107" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-770" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="usdPershares">
              14.00
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c107" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-771" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              762,028
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c107" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-772" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              762,028
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonnumeric contextref="c108" continued-taxonomy="false" enabled-taxonomy="true" format="ixt-sec:duryear" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-773" inside-table="true" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
              1.06
             </ix:nonnumeric>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">
            Total warrants
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c109" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-774" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              3,180,494
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c109" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-775" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              3,180,494
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td>
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="font-weight: bold; padding-bottom: 1.5pt">
            Options:
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c110" continued-taxonomy="false" decimals="5" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-776" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="usdPershares">
              0.00001
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c110" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-777" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              39,835
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c110" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-778" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              36,085
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonnumeric contextref="c111" continued-taxonomy="false" enabled-taxonomy="true" format="ixt-sec:duryear" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-779" inside-table="true" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
              6.98
             </ix:nonnumeric>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">
            Total options
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c112" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-780" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              39,835
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c112" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-781" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              36,085
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">
            Total warrants and options
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c113" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-782" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              3,220,329
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c113" continued-taxonomy="false" decimals="INF" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-783" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="shares">
              3,216,579
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
          </tr>
         </tbody>
        </table>
        <p style="margin-top: 0; margin-bottom: 0">
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_StockholdersEquityNoteDisclosureTextBlock-c0_cont_42" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="margin-left: 0.25in; margin-top: 0; margin-bottom: 0">
       This summary does not include 2,480,664 RSUs that are not vested asof June 30, 2021.
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <p style="margin-top: 0; margin-bottom: 0">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 71; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      F-
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      26
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15pt 0pt 0; text-align: right">
     <b>
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15pt 0pt 0; text-align: right">
     <b>
      PLURISTEM THERAPEUTICS INC. AND ITSSUBSIDIARIES
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15pt 0pt 0; text-align: right">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top">
       <td style="border-bottom: Black 1.5pt solid; width: 100%">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <b>
          NOTES TO CONSOLIDATED FINANCIAL    STATEMENTS
         </b>
        </p>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td style="font-size: 10pt">
        <span style="font-size: 10pt">
         <b>
          U.S. Dollars in thousands (except share and per share amounts)
         </b>
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
    </span>
    <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
    </span>
    <span>
     <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_OtherIncomeAndOtherExpenseDisclosureTextBlock-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-785" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
       <b>
        NOTE 10: - FINANCIAL INCOME, NET
       </b>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
       <b>
       </b>
      </p>
     </ix:nonnumeric>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_OtherIncomeAndOtherExpenseDisclosureTextBlock-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-787" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="true" name="psti:ScheduleOfFinancialIncomeNet" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
         <tbody>
          <tr style="vertical-align: bottom">
           <td style="text-align: justify">
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
            Year ended June 30,
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom">
           <td style="text-align: justify">
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
            2021
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
            2020
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="width: 76%; text-align: left">
            Foreign currency translation differences, net
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
            $
           </td>
           <td style="width: 9%; text-align: right">
            <span>
             <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-788" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              332
             </ix:nonfraction>
            </span>
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
            $
           </td>
           <td style="width: 9%; text-align: right">
            (
            <span>
             <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-789" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="true" isstandardonly="true" istextonly="false" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
              41
             </ix:nonfraction>
            </span>
           </td>
           <td style="width: 1%; text-align: left">
            )
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="text-align: left">
            Bank and broker commissions
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            (
            <span>
             <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-790" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="true" isstandardonly="false" istextonly="false" name="psti:BankAndBrokerCommissions" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
              23
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
            )
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            (
            <span>
             <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-791" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="true" isstandardonly="false" istextonly="false" name="psti:BankAndBrokerCommissions" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
              32
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
            )
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="text-align: left">
            Interest income on deposits
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-792" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:InterestIncomeOnDeposit" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              492
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-793" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:InterestIncomeOnDeposit" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              384
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="text-align: left">
            Gain from derivatives and fair value hedge derivatives
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-794" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              35
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-795" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:GainLossOnForeignCurrencyFairValueHedgeDerivatives" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              13
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="text-align: left; padding-bottom: 1.5pt">
            EIB loan interest expenses
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            (
            <span>
             <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-796" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="true" isstandardonly="false" istextonly="false" name="psti:EIBLoanInterestExpense" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" sign="-" tabindex="18" unitref="usd">
              78
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
            )
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            -
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="text-align: justify; padding-bottom: 4pt">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-797" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:Total" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              758
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-798" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:Total" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              324
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
          </tr>
         </tbody>
        </table>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
     </b>
    </p>
    <div>
    </div>
    <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
    </span>
    <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
    </span>
    <span>
     <ix:nonnumeric contextref="c0" continued-main-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_1" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-799" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:IncomeTaxDisclosureTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
       <b>
        NOTE 11: - TAXES ON INCOME
       </b>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-align: justify; text-indent: -27pt">
      </p>
     </ix:nonnumeric>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_2" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_1" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
       <tbody>
        <tr style="vertical-align: top; text-align: justify">
         <td style="width: 0">
         </td>
         <td style="width: 0.25in; text-align: left">
          A.
         </td>
         <td style="text-align: justify">
          Tax rates applicable to the Company:
         </td>
        </tr>
       </tbody>
      </table>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -14.2pt">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_3" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_2" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
       <tbody>
        <tr style="vertical-align: top; text-align: justify">
         <td style="width: 0.25in">
         </td>
         <td style="width: 0.25in; text-align: left">
          1.
         </td>
         <td style="text-align: justify">
          Pluristem Therapeutics:
         </td>
        </tr>
       </tbody>
      </table>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_4" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_3" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">
       The U.S. federaltax rate applicable to Pluristem Therapeutics is the corporate federal tax rate of
       <span>
        <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-803" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
         21
        </ix:nonfraction>
       </span>
       %, which is the result of the Tax Cuts and Jobs Actof 2017 (the “Tax Act”). Such corporate tax rate excludes state tax and local tax, if any, which rates depend on the state andcity in which Pluristem Therapeutics conducts its business.
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_5" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_4" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">
       On December 22, 2017, the Tax Actwas signed into law in the United States, lowering the corporate federal income tax rate from
       <span>
        <ix:nonfraction contextref="c114" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-805" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
         35
        </ix:nonfraction>
       </span>
       % to
       <span>
        <ix:nonfraction contextref="c115" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-806" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
         21
        </ix:nonfraction>
       </span>
       %, effective January 1, 2018.
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_6" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_5" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">
       The Tax Act provided for a one-timetransition tax on certain foreign earnings for the tax year 2017, and taxation of Global Intangible Low-Taxed Income (“GILTI”)earned by foreign subsidiaries beginning after
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_7" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_6" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">
       December 31, 2017. The GILTI tax imposesa tax on foreign income in excess of a deemed return on tangible assets of foreign corporations. The Tax Act also makes certain changesto the depreciation rules and implements new limits on the deductibility of certain executive compensation paid by Pluristem Therapeutics.Finally, while the Tax Act removes the 20 year limitation on net operating losses generated after December 31, 2017, all losses generatedafter December 31, 2017 can only be used to offset
       <span>
        <ix:nonfraction contextref="c116" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-809" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
         80
        </ix:nonfraction>
       </span>
       % of net income in the year they will be utilized.
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_8" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_7" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">
       This re-measurement was fully offsetby a valuation allowance, resulting in no impact to the Company’s income tax expense for the fiscal year ended June 30, 2021. Asa result, the Company’s financial results reflect in the income tax effects of the Tax Act, for which the accounting under ASC 740 iscomplete.
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_9" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_8" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">
       There was no one-time transition taxfor the Company under the Tax Act, nor will there be GILTI tax due for the current year, since the Subsidiary had losses for every yearto date.
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_10" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_9" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">
       In January 2018, Pluristem Therapeuticsregistered as an Israeli resident with the Israel Tax Authority (the “ITA”) and the Israeli Value Added Tax Authorities. Asa result, as of such date, Pluristem Therapeutics is classified as a dual resident for tax purposes, as a resident in both Israel andthe United States.
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <!-- Field: Page; Sequence: 72; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      F-
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      27
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       PLURISTEMTHERAPEUTICS INC. AND ITS SUBSIDIARIES
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; width: 100%">
        <p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          <b>
           NOTES                                            TO CONSOLIDATED FINANCIAL STATEMENTS
          </b>
         </span>
        </p>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <b>
          U.S.    Dollars in thousands (except share and per share amounts)
         </b>
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       NOTE11: - TAXES ON INCOME (CONT.)
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_11" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_10" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        InJune 2018, Pluristem Therapeutics and the Subsidiary submitted an election notice to the ITA to file a consolidated tax return in Israelcommencing with the 2018 tax year.
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_12" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_11" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
       <tbody>
        <tr style="vertical-align: top; text-align: justify">
         <td style="width: 0.25in">
         </td>
         <td style="width: 0.25in; text-align: left">
          <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
           2.
          </span>
         </td>
         <td style="text-align: justify">
          <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
           TheSubsidiary:
          </span>
         </td>
        </tr>
       </tbody>
      </table>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_13" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_12" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        Consolidatedtaxable income of Pluristem Therapeutics and the Subsidiary (the “Consolidated tax unit”) is subject to tax at the rate of
        <span>
         <ix:nonfraction contextref="c117" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-816" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
          <span>
           <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-817" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
            23
           </ix:nonfraction>
          </span>
         </ix:nonfraction>
        </span>
        % in 2021 and 2020.
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_14" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_13" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        TheConsolidated tax unit is filing its consolidated tax reports in dollars based on specific regulations of the ITA which allow, in specificcircumstances, filing tax reports in dollars (“Dollar Regulations”). Under the Dollar Regulations, the tax liability is calculatedin dollars according to certain orders. The tax liability, as calculated in dollars, is translated into NIS according to the exchangerate as of June 30 of each year.
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_15" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_14" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        TheSubsidiary has not received final tax assessments since its incorporation, however the assessments of the Subsidiary are deemed finalthrough 2015.
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_16" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_15" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        <b>
         TheLaw for the Encouragement of Capital Investments, 1959 (the “Law”):
        </b>
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: 0in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_17" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_16" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        TheSubsidiary has programs which meet the criteria of a “Beneficiary Enterprise”, in accordance with the Law, under the AlternativeBenefit Track starting with 2007 as the election year (the “2007 Program”) and 2012 as an election year to the expansion ofits “Beneficiary Enterprise” program (the “2012 Program”).
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_18" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_17" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        Underthe 2012 Program, the Subsidiary, which was located in the “Other National Priority Zone” with respect to the year 2012, wouldbe tax exempt in the first two years of the benefit period and subject to tax at the reduced rate of
        <span>
         <ix:nonfraction contextref="c118" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-823" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
          10
         </ix:nonfraction>
        </span>
        %-
        <span>
         <ix:nonfraction contextref="c119" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-824" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
          25
         </ix:nonfraction>
        </span>
        % for a period of five toeight years for the remaining benefit period (dependent on the level of foreign investments).
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_19" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_18" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        Inrespect of expansion programs pursuant to Amendment No. 60 to the Law, the duration of the benefit period has been amended, suchthat it starts at the later of the election year and the first year the Company earns taxable income provided that 12 years have notpassed since the beginning of the election year and for companies in National Priority Zone A - 14 years have not passed since thebeginning of the election year.
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_20" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_19" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        Thebenefit period for the Subsidiary’s 2007 Program expired in 2018 (12 years since the beginning of the election year– 2007) andthe benefit period for the Subsidiary’s 2012 Program is expected to expire in 2023 (12 years since the beginning of the election year- 2012).
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-827" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="true" name="psti:LiableForTaxAtRateApplicableProfits" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_21" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_20" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Ifa dividend is distributed out of tax exempt profits, as detailed above, the Subsidiary will become liable for taxes at the rate applicableto its profits from the Beneficiary Enterprise in the year in which the income was earned (tax at the rate of 10-25%, dependent on thelevel of foreign investments) and to a withholding tax rate of 15% (or lower, under an applicable tax treaty).
         </span>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">
        </p>
       </ix:continuation>
      </span>
     </ix:nonnumeric>
    </span>
    <div>
    </div>
    <div>
    </div>
    <!-- Field: Page; Sequence: 73; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      F-
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      28
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       PLURISTEMTHERAPEUTICS INC. AND ITS SUBSIDIARIES
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; width: 100%">
        <p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          <b>
           NOTES                                            TO CONSOLIDATED FINANCIAL STATEMENTS
          </b>
         </span>
        </p>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <b>
          U.S.    Dollars in thousands (except share and per share amounts)
         </b>
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       NOTE11: - TAXES ON INCOME (CONT.)
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: 0in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_22" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_21" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        <i>
         Accelerateddepreciation:
        </i>
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_23" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_22" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        TheSubsidiary is eligible for deduction of accelerated depreciation on buildings, machinery and equipment used by the “BeneficiaryEnterprise” at a rate of
        <span>
         <ix:nonfraction contextref="c43" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-831" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:BeneficiaryEnterprisePercentage" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
          200
         </ix:nonfraction>
        </span>
        % (or
        <span>
         <ix:nonfraction contextref="c44" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-832" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:BeneficiaryEnterprisePercentage" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
          400
         </ix:nonfraction>
        </span>
        % for buildings but not more than
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-833" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:DepreciationTaxRatePercentage" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
          20
         </ix:nonfraction>
        </span>
        % depreciation per year) from the first year of the assetsoperation.
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        <i>
        </i>
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_24" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_23" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        <i>
         Conditionsfor the entitlement to the benefits:
        </i>
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_25" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_24" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        Theabove mentioned benefits are conditional upon the fulfillment of the conditions stipulated by the Law, regulations promulgated thereunder,and the Ruling with respect to the beneficiary enterprise. Non-compliance with the conditions may cancel all or part of the benefitsand refund of the amount of the benefits, including interest. The management believes that the Subsidiary is meeting the aforementionedconditions.
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_26" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_25" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        <i>
         Amendmentsto the Law:
        </i>
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_27" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_26" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        InDecember 2010, the “Knesset” (Israeli Parliament) passed the Law for Economic Policy for 2011 and 2012 (Amended Legislation),2011, which prescribes, among others, amendments in the Law (“Amendment No. 68”). Amendment No. 68 became effective as ofJanuary 1, 2011. According to Amendment No. 68, the benefit tracks in the Law were modified and a flat tax rate became applicable toa company for all preferred income under its status as a preferred company with a preferred enterprise.
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_28" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_27" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        OnAugust 5, 2013, the Knesset issued the Law for Changing National Priorities (Legislative Amendments for Achieving Budget Targets for2013 and 2014), 2013 which consists of Amendment No. 71 to the Law (“Amendment No. 71”). According to Amendment No. 71, thetax rate on preferred income form a preferred enterprise in 2014 and thereafter will be
        <span>
         <ix:nonfraction contextref="c120" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-839" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:PreferredIncomeTaxRate" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
          16
         </ix:nonfraction>
        </span>
        % (in development area A it will be
        <span>
         <ix:nonfraction contextref="c121" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-840" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:PreferredIncomeTaxRate" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
          9
         </ix:nonfraction>
        </span>
        %).
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_29" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_28" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        AmendmentNo. 71 also prescribes that any dividends distributed to individuals or foreign residents from the preferred enterprise’s earnings asabove will be subject to tax at a rate of
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-842" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:EffectiveIncomeTaxRateReconciliationDeductions" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
          20
         </ix:nonfraction>
        </span>
        %.
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_30" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_29" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        TheSubsidiary did not apply Amendment No. 71 with respect to the preferred enterprise status, but may choose to apply Amendment No. 71 inthe future.
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_31" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_30" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        <span style="text-decoration:underline">
         InnovationBox Regime “Technological Preferred Enterprise”:
        </span>
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_32" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_31" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        InDecember 2016, the Knesset approved amendments to the Law that introduce an innovation box regime (the “Innovation BoxRegime”) for intellectual property (IP)-based companies, enhance tax incentives for certain industrial companies and reducethe standard corporate tax rate and certain withholding rates starting in 2017.
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_33" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_32" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        TheInnovation Box Regime was tailored by the Israeli government to a post-base erosion and profit shifting world, encouraging multinationalsto consolidate IP ownership and profits in Israel along with existing Israeli research and development (“R&amp;D”) functions.Tax benefits created to achieve this goal include a reduced corporate income tax rate of
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-847" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:EffectiveIncomeTaxRateReduced" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
          6
         </ix:nonfraction>
        </span>
        % on IP-based income and on capital gains fromfuture sale of IP.
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_34" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_33" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        The
        <span>
         <ix:nonfraction contextref="c43" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-849" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
          6
         </ix:nonfraction>
        </span>
        % rate would apply to qualifying Israeli companies that are part of a group with global consolidated revenue of over NIS
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-9" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-850" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:ConsolidatedRevenue" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="9" selected-taxonomy="false" tabindex="18" unitref="ils">
          10
         </ix:nonfraction>
        </span>
        billion(approximately $
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-8" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-851" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:IncomeTaxReconciliationTaxCreditsForeign" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="9" selected-taxonomy="false" tabindex="18" unitref="usd">
          2.9
         </ix:nonfraction>
        </span>
        billion). Other qualifying companies with global consolidated revenue below NIS
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-9" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-852" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:IncomeTaxReconciliationTaxCreditsForeign" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="9" selected-taxonomy="false" tabindex="18" unitref="ils">
          10
         </ix:nonfraction>
        </span>
        billion, would be subject to a
        <span>
         <ix:nonfraction contextref="c44" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-853" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
          12
         </ix:nonfraction>
        </span>
        % tax rate.
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <!-- Field: Page; Sequence: 74; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      F-
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      29
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       PLURISTEMTHERAPEUTICS INC. AND ITS SUBSIDIARIES
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; width: 100%">
        <p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          <b>
           NOTES                                            TO CONSOLIDATED FINANCIAL STATEMENTS
          </b>
         </span>
        </p>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <b>
          U.S.    Dollars in thousands (except share and per share amounts)
         </b>
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       NOTE11: - TAXES ON INCOME (CONT.)
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: 0in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_35" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_34" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        However,if the Israeli company is located in Jerusalem or in certain northern or southern parts of Israel, the tax rate is further reduced to
        <span>
         <ix:nonfraction contextref="c122" continued-taxonomy="false" decimals="3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-855" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:EffectiveIncomeTaxRateReduced" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
          7.5
         </ix:nonfraction>
        </span>
        %. Additionally, withholding tax on dividends for foreign investors would be subject to a reduced rate of
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-856" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsOther" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
          4
         </ix:nonfraction>
        </span>
        % for all qualifying companies(unless further reduced by a treaty).
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_36" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_35" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        Enteringthe regime is not conditioned on making additional investments in Israel, and a company could qualify if it invested at least
        <span>
         <ix:nonfraction contextref="c123" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-858" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsForeign" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
          7
         </ix:nonfraction>
        </span>
        % of thelast three years’ revenue in R&amp;D (or incurred at least NIS
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-6" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-859" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:OtherExpenses" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="6" selected-taxonomy="false" tabindex="18" unitref="ils">
          75
         </ix:nonfraction>
        </span>
        million in R&amp;D expenses per year) and met one of the followingthree conditions:
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_37" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_36" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        1.At least
        <span>
         <ix:nonfraction contextref="c43" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-861" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:EffectiveIncomeTaxRateEmployeesPercentage" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
          20
         </ix:nonfraction>
        </span>
        % of its employees are R&amp;D employees engaged in R&amp;D (or employs, in total, more than 200 R&amp;D employees);
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_38" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_37" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        2.Venture capital investments in the aggregate of NIS 8 million were previously made in the company; or
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_39" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_38" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        3.Average annual growth over three years of
        <span>
         <ix:nonfraction contextref="c44" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-864" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:EffectiveIncomeTaxRateEmployeesPercentage" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
          25
         </ix:nonfraction>
        </span>
        % in sales or employees.
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_40" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_39" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        Companiesnot meeting the above conditions may still be considered as a qualified company at the discretion of the IIA. Companies wishing to exitfrom the regime in the future will not be subject to claw back of tax benefits. The Knesset also approved a stability clause in orderto encourage multinationals to invest in Israel. Accordingly, companies will be able to confirm the applicability of tax incentives fora 10-year period under a pre-ruling process. Further, in line with the new Organization for Economic Co-operation and Development NexusApproach, the Israeli Finance Minister will promulgate regulations to ensure companies are benefiting from the regime to the extent qualifyingresearch and development expenditures are incurred.
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_41" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_40" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        Theregulations were set to be finalized by March 31, 2017, with new amendments to the Law coming into effect after the regulations havebeen finalized.
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_42" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_41" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        Taxableincome which is not produced as part of “Preferred Enterprise” income will be taxed at the regular tax rate (
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-868" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:IncomeTaxRegularTaxRate" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
          23
         </ix:nonfraction>
        </span>
        % in 2020).
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_43" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_42" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        Asof June 30, 2021, the Company’s management believes that the Company meets the conditions mentioned above to be considered as aTechnological Preferred Enterprise.
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_44" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_43" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">
       <tbody>
        <tr style="vertical-align: top; text-align: justify">
         <td style="width: 0.25in">
         </td>
         <td style="width: 0.25in; text-align: left">
          <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
           3.
          </span>
         </td>
         <td style="text-align: justify">
          <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
           PluristemGmbH:
          </span>
         </td>
        </tr>
       </tbody>
      </table>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-871" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="true" name="psti:GermanSubsidiaryIsTheCorporateTaxRate" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span>
       <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_45" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_44" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Thetax rate applicable to the German Subsidiary is the corporate tax rate of 15%, which is derived from the German Corporation Tax Act andSolidarity surcharge of 5.5% from the 15% corporate tax rate. This corporate tax rate excludes trade tax, which rate depends on the municipalityin which the German Subsidiary conducts its business. Trade tax is calculated on the basis of the trade income, to which the tax rateof 3.5% is applied. The measured amount is then multiplied by the applicable rate of assessment, the registered office of the GermanSubsidiary is in Potsdam, and in Potsdam, the applicable rate of assessment is 455%.
         </span>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          <b>
          </b>
         </span>
        </p>
       </ix:continuation>
      </span>
     </ix:nonnumeric>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_46" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_45" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
       <tbody>
        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
         <td style="padding: 0pt; font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-indent: 0pt">
          <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
           B.
          </span>
         </td>
         <td style="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0pt">
          <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
           Carryforward                                            losses for tax purposes
          </span>
         </td>
        </tr>
       </tbody>
      </table>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_47" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_46" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        Asof June 30, 2021, Pluristem Therapeutics had a U.S. federal net operating loss carryforward for income tax purposes in the amount ofapproximately $
        <span>
         <ix:nonfraction contextref="c124" continued-taxonomy="false" decimals="0" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-875" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:OperatingLossCarryforwards" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="usd">
          34,836
         </ix:nonfraction>
        </span>
        . Net operating loss carryforwards arising in taxable years, can be carried forward and offset against taxable incomefor 20 years and expire between 2023 and 2038.
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_48" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_47" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        Utilizationof U.S. net operating losses may be subject to substantial annual limitations due to the “change in ownership” provisions ofthe Internal Revenue Code of 1986 and similar state provisions. The annual limitation may result in the expiration of net operating lossesbefore utilization.
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_49" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_48" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font: 10pt Times New Roman, Times, Serif">
        InJanuary 2018, Pluristem Therapeutics registered as an Israeli resident with the ITA and the Israeli Value Added Tax Authorities. As ofJune 30, 2021, Pluristem Therapeutics and the Subsidiary consolidated accumulated losses, for tax purposes, are approximately $
        <span>
         <ix:nonfraction contextref="c124" continued-taxonomy="false" decimals="0" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-878" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:AccumulatedLossesCarryForward" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="usd">
          86,949
         </ix:nonfraction>
        </span>
        ,which may be carried forward and offset against taxable business income and business capital gain in the future for an indefinite period.
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">
       <span style="font: 10pt Times New Roman, Times, Serif">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_50" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_49" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font: 10pt Times New Roman, Times, Serif">
        TheSubsidiary has accumulated losses, for tax purposes, as of June 30, 2021, in the amount of approximately $
        <span>
         <ix:nonfraction contextref="c125" continued-taxonomy="false" decimals="0" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-880" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:AccumulatedLossesCarryForward" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="usd">
          129,286
         </ix:nonfraction>
        </span>
        , which may be carriedforward and offset against taxable business income and business capital gain in the future for an indefinite period.
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">
       <span style="font: 10pt Times New Roman, Times, Serif">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_51" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_50" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font: 10pt Times New Roman, Times, Serif">
        TheGerman Subsidiary has accumulated losses, for tax purposes, as of June 30, 2021, in the amount of approximately $
        <span>
         <ix:nonfraction contextref="c126" continued-taxonomy="false" decimals="0" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-882" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:AccumulatedLossesCarryForward" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="0" selected-taxonomy="false" tabindex="18" unitref="usd">
          584
         </ix:nonfraction>
        </span>
        , which may be carriedforward and offset against taxable business income and business capital gain in the future for an indefinite period.
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify">
       <span style="font: 10pt Times New Roman, Times, Serif">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <!-- Field: Page; Sequence: 75; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      F-
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      30
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       PLURISTEMTHERAPEUTICS INC. AND ITS SUBSIDIARIES
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt; width: 100%">
        <p style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          <b>
           NOTES                                            TO CONSOLIDATED FINANCIAL STATEMENTS
          </b>
         </span>
        </p>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-indent: 0pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <b>
          U.S.    Dollars in thousands (except share and per share amounts)
         </b>
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       NOTE11: - TAXES ON INCOME (CONT.)
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: 0in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_52" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_51" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
       <tbody>
        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
         <td style="padding: 0pt; font: 10pt Times New Roman, Times, Serif; width: 0px; text-indent: 0pt">
         </td>
         <td style="padding: 0pt; font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-indent: 0pt">
          <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
           C.
          </span>
         </td>
         <td style="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0pt">
          <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
           Loss                                            before income taxes
          </span>
         </td>
        </tr>
       </tbody>
      </table>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_53" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_52" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        Thecomponents of loss before income taxes are as follows:
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_54" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_53" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-886" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" text-block-taxonomy="true">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
         <tbody>
          <tr style="vertical-align: bottom">
           <td style="text-align: justify">
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
            Year ended June 30,
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom">
           <td style="text-align: justify">
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
            2021
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
            2020
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="width: 76%; text-align: left; text-indent: 0pt; padding-left: 0pt">
            Consolidated loss of Pluristem Therapeutics and the Israeli subsidiary
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
            $
           </td>
           <td style="width: 9%; text-align: right">
            <span>
             <ix:nonfraction contextref="c129" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-887" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              49,432
             </ix:nonfraction>
            </span>
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
            $
           </td>
           <td style="width: 9%; text-align: right">
            <span>
             <ix:nonfraction contextref="c130" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-888" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              29,001
             </ix:nonfraction>
            </span>
           </td>
           <td style="width: 1%; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="text-align: left; padding-bottom: 1.5pt; text-indent: 0pt; padding-left: 0pt">
            Pluristem GmbH
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c131" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-889" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              433
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c132" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-890" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              151
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="padding-bottom: 4pt; text-indent: 0pt; padding-left: 0pt">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-891" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              49,865
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <span>
             <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-892" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              29,152
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         </span>
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_55" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_54" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
       <tbody>
        <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
         <td style="padding: 0pt; font: 10pt Times New Roman, Times, Serif; width: 0px; text-indent: 0pt">
         </td>
         <td style="padding: 0pt; font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-indent: 0pt">
          <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
           D.
          </span>
         </td>
         <td style="padding: 0pt; font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0pt">
          <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
           Deferred                                            income taxes:
          </span>
         </td>
        </tr>
       </tbody>
      </table>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: 0in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_56" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_55" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        Deferredincome taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financialreporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets are as follows:
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42.55pt; text-align: justify; text-indent: 0in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_57" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_56" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <span class="float-left text-block-indicator-left position-absolute" title="One or more textblock facts are between this symbol and the right side symbol.">
      </span>
      <span class="float-right text-block-indicator-right position-absolute" title="One or more textblock facts are between this symbol and the left side symbol.">
      </span>
      <span>
       <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" escape="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-896" inside-table="false" isadditionalitemsonly="false" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" text-block-taxonomy="true">
        <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
         <tbody>
          <tr style="vertical-align: bottom">
           <td>
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
            June 30,
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom">
           <td>
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
            2021
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
           <td style="font-weight: bold; padding-bottom: 1.5pt">
           </td>
           <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
            2020
           </td>
           <td style="padding-bottom: 1.5pt; font-weight: bold">
           </td>
          </tr>
          <tr style="vertical-align: bottom">
           <td>
            Deferred tax assets:
           </td>
           <td>
           </td>
           <td colspan="2">
           </td>
           <td>
           </td>
           <td>
           </td>
           <td colspan="2">
           </td>
           <td>
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="width: 76%; text-align: left; text-indent: 0pt; padding-left: 0.125in">
            Operating loss carryforwards
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
            $
           </td>
           <td style="width: 9%; text-align: right">
            <span>
             <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-897" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              57,304
             </ix:nonfraction>
            </span>
           </td>
           <td style="width: 1%; text-align: left">
           </td>
           <td style="width: 1%">
           </td>
           <td style="width: 1%; text-align: left">
            $
           </td>
           <td style="width: 9%; text-align: right">
            <span>
             <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-898" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              49,034
             </ix:nonfraction>
            </span>
           </td>
           <td style="width: 1%; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="text-align: left; text-indent: 0pt; padding-left: 0.125in">
            Research and development credit carryforwards
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-899" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              5,907
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-900" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              5,432
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="text-align: left; text-indent: 0pt; padding-left: 0.125in">
            Issuance costs
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-901" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:DeferredTaxAssetsOther" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              352
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <div style="-sec-ix-hidden: hidden-fact-56">
             <span>
              <ix:nonfraction contextref="c4" continued-taxonomy="false" data-original-id="hidden-fact-56" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-902" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:DeferredTaxAssetsOther" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
               -
              </ix:nonfraction>
             </span>
            </div>
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="text-align: justify; padding-bottom: 1.5pt; text-indent: 0pt; padding-left: 0.125in">
            Allowances and reserves
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-903" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              336
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            <span>
             <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-904" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              271
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="text-indent: 0pt; padding-left: 0pt">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="text-align: justify; text-indent: 0pt; padding-left: 0pt">
            Total deferred tax assets before valuation allowance
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-905" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:DeferredTaxAssetsGross" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              63,899
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
            <span>
             <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-906" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:DeferredTaxAssetsGross" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              54,737
             </ix:nonfraction>
            </span>
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="text-align: justify; padding-bottom: 1.5pt; text-indent: 0pt; padding-left: 0pt">
            Valuation allowance
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            (
            <span>
             <ix:nonfraction contextref="c3" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-907" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:DeferredTaxAssetsValuationAllowance" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              63,899
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
            )
           </td>
           <td style="padding-bottom: 1.5pt">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: left">
           </td>
           <td style="border-bottom: Black 1.5pt solid; text-align: right">
            (
            <span>
             <ix:nonfraction contextref="c4" continued-taxonomy="false" decimals="-3" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-908" inside-table="true" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:DeferredTaxAssetsValuationAllowance" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="3" selected-taxonomy="false" tabindex="18" unitref="usd">
              54,737
             </ix:nonfraction>
            </span>
           </td>
           <td style="padding-bottom: 1.5pt; text-align: left">
            )
           </td>
          </tr>
          <tr style="vertical-align: bottom; ">
           <td style="text-indent: 0pt; padding-left: 0pt">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
           </td>
           <td style="text-align: left">
           </td>
           <td>
           </td>
           <td style="text-align: left">
           </td>
           <td style="text-align: right">
           </td>
           <td style="text-align: left">
           </td>
          </tr>
          <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
           <td style="text-align: justify; padding-bottom: 4pt; text-indent: 0pt; padding-left: 0pt">
            Net deferred tax asset
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <div style="-sec-ix-hidden: hidden-fact-57">
             <span>
              <ix:nonfraction contextref="c3" continued-taxonomy="false" data-original-id="hidden-fact-57" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-909" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:DeferredTaxAssetsNet" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
               -
              </ix:nonfraction>
             </span>
            </div>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
           <td style="padding-bottom: 4pt">
           </td>
           <td style="border-bottom: Black 4pt double; text-align: left">
            $
           </td>
           <td style="border-bottom: Black 4pt double; text-align: right">
            <div style="-sec-ix-hidden: hidden-fact-58">
             <span>
              <ix:nonfraction contextref="c4" continued-taxonomy="false" data-original-id="hidden-fact-58" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-910" inside-table="true" isadditionalitemsonly="true" isamountsonly="true" iscalculationsonly="true" iscustomonly="false" ishiddenelement="true" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:DeferredTaxAssetsNet" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18" unitref="usd" xsi:nil="true">
               -
              </ix:nonfraction>
             </span>
            </div>
           </td>
           <td style="padding-bottom: 4pt; text-align: left">
           </td>
          </tr>
         </tbody>
        </table>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
        </p>
       </ix:nonnumeric>
      </span>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
    </p>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_58" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_57" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        Asof June 30, 2021 and 2020, the Company has provided full valuation allowances in respect of deferred tax assets resulting from tax losscarryforwards and other temporary differences, since it has a history of operating losses and due to current uncertainty concerning itsability to realize these deferred tax assets in the future.
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_59" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_58" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        TheCompany accounts for its income tax uncertainties in accordance with ASC 740 which clarifies the accounting for uncertainties inincome taxes recognized in a Company’s financial statements and prescribes a recognition threshold and measurement attribute forthe financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_60" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_59" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        Asof June 30, 2021 and 2020, there were no unrecognized tax benefits that if recognized would affect the annual effective tax rate.
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" continuedat="_IncomeTaxDisclosureTextBlock-c0_cont_61" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_60" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        <b>
         Reconciliationof taxes at the federal statutory rate to Company’s provision for income taxes:
        </b>
       </span>
      </p>
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <div>
    </div>
    <span>
     <ix:continuation continued-taxonomy="true" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="_IncomeTaxDisclosureTextBlock-c0_cont_61" inside-table="false" isadditionalitemsonly="false" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
      <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">
       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        In2021 and 2020, the main reconciling item of the statutory tax rate of the Company (
        <span>
         <ix:nonfraction contextref="c43" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-916" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
          <span>
           <ix:nonfraction contextref="c127" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-917" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
            21
           </ix:nonfraction>
          </span>
         </ix:nonfraction>
        </span>
        % to
        <span>
         <ix:nonfraction contextref="c128" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-918" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
          <span>
           <ix:nonfraction contextref="c44" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-919" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="false" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
            23
           </ix:nonfraction>
          </span>
         </ix:nonfraction>
        </span>
        %) to the effective tax rate (
        <span>
         <ix:nonfraction contextref="c0" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-920" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:EffectiveTaxRateLossCarryforwardsPercentage" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
          <span>
           <ix:nonfraction contextref="c5" continued-taxonomy="false" decimals="2" enabled-taxonomy="true" format="ixt:numdotdecimal" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-921" inside-table="false" isadditionalitemsonly="false" isamountsonly="true" iscalculationsonly="false" iscustomonly="true" isnegativesonly="false" isstandardonly="false" istextonly="false" name="psti:EffectiveTaxRateLossCarryforwardsPercentage" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" scale="-2" selected-taxonomy="false" tabindex="18" unitref="pure">
            0
           </ix:nonfraction>
          </span>
         </ix:nonfraction>
        </span>
        %) is taxloss carryforwards, share-based compensation and other deferred tax assets for which a full valuation allowance was provided.
       </span>
      </p>
     </ix:continuation>
    </span>
    <div>
    </div>
    <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 76; Value: 1 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      F-
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      31
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
    </p>
    <div>
    </div>
    <div>
     <a id="p_014">
     </a>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">
      <b>
       Item9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      None.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <div>
     <a id="p_015">
     </a>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">
      <b>
       Item9A. Controls and Procedures.
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       <i>
       </i>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       <i>
        Evaluationof Disclosure Controls and Procedures
       </i>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Weconducted an evaluation under the supervision of our CEO and CFO (our principal executive officer and principal financial officer, respectively),regarding the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the ExchangeAct) as of June 30, 2021. Based on the aforementioned evaluation, management has concluded that our disclosure controls and procedureswere effective as of June 30, 2021.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       <i>
       </i>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       <i>
        Management’sAnnual Report on Internal Control over Financial Reporting
       </i>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Our management is responsiblefor establishing and maintaining adequate internal control over financial reporting. Our internal control over financial reporting hasbeen designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statementsfor external purposes in accordance with U.S. GAAP.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Our internal control overfinancial reporting includes policies and procedures that pertain to the maintenance of records that, in reasonable detail, accuratelyand fairly reflect transactions and dispositions of our assets; provide reasonable assurance that transactions are recorded as necessaryto permit preparation of financial statements in accordance with U.S. GAAP, and that receipts and expenditures are being made only inaccordance with authorization of our management and directors; and provide reasonable assurance regarding prevention or timely detectionof unauthorized acquisition, use or disposition of our assets that could have a material effect on our financial statements.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Becauseof its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Therefore, even thosesystems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate becauseof changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Managementassessed the effectiveness of our internal control over financial reporting on June 30, 2021. In making this assessment, management usedthe criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission 2013 framework in
      <i>
       Internal Control—IntegratedFramework
      </i>
      . Based on that assessment under those criteria, management has determined that, as of June 30, 2021, our internal controlover financial reporting was effective.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       <i>
       </i>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       <i>
        Changesin Internal Control Over Financial Reporting
       </i>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Therehave been no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f)under the Exchange Act) during the fourth quarter of Fiscal Year 2021 that have materially affected, or are reasonably likely to materiallyaffect, our internal control over financial reporting.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <div>
     <a id="p_016">
     </a>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
      <b>
       Item9B. Other Information.
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font: 10pt Times New Roman, Times, Serif">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     <span style="font: 10pt Times New Roman, Times, Serif">
      None.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font: 10pt Times New Roman, Times, Serif">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <div>
     <a id="p_023">
     </a>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase">
      <b>
       Item9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font: 10pt Times New Roman, Times, Serif">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     <span style="font: 10pt Times New Roman, Times, Serif">
      Notapplicable.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 77; Options: NewSection; Value: 41 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      41
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <div>
     <a id="p_017">
     </a>
    </div>
    <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">
      <b>
       PARTIII
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <div>
     <a id="p_018">
     </a>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">
      <b>
       Item10. Directors, Executive Officers and Corporate Governance.
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Ourdirectors and executive officers, their ages, positions currently held, and duration of such, are as follows:
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif">
       <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; width: 18%; border-bottom: black 1.5pt solid; padding-right: 0.5pt; padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <b>
          Name
         </b>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; width: 2%; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; width: 41%; border-bottom: black 1.5pt solid; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <b>
          Position    Held With Company
         </b>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; width: 2%; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; width: 6%; border-bottom: black 1.5pt solid; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <b>
          Age
         </b>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; width: 2%; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; width: 29%; border-bottom: black 1.5pt solid; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <b>
          Date    First Elected or Appointed
         </b>
        </span>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Zami    Aberman
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Executive    Chairman
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         67
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         June    23, 2019
        </span>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Yaky    Yanay
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          President
         </span>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Director
         </span>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Chief    Executive Officer
         </span>
        </p>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         50
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          February    4, 2014
         </span>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          February    5, 2015
         </span>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          June    23, 2019
         </span>
        </p>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Chen    Franco-Yehuda
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Chief    Financial Officer, Treasurer and Secretary
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         38
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         March    14, 2019
        </span>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Doron    Birger
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Director
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         70
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         July    15,2021
        </span>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Mark    Germain
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Director
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         70
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         May    17, 2007
        </span>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Moria    Kwiat
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Director
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         41
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         May    15, 2012
        </span>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Rami    Levi
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Director
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         59
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         June    1, 2021
        </span>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; ">
       <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Varda    Shalev
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Director
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         62
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0.5pt; padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         July    15,2021
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="width: 17%; padding-right: 0.5pt; padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Maital Shemesh-Rasmussen
        </span>
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 46%; padding-right: 0.5pt; padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Director
        </span>
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 5%; padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         51
        </span>
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 29%; padding-right: 0.5pt; padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         June 1, 2021
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="padding-right: 0.5pt; padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Doron Shorrer
        </span>
       </td>
       <td>
       </td>
       <td style="padding-right: 0.5pt; padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Director
        </span>
       </td>
       <td>
       </td>
       <td style="padding-right: 0.5pt; padding-left: 0.5pt; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         68
        </span>
       </td>
       <td>
       </td>
       <td style="padding-right: 0.5pt; padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         October 2, 2003
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <i>
       BusinessExperience
      </i>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Thefollowing is a brief account of the education and business experience of each director and executive officer during at least the pastfive years, indicating each person’s principal occupation during the period, and the name and principal business of the organizationby which they were employed.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       ZamiAberman
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Mr.Aberman joined the Company in September 2005 and has served as our Executive Chairman since June 2019, as our Co-Chief Executive Officerfrom March 2017 until June 2019, as our CEO from November 2005 until March 2017, and as President of the Company from September 2005until February 2014. He changed the Company’s strategy towards cellular therapeutics. Mr. Aberman’s vision to use the maternalsection of the Placenta (Decidua) as a source for cell therapy, combined with the Company’s 3D culturing technology, led to thedevelopment of our products. Since November 2005, Mr. Aberman has served as a director of the Company, and since April 2006, as Chairmanof the Board. He has 25 years of experience in marketing and management in the high technology industry. Mr. Aberman has held the CEOand Chairman positions of various companies located in Israel, the United States, Europe, Japan and Korea.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 78; Value: 41 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      42
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Mr.Aberman has operated within high-tech global companies in the fields of automatic optical inspection, network security, video over IP,software, chip design and robotics. He serves as the chairman of Rose Hitech Ltd., a private investment company. He previously servedas the chairman of VLScom Ltd., a private company specializing in video compression for HDTV and video over IP and as a director of OriSoftware Ltd., a company involved in data management. Prior to holding those positions, Mr. Aberman served as the President and CEO ofElbit Vision System Ltd. (EVSNF.OB), a company engaged in automatic optical inspection. Before joining the Company, Mr. Aberman servedas President and CEO of Netect Ltd., a company specializing in the field of internet security software and was the co-founder, Presidentand CEO of Associative Computing Ltd., which developed an associative parallel processor for real-time video processing. He also servedas Chairman of Display Inspection Systems Inc., specializing in laser based inspection machines and as President and CEO of RobomatixTechnologies Ltd.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In 1992, Mr. Aberman was awardedthe Rothschild Prize for excellence in his field from the President of the State of Israel. Mr. Aberman holds a B.Sc. in Mechanical Engineeringfrom Ben Gurion University, Israel.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Webelieve that Mr. Aberman’s qualifications to sit on our Board include his unique multidisciplinary innovative approach, years ofexperience in the financial markets in Israel and globally, as well as his experience in serving as the CEO of publicly traded entities.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       YakyYanay
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Mr.Yanay became a director of the Company in February 2015. He has served as our President from February 2014 and as our CEO from June 2019,previously serving as Co-CEO from March 2017. Mr. Yanay has served in variety of executive positions in Pluristem since 2006 includingas our CFO from November 2006 until February 2014 and from February 2015 until March 2017. He also served as our Chief Operating Officerfrom February 2014 until March 2017. From November 2006 to February 2014, he served as our Secretary and served as our Executive VicePresident from March 2013 until February 2014. From 2015 to 2018, Mr. Yanay served as the Co-Chairman of Israel Advanced Technology Industries(IATI), the largest umbrella organization representing Israel’s high tech and life science industries and since August 2012 hascontinually served as a Director of IATI, representing Israel’s life sciences industry. Prior to joining the Company, Mr. Yanayfounded and served as Chairman of “The Israeli Life Science Forum” and also served as the CFO of Elbit Vision Systems Ltd.,a public company. In addition, from July 2010 to April 2018, he served on the Board of Directors of Elbit Vision Systems Ltd. Prior tothese positions, Mr. Yanay served as manager of audit groups of the technology sector at Ernst &amp; Young Israel.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Mr. Yanay holds a bachelor’sdegree with honors in business administration and accounting from the College of Management Academic Studies of Rishon LeZion, Israel,and is a Certified Public Accountant in Israel.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Webelieve that Mr. Yanay’s qualifications to sit on our Board include his years of experience in the medical technology industry,his vast skill and expertise in accounting and economics, as well as his knowledge and familiarity with corporate finance.
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       ChenFranco-Yehuda
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Ms.Franco-Yehuda was appointed as our Chief Financial Officer, or CFO, effective as of March 17, 2019. Prior to being appointed as our CFO,Ms. Franco-Yehuda served as the Company’s Head of Accounting and Financial Reporting since July 2016 and, prior to that, the Company’sController since May 2013. Before joining the Company, from October 2008 to April 2013, Ms. Franco-Yehuda served as a manager of auditgroups relating to public and private companies in various industries at PricewaterhouseCoopers (PwC) and also as a lecturer of accountingclasses at the Open University of Israel from 2009 to 2014.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Ms. Franco-Yehuda holds abachelor’s degree in economics and accounting from Haifa University, Israel, and is a certified public accountant in Israel.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 79; Value: 41 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      43
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       DoronBirger
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Mr. Birger became a directorof the Company in July 2021. Mr. Doron Birger has been serving as the chairman of the board of directors of Sight Diagnostic Ltd. sinceJune 2014, Nurami Medical Ltd. since April 2016, Ultrasight Medical Imaging Ltd. from June 2019, Intelicanna Ltd. (TASE: INTL) from April2021 and Matricelf Ltd. (TASE:MTLF ) from December 2020, and as a director of IceCure Medical Ltd. (TASE: ICCM) since August 2012, VibrantLtd. since December 2014, Hera Med Ltd. (ASX: HMD) since November 2019, Citrine Global (OTC: CTGL) since March 2020, Kadimastem Ltd. (TASE:KDST) since December 2020 and Netiv Ha’or, a subsidiary of the Israel Electric Corporation Ltd., since March 2020 and as chairmanand director in a variety of non-profit organizations. Prior to that, Mr. Birger has served as member of the board of directors of MCSMedical Compression Systems (DBN) Ltd. (TASE:MDCL) from March 2015 to May 2018, Mekorot National Water Company Ltd. from November 2015to November 2018, and chairman of the board of directors of Insulin Medical Ltd. (TASE: INSL) from March 2016 to August 2017, IOPtimaLtd. from June 2012 to June 2019, MST Medical Surgical Technologies Ltd. from August 2009 to June 2019, Highcon Ltd. from November 2014to January 2018, Magisto Ltd. from September 2009 to July 2019, Real Imaging Ltd. from November 2018 to April 2019 and Medigus Ltd. (Nasdaqand TASE: MDGS) from May 2015 to September 2018. Mr. Birger holds a BA and MA in economics from the Hebrew University, Israel.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Webelieve that Mr. Birger’s qualifications to sit on our Board include his extensive experience in the high-tech sector and life-scienceindustry, his experience serving as a director of public companies, his vast skill and expertise in accounting and economics as wellas his knowledge and familiarity with corporate finance.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       MarkGermain
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Mr.Germain became a director of the Company in May 2007. Between May 2007 and February 2009, Mr. Germain served as Co-Chairman of our Board.Mr. Germain has been a merchant banker serving primarily the biotech and life sciences industries for over five years. He has been involvedas a founder, director, chairman of the board of, and/or investor in, over twenty companies in the biotech field and assisted many ofthem in arranging corporate partnerships, acquiring technology, entering into mergers and acquisitions, and executing financings andgoing public transactions. He graduated from New York University School of Law in 1975, Order of the Coif, and was a partner in a NewYork law firm practicing corporate and securities law before leaving in 1986. Since then, and until he entered the biotech field in 1991,he served in senior executive capacities, including as president of a public company that was sold in 1991. In addition to being a directorof the Company, Mr. Germain is a Managing Director at The ÆNTIB Group, a boutique merchant bank. From June 2018 through September30, 2019, Mr. Germain also served as Vice Chairman of the board of BiondVax Pharmaceuticals Ltd., a company based in Israel engagingin a Phase III clinical trials for a universal flu vaccine, and, effective September 30, 2019 has served as the chairman of the boardof BiondVax Pharmaceuticals Ltd.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Mr.Germain also serves or served as a director of the following companies that were reporting companies in the past: ChromaDex Inc., StemCell Innovations, Inc., Omnimmune Corp. and Collexis Holdings, Inc. He is also a co-founder and director of a number of private companiesin and outside the biotech field.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Webelieve that Mr. Germain’s qualifications to sit on our Board include his years of experience in the biotech industry, his experienceserving as a director of public companies, as well as his knowledge and familiarity with corporate finance.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       MoriaKwiat
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Dr. Kwiat became a directorof the Company in May 2012. Dr. Kwiat is Scientific and Clinical Researcher at AquaPass Medical, a medical device company that developsa treatment for heart failure. Between 2018 to 2021, she served as an analyst at aMoon, a leading Israeli life sciences venture fund.Between 2016 to 2017, she was a consultant and analyst at Frost &amp; Sullivan, producing equity research for public companies in thehealthcare domain. Dr. Kwiat has a broad academic background and scientific experience in inter-disciplinary fields, with specific expertiseat the interface between biology and materials field. She is the co-author of multiple scientific papers. Dr. Kwiat holds a Ph.D. in Chemistryspecializing in nanotechnology and material sciences, M.Sc. and B.Sc. in Biotechnology, from Tel Aviv University, Israel.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Webelieve that Dr. Kwiat’s qualifications to sit on our Board include her knowledge and experience as a scientist and a researcherin the fields of biotechnology and nanotechnology.
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 80; Value: 41 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      44
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       RamiLevi
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Mr. Levi became a directorof the Company in June 2021. Mr. Levi is the Founder and President of Catalyst Group International, LLC where, since 2009, he has providedconsulting services relating to strategic planning to notable clients in the private and public sectors. From 2004 to 2006, he servedas Senior Deputy General and Head of Marketing Administration at Israel’s Ministry of Tourism. He holds an MA with Honors in PoliticalScience from The Hebrew University of Jerusalem, Israel.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Webelieve that Mr. Levi’s qualifications to sit on our Board include his experience in strategic planning, business development andactivities in the government sector.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       VardaShalev
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Prof.Shalev became a director of the Company in July 2021. Prof. Shalev, MD has been serving as a professor at the department of epidemiologyat the medical school of Tel Aviv University, Israel since 2019. She has also been serving as a member of the board of directors of BATMAdvanced Communications Ltd. since November 2018. She is the Chief Medical Officer of Alike Ltd. since May 2020. Prof. Shalev establishedthe Department of Medical Informatics at Maccabi Health Care and was responsible for planning and developing its computerized medicalsystems. She has pioneered the development of multiple disease registries to support chronic disease management. She has also servedas the director of primary care division at Maccabi Health Care from October 2013 to June 2015 and as the Chief Executive Officer ofthe research and innovation center (KSM Institute and Maccabitech the epidemiological and clinical research arm of Israel’s MaccabiHealthcare Services) at Maccabi Health Care from July 2015 to May 2020. Prof. Shalev holds an MD from Ben Gurion University, Israel,and an MPH in Public Health Administration from Clark University, Massachusetts and her Doctoral Fellowship in Medical Informatics fromJohns Hopkins University.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Webelieve that Prof. Shalev’s qualifications to sit on our Board include her experience working in clinical environments and researchsettings at the intersection of health and technology.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      Maital Shemesh-Rasmussen
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font: 10pt Times New Roman, Times, Serif">
      <i>
      </i>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font: 10pt Times New Roman, Times, Serif">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Ms. Shemesh-Rasmussen becamea director of the Company in June 2021. Ms. Shemesh-Rasmussen has served as the Chief Commercial Officer of Octave Bioscience, Inc. sinceFebruary 2021. Prior to this role, Ms. Shemesh-Rasmussen served as the Global Head of Marketing at Roche Diagnostics Information Solutionsbetween 2018 and 2020. Between 2016 and 2018, she worked at Fitango Health, Inc. where she focused on marketing and business development.Between 2013 and 2016, she led Product Marketing at the Oracle Health Sciences Global Business Unit, as well as Marketing and BusinessDevelopment in the Oracle Digital Health Innovation Unit. Prior to these positions, Ms. Shemesh-Rasmussen served as Vice President atJPMorgan Chase Bank from 2002 until 2007. Ms. Shemesh-Rasmussen holds a BA in Behavioral Sciences from Ben Gurion University, Israel.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <i>
      </i>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We believe that Ms. Shemesh-Rasmussen’squalifications to sit on our Board include her experience in marketing for pharmaceutical companies, science, business development andinvestment banking.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <i>
      </i>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <b>
      Doron Shorrer
     </b>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font: 10pt Times New Roman, Times, Serif">
      <i>
      </i>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Mr. Shorrer became a directorof the Company in October 2003. Mr. Shorrer was one of the Company’s founders and served as its first Chairman until 2006. Since1998, Mr. Shorrer has served as the Chairman and CEO of Shorrer International Ltd., an investment and financial consulting company. Mr.Shorrer also serves as a director at each of Sigma Mutual Funds Ltd., Food Save Ltd. and G.D.M. Investments Ltd.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 81 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      45
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Mr. Shorrer has served asa director of Provident Fund for employees of the Israel Electric Company Ltd. and between 1999 and 2004 he was Chairman of the boardof directors of Phoenix Insurance Company, one of the largest insurance companies in Israel, and of Mivtachim Pension Funds Group, thelargest pension fund in Israel. Prior to serving in these positions, Mr. Shorrer held senior positions that included Arbitrator at theClaims Resolution Tribunal for Dormant Accounts in Switzerland; Economic and Financial Advisor, Commissioner of Insurance and CapitalMarkets for the State of Israel; Member of the board of directors of “Nechasim” of the State of Israel; Member Committee forthe Examination of Structural Changes in the Capital Market (The Brodet Committee); General Director of the Ministry of Transport; founderand managing partner of an accounting firm with offices in Jerusalem, Tel-Aviv and Haifa; Member of the Lecture Staff of the Hebrew UniversityBusiness Administration School; Chairman of Amal School Chain; Chairman of a Public Committee for Telecommunications; and Economic Consultantto the Ministry of Energy. In addition, Mr. Shorrer served as a director of Hebrew University employees and Massad Bank from the InternationalBank group from 2009 to 2018.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Among his many areas of expertise,Mr. Shorrer formulates, implements and administers business planning in the private and institutional sector, in addition to consultingon economic, accounting and taxation issues to a diverse audience ranging from private concerns to government ministries.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">
     Mr. Shorrer holds a BA inEconomics and Accounting and an M.B.A. in Business Administration (specialization in finance and banking) from the Hebrew University ofJerusalem, Israel, and is a Certified Public Accountant in Israel.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">
     We believe that Mr. Shorrer’squalifications to sit on our Board include his years of experience in the high-tech industry, his vast skill and expertise in accountingand economics, as well as his knowledge and familiarity with corporate finance.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
     There are no family relationships between any ofthe directors or officers named above.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <i>
       AuditCommittee and Audit Committee Financial Expert
      </i>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      UntilMay 31, 2021, the members of our Audit Committee were Doron Shorrer, Isaac Braun and Moria Kwiat. Mr. Braun was not re-nominated asa director for the 2021 annual meeting of shareholders, held on June 1, 2021, or the 2021 Annual Meeting, and his membership on the Boardand Audit Committee terminated on June 1, 2021. Effective June 3, 2021, the Board appointed Ms. Shemesh -Rasmussen to serve on the AuditCommittee. Mr. Shorrer is the Chairman of the Audit Committee, and our Board has determined that all members of the Audit Committee are“independent” as defined by the rules of the SEC and the Nasdaq rules and regulations. The Board also determined that Mr.Shorrer is an Audit Committee financial expert. The Audit Committee operates under a written charter that is posted on our website atwww.pluristem.com. The information on our website is not incorporated by reference into this Annual Report. The primary responsibilitiesof our Audit Committee include:
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 48px">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 24px">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Appointing,    compensating and retaining our registered independent public accounting firm;
        </span>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 48px">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 24px">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Overseeing    the work performed by any outside accounting firm;
        </span>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Assisting    the Board in fulfilling its responsibilities by reviewing: (i) the financial report provided by us to the SEC, our shareholders or    to the general public, and (ii) our internal financial and accounting controls; and
        </span>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 48px">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 24px">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Recommending,    establishing and monitoring procedures designed to improve the quality and reliability of the disclosure of our financial condition    and results of operations.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 82; Value: 41 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      46
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      OurAudit Committee held seven meetings from during Fiscal Year 2021.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.75in; text-indent: 0.25in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <i>
       CompensationCommittee
      </i>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
    </p>
    <div>
    </div>
    <p style="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      UntilMay 31, 2021, the members of our Compensation Committee were Doron Shorrer and Isaac Braun. Mr. Braun was not re-nominated as a directorfor the 2021 Annual Meeting, and his membership on the Board and Compensation Committee terminated that day. Effective June 3, 2021,the Board appointed Ms. Kwiat to serve on the Compensation Committee. The Board has determined that all of the members of the CompensationCommittee are “independent” as defined by the rules of the SEC and Nasdaq rules and regulations. The Compensation Committeeoperates under a written charter that is posted on our website at www.pluristem.com. The information on our website is not incorporatedby reference into this Annual Report. The primary responsibilities of our Compensation Committee include:
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Reviewing    and recommending to our Board of the annual base compensation, the annual incentive bonus, equity compensation, employment agreements    and any other benefits of our executive officers;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Administering    our equity based plans and making recommendations to our Board with respect to our incentive–compensation plans and equity–based    plans; and
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Annually    reviewing and making recommendations to our Board with respect to the compensation policy for such other officers as directed by    our Board.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      OurCompensation Committee held eight meetings during Fiscal Year 2021. During Fiscal Year 2021 the Compensation Committee engaged DeloitteIsrael to review the Company’s existing compensation structure for its executive officers and non-executive directors. Such reviewincluded a benchmark analysis that evaluated the compensation that we pay our CEO, CFO, Executive Chairman and non-executivedirectors in comparison to our peer group. On September 10, 2020, our Board, upon recommendation from our Compensation Committee, approvednew compensation arrangements for our CEO, CFO and Executive Chairman as well as an updated compensation policy for our non-executivedirectors.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <i>
      </i>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <i>
       NominatingCommittee
      </i>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <i>
      </i>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Themembers of our Nominating Committee are Mark Germain and Doron Shorrer. Mr. Germain is the Chairman of the Nominating Committee. TheBoard has determined that all of the members of the Nominating Committee are “independent” as defined by the rules of theSEC and Nasdaq rules and regulations. The Nominating Committee operates under a written charter that is posted on our website, www.pluristem.com.The information on our website is not incorporated by reference into this Annual Report. The primary responsibilities of our NominatingCommittee include:
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Overseeing    the composition and size of the Board, developing qualification criteria for Board members and actively seeking, interviewing and    screening individuals qualified to become Board members for recommendation to the Board;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Recommending    the composition of the Board for each annual meeting of shareholders; and
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-indent: -0.25in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Reviewing    periodically with the Chairman of the Board and the Chief Executive Officer the succession plans relating to positions held by directors,    and making recommendations to the Board with respect to the selection and development of individuals to occupy those positions.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <i>
      </i>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 83; Value: 41 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      47
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <i>
       DirectorNominations
      </i>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      TheNominating Committee is responsible for developing and approving criteria, with Board approval, for candidates for Board membership.The Nominating Committee is responsible for overseeing the composition and size of the Board, developing qualification criteria for Boardmembers and actively seeking, interviewing and screening individuals qualified to become Board members for recommendation to the Boardand for recommending the composition of the Board for each of the Company’s annual meetings. The Board as a whole is responsiblefor nominating individuals for election to the Board by the shareholders and for filling vacancies on the Board that may occur betweenannual meetings of the shareholders.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Nomineesfor director will be selected on the basis of their integrity, business acumen, knowledge of our business and industry, age, experience,diligence, conflicts of interest and the ability to act in the interests of all shareholders. No particular criteria will be a prerequisiteor will be assigned a specific weight, nor does the Company have a diversity policy. The Company believes that the backgrounds and qualificationsof its directors, considered as a group, should provide a composite mix of experience, knowledge and abilities that will allow the Boardto fulfill its responsibilities.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We have never received communicationsfrom shareholders recommending individuals to any of our independent directors. Therefore, we do not yet have a policy with regard tothe consideration of any director candidates recommended by shareholders. In Fiscal Year 2021, we did not pay a fee to any thirdparty to identify or evaluate, or assist in identifying or evaluating, potential nominees for our Board. We have not received anyrecommendations from shareholders for Board nominees. All of the nominees for election at the 2021 Meeting were current members of ourBoard, at that time.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <i>
       Codeof Ethics
      </i>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      OurBoard has adopted a Code of Business Conduct and Ethics that applies to, among other persons, members of our Board, our officers includingour CEO (being our principal executive officer) and our CFO (being our principal financial and accounting officer) and our employees.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      OurCode of Business Conduct and Ethics is posted on our Internet website at www.pluristem.com. The information on our website is not incorporatedby reference into this Annual Report. We intend to satisfy the disclosure requirement under Item 5.05 of Form 8-K regarding amendmentto, or waiver from, a provision of our Code of Conduct by posting such information on the website address specified above.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <i>
      </i>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <i>
       DelinquentSection 16(a) Reports
      </i>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; ">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; ">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">
      Section16(a) of the Exchange Act requires our executive officers and directors, and persons who own more than 10% of our common shares, to filereports regarding ownership of, and transactions in, our securities with the SEC and to provide us with copies of those filings.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; ">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">
      Wehave reviewed all forms provided to us or filed with the SEC. Based on that review and on written information given to us by our executiveofficers and directors, we believe that all Section 16(a) filings during the past fiscal year were filed on a timely basis and that alldirectors, executive officers and 10% beneficial owners have fully complied with such requirements during the past fiscal year, otherthan three
     </span>
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      reports on Form 4, filed on July 7, 2020,May 27, 2021 and June 1, 2021, which were filed late by Clover Wolf Capital – Limited Partnership, resulting in 4 transactions,3 transactions and 6 transactions, respectively, not being reported on a timely basis.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 84; Value: 41 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      48
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <div>
     <a id="p_019">
     </a>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">
      <b>
       Item 11.Executive Compensation.
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       CompensationDiscussion and Analysis
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     The Compensation Committeeof our Board is comprised solely of independent directors as defined by Nasdaq and non-employee directors as defined by Rule 16b-3 underthe Exchange Act. The Compensation Committee has the authority and responsibility to review and make recommendations to the Board regardingthe compensation of our CEO, Executive Chairman and CFO, and any other executive officers we may hire from time to time. Our named executiveofficers for Fiscal Year 2021 are those three individuals listed in the “Summary Compensation Table” below. Other informationconcerning the structure, roles and responsibilities of our Compensation Committee is set forth in in Item 10 – “Directors,Executive Officers and Corporate Governance
     <i>
      —
     </i>
     Compensation Committee” above.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     At our 2021 annual meetingof shareholders, we provided our shareholders with the opportunity to cast an advisory vote on our then named executive officers’compensation. Over 88% of the votes cast on this “2021 say-on-pay vote” were voted in favor of the proposal. We have consideredthe 2021 say-on-pay vote and we believe that the support from our shareholders for the 2021 say-on-pay vote proposal indicates that ourshareholders are supportive of our approach to executive compensation. At our 2019 annual meeting of shareholders, our shareholders votedin favor of the proposal to hold say-on-pay votes every two years. We will continue to consider the outcome of our say-on-pay votes whenmaking compensation decisions regarding our named executive officers.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Adiscussion of the policies and decisions that shape our executive compensation program, including the specific objectives and elements,is set forth below.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       ExecutiveCompensation Objectives and Philosophy
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Theobjective of our executive compensation program is to attract, retain and motivate talented executives who are critical for our continuedgrowth and success and to align the interests of these executives with those of our shareholders. To this end, our compensation programsfor executive officers are designed to achieve the following objectives:
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         attract,    hire, and retain talented and experienced executives;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         motivate,    reward and retain executives whose knowledge, skills and performance are critical to our success;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ensure    fairness among the executive management team by recognizing the contributions each executive makes to our success and the tenure    of each team member as a factor in achieving such success;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         focus    executive behavior on achievement of our corporate objectives and strategy;
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         build    a mechanism of “pay for performance”; and
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ●
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         align    the interests of management and shareholders by providing management with longer-term incentives through equity ownership.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 85; Value: 41 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      49
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      TheCompensation Committee reviews the allocation of compensation components regularly to ensure alignment with strategic and operating goals,competitive market practices and legislative changes. The Compensation Committee does not apply a specific formula to determine the allocationbetween cash and non-cash forms of compensation. Certain compensation components, such as base salaries, benefits and perquisites, areintended primarily to attract, hire, and retain well-qualified executives. Other compensation elements, such as long-term incentive opportunities,are designed to motivate and reward performance. Long-term incentives are intended to reward our long-term performance and executingour business strategy, and to strongly align named executive officers’ interests with those of shareholders. As such, from timeto time, the Compensation Committee, and/or the Board, may engage external consultants to provide the Company with data that the CompensationCommittee and/or Board may deem to be appropriate in determining the compensation of our executive officers, and the compensation, ifany, paid to the members of the Board.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Withrespect to equity compensation, the Compensation Committee makes awards to executives under our equity compensation plans as approvedby the Board. Executive compensation is paid or granted based on such matters as the Compensation Committee deems appropriate, includingour financial and operating performance, the alignment of the interests of the executive officers and our shareholders, the performanceof our common shares and our ability to attract and retain qualified individuals.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       Elementsof Executive Officer Compensation
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Our executive officer compensationprogram is comprised of: (i) base salary or monthly compensation; (ii) performance-based bonuses; (iii) long-term equity incentive compensationin the form of RSU awards; and (iv) benefits and perquisites.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Inestablishing overall executive compensation levels and making specific compensation decisions for our executive officers in Fiscal Year2021, the Compensation Committee considered a number of criteria, including the executive’s position, scope of responsibilities,prior base salary and annual incentive awards and expected contribution. In addition, the Compensation Committee conducted a compensationbenchmark analysis for the executive officers. In that regard, our Compensation Committee decided to provide our Executive Chairman,Mr. Aberman, our CEO, Mr. Yanay, and our CFO, Ms. Franco-Yehuda with base salaries, RSU awards, acceleration of such awards under certaincircumstances, and performance based bonuses in their respective employment and/or consulting agreement.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Generally,our Compensation Committee reviews and, as appropriate, approves compensation arrangements for our named executive officers, from timeto time but not less than once a year. The Compensation Committee also takes into consideration our CEO recommendations for the compensationof our CFO. Our CEO generally presents these recommendations at the time of our Compensation Committee’s review of executive compensationarrangements.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      OnSeptember 10, 2020, our Board, upon recommendation from our Compensation Committee, approved new compensation arrangements for our CEO,CFO and Executive Chairman as well as our non-executive directors. In that regard, the Compensation Committee engaged Deloitte Israelto review the Company’s compensation structure for its executive officers and non-executive directors. Such review included a benchmarkanalysis that evaluated the compensation that we pay our CEO, CFO, Executive Chairman and non-executive directors in comparisonto our peer group. When evaluating the appropriateness of our compensation peer group, the Compensation Committeeseeks to construct and approve a peer group of companies in similar industries of similar size, similar region or similar market capto that of our Company. As a result, the Company has revised its compensation structure for its CEO, CFO, Executive Chairman and non-executivedirectors as further described herein, which impacted such compensation for the fiscal year ending June 30, 2021.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 86; Value: 41 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      50
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       BaseSalary
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     The Compensation Committeeperforms a review of base salaries / monthly compensation for our named executive officers from time to time as appropriate. In determiningsalaries, the Compensation Committee members also take into consideration their understanding of the compensation practices of comparablecompanies (based on size and stage of development), independent third party market data such as compensation benchmark surveys to industry,including information relating to peer companies; individual experience and performance adjusted to reflect individual roles; and contributionto our clinical, regulatory, commercial, financial and operational performance. None of the factors above has a dominant weight in determiningthe compensation of our executive officers, and our Compensation Committee considers the factors as a whole when considering such compensation.In addition, our Compensation Committee may, from time to time, use comparative data regarding compensation paid by peer companies, forexample, as it conducted during Fiscal Year 2021, in order to obtain a general understanding of current trends in compensation practicesand ranges of amounts being awarded by other public companies, and not as part of an analysis or a formula. We may also change the basesalary / monthly compensation of an executive officer at other times due to market conditions. We believe that a competitive base salary/ monthly compensation is a necessary element of any compensation program that is designed to attract and retain talented and experiencedexecutives. We also believe that attractive base salaries can motivate and reward executives for their overall performance.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Basesalaries and/or monthly compensation are established in part based on the individual experience, skills and expected contributions ofour executives and our executives’ performance during the prior year. Compensation adjustments are made occasionally based on changesin an executive’s level of responsibility, Company progress or on changed local and specific executive employment market conditions.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      OnSeptember 10, 2020, at the recommendation of our Compensation Committee, following the benchmarking review conducted, our Board approved,effective as of January 1, 2021, on the one hand, an increase to the base monthly salary of our CEO and CFO such that the respectivesalaries will increase to 99,000 NIS and 65,000 NIS, and on the other hand, a decrease to the monthly consulting fee of our ExecutiveChairman to 142,250 NIS per month starting January 1, 2021 and effective through the earlier of December 31, 2021 or the filing of aBLA.
      <span>
       Upon the expiration of the consulting agreement, we currently intend to enter into a new consultingagreement with Mr. Aberman or an entity which he controls.
      </span>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       PerformanceBased Bonus
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Giventhe nature of our business, the determination of incentives for our executives is generally tied to success in promoting our Company’sdevelopment. We are continually seeking non-dilutive sources of funding. In addition, a key component of our strategy is to develop andmanufacture cell therapy products for the treatment of multiple disorders through collaboration with other companies and entering intolicensing agreements with such companies, such as our agreement with CHA. Therefore, to reward our executive officers, each of Mr. Yanayand Mr. Aberman will be entitled to a bonus equal to 1.5%, and Ms. Franco–Yehuda will be entitled to a bonus equal to 0.5%, ofamounts received by us from non-dilutive funding received, among other things, from corporate partnering and strategic deals.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     Our Board approved a targetbonus to our CEO, equal to up to seven times his monthly salary and to our CFO, of up to five and a half times her monthly salary, subjectto milestones and performance targets that was set by our Compensation Committee. In addition, according to their employment agreements,Ms. Franco-Yehuda and Mr. Yanay are also entitled to a special bonus of up to three times of their monthly salary at the discretion ofthe Board.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     During Fiscal Year 2021, wehave not paid bonuses in cash to our CEO and CFO, but accrued $126,000 and $64,000, respectively, for certain target bonuses as a resultof the achievement of certain operational, commercial and financial goals that were defined by the Compensation Committee. Following theBoard approval, we expect to pay such bonuses during October 2021.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 87; Value: 41 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      51
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       Long-TermEquity Incentive Compensation
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Long-termincentive compensation allows the executive officers to share in any appreciation in the value of our common shares. The CompensationCommittee believes that share participation aligns executive officers’ interests with those of our shareholders. The amounts ofthe awards are designed to reward past performance and create incentives to meet long-term objectives. Awards are made at a level expectedto be competitive within the biotechnology industry. We do not have a formula relating to the level of awards that is competitive withinthe biotechnology industry. In determining the amount of each grant, the Compensation Committee also takes into account the number ofshares held by the executive prior to the grant. For our executive management team, awards are made on a discretionary basis and notpursuant to specific criteria set out in advance.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      RSUawards provide our executive officers with the right to purchase shares of our common shares at a par value of $0.00001, subject to continuedemployment with our Company or the achievement of certain business or market milestones. In recent years, we granted our executive officersRSU awards.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Wechose to grant RSU awards and not options because RSU awards, once vested, always have an immediate financial value to the holder thereof,unlike options where the exercise price might be below the current market price of the shares and therefore not have any intrinsic valueto the holder thereof. Our Executive Chairman, CEO and CFO are entitled to acceleration of the vesting of their awards in the followingcircumstances: (1) if we terminate their employment or consulting arrangement with us or any of our subsidiaries for a reason other than“Justifiable Cause” (as defined in their employment or consulting arrangement contract), they will be entitled to accelerationof 100% of any unvested award and (2) if they resign, they will be entitled to acceleration of up to 50% of any unvested award subjectto the approval of the Board and (3) in the event of a change in control as defined in their consulting or employment agreement, as longas they continue to provide services to the Company or its subsidiaries, they will be entitled to an acceleration of 100% of any unvestedRSUs. All grants are approved, upon receipt of recommendation by our Compensation Committee, by our Board.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In September 2020, followinga benchmark analysis conducted by our compensation committee, we decided to grant our CEO and Executive Chairman 1,000,000 RSUs each.Of this award, 500,000 RSUs that were granted to each of them were linked to achievement of a market condition – our reaching $550million of market capitalization during the three year period from the date of the grant. We believe that such compensation aligns executiveofficers’ interests with those of our shareholders.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     For clarification purposes,the acceleration mechanism detailed above does not apply to the 500,000 RSUs granted to each of our CEO and Executive Chairman in September2020, that were linked to the achievement of our market capitalization reaching of $550 million during the three year period from thedate of the grant.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       Benefitsand Perquisites
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Generally,benefits available to Mr. Yanay and Ms. Franco-Yehuda are available to all employees on similar terms and include welfare benefits, paidtime-off, life and disability insurance and other customary or mandatory social benefits in Israel. We provide our named executive officerswith a phone and a Company car, or reimbursement for car or phone expenses, which are customary benefits in Israel to managers and officers.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">
      Whilethe agreement will be terminated on the earlier of December 31, 2021 or upon the filing of a BLA, we have agreed to pay Mr. Aberman anadjustment fee as provided above, but only during the period between January 1, 2021 and December 31, 2021, or in the event of a changeof control equal to nine months of consulting fees; provided, however that such adjustment fees shall be paid in two installments asfollows: (i) 38,250 NIS paid on January 1, 2021, and 1,307,250 NIS on December 31, 2021. In July 2021, the Board revised Mr. Aberman’seligibility to adjustment fees to 1,515,600 NIS in total to include nine months of car and related expenses, 1,477,350 NIS of which willbe paid on December 31, 2021.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; ">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; ">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 88; Value: 41 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      52
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; ">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">
      Mr.Yanay is entitled to a severance payment that equals a month’s compensation for each twelve-month period of employment or otherwiseproviding services to the Company, and an additional adjustment fee that equals the monthly salary amount multiplied by 6, plus the numberof years the employment agreement remains in force from September 12, 2018, but in any event no more than 9 years in the aggregate.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In conjunction with the adjustmentsmade to the base salaries during Fiscal Year 2021, the employment agreement of our CFO was amended to also provide for an adjustment feethat equals her monthly salary amount multiplied by three, plus the number of years the employment agreement remained in force from June30, 2020, but in any event no more than six months of adjustment fees in the aggregate.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; ">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; ">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Ms.Chen Franco-Yehuda is also entitled to severance pay upon termination of employment for any reason, including retirement, based on 8.333%of her monthly base salary, according to section 14 of the Severance Pay Law, 1963.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Wedo not believe that the benefits and perquisites described above deviate materially from the customary practice for compensation of executiveofficers by other companies similar in size and stage of development.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       Reportof the Compensation Committee
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">
     The Compensation Committeehas reviewed and discussed the foregoing Compensation Discussion and Analysis prepared under Item 402(b) of Regulation S-K with our managementand, based on such review and discussions, the Compensation Committee recommended to our Board that the Compensation Discussion and Analysisbe included in this Annual Report on Form 10-K and in our proxy statement relating to our next annual meeting of stockholders.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.55in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 65%">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 35%">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Compensation    Committee Members:
        </span>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Doron    Shorrer
        </span>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Moria    Kwiat
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       SummaryCompensation Table
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     The following table showsthe particulars of compensation owed to our named executive officers for the fiscal years ended June 30, 2021 and 2020. We do not currentlyhave any other executive officers.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
     <tbody>
      <tr style="vertical-align: bottom">
       <td style="border-bottom: black 1.5pt solid">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <b>
          Name and Principal Position
         </b>
        </span>
       </td>
       <td>
       </td>
       <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <b>
          Fiscal
          <br/>
          Year
          <sup>
           (1)
          </sup>
         </b>
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <b>
          Salary
          <br/>
          ($)
          <sup>
           (2)
          </sup>
         </b>
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td colspan="2" style="border-bottom: black 1.5pt solid">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
         <b>
          Non-Equity
          <br/>
          Plan
          <br/>
          Compensation
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
         <b>
          ($)
          <sup>
           (3)
          </sup>
         </b>
        </p>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td colspan="2" style="border-bottom: black 1.5pt solid">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
         <b>
          Bonus
         </b>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
         <b>
          ($)
          <sup>
           (4)
          </sup>
         </b>
        </p>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <b>
          Share-based
          <br/>
          Awards
          <br/>
          ($)
          <sup>
           (5)
          </sup>
         </b>
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <b>
          All Other
          <br/>
          Compensation
          <br/>
          ($)
          <sup>
           (6)
          </sup>
         </b>
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <b>
          Total
          <br/>
          ($)
         </b>
        </span>
       </td>
       <td>
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: #CCEEFF">
       <td style="width: 30%; padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Zami Aberman
        </span>
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 7%; text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         2021
        </span>
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 7%; text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         556,475
        </span>
       </td>
       <td style="width: 1%">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <sup>
          (7)
         </sup>
        </span>
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 7%; text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         -
        </span>
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 7%; text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         -
        </span>
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 7%; text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         8,741,402
        </span>
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 7%; text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         508,074
        </span>
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 7%; text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         9,805,951
        </span>
       </td>
       <td style="width: 1%">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: #CCEEFF">
       <td style="padding-left: 9pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <i>
          Executive Chairman
         </i>
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         2020
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         439,704
        </span>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <sup>
          (7)
         </sup>
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         -
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         -
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         -
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         61,540
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         501,244
        </span>
       </td>
       <td>
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
       </td>
       <td>
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: #CCEEFF">
       <td style="padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Yaky Yanay
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         2021
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         459,016
        </span>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <sup>
          (8)
         </sup>
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         126,000
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         -
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         8,741,402
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         27,588
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         9,354,006
        </span>
       </td>
       <td>
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: #CCEEFF">
       <td style="padding-left: 9pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <i>
          CEO
         </i>
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         2020
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         320,911
        </span>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <sup>
          (8)
         </sup>
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         -
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         -
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         -
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         29,466
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         350,377
        </span>
       </td>
       <td>
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
       </td>
       <td>
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: #CCEEFF">
       <td style="padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Chen Franco-Yehuda
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         2021
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         251,642
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         64,000
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         1,020,000
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         14,653
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         1,350,295
        </span>
       </td>
       <td>
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: #CCEEFF">
       <td style="padding-left: 9pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         CFO
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         2020
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         179,229
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         -
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         14,426
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         -
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         14,035
        </span>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         207,690
        </span>
       </td>
       <td>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (1)
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         The    information is provided for each fiscal year, which begins on July 1 and ends on June 30.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="margin: 0">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">
        <span style="font: 10pt Times New Roman, Times, Serif">
         (2)
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
         Amounts paid for Salary which were originallydenominated in NIS, were translated into U.S. dollars at the then current exchange rate for each payment. The salaries of Mr. Yanay andMs. Franco-Yehuda are comprised of base salaries and additional payments and provisions such as welfare benefits, paid time-off, lifeand disability insurance and other customary or mandatory social benefits to employees in Israel.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
         For Mr. Yanay and Mr. Aberman, theirsalaries also include additional amounts equal to one monthly salary of NIS 80,000, or approximately $25,000 and NIS 149,500, or approximately$44,000, respectfully.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
         <span style="font: 10pt Times New Roman, Times, Serif">
         </span>
        </p>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font: 10pt Times New Roman, Times, Serif">
         (3)
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          ForMr. Yanay and Ms. Franco-Yehuda, we have accrued, but have not yet paid, bonuses during Fiscal Year 2021 of $126,000 and $64,000 respectively,for certain target bonuses as a result of the achievement of certain milestones that were defined by the Compensation Committee. We expectto pay such bonuses during October 2021.
         </span>
        </p>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="margin: 0">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="vertical-align: top">
       <td style="font-size: 10pt; width: 24px">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (4)
        </span>
       </td>
       <td style="text-align: justify; font-size: 10pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         In fiscal year 2020, we paid to Ms. Franco-Yehuda a onetime bonus of NIS 50,000, or approximately $14,000.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="margin: 0">
    </p>
    <div>
    </div>
    <p style="margin: 0">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 89; Value: 41 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      53
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="margin-top: 0; margin-bottom: 0">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 24px; font-size: 10pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (5)
        </span>
       </td>
       <td style="text-align: justify; font-size: 10pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         The fair value recognized for the share-based awards was determined as of the grant date in accordance with Accounting Standard Codification, or ASC, Topic 718. The assumptions used in the calculations for these amounts are included in Note 9 to our audited consolidated financial statements for Fiscal Year 2021 included elsewhere in this Annual Report (see also “Grants of Plan-Based Awards” table presented below).
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="margin-top: 0; margin-bottom: 0">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 0.25in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (6)
        </span>
       </td>
       <td>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
         Mr. Aberman is entitled to adjustment fees of    NIS 1,515,600, or approximately $443,000, out of which we paid NIS 38,250, or approximately $11,000, during Fiscal Year 2021, and we expect    to pay the rest of the adjustment fees during January 2022. Additionally, this column includes costs in connection with car or car expenses    reimbursement and mobile phone expenses for Mr. Aberman. We have also paid Mr. Yanay the tax associated with the company car benefit included    in this column, which is grossed-up. For Mr. Yanay the gross-up is part of the amount in the “Salary” column.
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
        </p>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (7)
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Includes $6,201 and $18,486 paid in cash to Mr. Aberman as compensation for services as a director in fiscal year 2021 and 2020 respectively. Starting October 2020, Mr. Aberman was not entitled to compensation for services as a director.
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td>
       </td>
       <td>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (8)
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Includes $6,194 and $18,400 paid in cash to Mr. Yanay as compensation for services as a director in Fiscal Year 2021 and 2020, respectively. Starting October 2020, Mr. Yanay was not entitled to compensation for services as a director.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="margin-top: 0; margin-bottom: 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       Employmentand Consulting Agreements
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      DuringFiscal Year 2021, we had the following written agreements and other arrangements concerning compensation with our named executive officers:
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-indent: -21.25pt">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (a)
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Mr.    Aberman is engaged with us as a consultant and currently receives a monthly consulting fee of NIS 142,500 (approximately $43,000 per    month). On September 10, 2020, at the recommendation of our Compensation Committee, our Board approved, effective as of January 1,    2021 a decrease to the monthly consulting fee of our Executive Chairman from 149,500 to NIS 142,250 per month. In addition, Mr.    Aberman was entitled once a year to receive an additional amount that equals the monthly consulting fee. All amounts that were paid,    were paid plus value added tax. Mr. Aberman is also entitled to a performance-based bonus of 1.5% from amounts received by us from    non-diluting funding and strategic deals during the term of his consulting agreement and nine months afterwards. Mr. Aberman is also    entitled to car expenses reimbursement.
        </span>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (b)
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Starting January 1, 2021, Mr. Yanay’s monthly salary is NIS 99,000,approximately $30,000 per month. On September 10, 2020, at the recommendation of our Compensation Committee, our Board approved, effectiveas of January 1, 2021, an increase to the base salary of our CEO such that the salary will increase to NIS 99,000 from NIS 80,000. Mr.Yanay is provided with a cellular phone and a Company car pursuant to the terms of his agreement. Furthermore, Mr. Yanay is entitled toa performance based bonus of 1.5% from amounts received by us from non-diluting funding and strategic deals and a target bonus equal toup to seven times his monthly salary subject to milestones and performance targets that was set by our Compensation Committee. The Boardmay also grant Mr. Yanay a discretionary bonus of up to 3 months of his monthly salary.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in">
        <span style="font: 10pt Times New Roman, Times, Serif">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">
        <span style="font: 10pt Times New Roman, Times, Serif">
         (c)
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Starting January 1, 2021 Ms. Franco-Yehuda’s monthly salary isNIS 65,000. On September 10, 2020, at the recommendation of our Compensation Committee, our Board approved, effective as of January 1,2021, an increase to the base salary of our CFO such that the salary will increase to NIS 65,000 from NIS 42,000. Ms. Franco-Yehuda receivescar and cellular phone expense reimbursements pursuant to the terms of her agreement. Furthermore, Ms. Franco-Yehuda is entitled to aperformance based bonus of 0.5% from amounts received by us from non-diluting funding and strategic deals and a target bonus equal toup to five and a half times her monthly salary, subject to milestones and performance targets that was set by our Compensation Committee.The Board may also grant Ms. Franco-Yehuda a discretionary bonus of up to 3 months of her monthly salary.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <i>
      </i>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <i>
       PotentialPayments Upon Termination or Change-in-Control
      </i>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We have no plans or arrangementsin respect of remuneration received or that may be received by our executive officers to compensate such officers in the event of terminationof employment (as a result of resignation, retirement, change-in-control) or a change of responsibilities following a change-in-control,except for the following: (i) in the event of termination of Mr. Aberman’s consulting agreement, he will be entitled to receivean adjustment fee that equals the monthly consulting fees and car expenses multiplied by nine. We paid NIS 38,250, or approximately $11,000,of the adjustment fee in January 2021 and we expect to pay an additional NIS 1,477,350, or approximately $432,000, in January 2022; (ii)in the event of termination of Mr. Yanay employment, he is entitled to a severance payment, under Israeli law, that equals a month’scompensation for each twelve-month period of employment or otherwise providing services to the Company, and an additional adjustment feethat equals the monthly base salary multiplied by six, plus the number of years the employment agreement is in force from September 12,2018, but in any event no more than nine months in the aggregate; and (iii) in the event of termination of Ms. Franco-Yehuda’s employment,she is entitled to a severance payment, under Section 14 of the Israeli Severance Pay Law, and an adjustment fee that equals her monthlysalary amount multiplied by three, plus the number of years the employment agreement remains in force from June 30, 2020, but in any eventno more than six years in the aggregate.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In addition, Mr. Aberman,Mr. Yanay and Ms. Franco-Yehuda are entitled to acceleration of the vesting of their share options and restricted share in the followingcircumstances: (1) if we terminate their employment for a reason other than cause (as may be defined in each respective agreement), theywill be entitled to acceleration of 100% of any unvested awards and (2) if they resign, they will be entitled to acceleration of 50%of any unvested award, subject to the approval of the Board. In addition, Mr. Aberman, Mr. Yanay and Ms. Franco-Yehuda are also entitledto acceleration of 100% of any unvested award in case of our change in control as defined in their respective consulting and employmentagreements.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     For clarification purposes,the acceleration mechanism detailed above does not apply to the 500,000 RSUs granted to each of our CEO and Executive Chairman in September2020, that were linked to the achievement of our market capitalization reaching of $550 million during the three year period from thedate of the grant.
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 90; Value: 41 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      54
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Thefollowing table displays the value of what our CEO, Executive Chairman and CFO would have received from us had their employment beenterminated, or a change in control of us happened on June 30, 2021.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
     <tbody>
      <tr style="vertical-align: bottom">
       <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">
        Officer
       </td>
       <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">
       </td>
       <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">
        Salary
       </td>
       <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">
        <sup>
        </sup>
       </td>
       <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">
       </td>
       <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">
        Accelerated Vesting of RSUs
        <sup>
         (1)
        </sup>
       </td>
       <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">
        <sup>
        </sup>
       </td>
       <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt">
       </td>
       <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">
        Total
       </td>
       <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold">
       </td>
      </tr>
      <tr style="vertical-align: bottom">
       <td>
       </td>
       <td>
       </td>
       <td colspan="2">
       </td>
       <td>
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td colspan="2">
       </td>
       <td>
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td colspan="2">
       </td>
       <td>
       </td>
      </tr>
      <tr style="vertical-align: bottom">
       <td>
        Zami Aberman
       </td>
       <td>
       </td>
       <td colspan="2">
       </td>
       <td>
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td colspan="2">
       </td>
       <td>
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td colspan="2" style="text-align: right">
       </td>
       <td>
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="width: 64%; text-align: left; padding-left: 9pt">
        Terminated due to officer resignation
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 1%; text-align: left">
        $
       </td>
       <td style="width: 9%; text-align: right">
        453,792
       </td>
       <td style="width: 1%; text-align: left">
        <sup>
        </sup>
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 1%; text-align: left">
        $
       </td>
       <td style="width: 9%; text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         841,500
        </span>
       </td>
       <td style="width: 1%; text-align: left">
        <sup>
         (2)
        </sup>
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 1%; text-align: left">
        $
       </td>
       <td style="width: 9%; text-align: right">
        1,295,292
       </td>
       <td style="width: 1%; text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td style="text-align: left; padding-left: 9pt">
        Terminated due to discharge of officer
       </td>
       <td>
       </td>
       <td style="text-align: left">
        $
       </td>
       <td style="text-align: right">
        453,792
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
        $
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         1,683,000
        </span>
       </td>
       <td style="text-align: left">
        <sup>
         (3)
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
        $
       </td>
       <td style="text-align: right">
        2,136,792
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-align: left; padding-left: 9pt">
        Change in control
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        -
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
        $
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         1,683,000
        </span>
       </td>
       <td style="text-align: left">
        <sup>
         (4)
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
        $
       </td>
       <td style="text-align: right">
        1,683,000
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-align: left">
        Yaky Yanay
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td style="text-align: left; padding-left: 9pt">
        Terminated due to officer resignation
       </td>
       <td>
       </td>
       <td style="text-align: left">
        $
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         565,689
        </span>
       </td>
       <td style="text-align: left">
        <sup>
         (5)
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
        $
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         841,500
        </span>
       </td>
       <td style="text-align: left">
        <sup>
         (2)
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
        $
       </td>
       <td style="text-align: right">
        1,407,189
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-align: left; padding-left: 9pt">
        Terminated due to discharge of officer
       </td>
       <td>
       </td>
       <td style="text-align: left">
        $
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         565,689
        </span>
       </td>
       <td style="text-align: left">
        <sup>
         (5)
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
        $
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         1,683,000
        </span>
       </td>
       <td style="text-align: left">
        <sup>
         (3)
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
        $
       </td>
       <td style="text-align: right">
        2,248,689
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td style="text-align: left; padding-left: 9pt">
        Change in control
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        -
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
        $
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         1,683,000
        </span>
       </td>
       <td style="text-align: left">
        <sup>
         (4)
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
        $
       </td>
       <td style="text-align: right">
        1,683,000
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td style="text-align: left">
        Chen Franco Yehuda
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-align: left; padding-left: 9pt">
        Terminated due to officer resignation
       </td>
       <td>
       </td>
       <td style="text-align: left">
        $
       </td>
       <td style="text-align: right">
        79,755
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
        $
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         169,290
        </span>
       </td>
       <td style="text-align: left">
        <sup>
         (2)
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
        $
       </td>
       <td style="text-align: right">
        249,045
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td style="text-align: left; padding-left: 9pt">
        Terminated due to discharge of officer
       </td>
       <td>
       </td>
       <td style="text-align: left">
        $
       </td>
       <td style="text-align: right">
        79,755
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
        $
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         338,580
        </span>
       </td>
       <td style="text-align: left">
        <sup>
         (3)
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
        $
       </td>
       <td style="text-align: right">
        418,335
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-align: left; padding-left: 9pt">
        Change in control
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        -
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
        $
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         338,580
        </span>
       </td>
       <td style="text-align: left">
        <sup>
         (4)
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
        $
       </td>
       <td style="text-align: right">
        338,580
       </td>
       <td style="text-align: left">
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (1)
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Value    shown represents the difference between the closing market price of our common shares on June 30, 2021 of $3.96 per share and the    applicable exercise price of each grant.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (2)
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Up    to 50% of all unvested RSUs issued under the applicable equity incentive plans vest upon resignation under the terms of those plans,    subject to the approval of the Board at its sole discretion.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (3)
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Allunvested RSUs issued under the applicable equity incentive plans vest upon an involuntary termination due to discharge, except for cause,excluding 500,000 RSUs that will vest upon achievement of increasing market capitalization of our common shares on the Nasdaq GlobalMarket to $550 million within no more than 3 years from the date of grant.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (4)
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Allunvested RSUs issued under the applicable equity incentive plans vest upon a change in control under the terms of those plans excluding500,000 RSUs that will vest upon achievement of increasing market capitalization of our common shares on the Nasdaq Global Market to$550 million within no more than 3 years from the date of grant.
        </span>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif">
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (5)
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Asof June 30, 2021, the value of the severance fund net of Mr. Yanay is $220,000. For severance payments, we will need to pay the differencebetween Mr. Yanay’s eligibility to receive severance payment and the value of the fund, which as of June 30, 2021, amounted to$345,000.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <i>
       Pension,Retirement or Similar Benefit Plans
      </i>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Wehave no arrangements or plans, except for those we are obligated to maintain pursuant to the Israeli law, under which we provide pension,retirement or similar benefits for directors or executive officers. Our directors and executive officers may receive share options, RSUsor restricted shares at the discretion of our Board in the future.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 91; Value: 41 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      55
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       OutstandingEquity Awards at the End of Fiscal Year 2021
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     The following table presentsthe outstanding equity awards held as of June 30, 2021 by our named executive officers, all of which have been issued pursuant to our2019 Equity Compensation Plan, or the 2019 Plan, and 2016 Equity Compensation Plan, or the 2016 Plan:
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
     <tbody>
      <tr style="vertical-align: bottom">
       <td style="border-bottom: Black 1.5pt solid; font-weight: bold">
        Name
       </td>
       <td style="padding-bottom: 1.5pt; font-weight: bold">
       </td>
       <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">
        Number of shares that have not vested
        <br/>
        (#)
       </td>
       <td style="padding-bottom: 1.5pt; font-weight: bold">
       </td>
       <td style="padding-bottom: 1.5pt; font-weight: bold">
       </td>
       <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">
        Market value of shares that have not vested
        <br/>
        ($)
       </td>
       <td style="padding-bottom: 1.5pt; font-weight: bold">
       </td>
       <td style="padding-bottom: 1.5pt; font-weight: bold">
       </td>
       <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">
        Equity
        <br/>
        incentive
        <br/>
        plan awards: Number of shares that have not vested
        <br/>
        (#)
       </td>
       <td style="padding-bottom: 1.5pt; font-weight: bold">
        <sup>
        </sup>
       </td>
       <td style="padding-bottom: 1.5pt; font-weight: bold">
       </td>
       <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">
        Equity
        <br/>
        incentive
        <br/>
        plan awards: Market value of shares that have not vested
        <br/>
        ($)
       </td>
       <td style="padding-bottom: 1.5pt; font-weight: bold">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="width: 52%; text-align: left; padding-left: 0.5pt">
        Zami Aberman
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 1%; text-align: left">
       </td>
       <td style="width: 9%; text-align: right">
        -
       </td>
       <td style="width: 1%; text-align: left">
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 1%; text-align: left">
       </td>
       <td style="width: 9%; text-align: right">
        -
       </td>
       <td style="width: 1%; text-align: left">
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 1%; text-align: left">
       </td>
       <td style="width: 9%; text-align: right">
        500,000
       </td>
       <td style="width: 1%; text-align: left">
        <sup>
         (1)
        </sup>
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 1%; text-align: left">
       </td>
       <td style="width: 9%; text-align: right">
        1,980,000
       </td>
       <td style="width: 1%; text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="padding-left: 0.5pt">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        406,250
       </td>
       <td style="text-align: left">
        <sup>
         (2)
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        1,608,750
       </td>
       <td style="text-align: left">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        -
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        -
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="padding-left: 0.5pt">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        18,750
       </td>
       <td style="text-align: left">
        <sup>
         (3)
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        74,250
       </td>
       <td style="text-align: left">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        -
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        -
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td style="padding-left: 0.5pt">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-align: left; padding-left: 0.5pt">
        Yaky Yanay
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        -
       </td>
       <td style="text-align: left">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        --
       </td>
       <td style="text-align: left">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        500,000
       </td>
       <td style="text-align: left">
        <sup>
         (1)
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        1,980,000
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="padding-left: 0.5pt">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        406,250
       </td>
       <td style="text-align: left">
        <sup>
         (2)
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        1,608,750
       </td>
       <td style="text-align: left">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        -
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        -
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="padding-left: 0.5pt">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        18,750
       </td>
       <td style="text-align: left">
        <sup>
         (3)
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        74,250
       </td>
       <td style="text-align: left">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        -
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        -
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td style="padding-left: 0.5pt">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-align: left; padding-left: 0.5pt">
        Chen Franco-Yehuda
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        750
       </td>
       <td style="text-align: left">
        <sup>
         (4)
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        2,970
       </td>
       <td style="text-align: left">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        -
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        -
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="padding-left: 0.5pt">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        3,500
       </td>
       <td style="text-align: left">
        <sup>
         (5)
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        13,860
       </td>
       <td style="text-align: left">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        -
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        -
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="padding-left: 0.5pt">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        81,250
       </td>
       <td style="text-align: left">
        <sup>
         (6)
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        321,750
       </td>
       <td style="text-align: left">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        -
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        -
       </td>
       <td style="text-align: left">
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="margin-top: 0; margin-bottom: 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 0.25in; font-size: 10pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (1)
        </span>
       </td>
       <td style="text-align: justify; font-size: 10pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         500,000 RSUs vest in full upon milestone achievement of increasing ourmarket capitalization on the Nasdaq Global Markets to $550 million within no more than three years from the date of grant.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.5in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 0.25in; text-align: justify; font-size: 10pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (2)
        </span>
       </td>
       <td style="text-align: justify; font-size: 10pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         406,250 RSUs vest in 13 equal installments of 31,250 on September 10, 2021 and every three months thereafter.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 0.25in; text-align: justify; font-size: 10pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (3)
        </span>
       </td>
       <td style="text-align: justify; font-size: 10pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         18,750 RSUs vest in six equal installments of 3,125 on September 19, 2021 and every three months thereafter.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 0.25in; text-align: justify; font-size: 10pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (4)
        </span>
       </td>
       <td style="text-align: justify; font-size: 10pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         750 RSUs vest in six equal installments of 125 on September 19, 2021 and every three months thereafter.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 0.25in; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (5)
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         3,500 RSUs vest in seven equal installments of 500 on September 28, 2021 and every three months thereafter.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 0.25in; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (6)
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         81,250 RSUs vest in 13 equal installments of 6,250 on September 11, 2021 and every three months thereafter.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <b>
      <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      </span>
     </b>
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 92; Value: 41 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      56
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       Long-TermIncentive Plans-Awards in Last Fiscal Year
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     We have no long-term incentiveplans, other than the 2016 Plan and the 2019 Plan, described in Item 12 below.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       DirectorCompensation
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Thefollowing table provides information regarding compensation earned by, awarded or paid to each person for serving as a director who isnot an executive officer during Fiscal Year 2021:
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
     <tbody>
      <tr style="vertical-align: bottom">
       <td style="border-bottom: Black 1.5pt solid; font-weight: bold">
        Name
       </td>
       <td style="padding-bottom: 1.5pt; font-weight: bold">
       </td>
       <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">
        Fees Earned or Paid in Cash
        <br/>
        ($)
       </td>
       <td style="padding-bottom: 1.5pt; font-weight: bold">
        <sup>
        </sup>
       </td>
       <td style="padding-bottom: 1.5pt; font-weight: bold">
       </td>
       <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">
        Stock Awards
        <br/>
        ($)
        <sup>
         (1)
        </sup>
       </td>
       <td style="padding-bottom: 1.5pt; font-weight: bold">
       </td>
       <td style="padding-bottom: 1.5pt; font-weight: bold">
       </td>
       <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">
        Total
        <br/>
        ($)
       </td>
       <td style="padding-bottom: 1.5pt; font-weight: bold">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="width: 64%; text-align: left; padding-left: 0.5pt">
        Isaac Braun
        <sup>
         (2)
        </sup>
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 1%; text-align: left">
       </td>
       <td style="width: 9%; text-align: right">
        34,207
       </td>
       <td style="width: 1%; text-align: left">
        <sup>
        </sup>
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 1%; text-align: left">
       </td>
       <td style="width: 9%; text-align: right">
        204,000
       </td>
       <td style="width: 1%; text-align: left">
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 1%; text-align: left">
       </td>
       <td style="width: 9%; text-align: right">
        238,207
       </td>
       <td style="width: 1%; text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td style="text-align: left; padding-left: 0.5pt">
        Mark Germain
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        110,175
       </td>
       <td style="text-align: left">
        <sup>
         (4)
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        204,000
       </td>
       <td style="text-align: left">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        314,175
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-align: left; padding-left: 0.5pt">
        Moria Kwiat
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        35,412
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        204,000
       </td>
       <td style="text-align: left">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        239,412
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td style="text-align: left; padding-left: 0.5pt">
        Rami Levi
        <sup>
         (3)
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        17,500
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        144,400
       </td>
       <td style="text-align: left">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        161,900
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-align: left; padding-left: 0.5pt">
        Maital Shemesh-Rasmussen
        <sup>
         (3)
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        17,750
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        144,400
       </td>
       <td style="text-align: left">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        162,150
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td style="text-align: left; padding-left: 0.5pt">
        Doron Shorrer
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        46,026
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        204,000
       </td>
       <td style="text-align: left">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        250,026
       </td>
       <td style="text-align: left">
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (1)
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">
         The fair value recognized for the Stock Awards was determined as ofthe grant date in accordance with ASC 718. Assumptions used in the calculations for these amounts are included in Note 9 to ourconsolidated financial statements for Fiscal Year 2021 included elsewhere in this Annual Report.
        </p>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -33.75pt">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (2)
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Effective    as of June 1, 2021, Mr. Braun ceased to serve on the Board.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -33.75pt">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (3)
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Effective    as of January 5, 2021, this director was appointed to serve on the Board.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -33.75pt">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (4)
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Includes    a bonus to Mr. Germain in the amount of $75,000 for his contribution in connection with the EIB Finance Agreement.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -33.75pt">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      OnSeptember 10, 2020, our Board, upon the recommendation of our Compensation Committee, approved the change of their compensation componentsto an annual fee of $35,000. In addition, members of our Board of Director committees are compensated as follows (i) the Chairman ofour Audit Committee receives an additional annual fee of $10,000 and, in the event of an annual equity grant issued to directors, oran Annual Director Grant, an additional 10% of equity securities in addition to such grant, and each other member of the Audit Committeeshall receive an additional annual fee of $3,000 and, in the event of an Annual Director Grant, an additional 3% of equity securitiesin addition to such grant; (ii) the Chairman of our Compensation Committee receives an additional annual fee of $4,000 and, in the eventof an Annual Director Grant, an additional 4% of equity securities in addition to such grant, and each other member of the CompensationCommittee receives an additional annual fee of $2,000 and, in the event of an Annual Director Grant, an additional 2% of equity securitiesin addition to such grant; and (iii) the Chairman of our Nominating Committee receives an additional annual fee of $4,000 and, in theevent of an Annual Director Grant, an additional 4% of equity securities in addition to such grant, and each other member of the NominatingCommittee receives an additional annual fee of $2,000 and, in the event of an Annual Director Grant, an additional 2% of equity securitiesin addition to such grant.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Inexceptional circumstances members of the Board may receive bonuses of up to $75,000 per year for extraordinary performance, as well asdiscretionary bonuses in special circumstances as the Board or the Compensation Committee may decide. During 2021, we paid Mr. Mark Germain$75,000 for his contribution in connection with the EIB Finance Agreement.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 93; Value: 41 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      57
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      DuringFiscal Year 2021, we paid a total of $187,081 excluding the bonus paid to Mr. Germain in cash to directors as compensation.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Asof June 30, 2021, we have outstanding grants to our non-executive directors aggregating 382,612 restricted shares and RSUs of which 260,156were exercisable or vested, as the case may be, as follows:
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
     <tbody>
      <tr style="vertical-align: bottom">
       <td style="border-bottom: Black 1.5pt solid; font-weight: bold">
        Name
       </td>
       <td style="padding-bottom: 1.5pt; font-weight: bold">
       </td>
       <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">
        Total of Options, restricted shares and RSUs Granted
       </td>
       <td style="padding-bottom: 1.5pt; font-weight: bold">
       </td>
       <td style="padding-bottom: 1.5pt; font-weight: bold">
       </td>
       <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">
        Total of restricted shares and RSUs exercisable and vested
       </td>
       <td style="padding-bottom: 1.5pt; font-weight: bold">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="width: 76%; text-align: left">
        Isaac Braun
        <sup>
         (1)
        </sup>
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 1%; text-align: left">
       </td>
       <td style="width: 9%; text-align: right">
        78,621
       </td>
       <td style="width: 1%; text-align: left">
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 1%; text-align: left">
       </td>
       <td style="width: 9%; text-align: right">
        78,621
       </td>
       <td style="width: 1%; text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td style="text-align: left">
        Mark Germain
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        100,645
       </td>
       <td style="text-align: left">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        60,998
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-align: left">
        Moria Kwiat
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        55,750
       </td>
       <td style="text-align: left">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        34,594
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td style="text-align: left">
        Rami Levi
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        20,000
       </td>
       <td style="text-align: left">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        0
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-align: left">
        Maital Rasmussen
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        20,000
       </td>
       <td style="text-align: left">
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        0
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td style="text-align: left; padding-bottom: 1.5pt">
        Doron Shorrer
       </td>
       <td style="padding-bottom: 1.5pt">
       </td>
       <td style="border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="border-bottom: Black 1.5pt solid; text-align: right">
        107,596
       </td>
       <td style="padding-bottom: 1.5pt; text-align: left">
       </td>
       <td style="padding-bottom: 1.5pt">
       </td>
       <td style="border-bottom: Black 1.5pt solid; text-align: left">
       </td>
       <td style="border-bottom: Black 1.5pt solid; text-align: right">
        85,943
       </td>
       <td style="padding-bottom: 1.5pt; text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="font-weight: bold; padding-bottom: 4pt">
        Total
       </td>
       <td style="padding-bottom: 4pt">
       </td>
       <td style="border-bottom: Black 4pt double; text-align: left">
       </td>
       <td style="border-bottom: Black 4pt double; text-align: right">
        382,612
       </td>
       <td style="padding-bottom: 4pt; text-align: left">
       </td>
       <td style="padding-bottom: 4pt">
       </td>
       <td style="border-bottom: Black 4pt double; text-align: left">
       </td>
       <td style="border-bottom: Black 4pt double; text-align: right">
        260,156
       </td>
       <td style="padding-bottom: 4pt; text-align: left">
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (1)
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Mr.    Braun was not re-nominated as a director nominee, and therefore, effective as of June 1, 2021, Mr. Braun ceased to serve on the Board.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 25.1pt; text-indent: -0.25in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     For all directors, the vestingof directors’ share options, RSUs and restricted share accelerates in the following circumstances: (1) if the director is not re-nominatedto serve on the Board or the director is not re-elected by stockholders at a special or annual meeting, this will result in the accelerationof 100% of any unvested award, and (2) the voluntary resignation of a director will result in the acceleration of up to 50% of any unvestedaward subject to Board approval. In addition, a change in control will result in the acceleration of 100% of any unvested award of ourdirectors.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Mr.Braun was not re-nominated as a director nominee at the 2021 Annual Meeting and on June 1, 2021, all unvested awards held by Mr. Braunwere accelerated, resulting in the vesting of 22,139 RSUs for Mr. Braun.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Otherthan as described above, we have no present formal plan for compensating our directors for their service in their capacity as directors.Directors are entitled to reimbursement for reasonable travel and other out-of-pocket expenses incurred in connection with attendanceat meetings of our Board as per policy approved by our Compensation Committee. The Board may award special remuneration to any directorundertaking any special services on our behalf other than services ordinarily required of a director.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Otherthan indicated above, no director received and/or accrued any compensation for his or her services as a director, including committeeparticipation and/or special assignments during Fiscal Year 2021.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <div>
     <a id="p_020">
     </a>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">
      <b>
       Item12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
      </b>
     </span>
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     The following table sets forthcertain information, to the best knowledge and belief of the Company, as of September 3, 2021 (unless provided herein otherwise), withrespect to holdings of our common shares by (1) each person known by us to be the beneficial owner of more than 5% of the total numberof our common shares outstanding as of such date; (2) each of our directors; (3) each of our named executive officers; and (4) all ofour directors and our executive officers as a group.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 94; Value: 41 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      58
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 35.45pt">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Unlessotherwise indicated, the address of each person listed below is c/o Pluristem Therapeutics Inc., MATAM Advanced Technology Park, BuildingNo. 5, Haifa, Israel, 3508409.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
     <tbody>
      <tr style="vertical-align: bottom">
       <td style="font-weight: bold; border-bottom: Black 1.5pt solid">
        Name of Beneficial Owner
       </td>
       <td style="font-weight: bold; padding-bottom: 1.5pt">
       </td>
       <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
        Beneficial
        <br/>
        Number of
        <br/>
        Shares
        <sup>
         (1)
        </sup>
       </td>
       <td style="padding-bottom: 1.5pt; font-weight: bold">
        <sup>
        </sup>
       </td>
       <td style="font-weight: bold; padding-bottom: 1.5pt">
       </td>
       <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
        Percentage of Shares Beneficially Owned
       </td>
       <td style="padding-bottom: 1.5pt; font-weight: bold">
       </td>
      </tr>
      <tr style="vertical-align: bottom">
       <td>
       </td>
       <td>
       </td>
       <td colspan="2">
       </td>
       <td>
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td colspan="2">
       </td>
       <td>
       </td>
      </tr>
      <tr style="vertical-align: bottom">
       <td style="text-decoration: underline; text-align: left">
        Directors and Named Executive Officers
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="width: 76%; text-align: left">
        Zami Aberman
        <br/>
        Executive Chairman of the Board of Directors
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 1%; text-align: left">
       </td>
       <td style="width: 9%; text-align: right">
        621,630
       </td>
       <td style="width: 1%; text-align: left">
        <sup>
         (2)
        </sup>
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 1%; text-align: left">
       </td>
       <td style="width: 9%; text-align: right">
        1.9
       </td>
       <td style="width: 1%; text-align: left">
        %
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-align: left">
        Yaky Yanay
        <br/>
        CEO, President and Director
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        548,474
       </td>
       <td style="text-align: left">
        <sup>
         (2)
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        1.7
       </td>
       <td style="text-align: left">
        %
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-align: left">
        Chen Franco-Yehuda
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        39,091
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        *
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td>
        CFO
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-align: left">
        Doron Birger
        <br/>
        Director
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        -
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        *
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-align: left">
        Doron Shorrer
        <br/>
        Director
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        91,506
       </td>
       <td style="text-align: left">
        <sup>
         (5)
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        *
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-align: left">
        Isaac Braun
        <br/>
        Director
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        88,621
       </td>
       <td style="text-align: left">
        <sup>
         (3)
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        *
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-align: left">
        Maital Rasmussen
        <br/>
        Director
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        3,750
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        *
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-align: left">
        Mark Germain
        <br/>
        Director
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        63,681
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        *
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-align: left">
        Moria Kwiat
        <br/>
        Director
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        42,543
       </td>
       <td style="text-align: left">
        <sup>
         (4)
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        *
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-align: left">
        Rami Levi
        <br/>
        Director
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        3,750
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        *
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-align: left">
        Varda Shalev
        <br/>
        Director
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        -
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        *
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-decoration: underline; text-align: left">
        Directors and Executive Officers as a group (11 persons)
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        1,503,046
       </td>
       <td style="text-align: left">
        <sup>
         (6)
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        4.7
       </td>
       <td style="text-align: left">
        %
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-decoration: underline">
        5% Shareholders
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
        <sup>
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
       </td>
       <td style="text-align: left">
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-decoration: underline; text-align: left">
        Clover Wolf Capital – Limited Partnership
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        2,340,085
       </td>
       <td style="text-align: left">
        <sup>
         (7)
        </sup>
       </td>
       <td>
       </td>
       <td style="text-align: left">
       </td>
       <td style="text-align: right">
        7
       </td>
       <td style="text-align: left">
        %
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         *
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         less                                            than 1%
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-indent: 0.5in">
     <span style="font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 95; Value: 41 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      59
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 24px">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (1)
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Basedon 32,004,785 common shares issued and outstanding as of September 3, 2021. Except as otherwise indicated, we believe that the beneficialowners of the common shares listed above, based on information furnished by such owners, have sole investment and voting power with respectto such shares, subject to community property laws where applicable. Beneficial ownership is determined in accordance with the rulesof the SEC and generally includes voting or investment power with respect to securities.
         </span>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
         <span style="font-size: 10pt">
         </span>
        </p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Shares    subject to options, warrants or right to purchase or through the conversion of a security currently exercisable or convertible, or    exercisable or convertible within 60 days, are reflected in the table above and are deemed outstanding for purposes of computing    the percentage ownership of the person holding such option or warrants, but are not deemed outstanding for purposes of computing    the percentage ownership of any other person.
         </span>
        </p>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 24px">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (2)
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Includes    a warrant to acquire up to 7,143 shares.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 24px">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (3)
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Includes    a warrant to acquire up to 5,000 shares.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 24px">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (4)
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Includes    a warrant to acquire up to 2,857 shares.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 24px">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (5)
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Includes    a warrant to acquire up to 1,429 shares.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 24px">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (6)
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Includes    warrants to acquire up to 23,572 shares.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 24px; font-size: 10pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         (7)
        </span>
       </td>
       <td style="text-align: justify; font-size: 10pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Basedsolely on information provided by the holder. Clover Wolf Ltd. is the General Partner of Clover Wolf Capital – Limited Partnership.Adi Wolf is the Managing Member and Chief Executive Officer of Clover Wolf Capital – Limited Partnership and also the Chief ExecutiveOfficer of Clover Wolf Ltd. All investment decisions are made by Adi Wolf, and thus the power to vote or direct the votes of these commonshare, as well as the power to dispose or direct the disposition of such common shares is held by Adi Wolf through Clover Wolf Capital– Limited Partnership and Clover Wolf Ltd. The address of Clover Wolf Capital – Limited Partnership is 24 Bodenhimer Street,Tel Aviv, Israel 6200838.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
       EquityCompensation Plan Information
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     At our annual meeting of ourshareholders held on May 31, 2016, our shareholders approved the 2016 Plan. Under the 2016 Plan, options, restricted share and RSUs maybe granted to our officers, directors, employees and consultants or the officers, directors, employees and consultants of our subsidiary.Under the 2016 Plan, the plan administrator is authorized to grant awards to acquire common shares, restricted shares and RSUs, in eachcalendar year, in a number not exceeding 2.75% of the number of our common shares issued and outstanding on a fully diluted basis on theimmediately preceding December 31.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     In addition, at our annualmeeting of our shareholders held on June 13, 2019, our shareholders approved the 2019 Plan. Under the 2019 Plan, options, restricted sharesand RSUs may be granted to our officers, directors, employees and consultants or the officers, directors, employees and consultants ofour subsidiary. Under the 2019 Plan, the plan administrator is authorized to grant options to acquire common shares, restricted sharesand RSUs in a number not exceeding 16% of the number common shares issued and outstanding immediately prior to the grant of such awardson a fully diluted basis.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 96; Value: 41 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      60
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Thefollowing table summarizes certain information regarding our equity compensation plans as of June 30, 2021:
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
       <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <b>
          Plan    Category
         </b>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <b>
          Number    of securities to be issued upon
          <br/>
          exercise of outstanding options
         </b>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <b>
          Weighted-average    exercise
          <br/>
          price of outstanding options
         </b>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: center">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <b>
          Number    of securities remaining available for future issuance under equity compensation plans (2016 Plan and 2019 Plan)
         </b>
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
       <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; padding-left: 0.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Equity    compensation plan approved by security holders
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         39,835
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         $
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         0.00001
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         4,677,366
        </span>
       </td>
       <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <div>
     <a id="p_021">
     </a>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">
      <b>
       Item13. Certain Relationships and Related Transactions and Director Independence.
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Exceptfor the arrangements described in Item 11, during fiscal years 2021 and 2020, we did not participate in any transaction, and we are notcurrently participating in any proposed transaction, or series of transactions, in which the amount involved exceeded the lesser of $120,000or one percent of the average of our total assets at year end for the last two completed fiscal years, and in which, to our knowledge,any of our directors, officers, five percent beneficial security holders, or any member of the immediate family of the foregoing personshad, or will have, a direct or indirect material interest.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     The Board has determined thatDoron Birger, Doron Shorrer, Maital Shemesh-Rasmussen, Mark Germain, Moria Kwiat, and Varda Shalev are “independent” directors,as defined by the rules of the SEC and the Nasdaq rules and regulations.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <div>
     <a id="p_022">
     </a>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">
      <b>
       Item14. Principal Accounting Fees and Services
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      Thefees for services provided by our independent registered public accounting firm to the Company and paid in the last two fiscal yearswere as follows:
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
     <tbody>
      <tr style="vertical-align: bottom">
       <td style="text-align: center">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="font-weight: bold; padding-bottom: 1.5pt">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
        <span style="font-size: 10pt">
         Twelve    months ended on June 30,
         <br/>
         2021
        </span>
       </td>
       <td style="padding-bottom: 1.5pt; font-weight: bold">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="font-weight: bold; padding-bottom: 1.5pt">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">
        <span style="font-size: 10pt">
         Twelve    months ended on June 30,
         <br/>
         2020
        </span>
       </td>
       <td style="padding-bottom: 1.5pt; font-weight: bold">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: bottom">
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td colspan="2">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td colspan="2">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="width: 76%; text-align: left; padding-left: 0.5pt">
        <span style="font-size: 10pt">
         Audit Fees
        </span>
       </td>
       <td style="width: 1%">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="width: 1%; text-align: left">
        <span style="font-size: 10pt">
         $
        </span>
       </td>
       <td style="width: 9%; text-align: right">
        <span style="font-size: 10pt">
         105,000
        </span>
       </td>
       <td style="width: 1%; text-align: left">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="width: 1%">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="width: 1%; text-align: left">
        <span style="font-size: 10pt">
         $
        </span>
       </td>
       <td style="width: 9%; text-align: right">
        <span style="font-size: 10pt">
         110,041
        </span>
       </td>
       <td style="width: 1%; text-align: left">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td style="padding-left: 0.5pt">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: left">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: right">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: left">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: left">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: right">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: left">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-align: left; padding-left: 0.5pt">
        <span style="font-size: 10pt">
         Audit-Related Fees
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: left">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         None
        </span>
       </td>
       <td style="text-align: left">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: left">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         None
        </span>
       </td>
       <td style="text-align: left">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td style="padding-left: 0.5pt">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: left">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: right">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: left">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: left">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: right">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: left">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-align: left; padding-left: 0.5pt">
        <span style="font-size: 10pt">
         Tax Fees
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: left">
        <span style="font-size: 10pt">
         $
        </span>
       </td>
       <td style="text-align: right">
        <span style="font-size: 10pt">
         28,507
        </span>
       </td>
       <td style="text-align: left">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: left">
        <span style="font-size: 10pt">
         $
        </span>
       </td>
       <td style="text-align: right">
        <span style="font-size: 10pt">
         27,072
        </span>
       </td>
       <td style="text-align: left">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td style="padding-left: 0.5pt">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: left">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: right">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: left">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: left">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: right">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: left">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.5pt">
        <span style="font-size: 10pt">
         All Other Fees
        </span>
       </td>
       <td style="padding-bottom: 1.5pt">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="border-bottom: Black 1.5pt solid; text-align: left">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="border-bottom: Black 1.5pt solid; text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         None
        </span>
       </td>
       <td style="padding-bottom: 1.5pt; text-align: left">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="padding-bottom: 1.5pt">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="border-bottom: Black 1.5pt solid; text-align: left">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="border-bottom: Black 1.5pt solid; text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         None
        </span>
       </td>
       <td style="padding-bottom: 1.5pt; text-align: left">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: bottom; ">
       <td style="padding-left: 0.5pt">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: left">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: right">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: left">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: left">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: right">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: left">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
       <td style="text-align: left; padding-bottom: 4pt; padding-left: 0.5pt">
        <span style="font-size: 10pt">
         Total Fees
        </span>
       </td>
       <td style="padding-bottom: 4pt">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="border-bottom: Black 4pt double; text-align: left">
        <span style="font-size: 10pt">
         $
        </span>
       </td>
       <td style="border-bottom: Black 4pt double; text-align: right">
        <span style="font-size: 10pt">
         133,507
        </span>
       </td>
       <td style="padding-bottom: 4pt; text-align: left">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="padding-bottom: 4pt">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="border-bottom: Black 4pt double; text-align: left">
        <span style="font-size: 10pt">
         $
        </span>
       </td>
       <td style="border-bottom: Black 4pt double; text-align: right">
        <span style="font-size: 10pt">
         137,113
        </span>
       </td>
       <td style="padding-bottom: 4pt; text-align: left">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <i>
       AuditFees
      </i>
      . These fees were comprised of (i) professional services rendered in connection with the audit of our consolidated financialstatements for our Annual Report on Form 10-K, (ii) the review of our quarterly consolidated financial statements for our quarterly reportson Form 10-Q, (iii) audit services provided in connection with other regulatory or statutory filings.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 97; Value: 41 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      61
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <i>
      </i>
     </span>
    </p>
    <div>
    </div>
    <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <i>
       TaxFees.
      </i>
      These fees relate to our tax compliance and tax advisory projects.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <i>
      </i>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      <i>
       AllOther Fees
      </i>
      . These fees were comprised of fees related to assistance in preparation of IIA as well as other grant applications.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      SECrules require that before the independent registered public accounting firm are engaged by us to render any auditing or permittednon-audit related service, the engagement be:
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0">
       </td>
       <td style="width: 0.5in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         1.
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         pre-approved                                            by our Audit Committee; or
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0">
       </td>
       <td style="width: 0.5in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         2.
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         entered                                            into pursuant to pre-approval policies and procedures established by the Audit Committee,                                            provided the policies and procedures are detailed as to the particular service, the Audit                                            Committee is informed of each service, and such policies and procedures do not include delegation                                            of the Audit Committee’s responsibilities to management.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      TheAudit Committee pre-approves all services provided by our independent registered public accounting firm. All of the above services andfees were reviewed and approved by the Audit Committee before the services were rendered.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      OnMarch 25, 2021, our Audit Committee dismissed Kost Forer Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global, as our independentregistered public accounting firm, effective after their completion of the review of the Company’s consolidated financial statementsfor the three months ending March 31, 2021. In addition, on March 25, 2021, our Audit Committee appointed Kesselman &amp; Kesselman,Certified Public Accountants (Isr.), a member firm of PricewaterhouseCoopers International Limited, or PWC, as our independent registeredpublic accounting firm for the fiscal year ending June 30, 2021, whose appointment took place upon the dismissal of our former auditors.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
      TheAudit Committee has considered the nature and amount of fees billed by Kost Forer Gabbay &amp; Kasierer, a member of Ernst &amp; YoungGlobal, and Kesselman &amp; Kesselman, Certified Public Accountants (Isr.), a member firm of PricewaterhouseCoopers International Limited,and believes that the provision of services for activities unrelated to the audit was compatible with maintaining Kost Forer Gabbay &amp;Kasierer’s independence and it is compatible with maintaining Kesselman &amp; Kesselman’s, Certified Public Accountants (Isr.),a member firm of PricewaterhouseCoopers International Limited, independence.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     As of June 30, 2021, we haveaccrued approximately $70,000 for the annual audit fees for the Fiscal Year ended June 30,2021, which we expect to pay PWC during fiscalyear 2022.
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 98; Value: 41 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      62
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
     <span style="font-size: 10pt; text-transform: uppercase">
     </span>
    </p>
    <div>
    </div>
    <div>
     <a id="p_024">
     </a>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">
     <span style="font-size: 10pt; text-transform: uppercase">
      <b>
       PARTIV
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <div>
     <a id="p_025">
     </a>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-size: 10pt; text-transform: uppercase">
      <b>
       Item15. Exhibits.
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="margin-top: 0; margin-bottom: 0">
     <span style="font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="width: 7%; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         3.1
        </span>
       </td>
       <td style="width: 1%">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="width: 92%; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="http://www.sec.gov/Archives/edgar/data/1158780/000121390020017673/ea124148ex4-1_pluristem.htm" tabindex="18">
          Composite    Copy of the Company’s Articles of Incorporation as amended on July 2, 2020 (incorporated by reference to Exhibit 4.1 of our    registration statement on Form S-3 filed on July 16, 2020).
         </a>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         3.2
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="http://www.sec.gov/Archives/edgar/data/1158780/000121390020017673/ea124148ex4-2_pluristem.htm" tabindex="18">
          Composite    Copy (marked) of the Company’s Articles of Incorporation as amended on July 2, 2020 (incorporated by reference to Exhibit 4.2    of our registration statement on Form S-3 filed on July 16, 2020).
         </a>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         3.3
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="http://www.sec.gov/Archives/edgar/data/1158780/000121390020026105/f10k2020ex3-3_pluristem.htm" tabindex="18">
          Amended    and Restated By-laws as amended on September 10, 2020 (incorporated by reference to Exhibit 3.3  of our annual report on Form    10-K filed on September 10, 2020).
         </a>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         4.1
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891317000130/exhibit_4-1.htm" tabindex="18">
          Form    of Common Share Purchase Warrant dated January 25, 2017 (incorporated by reference to Exhibit 4.1 of our current report on Form 8-K    filed on January 20, 2017).
         </a>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         4.2
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891319001051/exhibit_4-1.htm" tabindex="18">
          Form    of Common Share Purchase Warrant dated April 2019 (incorporated by reference to Exhibit 4.1 of our current report on Form 8-K filed    on April 5, 2019).
         </a>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         4.3
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="http://www.sec.gov/Archives/edgar/data/1158780/000121390020026105/f10k2020ex4-3_pluristem.htm" tabindex="18">
          Description    of Securities (incorporated by reference to Exhibit 4.3 of our annual report on Form 10-K filed on September 10, 2020).
         </a>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         10.1
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891311002580/exhibit_10-2.htm" tabindex="18">
          Summary    of Lease Agreement dated January 22, 2003, by and between Pluristem Ltd. and MTM – Scientific Industries Center Haifa Ltd.,    as supplemented on December 11, 2005, June 12, 2007 and July 19, 2011 (incorporated by reference to Exhibit 10.2 of our annual report    on Form 10-K filed September 12, 2011).
         </a>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         10.2
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891313002659/exhibit_10-3.htm" tabindex="18">
          Summary    of Supplement to the Lease Agreement by and between Pluristem Ltd. and MTM – Scientific Industries Center Haifa Ltd dated July    31, 2012 (incorporated by reference to Exhibit 10.3 of our annual report on Form 10-K filed on September 11, 2013).
         </a>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         10.3
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891313002659/exhibit_10-4.htm" tabindex="18">
          Summary    of Supplement to the Lease Agreement by and between Pluristem Ltd. and MTM – Scientific Industries Center Haifa Ltd dated December    31, 2012 (incorporated by reference to Exhibit 10.4 of our annual report on Form 10-K filed on September 11, 2013).
         </a>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         10.4
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891315001496/exhibit_10-1.htm" tabindex="18">
          Summary    of Supplement to the Lease Agreement by and between Pluristem Ltd. and MTM – Scientific Industries Center Haifa Ltd dated February    3, 2015 (incorporated by reference to Exhibit 10.1 of our quarterly report on Form 10-Q filed on May 6, 2015).
         </a>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         10.5
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="http://www.sec.gov/Archives/edgar/data/1158780/000108503707001248/ex10-1.htm" tabindex="18">
          Assignment    Agreement dated May 15, 2007 between Pluristem Therapeutics Inc. and each of Technion Research and Development Foundation Ltd., Shai    Meretzki, Dr. Shoshana Merchav (incorporated by reference to Exhibit 10.1 of our current report on Form 8-K filed on May 24, 2007).
         </a>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         10.6
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="http://www.sec.gov/Archives/edgar/data/1158780/000108503707001248/ex10-2.htm" tabindex="18">
          Assignment    Agreement dated May 15, 2007 between Pluristem Therapeutics Inc. and Yeda Research and Development Ltd. (incorporated by reference    to Exhibit 10.2 of our current report on Form 8-K filed on May 24, 2007).
         </a>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         10.7
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891313002659/exhibit_10-8.htm" tabindex="18">
          Exclusive    License and Commercialization Agreement dated June 26, 2013, between Pluristem Ltd. and CHA (incorporated by reference to Exhibit    10.8 of our annual report on Form 10-K filed on September 11, 2013).
         </a>
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="margin: 0">
     <span style="font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="margin: 0">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 99; Options: NewSection; Value: 63 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      63
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="margin: 0">
     <span style="font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify; width: 7%">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         10.8+
        </span>
       </td>
       <td style="width: 1%">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify; width: 92%">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="http://www.sec.gov/Archives/edgar/data/1158780/000121390020026105/f10k2020ex10-8_pluristem.htm" tabindex="18">
          Summary    of Directors’ Ongoing Compensation (incorporated by reference to Exhibit 10.8 of our annual report on Form 10-K filed on September    10, 2020).
         </a>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         10.9+
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="http://www.sec.gov/Archives/edgar/data/1158780/000121390021007437/f10q1220ex10-1_pluristem.htm" tabindex="18">
          Form    of Indemnification Agreement between Pluristem Therapeutics Inc. and each of our directors and officers (incorporated by reference    to Exhibit 10.1 of our quarterly report on Form 10-Q filed on February 8, 2021).
         </a>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         10.10+
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891316004972/zk1618299.htm" tabindex="18">
          2016    Equity Compensation Plan (incorporated by reference to our Definitive Proxy Statement on Schedule 14A filed on April 4, 2016).
         </a>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         10.11+
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891316006442/exhibit_10-17.htm" tabindex="18">
          Form    of Share Option Agreement under the 2016 Equity Compensation Plan (incorporated by reference to Exhibit 10.17 of our annual report    on Form 10-K filed on September 7, 2016).
         </a>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         10.12+
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891316006442/exhibit_10-18.htm" tabindex="18">
          Form    of Restricted Share Agreement under the 2016 Equity Compensation Plan (incorporated by reference to Exhibit 10.18 of our annual report    on Form 10-K filed on September 7, 2016).
         </a>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         10.13+
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="http://www.sec.gov/Archives/edgar/data/1158780/000117891316006442/exhibit_10-19.htm" tabindex="18">
          Form    of Restricted Share Agreement (Israeli directors and officers) under the 2016 Equity Compensation Plan (incorporated by reference    to Exhibit 10.19 of our annual report on Form 10-K filed on September 7, 2016).
         </a>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         10.14+
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="https://www.sec.gov/Archives/edgar/data/1158780/000117891319001212/zk1922966.htm" tabindex="18">
          2019    Equity Compensation Plan (incorporated by reference to our Definitive Proxy Statement on Schedule 14A filed on April 25, 2019).
         </a>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         10.15+
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="http://www.sec.gov/Archives/edgar/data/1158780/000121390019017859/f10k2019ex10-19_pluristem.htm" tabindex="18">
          Form    of Share Option Agreement under the 2019 Equity Compensation Plan (incorporated by reference to Exhibit 10.19 of our annual report    on Form 10-K filed on September 12, 2019).
         </a>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         10.16+
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="http://www.sec.gov/Archives/edgar/data/1158780/000121390019017859/f10k2019ex10-20_pluristem.htm" tabindex="18">
          Form    of Restricted Share Agreement under the 2019 Equity Compensation Plan (incorporated by reference to Exhibit 10.20 of our annual report    on Form 10-K filed on September 12, 2019).
         </a>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         10.17+
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="https://www.sec.gov/Archives/edgar/data/1158780/000121390019017859/f10k2019ex10-20_pluristem.htm" tabindex="18">
          Form    of Restricted Share Agreement (Israeli directors and officers) under the 2019 Equity Compensation Plan (incorporated by reference    to Exhibit 10.21 of our annual report on Form 10-K filed on September 12, 2019).
         </a>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="width: 8%; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         10.18*+
        </span>
       </td>
       <td style="width: 1%">
       </td>
       <td style="width: 91%; text-align: justify">
        <a href="https://www.sec.gov/Archives/edgar/data/1158780/000121390021047664/f10k2021ex10-18_pluristem.htm" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Form    of Restricted Stock Unit Agreement (executive officers) under the 2019 Equity Compensation Plan.
         </span>
        </a>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
       </td>
       <td>
       </td>
       <td style="text-align: justify">
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         10.19*+
        </span>
       </td>
       <td>
       </td>
       <td style="text-align: justify">
        <a href="https://www.sec.gov/Archives/edgar/data/1158780/000121390021047664/f10k2021ex10-19_pluristem.htm" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Form of Restricted Stock Unit Agreement (directors) under the 2019 Equity Compensation Plan.
         </span>
        </a>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
       </td>
       <td>
       </td>
       <td style="text-align: justify">
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        10.20*+
       </td>
       <td>
       </td>
       <td style="text-align: justify">
        <a href="https://www.sec.gov/Archives/edgar/data/1158780/000121390021047664/f10k2021ex10-20_pluristem.htm" tabindex="18">
         Form of Restricted Stock Unit Agreement (employees) under the 2019 Equity Compensation Plan.
        </a>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
       </td>
       <td>
       </td>
       <td style="text-align: justify">
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify; width: 7%">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         10.21+
        </span>
       </td>
       <td style="width: 1%">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify; width: 92%">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="http://www.sec.gov/Archives/edgar/data/1158780/000121390020026105/f10k2020ex10-17_pluristem.htm" tabindex="18">
          Amended    and Restated Consulting Agreement between Pluristem Ltd. and Rose High Tech Ltd. dated September 10, 2020 (incorporated by reference    to Exhibit 10.17 of our annual report on Form 10-K filed on September 10, 2020).
         </a>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         10.22+
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="http://www.sec.gov/Archives/edgar/data/1158780/000121390020026105/f10k2020ex10-18_pluristem.htm" tabindex="18">
          Amended    and Restated Employment Agreement between Pluristem Ltd. and Yaky Yanay dated September 10, 2020 (incorporated by reference to Exhibit    10.18 of our annual report on Form 10-K filed on September 10, 2020).
         </a>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         10.23+
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="http://www.sec.gov/Archives/edgar/data/1158780/000121390020026105/f10k2020ex10-19_pluristem.htm" tabindex="18">
          Amended    and Restated Employment Agreement between Pluristem Ltd. and Chen Franco-Yehuda dated September 10, 2020 (incorporated by reference    to Exhibit 10.19 of our annual report on Form 10-K filed on September 10, 2020).
         </a>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         10.24^
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="http://www.sec.gov/Archives/edgar/data/1158780/000121390020026105/f10k2020ex10-20_pluristem.htm" tabindex="18">
          Finance    Contract between the European Investment Bank, as Lender, and Pluristem GmBH, as borrower, and Pluristem Therapeutics Inc. and Pluristem    Ltd., as Original Guarantors, dated April 29, 2020 (incorporated by reference to Exhibit 10.21 of our annual report on Form 10-K    filed on September 10, 2020).
         </a>
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="margin: 0">
     <span style="font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="margin: 0">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 100; Value: 63 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      64
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="margin: 0">
     <span style="font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         10.25
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="http://www.sec.gov/Archives/edgar/data/1158780/000121390020035275/f10q0920ex10-1_pluristem.htm" tabindex="18">
          Guarantee    Agreement by and among the European Investment Bank, Pluristem Therapeutics, Inc. and Pluristem GmbH, dated September 30, 2020 (incorporated    by reference to Exhibit 10.1 of our quarterly report on Form 10-Q filed on November 5, 2020).
         </a>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         10.26
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="http://www.sec.gov/Archives/edgar/data/1158780/000121390020035275/f10q0920ex10-1_pluristem.htm" tabindex="18">
          Guarantee    Agreement by and among the European Investment Bank, Pluristem Ltd. and Pluristem GmbH dated, September 30, 2020 (incorporated by    reference to Exhibit 10.1 of our quarterly report on Form 10-Q filed on November 5, 2020).
         </a>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         10.27
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="http://www.sec.gov/Archives/edgar/data/1158780/000121390020017673/ea124148ex1-2_pluristem.htm" tabindex="18">
          Open    Market Sales Agreement, dated July 16, 2020, between the Company and Jefferies LLC (incorporated by reference to Exhibit 1.2 of our    registration statement on Form S-3 filed on July 16, 2020).
         </a>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         10.28*+
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <a href="https://www.sec.gov/Archives/edgar/data/1158780/000121390021047664/f10k2021ex10-28_pluristem.htm" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Letter agreement by and between Pluristem Ltd. and Rose High Tech Ltd., dated September 13, 2021.
         </span>
        </a>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         10.29*+
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <a href="https://www.sec.gov/Archives/edgar/data/1158780/000121390021047664/f10k2021ex10-29_pluristem.htm" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Letter agreement by and between Pluristem Ltd. and Yaky Yanay, dated September 13, 2021.
         </span>
        </a>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         10.30*+
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <a href="https://www.sec.gov/Archives/edgar/data/1158780/000121390021047664/f10k2021ex10-30_pluristem.htm" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Letter agreement by and between Pluristem Ltd. and Chen Franco-Yehuda, dated September 13, 2021.
         </span>
        </a>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         21.1
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="http://www.sec.gov/Archives/edgar/data/1158780/000121390020026105/f10k2020ex21-1_pluristem.htm" tabindex="18">
          List    of Subsidiaries of the Company (incorporated by reference to Exhibit 21.1 of our annual report on Form 10-K filed on September 10,    2020).
         </a>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="width: 7%; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         23.1*
        </span>
       </td>
       <td style="width: 1%">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="width: 92%; text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="https://www.sec.gov/Archives/edgar/data/1158780/000121390021047664/f10k2021ex23-1_pluristem.htm" tabindex="18">
          Consent of Kost Forer Gabbay &amp; Kasierer, A member of Ernst &amp; Young Global.
         </a>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         23.2*
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         <a href="https://www.sec.gov/Archives/edgar/data/1158780/000121390021047664/f10k2021ex23-2_pluristem.htm" tabindex="18">
          Consent of Kesselman &amp; Kesselman, Independent Registered Public Accounting Firm.
         </a>
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         31.1*
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <a href="https://www.sec.gov/Archives/edgar/data/1158780/000121390021047664/f10k2021ex31-1_pluristem.htm" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Certification pursuant to Rule 13a-14(a)/15d-14(a) of Yaky Yanay.
         </span>
        </a>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         31.2*
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <a href="https://www.sec.gov/Archives/edgar/data/1158780/000121390021047664/f10k2021ex31-2_pluristem.htm" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Certification pursuant to Rule 13a-14(a)/15d-14(a) of Chen Franco-Yehuda.
         </span>
        </a>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         32.1**
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <a href="https://www.sec.gov/Archives/edgar/data/1158780/000121390021047664/f10k2021ex32-1_pluristem.htm" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Certification pursuant to 18 U.S.C. Section 1350 of Yaky Yanay.
         </span>
        </a>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         32.2**
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <a href="https://www.sec.gov/Archives/edgar/data/1158780/000121390021047664/f10k2021ex32-2_pluristem.htm" tabindex="18">
         <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
          Certification pursuant to 18 U.S.C. Section 1350 of Chen Franco-Yehuda.
         </span>
        </a>
       </td>
      </tr>
      <tr style="vertical-align: top; ">
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top; background-color: rgb(204,238,255)">
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         101*
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         The following materials    from our Annual Report on Form 10-K for the fiscal year ended June 30, 2021 formatted in XBRL (eXtensible Business Reporting Language):    (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, (iii) the Consolidated Statements of Comprehensive    Loss, (iv) the Statements of Changes in Equity, (v) the Consolidated Statements of Cash Flows, and (vi) the Notes to the Consolidated    Financial Statements, tagged as blocks of text and in detail.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="margin-top: 0; margin-bottom: 0">
     <span style="font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         *
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Filed                                            herewith.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         **
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Furnished                                            herewith.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         +
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Management                                            contract or compensation plan.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
     <tbody>
      <tr style="vertical-align: top; text-align: justify">
       <td style="width: 0">
       </td>
       <td style="width: 0.25in; text-align: left">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         ^
        </span>
       </td>
       <td style="text-align: justify">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Certain                                            identified information in the exhibit has been excluded from the exhibit because it is both                                            (i) not material and (ii) would likely cause competitive harm to Pluristem if publicly disclosed.
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="margin-top: 0; margin-bottom: 0">
     <span style="font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <div>
     <a id="p_026">
     </a>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-size: 10pt; text-transform: uppercase">
      <b>
       Item16. Form 10-K Summary.
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-size: 10pt">
      None.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
     <span style="font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 101; Value: 63 -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      65
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
     <p style="margin: 0pt">
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
     <span style="font-size: 10pt">
      <b>
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
     <span style="font-size: 10pt">
      <b>
       SIGNATURES
      </b>
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">
     <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
     </span>
     <span style="font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">
     <span style="font-size: 10pt">
      Pursuantto the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signedon its behalf by the undersigned, thereunto duly authorized.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-size: 10pt">
      Pluristem Therapeutics Inc.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 4%; font-size: 10pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         By:
        </span>
       </td>
       <td style="width: 36%; border-bottom: black 1.5pt solid; font-size: 10pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         /s/    Yaky Yanay
        </span>
       </td>
       <td style="width: 60%; font-size: 10pt">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td style="font-size: 10pt">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="font-size: 10pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Yaky Yanay, Chief Executive    Officer
        </span>
       </td>
       <td style="font-size: 10pt">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr>
       <td>
       </td>
       <td style="vertical-align: top; font-size: 10pt">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="vertical-align: bottom; text-align: right; font-size: 10pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Dated:    September 13, 2021
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">
     <span style="font-size: 10pt">
      Pursuant to therequirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrantand in the capacities and on the dates indicated.
     </span>
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 4%">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         By:
        </span>
       </td>
       <td style="width: 36%; border-bottom: black 1.5pt solid">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         /s/    Yaky Yanay
        </span>
       </td>
       <td style="width: 60%">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Yaky Yanay, Chief Executive Officer, President and    Director
         <br/>
         (Principal Executive Officer)
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr>
       <td>
       </td>
       <td style="vertical-align: top">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="vertical-align: bottom; text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Dated:    September 13, 2021
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 4%">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         By:
        </span>
       </td>
       <td style="width: 36%; border-bottom: black 1.5pt solid">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         /s/    Chen Franco-Yehuda
        </span>
       </td>
       <td style="width: 60%">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Chen Franco-Yehuda, Chief Financial Officer
         <br/>
         (Principal Financial Officer and Principal Accounting Officer)
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr>
       <td>
       </td>
       <td style="vertical-align: top">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="vertical-align: bottom; text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Dated:    September 13, 2021
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 4%">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         By:
        </span>
       </td>
       <td style="width: 36%; border-bottom: black 1.5pt solid">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         /s/    Zami Aberman
        </span>
       </td>
       <td style="width: 60%">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Zami Aberman, Executive Chairman of the Board of Directors
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td colspan="3" style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Dated: September    13, 2021
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td colspan="3">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         By:
        </span>
       </td>
       <td style="border-bottom: black 1.5pt solid">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         /s/ Doron    Birger
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Doron Birger, Director
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td colspan="3" style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Dated: September    13, 2021
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td colspan="3">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         By:
        </span>
       </td>
       <td style="border-bottom: black 1.5pt solid">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         /s/ Mark Germain
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="padding-bottom: 1.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Mark Germain, Director
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td colspan="3" style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Dated: September    13, 2021
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td colspan="3">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         By:
        </span>
       </td>
       <td style="border-bottom: black 1.5pt solid">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         /s/ Moria    Kwiat
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="padding-bottom: 1.5pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Moria Kwiat, Director
        </span>
       </td>
       <td>
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td colspan="3" style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Dated: September    13, 2021
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 4%; font-size: 10pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         By:
        </span>
       </td>
       <td style="width: 36%; border-bottom: black 1.5pt solid; font-size: 10pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         /s/    Rami Levi
        </span>
       </td>
       <td style="width: 60%; font-size: 10pt">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td style="font-size: 10pt">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="padding-bottom: 1.5pt; font-size: 10pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Rami    Levi, Director
        </span>
       </td>
       <td style="font-size: 10pt">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td colspan="3" style="text-align: right; font-size: 10pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Dated:    September 13, 2021
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
     <span style="font-size: 10pt">
     </span>
    </p>
    <div>
    </div>
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
     <tbody>
      <tr style="vertical-align: top">
       <td style="width: 4%; font-size: 10pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         By:
        </span>
       </td>
       <td style="width: 36%; border-bottom: black 1.5pt solid; font-size: 10pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         /s/    Prof. Varda Shalev
        </span>
       </td>
       <td style="width: 60%; font-size: 10pt">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td style="font-size: 10pt">
        <span style="font-size: 10pt">
        </span>
       </td>
       <td style="padding-bottom: 1.5pt; font-size: 10pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Prof.    Varda Shalev, Director
        </span>
       </td>
       <td style="font-size: 10pt">
        <span style="font-size: 10pt">
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td colspan="3" style="text-align: right; font-size: 10pt">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Dated:    September 13, 2021
        </span>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td colspan="3">
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         By:
        </span>
       </td>
       <td style="border-bottom: black 1.5pt solid">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         /s/ Maital Shemesh-Rasmussen
        </span>
       </td>
       <td>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Maital Shemesh-Rasmussen, Director
        </span>
       </td>
       <td>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td colspan="3">
        <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">
         Dated: September 13, 2021
        </p>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td colspan="3">
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         By:
        </span>
       </td>
       <td style="border-bottom: black 1.5pt solid">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         /s/ Doron Shorrer
        </span>
       </td>
       <td>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td>
       </td>
       <td>
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Doron Shorrer, Director
        </span>
       </td>
       <td>
       </td>
      </tr>
      <tr style="vertical-align: top">
       <td colspan="3" style="text-align: right">
        <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
         Dated: September 13, 2021
        </span>
       </td>
      </tr>
     </tbody>
    </table>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <!-- Field: Page; Sequence: 102; Options: Last -->
    <div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid">
     <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">
      <!-- Field: Sequence; Type: Arabic; Name: PageNo -->
      66
      <!-- Field: /Sequence -->
     </p>
    </div>
    <div>
    </div>
    <!-- Field: /Page -->
    <div>
    </div>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    </p>
    <div>
    </div>
    <div style="display: none">
     <ix:header>
      <ix:hidden>
       <ix:nonfraction id="hidden-fact-0" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-1" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-2" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-3" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-4" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-5" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-6" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-7" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-8" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-9" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-10" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-11" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-12" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-13" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-14" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-15" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-16" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-17" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-18" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-19" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-20" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-21" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-22" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-23" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-24" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-25" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-26" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-27" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-28" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-29" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-30" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-31" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-32" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-33" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-34" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-35" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-36" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-37" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-38" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-39" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-40" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-41" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-42" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-43" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-44" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-45" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-46" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-47" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-48" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-49" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-50" unitref="shares" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-51" unitref="usdPershares" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-52" unitref="usdPershares" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-53" unitref="shares" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-54" unitref="usdPershares" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-55" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-56" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-57" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <ix:nonfraction id="hidden-fact-58" unitref="usd" xsi:nil="true">
       </ix:nonfraction>
       <span>
        <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-922" inside-table="false" isadditionalitemsonly="true" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="dei:AmendmentFlag" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
         false
        </ix:nonnumeric>
       </span>
       <span>
        <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-923" inside-table="false" isadditionalitemsonly="true" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="dei:CityAreaCode" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
         972
        </ix:nonnumeric>
       </span>
       <span>
        <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-924" inside-table="false" isadditionalitemsonly="true" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="dei:CurrentFiscalYearEndDate" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
         --06-30
        </ix:nonnumeric>
       </span>
       <span>
        <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-925" inside-table="false" isadditionalitemsonly="true" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="dei:DocumentFiscalPeriodFocus" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
         FY
        </ix:nonnumeric>
       </span>
       <span>
        <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-926" inside-table="false" isadditionalitemsonly="true" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="dei:EntityCentralIndexKey" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
         0001158780
        </ix:nonnumeric>
       </span>
       <span>
        <ix:nonnumeric contextref="c0" continued-taxonomy="false" enabled-taxonomy="true" highlight-taxonomy="false" hover-taxonomy="false" id="fact-identifier-927" inside-table="false" isadditionalitemsonly="true" isamountsonly="false" iscalculationsonly="false" iscustomonly="false" isnegativesonly="false" isstandardonly="true" istextonly="true" name="dei:LocalPhoneNumber" onclick="Taxonomies.clickEvent(event, this)" onkeyup="Taxonomies.clickEvent(event, this)" onmouseenter="Taxonomies.enterElement(event, this);" onmouseleave="Taxonomies.leaveElement(event, this);" selected-taxonomy="false" tabindex="18">
         74-7108600
        </ix:nonnumeric>
       </span>
      </ix:hidden>
      <ix:references>
       <link:schemaref xlink:href="psti-20210630.xsd" xlink:type="simple">
       </link:schemaref>
      </ix:references>
      <ix:resources xmlns="http://www.xbrl.org/2003/instance">
       <xbrli:context id="c0">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c1">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2021-09-03
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c2">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2020-12-31
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c3">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2021-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c4">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2020-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c5">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2019-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2020-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c6">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
           us-gaap:CommonStockMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2019-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c7">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
           us-gaap:AdditionalPaidInCapitalMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2019-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c8">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
           us-gaap:RetainedEarningsMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2019-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c9">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2019-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c10">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
           us-gaap:CommonStockMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2019-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2020-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c11">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
           us-gaap:AdditionalPaidInCapitalMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2019-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2020-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c12">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
           us-gaap:RetainedEarningsMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2019-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2020-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c13">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
           us-gaap:CommonStockMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2020-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c14">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
           us-gaap:AdditionalPaidInCapitalMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2020-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c15">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
           us-gaap:RetainedEarningsMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2020-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c16">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
           us-gaap:CommonStockMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c17">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
           us-gaap:AdditionalPaidInCapitalMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c18">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
           us-gaap:RetainedEarningsMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c19">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
           us-gaap:CommonStockMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2021-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c20">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
           us-gaap:AdditionalPaidInCapitalMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2021-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c21">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
           us-gaap:RetainedEarningsMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2021-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c22">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:RangeAxis">
           srt:MinimumMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
           psti:LaboratoryEquipmentMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2021-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c23">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:RangeAxis">
           srt:MaximumMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
           psti:LaboratoryEquipmentMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2021-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c24">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
           psti:ComputersAndPeripheralEquipmentMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2021-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c25">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
           psti:OfficeFurnitureAndEquipmentMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2021-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c26">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
           us-gaap:LeaseholdImprovementsMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c27">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
           us-gaap:OtherMachineryAndEquipmentMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2021-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c28">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
           us-gaap:OtherMachineryAndEquipmentMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2020-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c29">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
           us-gaap:ComputerEquipmentMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2021-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c30">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
           us-gaap:ComputerEquipmentMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2020-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c31">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
           us-gaap:OfficeEquipmentMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2021-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c32">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
           us-gaap:OfficeEquipmentMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2020-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c33">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
           us-gaap:LeaseholdImprovementsMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2021-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c34">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">
           us-gaap:LeaseholdImprovementsMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2020-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c35">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-04-01
         </xbrli:startdate>
         <xbrli:enddate>
          2020-04-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c36">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
           psti:FirstTrancheConsistingMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2020-04-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c37">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
           psti:SecondTrancheConsistingMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2020-04-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c38">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
           psti:ThirdTrancheConsistingMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2020-04-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c39">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
           psti:FirstTrancheConsistingMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2021-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c40">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
           psti:FirstTrancheConsistingMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c41">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
           psti:SecondTrancheConsistingMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2021-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c42">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">
           psti:SecondTrancheConsistingMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c43">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:RangeAxis">
           srt:MinimumMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c44">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:RangeAxis">
           srt:MaximumMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c45">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           psti:SmartMoneyGrantMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c46">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           psti:SmartMoneyGrantMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2021-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c47">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           psti:AdditionalSmartMoneyGrantMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c48">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           psti:AdditionalSmartMoneyGrantMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2021-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c49">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           psti:TelAvivSouraskyMedicalCenterMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2017-09-01
         </xbrli:startdate>
         <xbrli:enddate>
          2017-09-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c50">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           psti:TelAvivSouraskyMedicalCenterMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2017-09-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c51">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           psti:ShalavMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2021-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c52">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           psti:ShalavMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c53">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:VestingAxis">
           psti:FirstTrancheMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-04-01
         </xbrli:startdate>
         <xbrli:enddate>
          2020-04-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c54">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:RangeAxis">
           srt:MinimumMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2020-04-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c55">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:RangeAxis">
           srt:MaximumMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2020-04-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c56">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2019-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2019-07-31
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c57">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">
           psti:OpenMarketSalesAgreementJefferiesLLCMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2019-02-01
         </xbrli:startdate>
         <xbrli:enddate>
          2019-02-06
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c58">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">
           psti:OpenMarketSalesAgreementJefferiesLLCMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2019-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c59">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">
           psti:OpenMarketSalesAgreementJefferiesLLCMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2018-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2019-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c60">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">
           psti:OpenMarketSalesAgreementJefferiesLLCMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2020-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c61">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">
           psti:OpenMarketSalesAgreementJefferiesLLCMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2019-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2020-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c62">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">
           psti:InvestorsMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2019-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2020-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c63">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">
           psti:InvestorsMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2020-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c64">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">
           psti:InvestorsMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2020-05-05
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c65">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">
           psti:InvestorsMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-05-01
         </xbrli:startdate>
         <xbrli:enddate>
          2020-05-05
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c66">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">
           psti:OpenMarketSalesAgreementJefferiesLLCMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2020-07-23
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c67">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">
           psti:NewATMAgreementMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2020-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c68">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">
           psti:NewATMAgreementMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrYmWU+aFLQsycbcfWiQpLK2f6RhaXSm95vbh5x9kO0h4Y9cxCMeapIY/VqSbRimsIT+E7txqy5cqyPNVZJpcXs89rWwpqv1kLN8H4uNjBoTce5r/9PZcqJheeylvXZ61emXcjT7h7z7oon6gP7kwZyFtfGNZGR2w/IWdYtEz5kN4aGuG3yU2YwxFIwomRe1JXBwuhlNXpxLXnYRzkEPk1a9ApzP1s1HArs=] CSR-->
        <xbrli:period>
         <xbrli:startdate>
          2019-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2020-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c69">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">
           psti:InvestorsMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c70">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:RelatedPartyTransactionAxis">
           psti:InvestorsMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2021-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c71">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">
           psti:SecuritiesPurchaseAgreementMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2021-02-02
         </xbrli:startdate>
         <xbrli:enddate>
          2021-02-02
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c72">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:FinancialInstrumentAxis">
           psti:SecuritiesPurchaseAgreementMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c73">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           us-gaap:RestrictedStockUnitsRSUMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:PlanNameAxis">
           psti:TwoThousandNineteenOptionPlanMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-09-01
         </xbrli:startdate>
         <xbrli:enddate>
          2020-09-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c74">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           us-gaap:RestrictedStockUnitsRSUMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:PlanNameAxis">
           psti:TwoThousandNineteenOptionPlanMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2020-09-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c75">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">
           psti:NonemployeeConsultantsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">
           us-gaap:StockOptionMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c76">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">
           psti:NonemployeeConsultantsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">
           us-gaap:StockOptionMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2018-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c77">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">
           psti:NonemployeeConsultantsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">
           us-gaap:StockOptionMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2018-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2019-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c78">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">
           psti:NonemployeeConsultantsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">
           us-gaap:StockOptionMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2019-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c79">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">
           psti:NonemployeeConsultantsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">
           us-gaap:StockOptionMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2020-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c80">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">
           psti:NonemployeeConsultantsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">
           us-gaap:StockOptionMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2021-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c81">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">
           psti:NonemployeeConsultantsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">
           us-gaap:StockOptionMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">
           us-gaap:ResearchAndDevelopmentExpenseMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c82">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">
           psti:NonemployeeConsultantsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">
           us-gaap:StockOptionMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">
           us-gaap:ResearchAndDevelopmentExpenseMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2019-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2020-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c83">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">
           psti:NonemployeeConsultantsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">
           us-gaap:StockOptionMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">
           us-gaap:GeneralAndAdministrativeExpenseMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c84">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">
           psti:NonemployeeConsultantsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">
           us-gaap:StockOptionMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">
           us-gaap:GeneralAndAdministrativeExpenseMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2019-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2020-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c85">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">
           psti:NonemployeeConsultantsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:DerivativeInstrumentRiskAxis">
           us-gaap:StockOptionMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2019-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2020-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c86">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">
           psti:EmployeesAndDirectorsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           us-gaap:RestrictedStockUnitsRSUMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c87">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">
           psti:EmployeesAndDirectorsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           us-gaap:RestrictedStockUnitsRSUMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2020-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c88">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">
           psti:EmployeesAndDirectorsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           us-gaap:RestrictedStockUnitsRSUMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2019-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c89">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">
           psti:EmployeesAndDirectorsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           us-gaap:RestrictedStockUnitsRSUMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2019-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2020-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c90">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">
           psti:EmployeesAndDirectorsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           us-gaap:RestrictedStockUnitsRSUMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2021-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c91">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">
           psti:EmployeesAndDirectorsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           us-gaap:RestrictedStockUnitsRSUMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">
           us-gaap:ResearchAndDevelopmentExpenseMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c92">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">
           psti:EmployeesAndDirectorsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           us-gaap:RestrictedStockUnitsRSUMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">
           us-gaap:ResearchAndDevelopmentExpenseMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2019-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2020-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c93">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">
           psti:EmployeesAndDirectorsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           us-gaap:RestrictedStockUnitsRSUMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">
           us-gaap:GeneralAndAdministrativeExpenseMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c94">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">
           psti:EmployeesAndDirectorsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           us-gaap:RestrictedStockUnitsRSUMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">
           us-gaap:GeneralAndAdministrativeExpenseMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2019-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2020-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c95">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">
           psti:ConsultantsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           us-gaap:RestrictedStockUnitsRSUMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c96">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">
           psti:ConsultantsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           psti:RSAndRSUsMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2020-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c97">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">
           psti:ConsultantsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           psti:RSAndRSUsMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2019-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c98">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">
           psti:ConsultantsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           psti:RSAndRSUsMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c99">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">
           psti:ConsultantsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           psti:RSAndRSUsMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2019-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2020-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c100">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">
           psti:ConsultantsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           psti:RSAndRSUsMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2021-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c101">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">
           psti:ConsultantsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           psti:RSAndRSUsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">
           us-gaap:ResearchAndDevelopmentExpenseMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c102">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">
           psti:ConsultantsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           psti:RSAndRSUsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">
           us-gaap:ResearchAndDevelopmentExpenseMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2019-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2020-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c103">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">
           psti:ConsultantsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           psti:RSAndRSUsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">
           us-gaap:GeneralAndAdministrativeExpenseMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c104">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:TitleOfIndividualAxis">
           psti:ConsultantsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           psti:RSAndRSUsMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:IncomeStatementLocationAxis">
           us-gaap:GeneralAndAdministrativeExpenseMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2019-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2020-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c105">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">
           psti:SevenPerShareMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
           us-gaap:WarrantMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2021-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c106">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">
           psti:SevenPerShareMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
           us-gaap:WarrantMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c107">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">
           psti:FourteenPerShareMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
           us-gaap:WarrantMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2021-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c108">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">
           psti:FourteenPerShareMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
           us-gaap:WarrantMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c109">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:StatementEquityComponentsAxis">
           us-gaap:WarrantMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2021-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c110">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           us-gaap:EmployeeStockMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">
           psti:ZeroPointOnePerShareMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2021-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c111">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           us-gaap:EmployeeStockMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">
           psti:ZeroPointOnePerShareMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c112">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           us-gaap:EmployeeStockMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2021-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c113">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:AwardTypeAxis">
           psti:WarrantsAndOptionsMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2021-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c114">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:RangeAxis">
           srt:MaximumMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2017-12-01
         </xbrli:startdate>
         <xbrli:enddate>
          2017-12-22
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c115">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:RangeAxis">
           srt:MinimumMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2017-12-01
         </xbrli:startdate>
         <xbrli:enddate>
          2017-12-22
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c116">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2017-12-01
         </xbrli:startdate>
         <xbrli:enddate>
          2017-12-31
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c117">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:IncomeTaxAuthorityNameAxis">
           psti:PluristemTherapeuticsMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2019-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2020-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c118">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:RangeAxis">
           srt:MinimumMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:PlanNameAxis">
           psti:UnderThe2012ProgramMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c119">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:RangeAxis">
           srt:MaximumMember
          </xbrldi:explicitmember>
          <xbrldi:explicitmember dimension="us-gaap:PlanNameAxis">
           psti:UnderThe2012ProgramMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c120">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:RangeAxis">
           srt:MaximumMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2013-08-01
         </xbrli:startdate>
         <xbrli:enddate>
          2013-08-05
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c121">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:RangeAxis">
           srt:MinimumMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2013-08-01
         </xbrli:startdate>
         <xbrli:enddate>
          2013-08-05
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c122">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:IncomeTaxAuthorityNameAxis">
           psti:IsraelMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c123">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:IncomeTaxAuthorityNameAxis">
           us-gaap:InternalRevenueServiceIRSMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c124">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:IncomeTaxAuthorityNameAxis">
           psti:PluristemTherapeuticsMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2021-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c125">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:ConsolidatedEntitiesAxis">
           srt:SubsidiariesMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2021-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c126">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:IncomeTaxAuthorityNameAxis">
           psti:GermanSubsidiaryMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:instant>
          2021-06-30
         </xbrli:instant>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c127">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:RangeAxis">
           srt:MinimumMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2019-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2020-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c128">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="srt:RangeAxis">
           srt:MaximumMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2019-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2020-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c129">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:IncomeTaxAuthorityNameAxis">
           psti:ConsolidatedLossOfPluristemTherapeuticsAndTheIsraeliSubsidiaryMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c130">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:IncomeTaxAuthorityNameAxis">
           psti:ConsolidatedLossOfPluristemTherapeuticsAndTheIsraeliSubsidiaryMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2019-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2020-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c131">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:IncomeTaxAuthorityNameAxis">
           psti:PluristemGmbHMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2020-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2021-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:context id="c132">
        <xbrli:entity>
         <xbrli:identifier scheme="http://www.sec.gov/CIK">
          0001158780
         </xbrli:identifier>
         <xbrli:segment>
          <xbrldi:explicitmember dimension="us-gaap:IncomeTaxAuthorityNameAxis">
           psti:PluristemGmbHMember
          </xbrldi:explicitmember>
         </xbrli:segment>
        </xbrli:entity>
        <xbrli:period>
         <xbrli:startdate>
          2019-07-01
         </xbrli:startdate>
         <xbrli:enddate>
          2020-06-30
         </xbrli:enddate>
        </xbrli:period>
       </xbrli:context>
       <xbrli:unit id="shares">
        <xbrli:measure>
         xbrli:shares
        </xbrli:measure>
       </xbrli:unit>
       <xbrli:unit id="usd">
        <xbrli:measure>
         iso4217:USD
        </xbrli:measure>
       </xbrli:unit>
       <xbrli:unit id="usdPershares">
        <xbrli:divide>
         <xbrli:unitnumerator>
          <xbrli:measure>
           iso4217:USD
          </xbrli:measure>
         </xbrli:unitnumerator>
         <xbrli:unitdenominator>
          <xbrli:measure>
           xbrli:shares
          </xbrli:measure>
         </xbrli:unitdenominator>
        </xbrli:divide>
       </xbrli:unit>
       <xbrli:unit id="pure">
        <xbrli:measure>
         xbrli:pure
        </xbrli:measure>
       </xbrli:unit>
       <xbrli:unit id="eur">
        <xbrli:measure>
         iso4217:EUR
        </xbrli:measure>
       </xbrli:unit>
       <xbrli:unit id="ils">
        <xbrli:measure>
         iso4217:ILS
        </xbrli:measure>
       </xbrli:unit>
       <ix:relationship fromrefs="hidden-fact-4" torefs="ix_0_footnote">
       </ix:relationship>
       <ix:relationship fromrefs="hidden-fact-9 hidden-fact-10 hidden-fact-12 hidden-fact-14 hidden-fact-16 hidden-fact-20 hidden-fact-22 hidden-fact-26 hidden-fact-28 hidden-fact-29 hidden-fact-28 hidden-fact-29 hidden-fact-30 hidden-fact-32 hidden-fact-34 hidden-fact-36 hidden-fact-40 hidden-fact-42 hidden-fact-44" torefs="ix_1_footnote">
       </ix:relationship>
      </ix:resources>
     </ix:header>
    </div>
   </div>
  </div>
 </div>
</body>